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Escalating maternity litigation costs threaten the stability of any health system and are 
unsustainable. Improving patient care and reducing preventable harm during childbirth 
remain crucial in overcoming this litigation crisis. In order to make the widespread 
improvements in obstetric care required to alleviate this litigation burden, a system-
based approach, acknowledging all levels (micro, meso and macro) of a health 
system, may be needed.   
 
This thesis explores the use of a system-based approach to improve maternity care 
and tackle the increasing cost of litigation in obstetrics. Chapter 1 provides a general 
introduction to the thesis.  
 
Part 1 of the thesis adopts a ‘bottom-up’ approach and focusses on the health 
economics of multi-professional simulation training for obstetric emergencies. Chapter 
2 demonstrates that adults with obstetric brachial plexus injuries (OBPIs) and 
caregivers of children with permanent OBPIs have a worse quality of life compared to 
the general population. Chapter 3 highlights the cost of a multi-professional simulation 
training programme for obstetric emergencies. Chapter 4 investigates the cost-utility 
of simulation training for obstetric emergencies with particular regard to its impact on 
reducing OBPIs. This study demonstrates that national implementation of multi-
professional obstetric training can be both cost-effective and cost-saving. 
 
Part 2 of the thesis uses a ‘top-down’ approach and focusses on the role of the state-
based medical indemnifier (MI) in influencing and improving patient care. Chapter 5 
explores how MIs engage with clinical staff and offers some recommendations for how 
they could have a more effective role in patient safety. Chapter 6 demonstrates that 
obstetric simulation training is associated with a reduction in the maternity claim rate 
and mean monthly litigation cost. Chapter 7 identifies the rate of low 5-minute Apgar 
scores as a predictor of future litigation. Finally, Chapter 8 provides an overall 
summary of the thesis and its key messages.  
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Chapter 1  
 







Preventable harm during childbirth can have lifelong implications for babies and 
mothers. Aside from the devastating impact on patients and their families, these 
injuries also represent a very significant cost to a health system in the form of litigation. 
In England, the National Health Service (NHS) spent £3.1 billion on maternity litigation 
between 2000 to 2010 (1). This represented an additional cost of £600 for each baby 
born that decade (2). Worryingly, obstetric claims from England in 2017/18 alone are 
expected to be worth around £2 billion, equating to an additional cost of around £3,000 
per infant born that year (3). Such troubling increases in maternity litigation costs could 
threaten the stability of any health system and cannot be sustainable. Improving 
patient care and reducing preventable harm during childbirth are imperative in 
containing this litigation crisis. Training is regularly recommended as an avenue for 
making childbirth safer and is one possible solution (4-8). 
 
Health systems however are complex and consist of many interdependent 
components that can interact with multiple other components, often in unpredictable 
ways (9). The plethora of individuals and organisations within a health system all strive 
to provide the best possible care for patients, but harm can, and does occur because 
of system failures (9,10). To further complicate an already complex system, the lack 
of coordination between the different actors (11) as well as unnecessary bureaucracy, 
may divert resources away from their shared ambition for safer patient care (12). As a 
result, complex health systems are difficult to simplify, but opportunities to make 
simple, positive changes exist throughout any health system. Such changes, however, 
might have greatest impact if they are aligned through all levels of a health system. 
For example, a long-term rota gap in a speciality with a high attrition rate might be 
temporarily solved by redistributing medical personnel on the day (micro level) or by 
appointing a long-term locum (meso level). However, it will only be rectified if the 
underlying reasons for a high attrition rate are addressed (macro level). It therefore 
follows that in order to make the widespread improvements in obstetric care required 
to alleviate the litigation burden, a broader outlook recognising the impact and 
interactions of the different facets of a health system may be needed. System-based 
approaches to patient safety, which aim to address all levels of a health system, are 





alignment of all stakeholders and patient safety objectives from ‘women to Whitehall’, 
and back again.  
  
This thesis explores the use of a system-based approach to improve maternity care 
and tackle the growing cost of litigation in obstetrics. Given its inherent complexity, it 
would not be feasible to try and investigate all aspects of a health system, even within 
the confines of maternity care. The thesis will concentrate on two distinct areas that 
are related to cost. The first part of the thesis employs a ‘bottom-up’ approach, starting 
by assessing the quality of life of patients and families affected by an important birth 
injury and then investigating the health economics behind multi-professional 
simulation training in obstetric emergencies and whether it offers value for money. The 
second part of the thesis uses a ‘top-down’ approach by exploring the role of a key 
decision-maker in a health system — the state-based medical indemnifier — in 
influencing and improving patient care, and consequently, reducing litigation costs. 
Both approaches are centred around cost and attempt to improve alignment across all 
levels of a health system.  
 
1.2 Current challenges to maternity services in England/UK 
The UK is generally a safe place to give birth. The maternal death rate in the UK 
decreased by 34% between 2003-2005 and 2013-2015 (15). Over the period 1993-
2015, the rate of intrapartum deaths – defined as normally formed babies of 2.5kg or 
more who were stillborn or who died within one week of life where the death was 
related to labour (16) – fell by over 50% from 0.62 per 1,000 births to 0.28 per 1,000 
births (7).  
 
Despite these reassuring trajectories, there remains considerable variation in the 
quality of maternity services provided (8). Confidential Enquiries into maternal and 
perinatal mortality and morbidity have repeatedly highlighted cases where better care 
may have led to different outcomes (6,7,17,18). In the latest UK Confidential Enquiry 
into maternal deaths, improvements in care may have made a difference to 41% of 
the women who died in 2013-2015 (15). The most recent UK Perinatal Confidential 
Enquiry found that in 79% of neonatal deaths better care may have resulted in a 





led by the Royal College of Obstetricians and Gynaecologists (RCOG), aiming to halve 
the incidence of stillbirth, neonatal death and severe brain injury related to incidents 
during term labour by 2020. Their report also found an alarmingly high number of 
babies (76%) who might have had different outcomes with different care (19). In these 
cases, critical contributory factors were identified, including delays expediting delivery, 
failure to follow guidelines, poor inter-professional communication, failure to escalate 
and errors in both recognising and reacting to problems with the fetal heart rate during 
labour (19). An independent investigation of a poorly performing maternity unit 
identified widespread deficiencies including substandard clinical competence, poor 
multi-professional relationships, failures in risk management and recurrent missed 
opportunities to learn and intervene by the unit, the NHS Trust and the regulatory 
system (20). 
 
The effects of preventable harm on mothers, babies and their families are substantial. 
However, avoidable harm in maternity care also represents a major cost to the NHS 
in terms of litigation. From 2000-2010, maternity claims cost the English NHS £3.1 
billion (1). The cost of clinical negligence has continued to rise. In 2017/18, £2.2 billion 
was paid out for all medical malpractice claims in England, with almost £596 million of 
this required for legal fees (21). The value of the obstetric claims received in 2017/18 
in England is expected to reach around £2 billion, which will already be two thirds of 
what was spent in a decade (2000-2010) (21). Medical indemnity claims, particularly 
the high value obstetric cases, drain the NHS of money that might otherwise have 
been invested in frontline patient care. Patients suffering from adverse events and 
preventable harm should be compensated but the rate of escalation in litigation 
expenditure cannot be sustainable (22). Measures to improve patient safety may lead 
to a reduction in avoidable  birth injuries and therefore a reduction in the costs 
associated with litigation. 
 
More can still be done to further reduce preventable harm to mothers and babies. The 
Department of Health acknowledged this with its ambition to reduce the rates of 
stillbirths, neonatal and maternal deaths, and brain injuries that occur during or soon 
after birth by 20% by 2020, and by 50% by 2030 (23). More recently, the NHS Long 
Term Plan highlighted the intention to accelerate action and set a new target of 





injury by 50% by 2025 (24). A more coordinated and system-based approach is 
needed to help realise this aim and tackle the growing litigation burden associated with 
maternity services. Make widespread improvements to patient care and litigation rates 
should fall accordingly.  
 
1.3 Vehicles for investigation 
As it is not possible to analyse every facet of the English/UK maternity health system, 
I have chosen two components to focus on and act as vehicles for investigation in this 
thesis. Firstly, I have identified multi-professional simulation training for obstetric 
emergencies as my vehicle for investigating a ‘bottom-up’ and system-based 
approach to improving patient safety and reducing avoidable harm. Maternity team 
training is frequently recommended as a way of improving care (4-7). Despite these 
endorsements and the growing body of research analysing the effects of multi-
professional, obstetric simulation training (25,26), the costs of implementing and 
running such training continue to be omitted. A systematic review of costings in 
simulation-based medical education research concluded that cost reporting was 
infrequent, with only 59 studies from a possible 967 (6.1%) quantifying costs regarding 
simulation training (27). Whilst the clinical effectiveness of simulation training is 
important for clinicians and patients, the cost and cost-effectiveness should be equally 
relevant for decision-makers or commissioners who are deciding how best to allocate 
and prioritise limited healthcare funds.  
 
Secondly, I have chosen the state-based medical indemnifier (MI) – a public body 
responsible for providing indemnity for clinical negligence in a region or country – as 
my vehicle for investigating a ‘top-down’ and system-wide approach to improving 
maternity care and reducing preventable harm. MIs in general are not responsible for 
patient safety but should have a role in preventing harm and improving patient care 
(28,29). Cost savings from avoidable litigation could be used to influence frontline 
care. This could be in the form of supporting patient safety initiatives (30-33) or 
incentive schemes (34,35). 
 
Multi-professional simulation training in obstetric emergencies and the state-based MI 





approaches to maternity safety. This bi-directional approach offers a more complete 
and representative examination of the English/UK maternity health system than 
studying the ‘bottom-up’ and ‘top-down’ approaches in isolation. Crucially, the ‘bottom-
up’ and ‘top-down’ approaches involve all levels of a health system. These levels will 
now be explored.  
 
1.4 Levels of a health system 
Ferlie and Shortell identified four levels within a health system that should all be 
considered in quality improvement endeavours to maximise the probability of their 
success. These four levels of change included the individual, the team, the 
organisation and the environment (36). In this model, the individual is the healthcare 
practitioner, the team is the group of healthcare professionals responsible for looking 
after the patient, the organisation is usually a hospital but could be a general practice, 
and the environment is the wider context in which the organisation operates. This latter 
level features other systems, such as the legal and political systems, as well as 
regulators, professional bodies, insurers and other influential agencies.  
 
The Ferlie and Shortell model was subsequently adapted in two ways. Firstly, the 
individual level was replaced by the patient – a change befitting the increasing 
emphasis on patient-centred care. Secondly, rather than four distinct levels within a 
health system, a ‘nested’ model was proposed, with each level incorporated by the 
next (37). In this model, the patient (first level of the system) is part of the care team 
(the second level of the health system), taking an active role in the design and 
coordination of their own care. The team itself is part of the organisation (the third 
level), which provides the infrastructure and resources that are necessary in delivering 
care to the patient. Lastly, the organisation is encompassed by the final level of a 
health system – the regulatory and policy environment – which influences how the 
organisation operates (37).  
 
Another model categorises a health system into three levels – micro, meso and macro 
(38,39). The individual and team levels can be grouped together to form the micro 
level of a health system. The meso level is akin to the organisational level and the 





The micro level of a health system can be described as a collection of clinical 
microsystems. These are small groups of healthcare professionals who have shared 
aims, processes and information, and work regularly together to provide care to a 
discrete subpopulation of patients (40). There is a plethora of clinical microsystems; 
anybody who has accessed health services will have encountered them. Examples of 
clinical microsystems include general practices, transplant units, paediatric 




















1.4.1 The maternity team as a clinical microsystem 
A typical, core maternity team on a delivery suite will consist of obstetricians, 
anaesthetists, midwives and maternity care assistants. This multi-professional team 
will be responsible for caring for women in labour and pregnant women who are 
unwell. Whilst the individuals may change on a daily basis, the team composition 
remains constant. A midwife coordinator usually manages the delivery ward as a 























































Obstetricians are involved if there are medical concerns and are needed for operative 
births, like deliveries by forceps or caesarean section. Anaesthetists are available to 
provide pain relief and are consulted if medical issues arise. At times of obstetric 
emergencies, which are frequent and unpredictable, all members of the maternity 
team also have crucial and clearly defined roles.  
 
1.4.2  The macro level of a health system and regulatory mechanisms 
There are a multitude of actors involved in patient care at the micro level. The same 
applies at the meso and macro levels of a health system. In the context of maternity 
care in England, there are many organisations occupying the macro space, such as 
the General Medical Council (GMC), the Nursing and Midwifery Council (NMC), the 
Royal College of Obstetricians and Gyanecologists (RCOG), the Care Quality 
Commission (CQC), the National Institute for Health and Care Excellence (NICE) and 
NHS Resolution (the body that handles clinical negligence claims against the NHS). 
This list is non-exhaustive and there are many more macro level organisations. All 
these agencies utilise a wide range of macro levers designed to influence behaviour 
at all levels of a health system. 
 
Regulation has been understood to be a form of governance performed by either 
governments or non-state actors, who adopt a range of approaches to steer the course 
of events (41,42). Using this definition, macro level levers can be regarded as forms 
of regulation or regulatory mechanisms, as they seek to affect actions and behaviours. 
This broad view of regulation includes organisations that are not traditionally 
considered to be formal regulators – these are regulators who possess the following 
qualities: authority, third-party accountability, central oversight and act in the public 
interest (43).  
 
There are three main reasons for regulating a health system: protection of the public 
and assuring minimally acceptable standards of care, performance and quality 
improvement, and provision of accountability (42,44). Medical scandals regarding 
children’s heart surgery in Bristol (45), Harold Shipman (46) and more recently, 
substandard care in Mid Staffordshire (47), have led to significant regulatory reform in 





have also been increased pressures to improve quality in light of variations in the care 
received by patients, and to provide greater accountability for clinical performance and 
value for money (42). However, there will be trade-offs between these regulatory aims. 
For example, encouraging improvement may require ambitious standards and targets 
rather than setting them at the minimum acceptable level for quality assurance (43,44). 
Macro level levers can be classified using a regulatory pyramid of health sector 
mechanisms (Figure 1-2). The pyramid is arranged into six tiers: voluntarism, market 
mechanisms, self-regulation, co-regulation, meta-regulation and command/control. 
‘Softer’ and more collaborative measures are located are the base of the pyramid, with 















Voluntarism relies on individuals or organisations to undertake the right tasks on their 
own accord (42). Maintaining a personal surgical logbook in obstetrics and 
gynaecology is an example of this type of regulatory mechanism. Voluntarism 
approaches are therefore not macro level levers but instead, depend on the autonomy 
of individual healthcare professionals at the micro level (and hospitals at the meso 
level) in deciding their conduct (48). Market mechanisms may include incentive 
schemes and pay-for-performance. Self-regulation is based on the autonomy of a 
profession, where organised groups, such as professional Colleges, attempt to 















Figure 1-2 Regulatory pyramid of health sector mechanisms. 






professional Colleges are good examples of self-regulation. Co-regulation may involve 
a number of agencies collaborating and agreeing on codes of practice. Meta-
regulation is concerned with regulating the regulators (42). The Professional 
Standards Authority is a meta-regulator, overseeing the work of nine statutory bodies 
that regulate healthcare professionals in the UK (49). Finally, command and control 
mechanisms, as the name would suggest, involve enforcement by the government or 
by law (42). The statutory Duty of Candour for healthcare organisations in England is 
an example of a command/control regulatory mechanism (50). 
 
In Ayres and Braithwaite’s ‘responsive regulation’ model, regulators should be 
sensitive to the context, motivation and conduct of the regulated (41). This ‘responsive 
regulation’ paradigm is suitable for healthcare as there are many actors in a health 
system with regulatory influence as well as a history of professional autonomy (42). 
The deluge of agencies within the macro sector can result in overlapping 
responsibilities (10,12) and inefficiencies (51). Repetitive regulatory activities waste 
time (12) and multiple sources of guidance add to the cognitive burden of healthcare 
professionals (52). The Professional Standards Authority introduced the idea of ‘right 
touch’ regulation, which suggests that regulation should aim to be proportionate, 
consistent, targeted, transparent, accountable and agile. In the ‘right touch’ model, the 
minimum regulatory force is used to achieve the desired effect (49). This approach 
may help to reduce the regulatory burden in health systems. Ultimately, excessive 
regulation results in increased expenditure (12), therefore undermining one of the 
regulatory aims of providing accountability in terms of obtaining value for money. 
Better coordination and alignment, both within the macro sector and across the health 
system, would help to address this problem. 
 
1.5 Understanding decision-makers 
In order for clinical researchers to help harmonise the health system, a better 
understanding of the decision-making processes at the meso and macro levels may 
be needed. Decision-making is complex and has been described as a ‘diffuse, 
haphazard, and somewhat volatile process’ (p.140) (53). Healthcare decision-makers 





trying to make sense of research evidence — there may be social, financial or political 
pressures, not to mention their own experiences, beliefs and interests (53,54).  
 
In an attempt to facilitate research knowledge transfer to decision-makers, Lavis et al. 
devised a strategic framework based on five elements: the message, the audience, 
the messenger, the knowledge-transfer process, and evaluation (55). In this 
framework, it was suggested that research evidence should be assimilated into 
actionable messages which are specific to their target audiences and delivered by 
credible messengers (55). Interactive engagement between researchers and 
policymakers is needed using a common language. Moreover, the effectiveness of 
knowledge transfer should be measured by outcomes, such as presentations, 
changes in awareness or attitudes, and actual decisions being made based on 
research evidence (55). Presentations alone, however, are unlikely to be a reliable 
measure of effective knowledge transfer. Two systematic reviews highlighted personal 
contact between researchers and policymakers as an important facilitator of the use 
of research evidence in policymaking (56,57). Other facilitators of the uptake of 
research in decision-making included the timeliness and relevance of the evidence 
(56,57), and improved dissemination (57). Although there is no shortage of advice for 
academics wishing to influence policymaking, a recent systematic review concluded 
that this advice is mostly based on personal experience, rather than empirical 
evidence (58). 
 
There is an art to decision-making that involves juggling competing agendas and 
building compelling arguments for certain courses of action using information from an 
array of sources. The information used however, is seldom from academic research 
(59). Maybin described different senior civil servants and ministers in England’s 
Department of Health as having ‘particular tastes for different types of knowledge’ 
(p.292) (60). Policymakers may prioritise other competing pressures or sources of 
information over research evidence (53,54) and may equally draw on emotions and 
gut feelings to make decisions (61). Decision-makers may lack the skills required to 
critically analyse different research evidence (57) and may not value the hierarchy of 
scientific evidence in the same way that researchers or clinicians do (61). One case 
study identified that even government commissioned research had very little bearing 





use research to justify inaction or decisions post hoc, rather than to inform the 
decision-making process going forward (53,62). 
 
1.6 The use of economic evaluations in decision-making  
Economic evaluations are established research methods for assessing the costs and 
effectiveness of alternative healthcare interventions (63). However, systematic 
reviews have found that the use of economic evaluations in health policy decisions 
has been limited in general (64) and specifically at the meso and micro levels (65). 
One literature review found that only 30% of meso level decisions and 13% of micro 
level decisions were majorly influenced by economic evaluations (66). The impact of 
economic data at the macro level was even worse, with only 5% of decisions being 
influenced by economic evaluations in a major way (66). Despite these findings, 
economic evaluations remain important factors in the health policy process – cost-
effectiveness was the fourth most reported criterion (out of a total of 58 criteria) in a 
literature review assessing decision criteria for resource allocation and healthcare 
decision-making (67).  
 
Williams et al. investigated the use of economic evaluations in decision-making within 
the NHS through the analyses of new technology request forms used in primary and 
secondary care, and case studies of regional committees (64). The analysis of the 
technology request forms revealed that although 86% of secondary care organisations 
asked for some form of cost information, only 19% wanted cost-effectiveness data. A 
lack of health economics expertise was reported in the regional committee interviews 
but there was a sense that this knowledge was desirable rather than essential (64).  
 
Possible barriers to the use of economic evaluations have been put forward, such as 
poor availability of economic analyses (64,65,68), potential risk of bias with company 
sponsored studies (64,68,69), difficulties with interpreting results (64,65,68), variation 
in analytical methodologies (64,69), and concerns about the robustness of the 
evaluations (64,65). It has been acknowledged however, that tackling one barrier 
might exacerbate another (70). For example, the use of simpler analytical techniques 
may aid understanding, but the quality and robustness of the analysis may be 






1.6.1 Economic evaluations and NICE 
Despite the apparent poor use of cost-effectiveness data in policymaking, economic 
evaluations appear to have a prominent role in the decision-making process of NICE 
and its technology appraisal programme (64). NICE is a non-departmental public body 
(NDPB) in England and is responsible for providing national clinical guidance and 
appraising new or existing health technologies (71). The NICE Appraisal Committee 
review clinical and cost-effectiveness evidence for different health technologies at the 
request of the Department of Health. Economic evaluations are compulsory 
components of the appraisal process (72). Cost-utility analyses using generic 
measures of health, such as the quality adjusted life year (QALY), are the preferred 
form of economic evaluations of NICE. The EuroQoL EQ-5D questionnaire is also the 
recommended generic health status instrument for these analyses (72). The use of 
generic health outcomes, such as QALYs, enables comparison between economic 
evaluations in different areas of healthcare, although this is only true if the same 
generic health status instruments have been used.  
 
NICE can either recommend or not recommend a particular health technology or 
treatment for use in the NHS after assessing the available evidence. Interviews with 
members of the NICE Appraisal Committee revealed two different approaches to the 
use of economic evaluations during appraisals: some viewed them as analytical 
frameworks for discussion whilst others only considered them once they were satisfied 
that the health technologies were clinically effective (64).  
 
Regardless of the approach, economic evaluations and the use of a cost-effectiveness 
threshold are central to NICE’s decision-making process (64). The cost-effectiveness 
threshold for NICE is generally thought to be £20,000 to £30,000 per QALY (73), 
although these cut-offs are arbitrary and subject to a degree of variability (64). At its 
simplest, any intervention or health technology which is able to gain one QALY for less 
than the cost-effectiveness threshold is deemed to be cost-effective, and therefore 
value for money (Figure 1-3).  
 
Cost-effective technologies and interventions are more likely to be recommended for 





the burden of disease or the effect of uncertainty, may influence the decision-making 
process (74). Previous analysis of NICE decisions found that some technologies and 
interventions with costs per QALY above the threshold were recommended whilst 























1.7 Bridging the gap between research and policy-making  
Research methodology and clinical results can be complicated. As mentioned before, 
policymakers may not have the capacity or headspace to examine such information 
efficiently. Monetary cost, however, is universally understood and whilst an important 
factor in its own right, may also help to make research findings more accessible to key 
decision-makers. Despite this, many policy recommendations lack information 
regarding costs (75) and this is exacerbated by researchers’ poor reporting of costings 
(27). Perhaps unsurprisingly, the paucity of cost implications has been identified as a 
barrier to the uptake of research evidence in policymaking (57). Acknowledgement of 
the costs will be useful for policymaking but cost-effectiveness data from economic 
evaluations should offer more persuasive arguments. Financial information can have 
an integral part in decision-making, as evidenced by NICE, and could be a unifying 


























Figure 1-3 Cost-effectiveness plane with NICE cost-effectiveness 





common language would facilitate better alignment through all levels of a health 
system.  
 
1.8 Simulation training  
A potential avenue for improving intrapartum care is through maternity team training, 
which is frequently recommended in national enquiries and reports in the UK (4-7) and 
across the world (76,77). One type of training which is increasingly being adopted in 
the field of obstetrics is simulation-based team training. Gaba described simulation as 
‘a technique, not a technology, to replace or amplify real experiences with guided 
experiences, often immersive in nature, that evoke or replicate substantial aspects of 
the real world in a fully interactive fashion’ (p.i2) (78). Simulation training enables 
healthcare professionals to be exposed to low-frequency but high-risk clinical 
scenarios in safe environments, where mistakes can be made and learned from (79). 
It can either be run off-site in purposefully built simulation centres and hospital 
classrooms, or in situ in the clinical areas in which healthcare is delivered to patients 
(80,81). Simulation-based training can be task-orientated (82,83) or focus on other 
skills such as communication, decision-making and team-working (84,85). 
Technologies can assist in simulated training sessions. High fidelity mannequins can 
provide physical signs and have real-time responses to interventions or medications 
(86). In contrast, low fidelity mannequins do not have the same technological 
functionality but may also be useful for training (87).  
 
1.8.1 Multi-professional simulation training for obstetric emergencies 
Safe care during obstetric emergencies requires members of a maternity team to 
possess a wide range of skills: proficiency in practical procedures, situational 
awareness, and the ability to communicate clearly as well as make time-critical 
decisions under pressure. Multi-professional simulation training can target all of these 
domains, and also develop team-working. It is an ideal educational medium for training 
maternity teams in managing obstetric emergencies (25).  
 
There are a variety of obstetric emergencies training packages around the world. A 
few notable examples include Advanced Life Support in Obstetrics (ALSO) (88), 





Obstétrico y Neonatal: Tratamiento Óptimo y Oportuno (PRONTO) (90,91), Managing 
Obstetric Emergencies and Trauma (MOET) (92) and PRactical Obstetric Multi-
Professional Training (PROMPT) (32,93),  
 
Training programmes, including simulation-based training, can be evaluated using 
Kirkpatrick’s Model (94). In general, multi-professional simulation training for obstetric 
emergencies appears to comfortably fulfil Level 3 of Kirkpatrick’s Model — influencing 
and changing participant behaviour (94). Daniels et al. compared team performances 
in the management of two obstetric emergencies (shoulder dystocia and eclampsia) 
between a group that underwent simulation training and a group that received didactic 
teaching with limited ‘hands on’ practice (95). The team performances were better for 
both scenarios in the simulation group (95). A Dutch randomised control trial also 
assessed team performances in two obstetric emergencies (shoulder dystocia and 
maternal collapse) more than 6 months after a 1-day multi-professional team training 
session (intervention group) or no training (control group). Again, team performances 
in the intervention group were better than the control group (96). Other studies have 
demonstrated that simulation-based team training for obstetric emergencies is 
associated with improvements in clinical management (84) and safety attitudes 
(32,97), which are also at Level 3 of Kirkpatrick’s Model. 
 
The effects of multi-professional simulation training for obstetric emergencies on 
patient outcomes or clinical results (Level 4 of Kirkpatrick’s Model) (94) is more mixed. 
A study by Crofts et al. found that patient-actor perception of care improved following 
multi-professional simulation training (98). This finding appeared to be reproduced for 
actual patients with better patient-reported quality of care after training (99). In Alberta, 
MOREOB was associated with a 17% and 18% reduction in severe neonatal morbidity 
(severe respiratory distress syndrome, sepsis and brain haemorrhage) after 2 and 3 
years of training respectively (89). PROMPT has been associated with improvements 
in patient outcomes in England (93), America (100), Australia (32) and Zimbabwe 
(101). These improvements will be discussed in greater detail later in this chapter. In 
contrast to these positive effects, other studies investigating the impact of multi-
professional obstetric training have observed no effect (102-104), or counterintuitively, 
worse outcomes (105). Multi-professional simulation training for obstetric emergencies 





team training programmes work better than others and it is essential that we 
understand the active ingredients of effective training (107). 
 
Two reviews have suggested that regular, multi-professional and ‘in house’ training for 
obstetric emergencies is the most effective model (26,107). Other studies have also 
strengthened the argument for ‘in house’ (or in situ) training, or at the very least, 
suggested that training in simulation centres confers no added advantage. A 
systematic review of multidisciplinary, simulation training for obstetric emergencies 
found that training in simulation centres did not further improve outcomes compared 
with local training (25). A recent randomised control trial investigating the effect of in 
situ simulation versus off-site simulation demonstrated no differences in knowledge 
and patient safety attitude between multi-professional maternity teams trained in these 
two settings (80). In this study, however, participants in the in situ group provided more 
suggestions for organisational change compared to the off-site group (80), highlighting 
the potential for making system improvements through local training (79,107).  
 
1.8.2 PROMPT as an exemplar  
PROMPT was one of the pioneers of local multi-professional training for obstetric 
emergencies and has been recognised as a leading example in the recent National 
Maternity Review in England (8). The PROMPT package was developed in the UK by 
a multidisciplinary maternity team in 2000. It consists of a ‘Course in a Box’, which 
contains course and trainer manuals, and adaptable training materials for local use. 
Hospitals that wish to implement PROMPT must first send a multi-professional 
maternity team to a ‘Train the Trainers’ course. After attending this session, the multi-
professional team are given the ‘Course in a Box’ and can then begin simulation 
training in their hospitals. PROMPT provides training on the management of a wide 
range of obstetric emergencies and scenarios: shoulder dystocia, cardiotocograph 
(fetal heart trace during labour) interpretation, eclampsia (seizures), sepsis, obstetric 
haemorrhage, cord prolapse, vaginal breech birth, maternal collapse, maternal cardiac 
arrest, twin birth, basic neonatal resuscitation and anaesthesia related emergencies 
(108). Maternity units are encouraged to adapt their PROMPT course and vary the 






The implementation of PROMPT has been associated with improvements in clinical 
outcomes in a variety of healthcare settings. A retrospective, observational study in 
England found a 49% reduction in the number of babies with low 5-minute Apgar 
scores following PROMPT training (93). The Apgar score is a measure of newborn 
condition and is based on the assessment of five signs: heart rate, respiratory effort, 
reflex irritability, muscle tone and colour (109). A score is given at 1 minute, 5 minutes 
and 10 minutes of life and the lower the score, the worse the condition of the baby 
around the time of birth. In the same study, the number of babies with hypoxic-
ischaemic encephalopathy (brain injury due to oxygen deprivation) was halved after 
training (93). This was the first study to demonstrate a link between simulation training 
for obstetric emergencies and improvements in clinical outcomes.  
 
PROMPT has had an impact on other clinical outcomes too. It was associated with a 
75% reduction in the number of neonatal injuries at birth after shoulder dystocia and 
also a 69% reduction in the number of obstetric brachial plexus injuries (OBPIs) (110). 
Shoulder dystocia is an obstetric emergency occurring when routine traction of the 
fetal head fails to accomplish delivery (111) and additional manoeuvres are required. 
It usually occurs when the anterior shoulder of a baby is impacted against the mother’s 
symphysis pubis (112). Inappropriate management of this emergency, such as using 
excessive traction, can result in neonatal injury, particularly to the brachial plexus, 
which is a collection nerves originating in the neck. OBPIs can either resolve 
spontaneously or become permanent (lasting for 12 months or more). One English 
unit has reported no permanent cases of brachial plexus injury in 562 episodes of 
shoulder dystocia after 12 years of sustained PROMPT training (113). 
 
Maternity units around the world have also published clinical improvements associated 
with PROMPT. In the US, the University of Kansas Hospital reported a progressive 
decline in the number of transient brachial plexuses injuries in the 7 years after 
PROMPT training started (100). Improvements in low 1-minute Apgar scores were 
observed a year after PROMPT training in 8 maternity units in Victoria, Australia (32). 
In Zimbabwe, a 34% reduction in hospital maternal mortality was observed over 3 
years following the introduction of PROMPT at Mpilo Central Hospital (101). PROMPT 





results from a stepped-wedge cluster randomised controlled trial of PROMPT in 
Scotland are currently awaited (115).  
 
The impact of PROMPT has extended beyond obstetrics and postgraduate training. 
Multi-professional simulation training, based on the PROMPT model, has been shown 
to improve the safety culture on surgical wards (85). Furthermore, an undergraduate 
version of PROMPT for student doctors and midwives demonstrated meaningful 
improvements in students’ attitudes to communication and teamwork, 
interprofessional interactions and interprofessional relationships following training. 
Knowledge acquisition also improved for both medical students and student midwives 
after training (116). The success of this has led to the development of an 
undergraduate PROMPT module, which can be implemented in universities as part of 
their undergraduate medical and midwifery curriculums.  
 
PROMPT is therefore a suitable vehicle for exploring how to use the language of cost 
and health economics in a ‘bottom-up’ and system-wide approach to maternity safety. 
 
1.9 Economic evaluations in obstetrics   
The quality of economic evaluations in obstetrics have historically been suboptimal. 
Smith and Blackmore conducted a review of 98 obstetrics and gynaecology economic 
evaluations published between 1990 to 1996, and found poor compliance with 
methodological criteria (117). Only 5.1% of the studies met all of the recommended 
standards, suggesting that the majority of the economic evaluations were either poorly 
designed, poorly conducted, poorly reported or a combination of the three (117). In 
terms of individual criterion, only 19% of the economic evaluations described the study 
perspective, and sensitivity analyses were performed in only 21% (117). Healthcare 
economic evaluations in other specialties also appeared to suffer from methodological 
flaws, with evidence of confusion in study design and reporting (118). 
 
Vintzileos and colleagues produced a reporting checklist to improve the quality of 
economic evaluations in obstetrics (119). This and other suggested guidelines have 
since informed the more definitive Consolidated Health Economic Evaluation 





evaluation reporting across all medical specialities and include a 24-item checklist 
(120).The latest review of economic analyses in obstetrics and gynaecology, covering 
1997 to 2009, found some improvements in quality when assessing against Smith and 
Blackmore’s original criteria (121). In this review, 40% of the evaluations now identified 
the study perspective and 61% conducted sensitivity analyses (121). 
 
1.9.1 Economic evaluations of training for obstetric emergencies  
To date, there has been one systematic review pooling five economic evaluations of 
emergency obstetric training (122). Five full economic evaluations (published after 
1990) met the inclusion criteria of this systematic review and the quality of these 
studies was assessed using the CHEERS checklist (120). A previously published 
scoring system was used (123). I have summarised the five economic evaluations 
identified in Banke-Thomas et al’s systematic review (122) and one study that has 
been published since the systematic review (124) (Table 1-1). 
 
Walker et al. conducted a cost-effectiveness analysis of three different midwifery 
training programmes in South Kalimantan, Indonesia (125). One training programme 
taught advanced life-saving skills to hospital-based midwives, another focused on 
basic life-saving skills for village midwives and the last programme was hospital 
internships for village midwives. Costs for administration, technical assistance, training 
needs assessment, site preparation, training of trainers, life-saving skills training, peer 
review, fund-raising and continuing education were all included. Clinical performance 
and percentage of competent (defined as scoring at least 70% in a training evaluation) 
midwives were chosen as the outcome measures (125). Rather than comparing the 
cost-effectiveness between training programmes, the authors instead compared each 
training programme with no training.  
 
The costs per trainee and the percentage difference in mean skill scores or number of 
competent midwives were used to calculate the cost-effectiveness ratio for each 
training programme. For advanced training, it cost US$49.7 per 1% increase in the 
mean skills scores (95% CI US$48.9, US$50.6) and US$3,210.9 per 1% increase in 
competent midwives (95% CI US$3157.9, US$3263.9). The basic training cost 





US$5,651.5 per 1% increase in competent staff (95% CI US$5581.1, US$5722.9). 
The internship programme appeared to be the least cost-effective overall when 
assessed by cost per 1% increase in score (US$154) but was more cost-effective than 
basic training when using cost per 1% increase in the number of competent village 
midwives (US$4,061) (125). A one-way sensitivity analysis found that cost had little 
influence on the overall cost-effectiveness (125). This economic evaluation was 
judged to have been of medium quality (122).  
 
The study was limited by the lack of an item-specific costing approach – the cost 
categories were broad, and it was impossible to pinpoint exact components and their 
associated costs. The choice of outcomes may also not have been the most 
appropriate. A percentage point increase in competent midwives is difficult to interpret 
and translate into a meaningful clinical difference. This outcome and the percentage 
increase in mean skills score also assumed a linear relationship between spending 
and competence, which may not be true (125). Finally, better performance in training 
evaluations does not necessarily translate into better patient outcomes. 
 
Osei et al. conducted a non-randomised, pre- and post-intervention comparison study  
to investigate whether a novel self-paced learning approach was more cost-effective 
than a traditional 3-week residential training course (126). The 3-week course 
focussed on life-saving skills and post abortion care training for both midwives and 
doctors. The self-paced learning approach covered the same content but featured 
more self-directed learning. Outcomes included knowledge of antenatal care, labour 
and delivery, and also clinical performance in antenatal care, management of obstetric 
complications and post abortion care. These were measured pre-intervention and 6 
months post-intervention (126). Knowledge was assessed by in-depth interviews with 
staff and assessment of clinical performance was based on observational fieldwork. 
Given the small caseload of deliveries, emergencies and post abortion care observed 
pre-intervention, it was decided that these domains should be assessed using 
simulated scenarios following the training (126). Costs included travelling expenses, 
per diems, room hire charges, stationary, fuel and supplies for training. Opportunity 
costs were also estimated based on staff time needed for both forms of training and 
these were converted to monetary costs as well. In terms of knowledge acquisition, 





training course was not effective in this regard at all. The self-paced learning cost an 
average of US$101 per participant per percentage change in the management of 
obstetric emergencies, compared to the residential course which cost US$138 – the 
self-paced learning approach was therefore more cost-effective. However, if the 
opportunity costs were included, the residential course was more cost-effective, 
costing US$162 per participant per percentage change, compared to US$168 for the 
self-paced learning (126). This economic evaluation was rated medium quality (122).  
 
On average, self-paced learners spent 511 hours spread over 4-6 months to complete 
the training, compared to traditional learners who spent 116 hours over 3 weeks (126). 
Although not explicitly mentioned, the opportunity costs appeared to include time for 
travelling and waiting, as well as training time. The authors acknowledged that there 
were other considerations to the opportunity costs besides the number of hours (126). 
For example, the authors recognised that the self-paced learners might have used 
their free time to do some of their training. This would have had minimal impact on 
service provision (and therefore productivity). One could argue that these opportunity 
costs could be excluded from the analysis, but the authors decided to include them to 
illustrate the maximum cost for this training approach (126).  
 
The methods used to assess effectiveness carried a great degree of uncertainty. 
Firstly, knowledge was assessed through a series of in-depth interviews. The authors 
did not elaborate on the methods used during the interviews and interviewing may not 
have been the most appropriate way of gauging knowledge. Clinical performance was 
also judged through observations of care or simulated scenarios, and patient 
interviews (126). Although observation guides were mentioned, these were not shared 
so it was unclear as to what was being assessed and to what standard. The cost-
effectiveness was expressed as cost per provider per percentage change in the 
management of obstetric emergencies. This is hard to translate into a meaningful 
clinical difference and is further undermined by the uncertainty regarding what was 










Interventions Outcome measures 
Quality of 
study 
Walker et al. (125) Indonesia CEA 
• Advanced life-saving skills for hospital midwives 
• Basic life-saving skills for village midwives 
• Internships for hospital midwives 
• Clinical performance 
• % competent midwives 
Medium 
Osei et al. (126) Ghana CEA 
• Self-paced learning 
• 3-week residential training course (including life-
saving skills) 
• Knowledge 









• Skilled Care Initiative • Not presented Medium 




• Surgical training for assistant medical officers 
• Training for doctors 
• Major obstetric surgeries 
performed over 30 years 
High 
Manasyan et al. 
(129) 
Zambia CUA • Essential Newborn Care training programme 
• 7-day neonatal mortality 
• Disability-adjusted life year 
(DALY) 
Medium 













• No training 
• Training in simulation without in situ repetition 
• Training in simulation centre with in situ repetition 
course after 6 months 
• Training in simulation centre with in situ repetition 
course after 3 months, 6 months and 9 months 
• Composite outcome of obstetric 
complications 
• Neonatal trauma due to 
shoulder dystocia 
High 
*not included in Banke-Thomas et al. systematic review  






Boulenger and Dmytraczenko’s study investigating the cost of the Skilled Care 
Initiative in Kenya and Tanzania (127) was deemed to be medium quality (122). 
However, on further review of this study, it became apparent that this was only a 
costing study rather than a full economic evaluation. The implementation and 
replication costs for the Skilled Care Initiative package, which included training, 
were calculated. The average annual cost of the Skilled Care Initiative per delivery 
with a skilled birth attendant was US$10.6 in Kenya and US$15 for Tanzania (127). 
Evaluation of outcomes were mentioned in the report but were not presented.  
 
Kruk et al. evaluated the cost-effectiveness of using surgically trained assistant 
medical officers (técnicos de cirurgia) instead of doctors (obstetricians or 
gynaecologists) in Mozambique (128). A modified societal perspective was 
adopted and a time horizon of 30 years was chosen. Training and deployment 
costs for both the técnicos de cirurgia and doctors were included, as well as their 
opportunity costs. The outcome measure for this study was the productivity of a 
técnico de cirurgia and a doctor in terms of major obstetric surgeries (caesarean 
sections, caesarean hysterectomies and laparotomies for ectopic pregnancy) 
performed over 30 years (128). Costs and surgical procedures were discounted at 
3% per year. At the end of the 30-year model, the cost per major obstetric surgery 
for a técnico de cirurgia was US$39 compared to US$144 for a doctor, making the 
training and deployment of técnicos de cirurgia the more cost-effective option. This 
remained true after a series of one-way sensitivity analyses, including the doubling 
of the técnicos’ salaries (128). This was assessed as a high quality economic 
evaluation by Banke-Thomas et al. (122).  
 
Manasyan et al. conducted a cost-utility analysis of the World Health 
Organisation’s Essential Newborn Care training programme in Zambia (129). The 
course was aimed at midwives and focussed on routine neonatal care, 
resuscitation and postnatal care. Costs were divided into initial and maintenance 
costs. Pre- and post-intervention 7-day neonatal mortality rates were compared to 
assess the effectiveness of the Essential Newborn Care training programme. The 
cost per life saved was estimated to be US$208 and the cost per disability-adjusted 





and are calculated by combining the number of years lived with a disability and the 
years of life lost due to premature mortality (130) This economic evaluation was 
rated as medium quality (122). There are a number of limitations to this cost-utility 
analysis. First, no sensitivity analyses were performed. Opportunity costs were 
also omitted from the analysis. Lastly, DALYs were not calculated by the standard 
method described above and the cost per DALY was simply determined by dividing 
the cost per life saved by the life expectancy (129). 
 
Van de Ven and colleagues performed a cost-effectiveness analysis of four 
different strategies for simulation-based team training in obstetric emergencies in 
the Netherlands: no training, training in a simulation centre without in situ repetition, 
training in a simulation centre with an in situ repetition course after 6 months, and 
training in a simulation centre followed by repeat in situ courses after 3, 6 and 9 
months (124). Direct costs included salaries of the medical trainers, training 
materials, catering and room hire. Opportunity costs were also included and were 
calculated by converting the time spent attending the training into monetary costs. 
A composite outcome of obstetric complications was used, which included Apgar 
score <7 at 5 minutes, neonatal trauma due to shoulder dystocia, eclampsia and 
hypoxic-ischaemic encephalopathy (brain injury due to oxygen starvation). 
Neonatal trauma due to shoulder dystocia (brachial plexus injuries, fractures and 
other injuries) was also chosen as a separate outcome measure (124). Training in 
a simulation centre with an in-situ repetition course after 6 months had an 
incremental cost-effectiveness ratio (ICER) of €3,432 per composite outcome 
avoided compared to no training. Training in a simulation centre with 3-monthly in-
situ repetition courses had an ICER of €5,115 per composite outcome prevented 
compared to training with only one on-site repetition course after 6 months. Using 
trauma due to shoulder dystocia as the outcome measure, training in a simulation 
centre with 3-monthly in-situ repetition courses had an ICER of €22,878 when 
compared to no training (124). The authors used probabilistic sensitivity analysis 
(PSA) to generate cost-effectiveness acceptability curves (CEACs) but did not 
present the full results of the PSA. Instead, only the results of one-way sensitivity 
analyses (adjusting the costs of the repetition training courses) were offered. 
Another limitation of this work was that the costs of the outcomes were not included 





difficult and was not attempted, but despite being able to estimate the average cost 
per trauma associated with shoulder dystocia (€4,617), it was not clear whether 
this figure was included in the modelling (124). Using the CHEERS checklist (120) 
and the same scoring system as before (123), this is a high quality economic 
evaluation.  
 
1.10 State-based medical indemnifiers 
In order to explore a system-based approach to improving maternity care from the 
other direction (‘top-down’), I have chosen the state-based medical indemnifier 
(MI) as a vehicle for investigation. A state MI is just one of the many agencies in 
the macro sector of a health system. Though not thought of as formal regulators, 
state MIs share some regulatory aims. Greater financial accountability will 
resonate strongly with state-based MIs, as they aim to compensate patients who 
have suffered from preventable harm whilst also attempting to contain costs to the 
health system. Realising another regulatory aim – improving performance – would 
also help achieve greater accountability in terms of value for money. In the context 
of maternity care, obstetric claims, and in particular, their prevention, may be the 
only source of spare money in a health system. Improving maternity safety and 
care would not only improve health outcomes, but could also reduce litigation, 
thereby releasing funds which would otherwise have been used for compensation. 
As a result, MIs should be interested in avoiding harm and improving care (28,29). 
However, MIs are not patient safety organisations and require clinical input to 
maximise any potential improvements to patient care. Whilst there is evidence of 
both private and state MIs being involved in patient safety projects (30-33), the 
mechanism of clinical-MI engagement remains understudied. In particular, there is 
very little empirical research investigating how state-based MIs engage and 
interact with clinical teams. A better understanding of this process would help to 
foster a more symbiotic relationship that would benefit the collective goals of 
improving patient safety and reducing litigation.  
 
1.11  The influence of state-based medical indemnifiers 
The obvious macro levers available to state MIs are market mechanisms in the 





or support patient safety initiatives (32,33), and any resultant money saved from 
avoided litigation could be reinvested in similar endeavours. Whether state MIs like 
it or not, the potential financial influence at their disposal assures their status as 
key decision-makers within their health systems. They have the opportunity to 
shape and drive the patient safety agenda. I will now describe some incentive 
schemes and patient safety initiatives related to maternity services.  
 
1.11.1 Clinical Negligence Scheme for Trusts (CNST), England  
The CNST is a pay-as-you-go, risk-pooling scheme operated by NHS Resolution 
(formerly known as NHS Litigation Authority), an arm’s-length body of the English 
Department of Health and the state-based MI for England. The scheme pays for 
the management and settlement of medical negligence claims brought against the 
NHS in England. Membership is voluntary although all NHS Trusts are currently 
members (131). Contributions to the scheme are taken annually and are calculated 
based on risk, paid claims experience in the previous 5 years and known 
outstanding claims. Maternity service contributions are calculated separately from 
other medical specialties (131). Discounts of up to 30% were previously available 
for the maternity component of the CNST contributions subject to compliance with 
a range of general and maternity-specific risk process measures (34). These 
discounts were stopped as it was found that meeting the standards did not 
necessarily lead to better patient outcomes (132). However, NHS Resolution 
recently announced a new maternity incentive scheme for 2018/19. An additional 
10% of the maternity contribution for each member was collected to fund this new 
incentive scheme (133). Maternity units will be able to recover this money (and a 
share of any unallocated funds) if they can demonstrate compliance with ten 
maternity safety actions, which include using effective systems for 
medical/midwifery workforce planning, ensuring 90% of each maternity unit staff 
group have attended in situ multi-professional maternity emergencies training 
within the last year and submitting data to a national-level dataset (Maternity 






1.11.2 Sign up to Safety incentivisation scheme, England 
In 2014, a national patient safety campaign in England was announced by the 
Secretary of State for Health. Its aim was to strengthen patient safety in the NHS 
(134). As part of this campaign, NHS Resolution – then known as NHS Litigation 
Authority – offered one-off financial incentives to hospitals who were planning to 
implement local patient safety initiatives that would address higher value and/or 
higher volume claims. Hospitals were invited to bid for up to 10% of their CNST 
contribution (35). A total of £8.6 million was allocated to 28 maternity units to try to 
reduce intrapartum harm. The successful hospitals implemented 83 different 
interventions between them. These interventions could be broadly classified into 
the following categories: fetal monitoring equipment, staff, ultrasound 
equipment/software, information technology, equipment, and training. I was part of 
the team that evaluated the scheme and around a year after the allocation of funds, 
we did not find any improvements in clinical outcomes (135). It is likely that this 
was an insufficient time frame for the effects of the interventions to be observed, 
especially as 21% of the interventions were not implemented at the time of the 
analysis (135). 
 
1.11.3 PROMPT in Victoria, Australia  
The Victorian Managed Insurance Authority (VMIA) – the state MI in Victoria, 
Australia – supported the implementation of PROMPT in maternity units in Victoria 
by providing funding (32). Each participating maternity unit received a total of three 
payments towards their training. At the start of the project (2010), PROMPT was 
only established in 8 hospitals. Over time, the reach of the programme expanded 
to 31 hospitals in Victoria, covering 84% of births in the state. The VMIA project 
coordinator held regular meetings with the PROMPT leads across the state. I was 
part of the team conducting the state-wide evaluation of the impact of PROMPT in 
Victoria and some of this work features later in this thesis.  
 
1.11.4 Perinatal Patient Safety Program, Sweden 
Landstingens Ömsesidiga Försäkringsbolag (LÖF) – the state MI in Sweden – 
provided administrative and financial support for the Perinatal Patient Safety 





part of this project, local maternity staff were first asked to identify areas of risk. A 
multi-professional peer-review team then visited the unit and assessed areas for 
improvement. Mutually agreed and locally relevant improvement measures were 
implemented, and experiences/results shared at the end of the Program (33). An 
online, interactive educational programme for cardiotocography (CTG) 
interpretation was also developed. An evaluation of this Program found no 
improvement in outcomes. Despite this, a downward trend in claims for avoidable 
birth injuries (7.5%, p=0.049) was observed after the Program (33).  
 
1.12 Claims data 
State-based MIs also possess under-utilised learning resources in the form of 
claims data. Although primarily collected for legal purposes, claims data can 
complement clinical information and help direct patient safety improvement efforts 
(136).  
 
Improving care and reducing harm to patients should result in reduced litigation. 
However, this logical assumption has only been tested by a few empirical studies 
(137,138). A statistical link between clinical outcomes and malpractice risk is 
potentially useful in policymaking. Such a connection suggests that hospitals and 
maternity units could attenuate their future litigation risk by providing safer patient 
care (137). This explicit association might be particularly important given that the 
direct costs of adverse events to hospitals may not be significant enough to create 
strong economic incentives for improvement (139). Claims data are essential for 
investigating this flow of events and continuing this underdeveloped area of 
research. In the context of maternity services, if there are maternal or neonatal 
outcomes that are strongly associated with maternity claims and are predictive of 
such litigation, then these indicators could be incorporated into MI schemes as 
ways to incentivise safer patient care.  
 
1.13  Overview of thesis  
The overall aims of this thesis are to explore whether a system-based approach to 
improving maternity care and reducing obstetric litigation is feasible and what this 





not possible. However, the selected vehicles for investigation and the specific 
research objectives in this thesis have been purposefully chosen and crafted to 
allow engagement with all levels of a health system. This thesis has the following 
research objectives: 
 
1. To investigate the quality of life of adults suffering from permanent obstetric 
brachial plexus injuries (OBPIs) 
2. To investigate the wider impact of permanent OBPIs by assessing the 
quality of life of caregivers of children with this outcome 
3. To calculate the cost of multi-professional simulation training for obstetric 
emergencies 
4. To evaluate the cost-utility of multi-professional simulation training for 
obstetric emergencies 
5. To explore existing models of engagement between clinical staff and 
medical indemnifiers (MIs), and how these may be more effective in 
improving patient outcomes 
6. To assess the potential impact of multi-professional simulation training for 
obstetric emergencies on litigation across a large, regional health system 
7. To investigate whether core maternity and neonatal indicators can predict 
litigation 
 
The chapters of this thesis and how they address each research objective are 
summarised in Table 1-2. 
 
Part 1 of the thesis (Chapters 2, 3 and 4) is concerned with using health economics 
analyses to express the value of multi-professional simulation training for obstetric 
emergencies. Firstly, Chapter 2 investigates the effect of an adverse perinatal 
outcome (permanent OBPIs) on affected adult individuals and also caregivers of 
children with this outcome through assessing their quality of life. Permanent OBPIs 
are preventable complications associated with childbirth that are lifelong and carry 
a heavy litigation burden for the NHS. As such, they are important injuries that 
warrant further investigation and are the focus of Part 1 of the thesis. The cost of 
training is important to departmental managers, commissioners and national 





professional simulation training programme for obstetric emergencies is 
presented. The findings from Chapters 2 and 3 inform the cost-utility analysis 
conducted in Chapter 4, which assesses the cost-effectiveness of multi-
professional simulation training for obstetric emergencies with particular regard to 
its impact on reducing OBPIs. These chapters complete the first part of the thesis 
and represent a ‘bottom-up’ approach to engaging with all levels of a health 
system: from the micro level with affected adult individuals and caregivers, up to 
the meso-macro interface, where cost information and economic evaluations are 
typically consulted.  
 
Table 1-2 Summary of chapters 
Research objectives 
Chapters 
Part 1 Part 2 
2 3 4 5 6 7 
1. To investigate the quality of life of adults 
suffering from permanent OBPIs 
●     
 
2. To investigate the wider impact of 
permanent OBPIs by assessing the quality 
of life of caregivers of children with OBPIs 
●     
 
3. To calculate the cost of multi-professional 
simulation training for obstetric 
emergencies 
 ●    
 
4. To evaluate the cost-utility of multi-
professional simulation training for 
obstetric emergencies 
  ●   
 
5. To explore existing models of engagement 
between clinical staff and MIs, and how 
these may be more effective in improving 
patient outcomes 
   ●  
 
6. To assess the impact of multi-professional 
simulation training for obstetric 
emergencies on maternity litigation across 
a large, regional health system 
    ●  
7. To investigate whether core maternity and 
neonatal indicators can predict litigation  





Part 2 of the thesis (Chapters 5, 6 and 7) approaches maternity care from the other 
direction: from the macro level down to the micro level. Chapter 5 begins this ‘top-
down’ approach by exploring how state-based MIs in the UK, Republic of Ireland, 
Sweden and Australia currently engage with clinical staff and how this engagement 
could be more effective in improving patient outcomes and reducing harm. Chapter 
6 assesses the potential impact of one form of clinical-MI engagement – supporting 
patient safety initiatives – on litigation costs. Clinical-MI engagement activities that 
are able to demonstrate improvements in patient care and/or litigation rates should 
be continued and are more likely to be supported. Any savings from such activities 
could also be reinvested in frontline services or used to fund more quality 
improvement efforts. Finally, Chapter 7 investigates possible maternity or neonatal 
litigation indicators – that is, core clinical outcomes related to care during childbirth 
which may predict future litigation. If identified, these could be the basis for new 
evidence-based macro levers for incentivising safer care. 
 
Both parts of the thesis are anchored by cost and involve all levels of a health 
system, but from different directions. Adopting a bi-directional and multi-level 
approach to maternity safety enables a better understanding of how a health 
system operates. This knowledge can then help improve alignment across all 
levels of the system. Figure 1-4 is a schematic overview of the thesis and its bi-
directional, multi-level approach. The English/UK health system is the primary 
focus of Part 1 of the thesis, whilst Part 2 has more of an Australian perspective 
due to the predominant use of Australian data. The work for this thesis was 
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2.1 Introduction 
The brachial plexus is a collection of nerves (the anterior divisions of cervical nerves 
C5-C8 and thoracic nerve T1) on either side of the neck which is responsible for the 
movement and sensation of the corresponding arm. Injuries to the brachial plexus can 
occur as a result of any trauma to the neck, including trauma at the time of birth. 
Brachial plexus injuries relating to birth have been interchangeably labelled as 
obstetric brachial plexus palsies, congenital brachial palsies, obstetric brachial plexus 
injuries and neonatal brachial plexus palsies in the published literature (110,140-142). 
For the purposes of this chapter and thesis, such injuries will be referred to as obstetric 
brachial plexus injuries (OBPIs).  
 
There are a number of theories for the mechanism behind OBPIs (140,143) but an 
important cause is excessive traction on a baby’s neck at the time of shoulder dystocia, 
which is an obstetric emergency occurring when routine traction of the fetal head fails 
to accomplish delivery (111) and additional manoeuvres are required. Shoulder 
dystocia usually occurs when the anterior shoulder of a baby is impacted against the 
mother’s symphysis pubis (112). Excessive traction on a baby’s neck can cause 
shearing or stretching of the nerves in the brachial plexus, resulting in either temporary 
or permanent damage. Temporary injuries resolve but any persisting symptoms 
lasting for 12 months or more from birth are considered permanent (113). 
 
OBPIs can be further defined by the extent of the injury using the Narakas 
Classification Scale (144). Narakas Group 1 (involving C5 and C6 nerves) affects 
shoulder and elbow movement. Narakas Group 2 (involving C5, C6 and C7 nerves) is 
similar to Group 1 but also affects the movement of the wrist (144). Both Narakas 
Groups 1 and 2 are also known as Erb’s palsies – the latter with the ‘waiter’s tip’ 
presentation, due to problems with wrist extension (141). Narakas Group 3 involves 
C5, C6, C7, C8 and T1 nerves, resulting in total paralysis of the arm and Narakas 
Group 4 is the same as Narakas Group 3 with the addition of miosis (constriction of 
pupil), ptosis (drooping of eyelid) and anhidrosis (lack of sweating), collectively known 
as Horner’s syndrome (144). There are other classification methods for these injuries, 
such as the Sunderland Classification (145) and Impairment Rating Scale (146), but 
the Narakas Classification Scale is the most commonly used (147).  
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In the UK and Republic of Ireland, the incidence of OBPs in 1998-1999 was estimated 
at 0.42 per 1,000 live births (1 in 2,300 births), with 52% of infants fully recovering from 
their injuries at 6 months (141). The Birthplace in England study, which investigated 
perinatal and maternal outcomes by planned place of birth, reported a similar OBPI 
incidence rate of 0.4 per 1,000 births in low risk women (99% CI 0.2-1.0) but a higher 
rate of 0.8 per 1,000 births in higher risk women (99% CI 0.3-2.3) in 2008-2010 (148). 
In this study, low and higher risk women were defined by the absence (low risk) or 
presence (higher risk) of any of the risk factors listed in the 2007 NICE intrapartum 
care guideline prior to the onset of labour (148,149). A review of 53 papers found the 
OBPI rate to be 1.5 per 1,000 births from US studies compared to 1.3 per 1,000 births 
from publications from other countries (142). In the same review, the rate of permanent 
OBPI in the US was estimated to be between 0.11-0.22 per 1,000 births compared to 
0.29-0.37 per 1,000 births in other countries (142).  
 
Despite the relative rarity, permanent OBPIs are important and can have significant 
implications for the affected individual, their family and the health system in general. 
A permanent OBPI is likely to have a substantial impact on the quality of life of an 
individual. Quality of life measures, such as utility scores, can be crucial components 
of economic evaluations, particularly cost-utility analyses. To date, the only utility 
scores related to OBPIs in the published literature have been assigned by a team of 
healthcare professionals predominantly specialising in urogynaecology or maternal-
fetal medicine (150). These utility scores were agreed by an expert panel with limited 
experience of managing OBPIs and no validated health status questionnaires were 
used. In addition, the utility scores in this study were often attributed to combinations 
of mother-newborn clinical scenarios – only one utility score was assigned to 
permanent OBPIs in isolation and this was for mild to moderate injuries, which were 
not clarified any further (150). Furthermore, it was difficult to ascertain whether these 
quality of life measures were determined using the perspective of the mother, the child 
or both. These issues therefore raise concerns about the relevance of these utility 
scores as accurate measures of the quality of life of individuals with OBPIs. Involving 
individuals who suffer from permanent OBPIs may provide a more realistic 
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Permanent OBPIs can also affect the quality of life of caregivers. There is a growing 
body of research investigating the impact of brachial plexus injuries on families and 
caregivers. For example, one small mixed-methods study reported that OBPI surgery 
for the affected child had a significant impact on the child’s family (p=0.02), but the 
severity of the injury did not (p=0.62) (151). In another study assessing the impact of 
both OBPIs and non-obstetric brachial plexus injuries on caregivers, severity was only 
marginally associated with impact on the family (p=0.05) (152). A small qualitative 
study involving 23 mothers of children with OBPIs illustrated the psychological distress 
attached to these injuries, such as anger with the diagnosis, preoccupation with the 
injury and constantly questioning the adequacy of the care they are providing (153). A 
Turkish study of 18 participants found that mothers of children who had fully recovered 
had lower depression and anxiety levels compared to mothers of children with 
permanent injuries (154). These studies begin to reveal the effects of OBPIs on 
caregivers and families, but as yet, there have been no attempts to present the quality 
of life of caregivers in the form of utility scores, which could then in turn be used in 
economic evaluations. The health benefits to informal caregivers are often forgotten 
in economic evaluations of healthcare interventions. However, NICE in England does 
acknowledge that the health effects on caregivers should be considered in economic 
evaluations (72) and the Second Panel on Cost-Effectiveness in Health and Medicine 
in the US also shares this view (155). 
 
Finally, OBPIs are important causes for litigation and therefore also affect the wider 
health system. From 1993 to 2002, there were 356 claims related to OBPIs in England 
(156). From 2000 to 2010, there were 250 shoulder dystocia claims in England, with 
a total value of over £103 million (1). Whilst only 20% of these claims were explicitly 
settled due to inappropriate manoeuvres or excessive traction, it is likely that the 
remainder were also settled due to permanent OBPIs (1). This is money that could 
otherwise have been spent on frontline patient care. 
 
Such potentially life-changing injuries warrant investigation into how they affect the 
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This chapter has the following aims: 
• To determine the quality of life of adults with OBPIs 
• To determine the quality of life of caregivers of children with permanent OBPIs 
• To compare the quality of life of both of these cohorts with that of the general 
population 
• To check for disparities in quality of life in both of these cohorts using a range 
of adult/caregiver/child characteristics 
Addressing these aims will provide tailored and meaningful utility scores that could be 
used in future economic evaluations of interventions designed to reduce OBPIs. 
 
2.2 Methods 
Two studies, collectively known as Erb’s palsy Quality of Life Studies (E=QuaLS), 
were designed to help achieve the aims. The first study assessed the quality of life of 
adults with OBPIs, which will now be referred to as E=QuaLS Affected adults. The 
second study assessed the quality of life of caregivers of children with permanent 
OBPIs, subsequently referred to as E=QuaLS Caregivers. Both involved the 
completion of quality of life and characteristics questionnaires. 
 
2.2.1 Ethical approval 
The studies were approved by the Faculty of Health Sciences Research Ethics 
Committee, University of Bristol (39641 and 39681).  
 
2.2.2 Study recruitment and samples 
E=QuaLS were designed and conducted with the support of the Erb’s Palsy Group 
which is a registered UK charity that provides support for those affected by OBPIs. 
The chairperson and other members of the Erb’s Palsy Group helped publicise 
E=QuaLS and were responsible for recruiting participants. Recruitment occurred from 
September 2016 till July 2017.  
 
Individuals aged 18 years old or over with permanent OBPIs were eligible for 
E=QuaLS Affected adults. A permanent OBPI was defined as any OBPI lasting for 12 
months or longer from birth (113). Only UK residents were considered for this study.  
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Caregivers of children (<18 years old) with permanent OBPIs were eligible to 
participate in E=QuaLS Caregivers. As before, permanent OBPIs were defined as any 
OBPI present for 12 months or more from birth (113). A caregiver was defined as 
anyone responsible for looking after the child with the injury. Again, only UK residents 
were allowed to take part in this study.  
 
Both E=QuaLS Affected adults and E=QuaLS Caregivers were advertised on the Erb’s 
Palsy Group website, newsletter and social media pages. Interested individuals who 
met the inclusion criteria for either study had to contact the Erb’s Palsy Group to 
register their interest. Potential participants were then sent a study information leaflet 
and an ‘agreement to participate’ template e-mail to return back if they still wished to 
participate. The template e-mail expressed consent to take part, preference on how to 
be contacted (via post or telephone) and if by telephone, a convenient time to be 
phoned (see 2.7 Chapter appendix). All interested participants could give consent to 
take part in E=QuaLS Affected adults or E=QuaLS Caregivers once they felt they had 
sufficient time to read the information leaflets and consider their options.  
 
A member of the Erb’s Palsy Group was in charge of forwarding lists of interested and 
eligible participants (for both studies) requesting to complete the questionnaires by 
phone to a non-medical administrator (hospital-based secretary). The administrator 
was funded by the charity and tried to contact each participant on up to three separate 
dates. If no contact had been established on any of these three occasions, the 
questionnaires and a stamped, addressed envelope were sent by the Erb’s Palsy 
Group to the participants.  
 
The annual Erb’s Palsy Group fun day was also attended to advertise the studies and 
recruit participants using paper copies of the questionnaires and ‘agreement to 
participate’ template. As the attendance list was known prior to the event, the 
information leaflets for both studies were e-mailed to the attendees in advance to 
explain what the studies involved and to ensure that there was sufficient time for 
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The administrative role of the Erb’s Palsy Group (advertising, recruitment, coordination 
of spreadsheets and postage of questionnaires) and the use of an external, non-
medical administrator were intended to reduce the risk of influencing questionnaire 
responses from participants.  
 
2.2.3 Questionnaires  
 
2.2.3.1 E=QuaLS Affected adults 
In this study, participants were asked to complete an EQ-5D-5L questionnaire and a 
characteristics questionnaire either by post or by telephone. The EQ-5D-5L 
questionnaire was developed by the EuroQoL Group and is a generic, preference-
based instrument assessing health over five dimensions: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression (157). Within each health 
dimension, there are five levels of functionality: no problems, slight problems, 
moderate problems, severe problems or extreme problems/unable to function. The 
EQ-5D-5L questionnaire can be found in 2.7 Chapter appendix. The EQ-5D 
questionnaires are the preferred generic health status instruments of NICE (72). There 
is a more established 3L version of the EQ-5D questionnaire (with only 3 levels for 
each health dimension) but the 5L version was chosen for this research as it has been 
developed to try and improve the instrument’s sensitivity in detecting small changes 
in health (157). As the EQ-5D questionnaires (3L or 5L versions) are preference-
based, the responses can be converted into utility scores using published value sets 
(158,159). These utility scores can then be used to determine the Quality Adjusted 
Life Years (QALYs) typically used in cost-utility analyses. 
 
Socio-demographic and clinical information for each participant was collected in the 
characteristics questionnaire (see 2.7 Chapter appendix). Socio-demographic data 
included age, gender, marital status, education status, employment status and 
disability benefits status. Clinical data consisted of hand preference, site of OBPI, 
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2.2.3.2 E=QuaLS Caregivers 
For this study, participants were asked to complete an EQ-5D-5L questionnaire (157), 
a characteristics questionnaire and an Adult Caregiver Quality of Life (AC-QoL) 
questionnaire (160) either by post or by telephone. The EQ-5D-5L questionnaire was 
selected for the same reasons previously mentioned.  
 
The characteristics questionnaire for E=QuaLS Caregivers provided socio-
demographic and clinical information for the caregiver and the child being cared for 
(see 2.7 Chapter appendix). Socio-demographic data for the caregiver consisted of 
age, gender, relationship to child, marital status, education status, employment status 
and whether the child was living with the caregiver. Socio-demographic details of the 
child included age, gender and education status. Clinical information included medical 
conditions for the caregiver and for the child, severity of the OBPI, previous OBPI 
surgery and other medical conditions. 
 
The AC-QoL questionnaire is a generic instrument assessing multiple domains of 
functioning in caregivers (160) (see 2.7 Chapter appendix). It was designed with input 
from caregivers who looked after people with both physical and/or mental health needs 
(160), and as such, is more applicable to caregivers in general than other 
questionnaires which assess the quality of life of people caring for patients with 
specific conditions (161,162). Furthermore, the AC-QoL questionnaire also attempts 
to capture the positive aspects of caregiving, like personal growth and sense of value 
(160). This offers a more balanced outlook on the quality of life associated with caring. 
Originally, the intention was to develop an algorithm that could map AC-QoL scores to 
the EQ-5D value sets, which would allow caregiver-specific utility scores and 
therefore, QALYs to be calculated. However, as the focus and direction of the thesis 
changed over time, this was not pursued.  
 
2.2.4 Data management 
All completed questionnaires were returned directly to the research office. Data 
management (including cleaning and coding) was conducted by me. Participants were 
given a unique study identification number and their details were input anonymously 
into electronic spreadsheets. These files were saved in a secure, online research data 
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storage facility managed by the University of Bristol and all paper copies of the 
completed questionnaire forms were stored in a locked filing cabinet in the research 
office. Both electronic and hard copy data will be retained securely for a minimum of 
10 years after the studies have been completed, as per the Medical Research Council 
guidelines (163).  
 
2.2.5  Analyses 
Analyses was perfomed using Stata version 14.2 (StataCorp, Texas, USA) and 
Microsoft® Excel for Mac. 
 
2.2.5.1 Assessment of adult and caregiver quality of life  
Quality of life was assessed using utility scores derived from the items collected in the 
EQ-5D-5L questionnaires. The EQ-5D-5L responses were mapped to an EQ-5D-3L 
valuation set (158), as recommended by NICE (164). The mapping process was 
performed using the eq5dmap command in Stata (165). Data from a Visual Analogue 
Scale (VAS) were also collected as part of the EQ-5D-5L questionnaire. However, 
these data were not required for the calculation of the utility scores so have not been 
presented.  
 
The utility scores of adults with an OBPI and caregivers of children with a permanent 
OBPI were compared with population norms reported in the 2008 Health Survey for 
England (166). The population norms calculated from the European VAS value set 
were used (167). Welch’s two-sample t-test was used to compare the study means 
and the population norms. Overall means were computed and compared as well as 
means categorised by gender, which was the only subcategory available.  
 
2.2.5.2 Assessment of participant characteristics and the utility score  
Univariable and multivariable linear regression analyses were conducted to assess 
the relationships between participant characteristics and the utility scores. Robust 
standard errors (using Huber-White sandwich estimators) were used for all of the 
regressions. The strength of evidence against the null hypothesis (that there is no 
association between the variable and the utility score) was indexed by the p-value 
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derived from the regressions, with increasing evidence against the null hypothesis with 
decreasing p-values.   
 
Variables with weak to strong evidence of association (p-value ≤0.10) with the utility 
score in the univariable analyses were considered for inclusion in the initial 
multivariable linear regression models. The following variables were also included in 
the initial multivariable regression modelling, regardless of their strength of evidence 
of association in the univariable analyses:  
• Age (for E=QuaLS Affected adults and E=QuaLS Caregivers) 
• Gender (for E=QuaLS Affected adults and E=QuaLS Caregivers) 
• Marital status (for E=QuaLS Affected adults and E=QuaLS Caregivers) 
• Employment status (for E=QuaLS Affected adults and E=QuaLS Caregivers) 
• Education status (for E=QuaLS Affected adults and E=QuaLS Caregivers) 
• Having ≥ 1 medical condition (for E=QuaLS Affected adults and E=QuaLS 
Caregivers) 
• Child age (for E=QuaLS Caregivers) 
• Child having ≥ 1 medical condition (for E=QuaLS Caregivers) 
Age, gender, marital status, employment status and education status have previously 
demonstrated some influence on perceptions of health (168-170). Having ≥ 1 medical 
condition (for the adult, caregiver or child) was also deemed to be an important 
variable.   
 
The influence of each characteristic on the initial multivariable regression models was 
investigated. Variables were retained in the final multivariable models if their p-value 
was ≤0.05 (Wald test) and/or if their removal impacted the effect size of the other 
parameters by >30%. Influential observations in the final models were identified using 
Cook’s distance and removed. In the final multivariable model, p-values around 0.05 
were assumed to represent weak evidence against the null hypothesis and p-values 
<0.001 as strong evidence (171).  
 
The Narakas score was originally chosen as a variable of interest a priori as it is a 
direct measure of the severity of OBPIs. Those with more severe forms of the condition 
may have worse quality of life. However, significant proportions of participants in both 
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E=QuaLS Affected adults (72%) and E=QuaLS Caregivers (59%) were unsure of their 
own or their child’s Narakas classification. As a consequence, it was not possible to 
perform any meaningful analyses with this characteristic. Previous surgery performed 
directly as a consequence of an OBPI was then selected as a proxy for the severity of 
an OBPI and forced into the multivariable models. Research has shown that previous 
OBPI surgery for an affected child has a significant impact on the child’s family (151). 
Previous OBPI surgery was also forced into the multivariable models in E=QuaLS 
Caregivers to test whether this was true for caregivers.  
 
Additional analyses and model checks were also performed on the final models to 
assess the following: 
• Effects of participants with missing data 
• Normal distribution of residuals in final models 
• Constant variance of errors (homoscedasticity) in final models 
• Effects of influential observations on the final models 
 
2.2.5.3 Assessment of the AC-QoL score and the utility score 
The correlation between the AC-QoL questionnaire scores and the utility scores was 
assessed using Spearman’s rank correlation coefficient. Again, p-values around 0.05 
were assumed to represent weak evidence against the null hypothesis (that there is 
no correlation between the two scores) and p-values <0.001 as strong evidence (171). 
 
 
2.3 Results  
2.3.1 E=QuaLS Affected adults 
2.3.1.1 Response rate and data flow  
In this study, 127 people registered their interest in participating but only 50 
participants were recruited (response rate 39%). To start with, 2 participants were 
excluded as they had incomplete EQ-5D-5L scores, leaving a total of 48 participants 
for assessing the quality of life. A further 6 participants were then excluded as their 
questionnaires contained missing data, leaving 42 participants for the regression 


































2.3.1.2 Study population 
All the participant characteristics for E=QuaLS Affected adults are summarised in 
Table 2-1, including subcategories for medical conditions. The median age of the 
participants in this study was 28 years, with an interquartile range of 22 years. The 
majority of the participants were female (72%) and almost two thirds had had surgery 
as a consequence of their OBPI (64%). A significant proportion of this study population 
did not know their Narakas score (72%). Two thirds of the subjects had one or more 
medical condition. There were missing data for education status (2%), employment 
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Age (years)* 28 (24, 46) 
Age subcategories (years)  
£24 18 (36) 
25-39 14 (28) 
40-54 6 (12) 
³55 12 (24) 
Gender  
Male 14 (28) 
Female 36 (72) 
Marital status  
No partner 33 (66) 
With partner 17 (34) 
Education status  
Secondary school/ college 20 (40) 
Higher education 29 (58) 
Missing data 1 (2) 
Employment status  
Manual work 6 (12) 
Non-manual work 18 (36) 
Not working 22 (44) 
Missing data 4 (8) 
Disability benefits  
Receives benefits related to 
OBPI 19 (38) 
Receives non-related benefits 1 (2) 
Receives no benefits 29 (58) 
Missing data 1 (2) 
Hand preference  
Left 19 (38) 
Right 31 (62) 
Injury site  
Left 26 (52) 
Right 23 (46) 
Both left and right 1 (2) 
Previous OBPI surgery  
Yes 32 (64) 
No 18 (36) 
Narakas (severity score)  
Know Narakas score 12 (24) 
Don’t know Narakas score 36 (72) 
Missing data 2 (4) 
Has ≥ 1 medical condition 33 (66) 
*Median, 25th, and 75th centiles presented as the 
distribution for age was skewed 
Table 2-1 Participant characteristics for E=QuaLS Affected adults 
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2.3.1.3 Quality of life (Affected adults) 
Subjects with incomplete EQ-5D-5L scores were excluded from this analysis (n=2).  
The mean utility scores stratified by gender are presented in Table 2-2. The overall 
mean utility score for adults with OBPIs was 0.56. The mean utility scores for males 
and females were 0.64 and 0.53 respectively. When compared with the general 
population, adults with OBPIs in this study had worse utility scores (and therefore 
quality of life) (p<0.001). This remained the case when comparing by male (p=0.001) 
and female (p<0.001) subcategories.  
 











SD* Difference 95% CI 
p- 
value 
Overall 0.56 (48) 0.28 0.86 0.24 -0.30 -0.38, -0.22 <0.001 
Male 0.64 (13) 0.21 0.88 0.16 -0.24 -0.37, -0.11 0.001 
Female 0.53 (35) 0.30 0.85 0.18 -0.32 -0.42, -0.22 <0.001 
 
*Obtained and calculated from 2008 Health Survey for England (166) 
 
 
2.3.1.4 Adult characteristics and the utility score 
Participants with missing data in any of the variables were further excluded, leading to 
a final sample of 42 for the regression analyses. The univariable analyses are 
summarised in Table 2-3. Previous OBPI surgery did not influence the utility score 
(p=0.411). Receiving disability benefits related to the OBPI appeared to be associated 
with the utility score (p=0.002). 
 
Having one or more medical condition also appeared to be associated with the utility 
score (p=0.028), as did having one or more musculoskeletal condition (p=0.003). 
Some evidence of weak association was found with having a partner (p=0.077) and 
having one or more gastrointestinal condition (p=0.087). No evidence of effect was 












Adult Characteristics n (%) Coefficient 95% CI R2 p-value 
Age (years) 42 (100) 0.0005 
-0.0037, 
0.0048 0.0015 0.801 




0.03 -0.11, 0.17 
0.03 
0.656 
40-54 -0.09 -0.46, 0.28 0.610 
³55 0.04 -0.15, 0.24 0.649 
Gender Ref Male 42 
(100) -0.06 -0.21, 0.09 0.01 0.445 Female 
Marital status Ref No partner 42 
(100) 0.14 -0.02, 0.29 0.07 0.077 Partner 
Education status Ref secondary 
school or college 42 
(100) -0.0046 -0.17, 0.16 0.0001 0.954 
Higher education 
Employment status Ref Not 
working     0.284 
Manual work  42 
(100) 
0.06 -0.14, 0.27 
0.06 
0.525 
Non-manual work  0.13 -0.03, 0.29 0.118 
Disability benefits No benefits 42 
(100) -0.26 -0.42, -0.10 0.26 0.002 Receives benefits related to OBPI 
Handed preference Ref Left 42 
(100) 0.02 -0.13, 0.17 0.0021 0.758 Right 
Injury site Ref Left      
Right 42 
(100) 
-0.11 -0.26, 0.05 0.14 0.174 
Both Omitted as only one observation 
Narakas Ref Know Narakas 42 
(100) -0.02 -0.26, 0.22 0.0010 0.876 Don’t know Narakas 
Previous OBPI surgery Ref No 42 
(100) -0.06 -0.21, 0.09 0.01 0.411 Yes 
Has ≥ 1 medical condition  
Ref None 42 (100) -0.15 -0.29, -0.02 0.09 0.028 Yes 
Has ≥ 1 cardiovascular condition 
Ref None 42 (100) -0.07 -0.32, 0.17 0.01 0.548 Yes 
Has ≥ 1 respiratory condition  
Ref None 42 (100) 0.13 -0.04, 0.30 0.03 0.126 Yes 
Has ≥ 1 gastrointestinal condition 
Ref None 42 
(100) -0.13 -0.27, 0.02 0.01 0.087 Yes 
Has ≥ 1 musculoskeletal condition 
Ref None 42 (100) -0.28 -0.46, -0.10 0.26 0.003 Yes 
Has ≥ 1 neurological condition  
Ref None 42 (100) -0.17 -0.45, 0.10 0.03 0.210 
Yes 
Has ≥ 1 endocrine condition  
Ref None 42 (100) -0.13 -0.36, 0.10 0.02 0.270 Yes 
Has ≥ 1 mental health condition  
Ref None 42 (100) -0.15 -0.43, 0.13 0.03 0.282 Yes 
Has ≥ 1 other condition  
Ref None 42 (100) -0.01 -0.13, 0.11 0.0002 0.876 Yes 
Table 2-3 Univariable regression analyses for E=QuaLS Affected adults 
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The variables selected for the initial multivariable linear regression model are 
presented in Table 2-4, which also describes the process used to determine the final 
model. Although there was weak evidence of association with having one or more 
gastrointestinal condition (p=0.087) and stronger evidence with having one or more 
musculoskeletal condition (p=0.003), these variables were excluded from the initial 
multivariable model to avoid collinearity in the variable accounting for the presence of 
any medical comorbidities. Three influential observations were identified and 
removed. The final model is presented in Table 2-5 and contains the following 





There was some evidence that adults with previous OBPI surgery had better utility 
scores, and therefore quality of life, than those who had no surgery after adjusting for 
the other variables in the final model (p=0.040). Adults in non-manual jobs also 
appeared to have better utility scores than those without employment after adjusting 
for previous OBPI surgery, marital status and disability benefits status (p=0.005). 
Full 
model Variables of full model 
Test 
model Variables of test model 
Tested 
variable 
Wald test  
(p-value) 
M1 U=I+Su+Em+Db+Med+M+A+G+Ed M2 U=I+Su+Em+Db+Med+M+A+G Ed 1.000 
M2 U=I+Su+Em+Db+Med+M+A+G M3 U=I+Su+Em+Db+M+A+G Med 0.985 
M3 U=I+Su+Em+Db+M+A+G M4 U=I+Su+Em+Db+M+G A 0.361* 
M3 U=I+Su+Em+Db+M+A+G M5 U=I+Su+Em+Db+A+G M 0.209* 
M3 U=I+Su+Em+Db+M+A+G M6 U=I+Su+Em+Db+M+A G 0.189 
M6 U=I+Su+Em+Db+M+A M7 U=I+Su+Em+Db+M A 0.477 
M7 U=I+Su+Em+Db+M M8 U=I+Su+Db+M Em 0.061* 
M7 U=I+Su+Em+Db+M M9 U=I+Su+Em+Db M 0.049 
M7 U=I+Su+Em+Db+M M10 U=I+Su+Em+M Db 0.001 
      
* variable retained as influencing effect size of other parameters by >30% 
U Utility score Med Has ≥1 medical condition   
I Intercept M Marital status   
Su Previous OBPI surgery A Age   
Em Employment status G Gender   
Db Disability benefits status Ed Education status  
  
Table 2-4 Selection process for final model for E=QuaLS Affected adults 
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There was no evidence of any difference in utility scores between adults in manual 
work and those without employment (p=0.835). Adults with a partner also had better 
utility scores than those without partners after accounting for the other variables in the 
model (p=0.009). In contrast, adults receiving disability benefits related to their injury 
had worse utility scores and therefore quality of life compared to those receiving no 
disability benefits (p=0.005). 
 
The influential observations were reinstated and the final multivariable model was 
rerun. Interestingly, previous OBPI surgery was no longer associated with the adult 
utility score after the inclusion of the three influential observations (p=0.281). The 
inferences for the other variables in the final adult multivariable model remained the 
same. The presence of missing data from 4 (8%) adult participants did not impact on 
the conclusions drawn from the final multivariable model. Details of the additional 
analyses and model checks for E=QuaLS Affected adults can be found in the 2.7 
Chapter appendix. 
 
2.3.2 E=QuaLS Caregivers 
2.3.2.1 Response rate and data flow 
This study attracted the interest of 132 people but recruited 78 participants (response 
rate 59%). Initially, one participant with 31 missing data points was excluded, leaving 
77 caregivers for assessing the quality of life. A further 8 participants were then 
excluded as their questionnaires contained missing data, leaving 69 participants for 
the regression analyses. This is summarised in a flowchart in Figure 2-2. 
Final multivariable model for adults (n=39) R2 0.42 
Variable Coefficient 95% CI p-value 
Previous OBPI surgery 
(Reference: No surgery) 0.13 0.01, 0.25 0.040 
Employed in manual work 0.02 -0.14, 0.17 0.835 
Employed in non-manual work 
(Reference: Not working) 0.18 0.06, 0.30 0.005 
Receives disability benefits related to 
OBPI 
(Reference: No benefits) 
-0.18 -0.31, -0.06 0.005 
Has partner 
(Reference: No partner) 0.14 0.04, 0.25 0.009 
 
Table 2-5 Final model for E=QuaLS Affected adults 
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2.3.2.2 Study population  
All the caregiver characteristics for E=QuaLS Caregivers are presented in Table 2-6. 
The mean age of caregivers was 40 years, with a standard deviation of 8. Almost all 
of the caregivers were female (92%) and many caregivers had a partner (74%). A high 
proportion of caregivers were in employment (82%) and just over half (58%) suffered 
from one or more medical condition.  
 
All the child characteristics are summarised in Table 2-7. The median age for children 
with permanent OBPIs was 8 years, with an interquartile range of 9. There was a 
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• Incomplete EQ-5D-5L 
scores (n=1) 
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• Containing any missing 
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of the children had had previous OBPI surgery (71%). Nearly half of the children had 




























There were missing data for the following variables: caregiver marital status (1%), 
caregiver education status (5%), caregiver employment status (1%), whether the child 
lived with the caregiver (37%), child education status (1%), Narakas score (3%) and 
the child having one or more medical condition (1%). 
 
2.3.2.3 Quality of life (Caregivers) 
Subjects with incomplete EQ-5D-5L scores were excluded from this analysis (n=1). 
The overall mean utility score for caregivers of children with permanent OBPIs was 
0.80, which was lower than the population norm (p=0.007), suggesting poorer quality 
of life compared to the general population. The mean utility score for male caregivers 
was 0.89 and for female caregivers it was 0.79. Female caregivers had worse utility 
Characteristics Total (n=78) 
Caregiver n (%) 
Age (years)* 40 (8) 
Age subcategories (years)  
£35 24 (31) 
36-45 35 (45) 
³46 19 (24) 
Gender  
Male 6 (8) 
Female 72 (92) 
Relationship to child  
Father 6 (8) 
Mother 72 (92) 
Marital status  
No partner 19 (24) 
With partner 58 (74) 
Missing 1 (1) 
Education status  
Secondary school/ college 41 (53) 
Higher education 33 (42) 
Missing 4 (5) 
Employment status  
Working 64 (82) 
Not working 13 (17) 
Missing 1 (1) 
Has ≥ 1 medical condition 45 (58) 
*Mean and standard deviation presented as caregiver age 
had a normal distribution 
Table 2-6 Summary of caregiver characteristics for E=QuaLS Caregivers 
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scores (and therefore quality of life) compared to the general population (p=0.010) 
whereas there was no evidence of a difference in utility scores when comparing by 


































Characteristics Total (n=78) 
Child n (%) 
Age (years)* 8 (2,13) 
Age subcategories (years)  
1 10 (13) 
2-5 25 (32) 
6-12 22 (28) 
13-17 21 (27) 
Gender  
Male 35 (45) 
Female 43 (55) 
Education status  
Too young for school 28 (36) 
Primary school 19 (24) 
Secondary school/college 30 (38) 
Missing 1 (1) 
Narakas (severity score)  
Know Narakas score 30 (38) 
Don’t know Narakas score 46 (59) 
Missing 2 (3) 
Previous OBPI surgery  
Yes 55 (71) 
No 23 (29) 
Has ≥ 1 medical condition  
Yes 33 (42) 
No 44 (56) 
Missing 1 (1) 












SD* Difference 95% CI 
p- 
value 
Overall 0.80 (77) 0.19 0.86 0.24 -0.06 -0.10,  -0.02 0.007 
Male 0.89 (6) 0.15 0.88 0.16 0.01 -0.15, 0.17 0.877 
Female 0.79 (71) 0.19 0.85 0.18 -0.06 -0.11,  -0.01 0.010 
 
*Obtained and calculated from 2008 Health Survey for England (166) 
Table 2-7 Summary of child characteristics for E=QuaLS Caregivers 
Table 2-8 Mean utility scores for caregivers and comparison with population 
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2.3.2.4 Caregiver/child characteristics and the utility score  
Any remaining subjects with missing data (n=8) were excluded prior to the regression 
analyses. One variable (whether the child lived with the caregiver) was also excluded 
from the regression analyses as 37% of its data were missing.  
 
The univariable regression analyses for E=QuaLS Caregivers are provided in Table 
2-9 and Table 2-10. Previous OBPI surgery (for the child) did not influence the utility 
score of the caregivers (p=0.116). There appeared to be weak associations between 
the following caregiver variables and the utility score: gender (p=0.087), relationship 
(p=0.087), having one or more respiratory condition (p=0.086), having one or more 
endocrine condition (p=0.099) and having one or more oncological condition 
(p=0.072).  
 
The following caregiver variables had stronger evidence of association with the utility 
score: having one or more medical condition (p=0.001), having one or more 
cardiovascular condition (p=0.001), having one or more musculoskeletal condition 
(p=0.001) and having one or more mental health condition (p=0.007).   
 
The evidence of effect of having one or more cardiovascular condition, having one or 
more mental health condition and having one or more oncological condition should be 
interpreted cautiously due to the small number of observations for these variables. 
The remaining caregiver variables did not influence the caregiver utility score (Table 
2-9) 
 
Having a child with one or more musculoskeletal condition appeared to be strongly 
associated with the caregiver utility score (p<0.001). As before, this association must 
be interpreted with caution given the extremely small number of observations (n=2). 
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Table 2-9 Univariable regression analyses for E=QuaLS Caregivers (caregivers) 
 
Caregiver Characteristics n (%) Coefficient 95% CI R2 p-value 
Age (years) 69 (100) 0.0005 -0.0047, 0.0056 0.0003 0.859 
Age subcategories (years) Ref £35     0.854 
36-45 69 (100) -0.02 -0.11, 0.07 0.0035 0.646 
³46 -0.03 -0.15, 0.10 0.663 
Gender Ref Male 
69 (100) -0.11 -0.23, 0.02 0.02 0.087 Female  
Relationship Ref Father 69 (100) -0.11 -0.23, 0.02 0.02 0.087 
Mother 
Marital status Ref No partner 69 (100) -0.01 -0.14, 0.12 0.0004 0.892 With partner 
Education status Ref secondary 
school/college 69 (100) 0.01 -0.08, 0.10 0.0006 0.832 
Higher education  
Employment Ref Not working 69 (100) 0.15 -0.05, 0.36 0.07 0.140 Working 
Has ≥ 1 medical condition Ref 
None 69 (100) -0.14 -0.22, -0.06 0.13 0.001 
Yes 
Has ≥ 1 CVS condition Ref None 
69 (100) -0.09 -0.14, -0.04 0.01 0.001 Yes* 
Has ≥ 1 respiratory condition Ref 
None 69 (100) -0.11 -0.24, 0.02 0.05 0.086 
Yes 
Has ≥ 1 GI condition Ref None 69 (100) 0.06 -0.11, 0.22 0.01 0.507 Yes 
Has ≥ 1 musculoskeletal condition 
Ref None 69 (100) -0.28 -0.45, -0.12 0.30 0.001 
Yes 
Has ≥ 1 neurological condition Ref 
None 69 (100) -0.14 -0.33, 0.05 0.08 0.142 
Yes 
Has ≥ 1 endocrine condition Ref 
None 69 (100) -0.14 -0.31, 0.03 0.08 0.099 
Yes 
Has ≥ 1 mental health condition 
Ref None 69 (100) -0.23 -0.40, -0.07 0.16 0.007 
Yes** 
Has ≥ 1 oncological condition Ref 
None 69 (100) -0.30 -0.63, 0.03 0.10 0.072 
Yes* 
Has ≥ 1 other condition Ref None 69 (100) -0.01 -0.17, 0.14 0.0004 0.869 
Yes 
      
 











Child Characteristics n (%) Coefficient 95% CI R2 p-value 
Age (years) 69 (100) -0.0012 -0.01, 0.01 0.0013 0.748 
Age subcategories (years) Ref 1     0.7257 
2-5 69 
(100) 
0.0024 -0.10, 0.10 
0.02 
0.963 
6-12 -0.07 -0.20, 0.06 0.313 
13-17 -0.01 -0.13, 0.11 0.857 
Gender Ref Male 69 
(100) -0.01 -0.10, 0.09 0.0002 0.906 Female 
Education status Ref Too young for 
school     0.829 
Primary school 69 
(100) 
0.02 -0.08, 0.12 0.01 0.687 
Secondary school/college -0.02 -0.12, 0.09 0.760 
Previous OBPI surgery Ref No 69 
(100) -0.06 -0.14, 0.02 0.03 0.116 Yes 
Narakas Ref Knowing 69 
(100) 0.02 -0.07, 0.12 0.0042 0.602 Not knowing Narakas 
Have ≥ 1 medical condition Ref 
None 69 (100) -0.03 -0.12, 0.07 0.0047 0.587 Yes 
Has ≥ 1 CVS condition Ref None 69 
(100) 0.02 -0.08, 0.13 0.0010 0.661 Yes 
Has ≥ 1 respiratory condition Ref 
None 69 (100) -0.09 -0.26, 0.09 0.03 0.336 Yes 
Has ≥ 1 GI condition Ref None 69 
(100) 0.10 -0.06, 0.26 0.01 0.206 Yes 
Has ≥ 1 musculoskeletal condition 
Ref None 69 (100) 0.20 0.15, 0.24 0.03 <0.001 Yes* 
Has ≥ 1 neurological condition Ref 
None 69 (100) 0.04 -0.06, 0.13 0.0037 0.431 Yes 
Has ≥ 1 endocrine condition Ref 
None 69 (100) Omitted as no observations Yes 
Has ≥ 1 mental health condition Ref 
None 69 
(100) -0.12 -0.28, 0.03 0.04 0.120 Yes 
Has ≥ 1 oncology condition Ref 
None 69 (100) Omitted as no observations Yes 
Has ≥ 1 other condition Ref None 69 
(100) 0.05 -0.05, 0.14 0.01 0.336 Yes 
      
 
*Only 2 observations  
Table 2-10 Univariable regression analyses for E=QuaLS Caregivers (child) 
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The variables selected for the initial multivariable linear regression model are 
presented in Table 2-11. The process used to determine the final model is also 
described here. Although there was evidence of association with some of the 
subcategories of medical conditions, these variables were excluded from the initial 
multivariable model to avoid collinearity in the variables accounting for the presence 
of medical comorbidities in the caregiver. 
 
 
Similarly, although there appeared to be strong evidence of an association between 
having a child with one or more musculoskeletal condition and the caregiver utility 
score (p<0.001), this variable was excluded to prevent collinearity in the variable for 
the presence of other medical conditions in the child. The caregiver relationship 
Full 
model Variables of full model 
Test 
model 




Wald test  
(p-value) 
N1 U=I+Su+A+G+M+Em+ Ed+Med+CA+CMed N2 
U=I+Su+A+G+Em+ 
Ed+Med+CA+CMed M 0.967 
N2 U=I+Su+A+G+Em+ Ed+Med+CA+CMed N3 
U=I+Su+A+G+Em+ 
Ed+Med+CMed CA 0.933 
N3 U=I+Su+A+G+Em+ Ed+Med+CMed N4 
U=I+Su+A+G+Em+ 
Med+CMed Ed 0.759 
N4 U=I+Su+A+G+Em+ Med+CMed N5 
U=I+Su+G+Em+ 
Med+CMed A 0.735* 
N4 U=I+Su+A+G+Em+ Med+CMed N6 
U=I+Su+A+G+Em+ 
Med CMed 0.682 
N6 U=I+Su+A+G+Em+Med N7 U=I+Su+G+Em+Med A 0.717 
N7 U=I+Su+G+Em+Med N8 U=I+Su+Em+Med G 0.118 
N8 U=I+Su+Em+Med N9 U=I+Su+Med Em 0.104* 
N8 U=I+Su+Em+Med N10 U=I+Su+Em Med 0.007 
     
*variable retained as influencing effect size of other parameters by >30% 
U Utility score G Gender (carer) Med 
 
Carer has ≥1 
medical condition 














Child has ≥1 
medical condition 





      
     
Table 2-11 Selection process for final model for E=QuaLS Caregivers 
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(p=0.087) was also excluded from the initial multivariable model as it was directly 
related to the gender of the caregiver. Six influential observations were identified and 
removed. The final model is presented in Table 2-12 and contains the following 
variables: previous OBPI surgery for child, caregiver employment status and having 









Previous OBPI surgery for the child was not associated with the caregiver utility score 
(p=0.869). Caregivers who worked appeared to have better utility scores compared to 
those without employment, after adjusting for the other variables in the final model 
(95% confidence interval (CI) 0.02, 0.20, p=0.024). In contrast, caregivers with one or 
more medical condition had worse utility scores, and therefore quality of life, than 
those who reported no health problems, after accounting for the other variables 
(p=0.001).  
 
The influential observations were reinstated and the final multivariable models were 
rerun. After the inclusion of the six influential observations, caregiver working status 
was no longer associated with the caregiver utility score (p=0.320) but the inferences 
for the other variables were unchanged. The presence of missing data from 1 (1%) 
caregiver did not impact on the conclusions drawn from the final multivariable model. 
Details of the additional analyses and model checks for E=QuaLS Caregivers can be 
found in the 2.7 Chapter appendix. 
 
2.3.2.5 Correlation between the AC-QoL score and the utility score 
Paired observations (n=67) were used to test for a correlation between the AC-QoL 
score and the utility score. A scatterplot of the two scores is presented in Figure 2-3. 
There is no clear linear relationship between the two scores.  
Final multivariable model for caregivers (n=63) R2 0.22 
Variable Coefficient 95% CI p-value 
Previous OBPI surgery for child 
(Reference: No surgery) -0.0050 -0.06, 0.05 0.869 
Working (caregiver) 
(Reference: Not working) 0.11 0.02, 0.20 0.024 
Has ≥1 medical condition (caregiver) 
(Reference: No medical comorbidities) -0.10 -0.16, -0.04 0.001 
Table 2-12 Final model for E=QuaLS Caregivers 
Chapter 2 
 
















Spearman’s rank correlation coefficient for the AC-QoL score and utility score was 
0.46 (p<0.001). There was therefore some evidence for a positive correlation between 




In this chapter, I have measured the quality of life associated with OBPIs with a 
recognised preference-based quality of life questionnaire (EuroQoL EQ-5D-5L). It is 
the first time that the quality of life of adults with OBPIs has been measured. The 
quality of life of caregivers of children with permanent OBPIs has not been investigated 
using a preference-based health status instrument until now.  
 
The mean utility score for adults with OBPIs was 0.56 (standard deviation 0.28) and 
for caregivers it was 0.80 (standard deviation 0.19). Both of these scores were lower 
than the population norms, suggesting that adults with OBPIs and caregivers of 
children with permanent OBPIs had worse quality of life compared to the general 
population (p<0.001 and p=0.007 respectively). This chapter also identified 
characteristics to consider when dealing with utility scores in populations of adults with 
OBPIs or caregivers of children with permanent OBPIs. For adults with OBPIs, 
Figure 2-3 Scatterplot of AC-QoL scores and utility scores 
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previous OBPI surgery, non-manual employment and having a partner were 
associated with the utility score, and therefore, quality of life. Receiving disability 
benefits related to the OBPI also influenced the utility score. For caregivers, 
employment status and the presence of one or more caregiver medical condition 
appeared to be associated with the utility score 
 
There have been very few publications regarding the utility scores associated with 
OBPIs. Culligan et al. estimated utility scores for various combinations of mother and 
child outcomes, some of which included permanent OBPIs. A utility score of 0.60 was 
assigned to mild-moderate OBPIs (150), which is similar to the mean utility score for 
adults with OBPIs (0.56) in this chapter (7% difference). However, the mean utility 
score from this work is a more reliable and accurate measure of the quality of life 
associated with OBPIs. Firstly, it was derived using a validated, preference-based 
quality of life instrument, rather than by estimation. Secondly, the utility scores 
presented here have involved participants suffering from the condition, instead of 
relying on professional judgement by a panel who rarely manage OBPIs. Lastly, the 
utility scores from E=QuaLS Affected adults have a clear perspective, unlike the 
estimates by Culligan et al. (150). The methods used in this chapter, and the utility 
scores calculated as a result, represent a significant improvement upon the previous 
literature. As such, the findings from this chapter could now supersede the old utility 
scores and be used in future economic evaluations of interventions targeting OBPIs. 
 
The EQ-5D-5L questionnaire was an appropriate instrument to use to calculate the 
utility scores in these cohorts. Despite being a generic instrument, the domains 
covered by the EQ-5D-5L, particularly self-care, usual activities, pain/discomfort and 
anxiety/depression, were relevant to OBPIs. No OBPI-specific instruments currently 
exist, although some recent qualitative research has identified some domains, such 
as arm/hand compensation and physical appearance (172), which would be worth 
including if a condition-specific instrument were to be developed.  
 
The best way of measuring and integrating the ‘spillover’ effects (the impact on 
caregivers and family members) of healthcare interventions into cost-effectiveness 
analyses is still debated (173). However, the EQ-5D questionnaire has been used to 
assess the health-related quality of life of caregivers of children with major congenital 
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anomalies (174) and autism (175). Generic health status instruments may not be able 
to fully capture the ‘spillover’ effects, particularly the potential positive aspects of caring 
(173). Despite this, some studies have demonstrated that the EQ-5D questionnaire 
has been able to detect changes in health-related quality of life in caregivers (174) and 
that it appears to be useful in measuring family members’ quality of life in economic 
evaluations (176). The evidence base supporting the EQ-5D-5L questionnaire is still 
currently lacking (177). However, the EQ-5D questionnaires remain the preferred 
health status instruments for NICE and the use of the 5L version is permitted (72). By 
using the EQ-5D-5L questionnaire for this work, the quality adjusted life years (QALYs) 
calculated from these utility scores would be comparable with the QALYs in other 
health technology assessments reviewed by NICE. 
 
Previous OBPI surgery was a reasonable proxy for the severity of the condition. Only 
a small proportion of adults (28%) and caregivers (41%) knew the Narakas score 
despite it being the most commonly used classification system for OBPIs (147). There 
are calls for the Narakas Classification Scale to be included as part of a common 
dataset for the initial assessment of OBPIs. These common datasets will provide some 
consistency in baseline measurements and improve future patient and caregiver 
awareness of the Narakas score (178). There is some evidence that having lower 
Narakas scores (I-II) reduces the likelihood of a permanent OBPI, and hence the need 
for surgery (179). Similarly, the presence of Horner’s syndrome, indicating Narakas 
score IV, increases the likelihood of a permanent OBPI and therefore operative 
management (179). In the final multivariable models, previous OBPI surgery was 
associated with the adult utility score but was not associated with the caregiver utility 
score. In comparison, one previous study has demonstrated that OBPI surgery had 
an impact on the child’s family (151).  
 
Instead of relying on participant awareness of the Narakas score, it may have been 
possible to develop simple questions that describe the different symptoms and 
problems related to each Narakas score. The responses to these questions could then 
be used to determine the Narakas score, and therefore, the severity of the condition. 
Involving adults with OBPIs and caregivers of children with permanent OBPIs in the 
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The AC-QoL questionnaire was included in E=QuaLS Caregivers to complement the 
EQ-5D questionnaire, as it has been designed to encompass multiple domains of 
functioning specifically related to caregiving (160). There was some evidence of a 
positive correlation between the AC-QoL score and the utility score. This relationship 
with a caregiver-focussed questionnaire may further support the use of the EQ-5D 
questionnaire in assessing the quality of life of caregivers. Despite this, it may still be 
useful to develop a mapping algorithm between the AC-QoL scores and the EQ-5D 
value sets, thereby allowing caregiver-specific utility scores to be derived. 
 
Linear regression models were suitable for analysing the associations between 
participant characteristics and the utility score. I did consider transforming the adult 
and caregiver utility scores as they both had skewed distributions. However, both final 
multivariable models satisfied the assumptions of linear regression (see additional 
analyses in the 2.7 Chapter appendix). This meant that the inferences from both final 
models were valid and transformation of the utility score was unnecessary.  
 
Whilst I mapped the EQ-5D-5L responses to an EQ-5D-3L valuation set as 
recommended by NICE, I did not use the suggested mapping method, which was 
developed by van Hout et al. (164,180). The approach by van Hout et al. has been 
recently criticised for its choice of data manipulation techniques (181) and for 
assuming independence between all the domains in the EQ-5D questionnaire (182). 
This assumption seems unreasonable given that significant pain is likely to impact on 
daily functioning as well as mental health. The eq5dmap command in Stata is mapping 
process based on a system of ordinal regressions and does not assume that the 
domains of the EQ-5D instrument are statistically independent (165,182). I used the 
EuroQoL Group dataset (180,183) as the reference for the mapping process. This 
dataset consists of a younger population and covers a broader range of diseases 
compared to the alternative reference dataset available (National Data Bank for 
Rheumatic Diseases) (184). Furthermore, the EuroQoL Group data was generated 
from 6 European countries, including England, making it the more relevant reference 




The quality of life associated with permanent obstetric brachial plexus injuries 
 63 
Adults with OBPIs may have lived with the condition for a long time and adapted to 
their situation. Furthermore, as these injuries were present from birth, there will be no 
comparative periods where they have been injury-free. These features may effectively 
‘normalise’ the injury and thus utility may not be affected by OBPIs. An alternative 
approach that would overcome this issue would be the use of capability measures, 
which would avoid individuals’ own preferences and instead rely on expert views (185). 
However, the data from E=QuaLS Affected adults does suggest that those with OBPIs 
do have lower utility scores, and therefore worse quality of life, compared to the 
general population. 
 
Measuring the quality of life of children (aged <18 years old) affected by OBPIs was 
not attempted. Young children may not have the cognitive capacity to comprehend or 
answer health related questions, and there are few preference-based, health status 
instruments derived from child populations (186,187). The Child Health Utility 9D 
(CHU 9D) is a generic health status instrument for children aged 7 to 11 years that 
has been valued using adult preferences (188). Although this conforms with NICE 
guidance (72), there has been research investigating methods for obtaining 
preferences from young children (189) and adolescents (190) for the CHU 9D 
questionnaire. Nevertheless, the QALYs generated from the CHU 9D questionnaire, 
regardless of the preference taken, would not be comparable to the EQ-5D derived 
QALYs in NICE health technology assessments. A small study (n=18) assessed the 
quality of life of adolescents (aged 10 to 17 years old) with permanent OBPIs using 
the Child Health Questionnaire and the Paediatric Outcomes Data Collection 
Instrument (191); whilst this provided some quantitative quality of life data, these 
scores cannot be used to calculate QALYs as they are not preference-based. There 
is a youth version of the EQ-5D questionnaire (EQ-5D-Y) but there are no valuation 
sets for this at present. Using the EQ-5D adult values for EQ-5D-Y would misrepresent 
a child’s health status (192). As a result, the EQ-5D-Y cannot generate reliable child 
QALYs for use in economic evaluations.  
 
Population norms reported in the 2008 Health Survey for England (166) were used in 
the absence of more recent evidence. Participants in E=QuaLS were from the UK but 
the utility scores were compared with English population norms from 2008 rather than 
UK population norms from 1998 (166). Firstly, as England accounts for a significant 
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proportion of the UK population, I felt that a set of English population norms would still 
be applicable to a UK cohort. Secondly, as the UK population norms were from nearly 
20 years ago, it was more appropriate to use the more up-to-date population norms 
available. I used the population norms calculated from the European Visual Analogue 
Scale (VAS) value set (167) to account for the fact that participants were from the UK 
and not purely England.  
 
OBPIs are rare and as such, participants were difficult to recruit. Collaborating with 
the Erb’s Palsy Group allowed access to their membership, the majority of whom 
would have been eligible to participate in E=QuaLS. I attended the annual Erb’s Palsy 
Group Fun Day to promote E=QuaLS and personally recruit participants. Interested 
individuals who could not be contacted by telephone were sent paper questionnaires 
(with stamped and addressed return envelopes) to complete at their convenience. The 
Erb’s Palsy Group also posted regular updates on their social media pages to 
maximise publicity and recruitment. Despite these measures, interest in the study and 
response rates were low. One reason for this may be because of the perceived lack 
of benefit in taking part in the research. Another possible reason for the low response 
rates could be the inclusion of potentially sensitive questions in the demographic 
questionnaires. For example, adults with OBPIs may have felt under undue scrutiny 
when asked about disability benefits and might have been unwilling to participate 
thereafter. Both demographic questionnaires were reviewed as part of the ethical 
approval process but there was no patient or public involvement in the design of these 
questions. Working together with adults with OBPIs and caregivers of children with 
permanent OBPIs in developing these questionnaires might have highlighted 
potentially sensitive issues that could then have been addressed or excluded before 
recruitment.  
 
The small sample sizes of adults with OBPIs and caregivers of children with 
permanent OBPIs limited the extent of our statistical investigations. As a result, this 
has limited statistical power and I may not have been able to confidently detect some 
true associations or may have detected some associations that may not be true. 
Moreover, the analyses were sensitive to the changes in the sample sizes and some 
associations were no longer evident in those additional analyses conducted on 
marginally larger samples. For example, previous OBPI surgery went from a positive 
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association with the adult utility score to no association. This clinical factor was chosen 
as a proxy for the severity of OBPIs, but it could be possible that surgery improves 
function to the extent that it results in better quality of life. However, the univariable 
regression analyses for both affected adults and caregivers did not suggest that 
previous OBPI surgery and the utility score were associated, suggesting that previous 
OBPI surgery (and therefore OBPI severity) had no impact on quality of life in these 
datasets. The final multivariable regression models were conducted without previous 
OBPI surgery (see additional analyses in the 2.7 Chapter appendix). Removing 
previous OBPI surgery from the final model for the caregivers did not change the 
inferences for the remaining variables. Removing previous OBPI surgery from the final 
model for affected adults did however change the inference for employment in non-
manual work (from positive association to no association). As I was limited by the small 
sample size in investigating this interaction further, I performed a cross-tabulation of 
employment status and previous OBPI surgery (see 2.7 Chapter appendix). This 
revealed that most adults who had had previous OBPI surgery were less likely to be 
employed (58%), suggesting some collinearity between employment status and 
previous OBPI surgery for affected adults. This further confirms the relevance of using 
previous OBPI surgery as a proxy for the severity of the condition, as adults who 
required surgery (i.e. had the severest form of OBPI) were less likely to work. 
 
Further analyses with larger samples are needed to check whether there are indeed 
any associations between the factors identified in this study and the utility score in 
these cohorts. The recruitment period could have been extended to try and improve 
the rate of participation. However, I was constrained by the time I had allocated to this 
work and made a pragmatic decision to stop recruitment and data collection when the 
response rate was consistently zero.  
 
Participants with missing data were excluded in a step-wise process, which further 
reduced the already small sample sizes. Given the initial small samples, data 
imputation would not have been worthwhile. However, during the sensitivity analyses 
for both studies, removing observations with missing data did not affect the inferences 
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Due to the cross-sectional nature of the studies, there may have been selection biases 
so the samples in these studies may not be fully representative of all adults in the UK 
with OBPIs or caregivers of children with permanent OBPIs. I did not have access to 
demographic information for the members of the Erb’s Palsy Group that were eligible 
to participate in E=QuaLS. As a result, I was not able to check whether the cohorts 
recruited were representative samples of the Erb’s Palsy Group. Furthermore, as 
these studies was based on questionnaires, the responses may also have been 
affected by recall biases.  
 
Despite the relatively small study populations, the quality of life of adults with OBPIs 
and caregivers of children with permanent OBPIs has not been investigated using 
these methods before, so these results represent the best available evidence. 
 
2.5 Conclusions 
These are the first studies to measure the quality of life associated with OBPIs (for 
both sufferers and caregivers) using a generic, preference-based health status 
instrument (EQ-5D-5L). Adults with OBPIs and caregivers of children with permanent 
OBPIs reported worse utility scores, and therefore quality of life, compared to the 
English general population. The utility scores generated in this chapter could now be 
used as part of cost-utility analyses of interventions related to improving the care, 
health and wellbeing of OBPI patients and their care providers. This exploratory work 
also identified some variables which appear to be associated with the utility score in 
these cohorts. Previous OBPI surgery, employment status, disability benefits status 
and marital status appeared to influence the adult utility scores. Caregiver employment 
status and the presence of one or more caregiver condition appeared to have an 
association with the caregiver utility scores. Further research with larger sample sizes 
is needed to confirm these associations. 
 
2.6 Publication 
The work from this chapter was condensed and published in Health and Quality of Life 
Outcomes in November 2018. The published article has been included in the 2.7 
Chapter appendix. The term caregivers was replaced with parents in this article as all 
participating caregivers were exclusively parents.  
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2.7 Chapter appendix  
2.7.1 Example of an ‘agreement to participate’ e-mail template  
  








Agreement to participate e-mail template 
 
 
Study title: Measuring quality of life in adults with obstetric 
brachial plexus injuries 
 
 
If you wish to participate in the above study, we would be grateful if 
you could copy and paste the statements below into an e-mail, 
complete the empty fields as appropriate and send to 
equalstudies@gmail.com with a subject heading of “Agreement to 
participate”. 
1. I confirm that I have read and understand the information sheet dated 
02/08/16 (version 1) for the Measuring quality of life in adults with 
obstetric brachial plexus injuries study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason. I also understand that 
withdrawing from the study will mean that my data will be withdrawn.  
3. I agree to take part in the Measuring quality of life in adults with 
obstetric brachial plexus injuries study.  
4. I would like to be contacted by phone/post (delete as appropriate) 
The best number to contact me on is  _______________________. The 
best time to contact me during the day is from _________ to 
__________. (complete or delete this statement as appropriate).  
My address is ______________________________ (please complete 
even if you wish to be phoned in case we are unable to reach you by 
telephone).  




rb’s palsy lity of ife tudies
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UK (English) © 2009 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group 
EQ-5D-5L Version1 for E=QuaLS Study 2 02/08/2016 
  
Under each heading, please tick the ONE box that best describes your health TODAY. 
MOBILITY  
I have no problems in walking about q 
I have slight problems in walking about q 
I have moderate problems in walking about q 
I have severe problems in walking about q 
I am unable to walk about q 
SELF-CARE  
I have no problems washing or dressing myself q 
I have slight problems washing or dressing myself q 
I have moderate problems washing or dressing myself q 
I have severe problems washing or dressing myself q 
I am unable to wash or dress myself q 
USUAL ACTIVITIES (e.g. work, study, housework, family or 
leisure activities)  
I have no problems doing my usual activities q 
I have slight problems doing my usual activities q 
I have moderate problems doing my usual activities q 
I have severe problems doing my usual activities q 
I am unable to do my usual activities q 
PAIN / DISCOMFORT  
I have no pain or discomfort q 
I have slight pain or discomfort q 
I have moderate pain or discomfort q 
I have severe pain or discomfort q 
I have extreme pain or discomfort q 
ANXIETY / DEPRESSION  
I am not anxious or depressed q 
I am slightly anxious or depressed q 
I am moderately anxious or depressed q 
I am severely anxious or depressed q 
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1.		 DOB______/_______/_______	 	 Age_____________	
	
2.	 Male	 Female	 Other	 Prefer	not	to	say	 
 
3.		 Marital	status	
	 Single	  Married/Civil	Partnership			 Divorced	 
 Separated	 Widowed	    Not	disclosed	 
 
4.		 Education	status	




	 Employed	    Unemployed   Retired									Voluntary	work 
 If	employed	à	Manual	work	 Non-manual	work	 
 
rb’s palsy lity of ife tudies
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	 Yes	  No	 
 If	you	claim	disability	benefits,	is	it	related	to	your	brachial	plexus	injury?	
Yes	  No	 
 
7.		 Are	you	left	or	right	handed?	
	 Left	  Right	 
	
8.		 Which	side	is	your	brachial	plexus	injury?	




	 I	  II	  III				 IV	  Not	known	 
 
10.		 Have	you	had	surgery	for	your	brachial	plexus	injury?	
	 Yes	  No	   
 
11.		 Do	you	suffer	from	any	medical	conditions?		
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1.		 DOB______/_______/_______	 	 Age_____________	
	




Mother	 Father	 	 Other_____________________________________________ 
 
4.		 Marital	status	
	 Single	  Married/Civil	Partnership			 Divorced	 
 Separated	 Widowed	    Not	disclosed	 
 
5.		 Education	status	








rb’s palsy lity of ife tudies
Chapter 2 
 


















9.	 Male	 Female	  Other		 Prefer	not	to	say 
 
10.		 Education	status	





	 I	  II	  III				 IV	  Not	known	 
 
12.		 Has	the	child	had	surgery	for	their	brachial	plexus	injury?	
	 Yes	  No	   
 
13.		 Does	the	child	suffer	from	any	medical	conditions?		












The quality of life associated with permanent obstetric brachial plexus injuries 
 73 





The Adult Carer Quality of Life Questionnaire (AC-QoL)
How to Fill in the Questionnaire
This questionnaire asks you about different aspects of your life as a carer. Please think about
your experience as a carer within the last two weeks and please tick the box that applies next
to each statement. There are no right or wrong answers; we are just interested in what life
is like for you as a carer. The questionnaire shouldn’t take more than 10 minutes.
Please answer all questions as honestly as you can.
Never Some of A lot of Always
the time the time
Support for Caring
01. I have a good level of emotional support
02. My needs as a carer are considered by professionals
03. I am happy with the professional support that is provided to me
04. I feel able to get the help and information I need
05. I have all the practical support I need
Never Some of A lot of Always
the time the time
Caring Choice
06. I feel that my life is on hold because of caring
07. My social life has suffered because of caring
08. I feel I have less choice about my future due to caring
09. I feel I have no control over my own life
10. Caring stops me doing what I want to do
Never Some of A lot of Always
the time the time
Caring Stress
11. I feel depressed due to caring
12. I feel worn out as a result of caring
13. I am mentally exhausted by caring
14. I am physically exhausted by caring
15. I feel stressed as a result of caring
Chapter 2 
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09Manual for the Adult Carer Quality of Life Questionnaire (AC-QoL)
Never Some of A lot of Always
the time the time
Money Matters
16. I worry about going into debt
17. I feel satisfied with my financial situation
18. I am able to save for a rainy day
19. I worry about money
20. There is enough money in our house to pay for the things we need
Never Some of A lot of Always
the time the time
Personal Growth
21. I have become a more tolerant person through my caring role
22. Because of caring, I have learnt a lot about myself
23. Because of caring, I feel that I have grown as a person
24. I have experienced many positive things through caring
25. I feel that I have become a better person by caring
Never Some of A lot of Always
the time the time
Sense of Value
26. I feel valued by the person I am looking after
27. The person I look after respects me for what I do
28. The person I look after makes me feel good about myself
29. I get a lot from the person I am looking after
30. I have a good relationship with the person I am caring for
Never Some of A lot of Always
the time the time
Ability to Care
31. I am satisfied with my performance as a carer
32. I can take care of the needs of the person I am caring for
33. I feel I am able to make the life of the person I am looking after better
34. I can manage most situations with the person I care for
35. I am able to deal with a difficult situation
Never Some of A lot of Always
the time the time
Carer Satisfaction
36. Caring is important to me
37. I resent having to be a carer
38. I feel frustrated with the person I am caring for
39. I enjoy being a carer
40. I am satisfied with my life as a carer
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2.7.6 Additional analyses for E=QuaLS Affected adults 













There were 4 participants with missing data for the variables included in the final model 
for E=QuaLS Affected adults. Welch’s two-sample t-test was used to compare the 
mean utility scores of these 4 participants with those that had complete data for these 
variables (Table 2-13). 
 
Table 2-13 Comparison of mean utility scores in missing and complete data 
(E=QuaLS Affected adults)  
 
There was no difference between the mean utility scores (p=0.542). This meant that 
the participants with missing data would not have affected the inferences drawn from 
the final multivariable model for the adults. 
 
A quantile-quantile (Q-Q) plot was used to check the distribution of the residuals for 
the final model presented in Figure 2-5. The residuals were close to being normally 
Comparison of mean utility scores in participants with missing data and participants 
with complete data for variables in final multivariable model for adults 
 
 Missing data mean (n=4) 
Complete data 
mean (n=44) Difference 95% CI p- value  
Utility score  0.48 0.57 -0.09 -0.47, 0.29 0.542 
 
Figure 2-4 Distribution of adult utility scores 
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distributed (Figure 2-5). As the distribution of the residuals was not perfectly normal, 
robust standard errors (using Huber-White sandwich estimators) were used for the 












A residual-versus-fitted values plot was used to assess for constant variance of errors 













The influential observations (n=3) were restored and the final model was then rerun. 
The addition of these influential observations resulted in a similar distribution of 
residuals but with one residual significantly deviating from the normal distribution 
Figure 2-6 Residuals-versus-fitted values plot for final model (Affected adults) 
Figure 2-5 Q-Q plot for final model for E=QuaLS Affected adults 
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(Figure 2-7). The new residual-versus-fitted plot was similar to the one without the 



























Figure 2-7 Q-Q plot with influential observations (E=QuaLS Affected adults) 
 
Figure 2-8 Residuals-versus-fitted plot with influential observations  
(E=QuaLS Affected adults) 
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Previous OBPI surgery did not appear to have an association with the utility score 
(p=0.281) after including the influential observations (Table 2-14). The inferences for 
the remaining variables in the final model remained unchanged after the influential 
observations were included.  
 
The inclusion of the influential participants distorted the final model, changed one of 
the inferences and began to violate the linear regression assumptions. Despite the 
skewed distribution of utility scores, the final multivariable model for adults (without 
the influential observations) met the assumptions for linear regression.  
 
The final multivariable regression model (without the influential observations) was run 
again but without previous OBPI surgery as a variable (Table 2-15). 
 









Removing previous OBPI surgery from the final model for adults changed the 
inference for employment in non-manual work (from positive association to no 
Final multivariable model for adults with influential observations (n=42) R2 0.37 
Variable  Coefficient 95% CI  p-value 
Previous OBPI surgery 0.08 -0.07, 0.22 0.281 
Employed in manual work 0.07 -0.10, 0.24 0.412 
Employed in non-manual work 0.19 0.02, 0.35 0.031 
Receives disability benefits related to OBPI -0.23 -0.39, -0.07 0.005 
Has partner 0.14 0.01, 0.27 0.039 
 
Final multivariable model for adults without previous OBPI surgery (n=39) R2 0.35 
Variable Coefficient 95% CI p-value 
Employed in manual work 0.02 -0.14, 0.18 0.802 
Employed in non-manual work 
(Reference: Not working) 0.12 -0.01, 0.25 0.065 
Receives disability benefits related to 
OBPI 
(Reference: No benefits) 
-0.16 -0.29, -0.03 0.016 
Has partner 
(Reference: No partner) 0.12 0.02, 0.23 0.024 
 
Table 2-14 Final model with influential observations (E=QuaLS Affected adults) 
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association). The inferences for the remaining variables were similar to before. A 
cross-tabulation of employment status and previous OBPI surgery revealed that most 
adults who had had previous OBPI surgery were not working (58%) (Table 2-16). This 
suggests some collinearity between employment status and previous OBPI surgery. 
 





No previous OBPI 
surgery 
Total 
Manual work 5 1 6 
Non-manual work 5 10 15 
Not working 14 4 18 
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2.7.7 Additional analyses for E=QuaLS Caregivers  













There was only 1 participant with missing data for the variables in the final 
multivariable model for the caregivers. This participant would not have affected the 
inferences drawn from the final multivariable model for the caregivers. 
 
A quantile-quantile (Q-Q) plot was used to assess the distribution of residuals for the 
final multivariable model for the caregivers (Figure 2-10). The residuals were not 
significantly deviated from the normal distribution. Again, as the distribution of the final 












Figure 2-10 Q-Q plot for final model for E=QuaLS 
Caregivers 
Figure 2-9 Distribution of caregiver utility scores 
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The residual-versus-fitted values plot demonstrated homoscedasticity (Figure 2-11). 
The final model was then rerun with the influential observations and rechecked. The 
new quantile-quantile plot and residual-versus-fitted values plot can be seen in Figure 















Figure 2-11 Residuals-versus-fitted values plot for final 
model (E=QuaLS Caregivers) 
Figure 2-12 Q-Q plot with influential observations (E=QuaLS Caregivers) 
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Inclusion of the influential observations resulted in two residuals being a considerable 
distance away from the line of normal distribution (Figure 2-12). The residual-versus-
fitted values plot including the influential observations (Figure 2-13) now illustrated 
possible decreasing variance of the residuals as the fitted values increased. 
 
 
Previous OBPI surgery for the child continued to have no impact on the utility score of 
the caregivers (p=0.314) after including the influential participants (Table 2-17). The 
inference for the presence of one or more medical condition in caregivers also 
remained the same after the influential observations were added (p=0.001). However, 
after including the influential participants, the working status of caregivers was no 
longer associated with the caregiver utility score (p=0.320).  
 
As before, the inclusion of the influential participants distorted the final model, changed 
one of the inferences and violated some of the linear regression assumptions. Despite 
Final multivariable model for caregivers with influential observations (n=69) R2 0.18 
Variable Coefficient 95% CI p-value 
Previous OBPI surgery for child -0.03 -0.10, 0.03 0.314 
Working (caregiver) 0.10 -0.10, 0.31 0.320 
Has ≥1 medical condition -0.12 -0.19, -0.05 0.001 
Figure 2-13 Residuals-versus-fitted plot with influential observations 
(E=QuaLS Caregivers) 
Table 2-17 Final model with influential observation (E=QuaLS Caregivers)  
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the skewed distribution of the caregiver utility scores, the final multivariable model 
(without influential observations) satisfied the assumptions for linear regression.  
 
The final multivariable regression model (without the influential observations) was run 
again but without previous OBPI surgery as a variable (Table 2-18). Removing 
previous OBPI surgery from the final model for the caregivers did not change the 
inferences for the remaining variables. 
 
















Final multivariable model for caregivers without previous OBPI surgery (n=63) R2 0.22 
Variable Coefficient 95% CI p-value 
Working (caregiver) 
(Reference: Not working) 0.11 0.02, 0.20 0.016 
Has ≥1 medical condition (caregiver) 
(Reference: No medical comorbidities) -0.10 -0.16, -0.04 0.001 
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Obstetric brachial plexus injuries (OBPIs):
health-related quality of life in affected
adults and parents
Christopher W. H. Yau1,2* , Elena Pizzo3, Chetankumar Prajapati4, Tim Draycott1 and Erik Lenguerrand2
Abstract
Background: Obstetric brachial plexus injuries (OBPIs) are rare but can have significant implications for those
affected, their caregivers and the health system. Symptoms can range from restricted movement to complete
paralysis of the arm. We investigated health-related quality of life in adults with OBPIs and parents of children with
permanent OBPIs, compared these with population norms, and investigated whether certain socio-demographic or
clinical factors were associated with the quality of life in these cohorts.
Methods: A cross-sectional study examined 50 affected adults and 78 parents. Participants completed EQ-5D-5 L
and characteristics questionnaires. EQ-5D-5 L responses were mapped onto an EQ-5D-3 L value set to generate
utility scores. Mean utility scores were compared with English population norms. Univariable and multivariable
linear regression models were conducted to assess for associations between participant characteristics and the
utility scores.
Results: The overall mean utility scores for affected adults and parents were 0.56 (SD 0.28) and 0.80 (SD 0.19)
respectively. Affected adults (95% CI (! 0.38, ! 0.22), p < 0.001) and parents of children with permanent OBPIs (95%
CI (! 0.10, ! 0.02), p = 0.007) had lower mean utility scores, and therefore quality of life, compared to English
population norms. For affected adults, previous OBPI surgery (95% CI (0.01, 0.25), p = 0.040), employment in non-
manual work (95% CI (0.06, 0.30), p = 0.005) and having a partner (95% CI (0.04, 0.25), p = 0.009) appeared to be
positively associated with the utility score. Affected adults receiving disability benefits related to OBPIs appeared to
have worse utility scores than those not receiving any disability benefits (95% CI (! 0.31, ! 0.06), p = 0.005). For
parents, employment was associated with better utility scores (95% CI (0.02, 0.20), p = 0.024) but the presence of
one or more medical condition appeared to be associated with worse utility scores (95% CI (! 0.16, ! 0.04), p = 0.
001).
Conclusions: Adults with OBPIs and parents of children with permanent OBPIs reported worse utility scores, and
therefore quality of life, compared to the English general population. We also identified certain characteristics as
possible factors to consider when dealing with utility scores in these cohorts. The utility scores in this study can be
used in future economic evaluations related to OBPIs.
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Obstetric brachial plexus injuries (OBPIs) are rare [1, 2]
but can have significant implications for those affected
[3], their caregivers [4] and the wider health system [5].
These injuries – sometimes referred to as Erb’s palsies –
can occur as a result of the mismanagement of an ob-
stetric emergency: shoulder dystocia; where the baby’s
head is delivered but its anterior shoulder is impacted
against the mother’s pelvic bone [6]. Inappropriate man-
agement of this emergency can lead to damage to the
brachial plexus, a collection of nerves on either side of
the neck which are responsible for sensation and move-
ment of the arm [7]. Symptoms can range from re-
stricted movement in the shoulder, elbow and wrist, to
complete paralysis of the arm [1, 3]. They can also be
transient or permanent (lasting for longer than
12 months after birth) [1, 8]. In England (2000 to 2010),
litigation costs associated with shoulder dystocia and
OBPIs amounted to over £103 million [5]. This is money
that could otherwise have been spent on frontline pa-
tient care.
These potentially life-changing injuries warrant inves-
tigation into how they affect the quality of life of both
sufferers and their caregivers using formal quality of life
utility scores. In this context, utility is used to describe
the preferences of individuals for a particular set of
health outcomes and is way of valuing different health
characteristics on a single scale [9, 10]. To date, the only
quality of life utility scores related to OBPIs have been
assigned at a distance, by healthcare professionals from
outside the specialties involved in OBPIs [11]. There has
been no direct assessment of the impact of OBPIs on in-
dividuals and although there is a growing body of re-
search investigating the effects of OBPIs on families and
caregivers [4, 12, 13], it has never been expressed using
utility scores.
We used a generic, preference-based health status in-
strument (EQ-5D-5 L) to determine the quality of life
utility scores of affected adults and parents of children
with permanent OBPIs. The utility scores of these co-
horts were compared with population norms. We also
investigated whether certain socio-demographic or clin-
ical factors were associated with the utility value.
Methods
Participants
Affected adults (!18 years old) and parents of children
with permanent OBPIs (lasting for 12 months or more
after birth) were recruited through, and in collaboration
with, the Erb’s Palsy Group (UK charity) [14]. The
Erb’s Palsy Group recruited participants and adver-
tised the study on their website and social media
pages. Participants were also recruited at an annual
Erb’s Palsy Group event.
All participants were asked to complete an EQ-5D-5 L
questionnaire [15] as well as a characteristics question-
naire by telephone or post. The EQ-5D -5 L question-
naire is a generic, preference-based instrument assessing
health over five dimensions: mobility, self-care, usual ac-
tivities, pain/discomfort and anxiety/depression. Within
each health dimension, there are five levels of function-
ality: no problems, slight problems, moderate problems,
severe problems or extreme problems/unable to function
[15]. The 5 L version was chosen over the 3 L version
(with only 3 levels for each health dimension) as it has
been developed to try and improve the instrument’s sen-
sitivity in detecting small changes in health [15]. The
characteristics questionnaire included
socio-demographic information and clinical details. The
characteristics questionnaire for the parents also in-
cluded questions regarding the child that was being
cared for. A non-medical administrator, separate from
the Erb’s Palsy Group, contacted participants who
wished to complete the questionnaires by telephone.
A total of 50 affected adults were initially recruited for
this study. Two participants were excluded as they had
incomplete EQ-5D-5 L scores, leaving a total of 48 af-
fected adults for calculating the utility scores. A further
6 adults (13%) were then excluded as their question-
naires contained missing data, leaving 42 participants for
the subsequent analyses. All of the affected adult charac-
teristics are summarised in Table 1.
Overall, 78 parents were initially recruited for this
study. One participant with an incomplete EQ-5D-5 L
score was excluded, leaving 77 parents for calculating
the utility scores. A further 8 parents (10%) were then
excluded as their questionnaires contained missing data,
leaving 69 parents for the remaining analyses. The char-
acteristics for the parents and the children they looked
after are summarised in Tables 2 and 3.
Utility scores
The responses from the EQ-5D-5 L questionnaires were
mapped onto an EQ-5D-3 L value set [16] to generate
utility scores. This has been recommended by the Na-
tional Institute for Health and Care Excellence (NICE)
in England [17, 18]. This mapping was performed using
the eq5dmap command in Stata [19]. Mean utility scores
for affected adults and parents of children with OBPIs
were compared with population norms from the 2008
Health Survey for England [20] using Welch’s
two-sample t-test.
Associations between utility score and participant
characteristics
The investigations were conducted separately for af-
fected adults and parents, using the same strategy, which
is described below. Univariable and multivariable linear
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regressions were conducted to assess for associations be-
tween participant characteristics and the utility scores.
Robust standard errors (using Huber-White sandwich
estimator) were used for all the regressions. The strength
of evidence against the null hypothesis (that there is no
association between the variable and the utility score)
was indexed by the p-value derived from the regressions,
with increasing evidence against the null hypothesis with
decreasing p-values [21]. Variables with weak to strong
evidence of association (p-value !0.10) with the utility
score in the univariable analyses were considered for in-
clusion in the initial multivariable linear regression
models. The following characteristics were also included
in the initial multivariable regression model, regardless
of their strength of association in the univariable
analyses:
! Age (for affected adults and parents)
! Gender (for affected adults and parents)
! Marital status (for affected adults and parents)
Table 1 Affected adult characteristics
Characteristics Total (n = 50)
Affected adults n (%)
Age (years)a 28 (24, 46)
Age subcategories (years)
! 24 18 (36)
25–39 14 (28)
40–54 6 (12)





No partner 33 (66)
With partner 17 (34)
Education status
Secondary school/ college 20 (40)
Higher education 29 (58)
Missing data 1 (2)
Employment status
Manual work 6 (12)
Non-manual work 18 (36)
Not working 22 (44)
Missing data 4 (8)
Disability benefits
Receives benefits related to OBPIs 19 (38)
Receives non-related benefits 1 (2)
Receives no benefits 29 (58)












Know Narakas score 12 (24)
Don’t know Narakas score 36 (72)
Missing data 2 (4)
Has "1 medical condition 33 (66)
aMedian, 25th, and 75th centiles presented as the distribution for age
was skewed
Table 2 Parent characteristics
Characteristics Total (n = 78)
Parent n (%)
Age (years)a 40 (8)
Age subcategories (years)
! 35 24 (31)
36–45 35 (45)








No partner 19 (24)
With partner 58 (74)
Missing 1 (1)
Education status
Secondary school/ college 41 (53)




Not working 13 (17)
Missing 1 (1)
Has "1 medical condition 45 (58)
aMean and standard deviation presented as parent age had a
normal distribution
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! Employment status (for affected adults and parents)
! Education status (for affected adults and parents)
! Presence of one or more medical condition (for
affected adults and parents)
! Child age (for parents)
! Presence of one or more child medical condition
(for parents)
Age, gender, marital status, employment status and
education status have previously been demonstrated to
influence perceptions of health [22–24]. The presence of
medical comorbidities was also deemed to be an import-
ant characteristic to include in the initial multivariable
models.
Previous OBPI surgery was chosen as a variable of
interest because it is a proxy for the severity of the con-
dition; more severe injuries are more likely to require
surgery. Previous OBPI surgery was forced into the mul-
tivariable models for the affected adults and the parents.
Originally, the Narakas score (a classification system for
OBPIs) [3] was selected, a priori, as an important char-
acteristic for investigation. However, a high proportion
of participants did not know their Narakas score (72%
adults and 59% parents), and therefore it was not pos-
sible to perform any meaningful analyses with this
characteristic.
The influence of each characteristic on the initial mul-
tivariable regression models was investigated. Variables
were retained in the final multivariable models if their
p-value was !0.05 (Wald test) and/or if their removal
impacted the effect size of the other parameters by >
30%. Influential observations in the final models were
identified using Cook’s distance and removed. In the
final multivariable model, p-values around 0.05 were as-
sumed to represent weak evidence against the null hy-
pothesis and p-values < 0.001 as strong evidence [21].
Stata version 14.2 (StataCorp, Texas, USA) and Micro-
soft® Excel for Mac were used to perform the analyses.
The University of Bristol Faculty of Health Sciences Re-
search Ethics Committee approved this study (39641
and 39681). We obtained informed consent (written or
e-mail) from all participants.
Results
Utility score (Table 4)
The overall mean utility score for affected adults was
0.56 (SD 0.28). The mean utility scores for males and fe-
males were 0.64 (SD 0.21) and 0.53 (SD 0.30) respect-
ively. When compared with the general population,
affected adults had worse utility scores (and therefore
quality of life) (95% CI (" 0.38, " 0.22), p < 0.001). This
remained the case when comparing by male (95% CI ("
0.37, " 0.11), p = 0.001) and female (95%CI (" 0.42, "
0.22), p < 0.001) subcategories.
The overall mean utility score for parents of children
with permanent OBPIs was 0.80 (SD 0.19), which was
lower than the population norm (95% CI (" 0.10, " 0.02),
p = 0.007), also suggesting poorer quality of life compared
to the general population. The mean utility score for fa-
thers was 0.89 (SD 0.15) but there was no evidence of a
difference compared to the general male population (95%
CI (" 0.15, 0.17), p = 0.877). For mothers, the utility was
0.79 (SD 0.19) suggesting that mothers had worse utility
scores (and therefore quality of life) compared to the gen-
eral female population (95% CI (" 0.11, " 0.01), p = 0.010).
Associations between the utility score and participant
characteristics (Table 5)
Previous OBPI surgery was not associated with the af-
fected adult utility score in the univariable regression
model (95% CI (" 0.21, 0.09), p = 0.411). Details of the
affected adult univariable regression analyses can be
found in Additional file 1. Employment status, marital
Table 3 Child characteristics
Characteristics Total (n = 78)
Child n (%)










Too young for school 28 (36)
Primary school 19 (24)
Secondary school/college 30 (38)
Missing 1 (1)
Narakas (severity score)
Know Narakas score 30 (38)









aMedian, 25th, and 75th centiles presented as the distribution for age
was skewed
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status, previous OBPI surgery and disability benefits sta-
tus were all included in the final multivariable model for
adults with OBPIs. The backward elimination steps used
to determine this final model are presented in Additional
file 2. Three influential observations were removed from
the final model. There was some evidence that adults
with previous OBPI surgery had better utility scores than
those who had no surgery after adjusting for the other
variables in the final model (95% CI (0.01, 0.25), p =
0.040). Affected adults in non-manual jobs also appeared
to have better utility scores than those without employ-
ment after adjusting for previous OBPI surgery, marital
status and disability benefits status (95% CI (0.06, 0.30),
p = 0.005). There was no evidence of any difference in
utility scores between affected adults in manual work
and those without employment (95% CI (! 0.14, 0.17), p
= 0.835). Affected adults with a partner also had better
utility scores than those without partners after account-
ing for the other variables in the model (95% CI (0.04,
0.25), p = 0.009). In contrast, affected adults receiving
disability benefits related to their injury had worse utility
scores and therefore quality of life compared to those re-
ceiving no disability benefits (95% CI (! 0.31, ! 0.06), p
= 0.005).
As before, previous OBPI surgery for the child was not
associated with the parent utility score in the univariable
regression model (95% CI (! 0.14, 0.02), p = 0.116). De-
tails of the parent/child univariable regression analyses
can be found in Additional files 3 and 4. Previous OBPI
surgery for the child, parental employment status and
having one or more medical condition (for the parent)
were included in the final multivariable model for the
parents. The backward elimination steps used to deter-
mine this final model are presented in Additional file 5.
Six influential observations were removed from the final
model. Previous OBPI surgery for the child was not as-
sociated with the parent utility score (95% CI (! 0.06,
0.05), p = 0.869). Parents who worked appeared to have
better utility scores compared to those without employ-
ment, after adjusting for the other variables in the final
model (95% CI (0.02, 0.20), p = 0.024). In contrast, par-
ents with one or more medical condition had worse util-
ity scores than those who reported no health problems,
after accounting for the other variables (95% CI (! 0.16,
! 0.04), p = 0.001).
Additional analyses (Additional file 6)
The influential observations were re-instated and the
final multivariable models were rerun. Interestingly, pre-
vious OBPI surgery was no longer associated with the af-
fected adult utility score after the inclusion of the three
influential observations (95% CI (! 0.07, 0.22), p = 0.281).
The inferences for the other variables in the final af-
fected adult multivariable model remained the same. In
the final parent multivariable model including influential
observations (n = 6), parental working status was no
Table 4 Mean utility scores
General population norma Affected adult utility score (n = 48) Parent utility score (n = 77)
Mean SD Mean SD Difference 95% CI p-value Mean SD Difference 95% CI p-value
Overall 0.86 0.24 0.56 0.28 !0.30 !0.38,
!0.22
< 0.001 0.80 0.19 !0.06 !0.10, ! 0.02 0.007
Male 0.88 0.16 0.64 0.21 !0.24 ! 0.37,
! 0.11
0.001 0.89 0.15 0.01 !0.15, 0.17 0.877
Female 0.85 0.18 0.53 0.30 !0.32 ! 0.42,
! 0.22
< 0.001 0.79 0.19 ! 0.06 ! 0.11, ! 0.01 0.010
aObtained and calculated from 2008 Health Survey for England [18]
Table 5 Final multivariable models
Variable Coefficient 95% CI p-value
Final multivariable model for affected adults (n = 39) R2 0.42
Previous OBPI surgery (Reference: No surgery) 0.13 0.01, 0.25 0.040
Employed in manual work (Reference: Not working) 0.02 !0.14, 0.17 0.835
Employed in non-manual work (Reference: Not working) 0.18 0.06, 0.30 0.005
Receives disability benefits related to OBPI (Reference: No benefits) !0.18 !0.31, ! 0.06 0.005
Has partner (Reference: No partner) 0.14 0.04, 0.25 0.009
Final multivariable model for parents (n = 63) R2 0.22
Previous OBPI surgery for child (Reference: No surgery) !0.0050 ! 0.06, 0.05 0.869
Working (parent) (Reference: Not working) 0.11 0.02, 0.20 0.024
Has "1 medical condition (parent) (Reference: No medical conditions) !0.10 ! 0.16, ! 0.04 0.001
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longer associated with the parent utility score (95% CI
(! 0.10, 0.31), p = 0.320) but the inferences for the other
variables were unchanged. The presence of missing data
from 4 (8%) adult participants and 1 (1%) parent did not
impact on the conclusions drawn from the final multi-
variable models.
Discussion
Both adults with OBPIs and parents of children with
permanent OBPIs had worse utility scores, and therefore
quality of life, compared to the general English popula-
tion. The mean utility score for affected adults was 0.56
(SD 0.28) and the mean utility score for the parents was
0.80 (SD 0.19). We also identified characteristics to con-
sider when dealing with utility scores in populations of
adults with OBPIs or parents of children with perman-
ent OBPIs. For affected adults: previous OBPI surgery,
employment status, disability benefits status and marital
status appeared to be associated with the utility score.
For parents: employment status and the presence of one
or more parental medical condition appeared to be asso-
ciated with the utility score.
Only one study has previously presented utility scores
associated with OBPIs [11]. Culligan et al. assigned util-
ity scores to different combinations of maternal-neonatal
outcomes, some of which included permanent OBPIs
[11]. A utility score of 0.60 was assigned by this group of
clinicians to mild-moderate OBPIs, and it is similar to
the affected adult utility score calculated in this study
(7% difference). However, the utility score derived by this
study is a more reliable and accurate measure of the
quality of life associated with OBPIs. Firstly, the utility
score was determined using a validated generic health
instrument and involved adults with the injury. Sec-
ondly, the affected adult utility score in this study has a
clear perspective. As the utility scores assigned by Culli-
gan et al. are for combinations of maternal-neonatal out-
comes, it is unclear whether the quality of life was being
assessed from the viewpoint of the mother, the baby, or
both [11].
The EQ-5D-5 L questionnaire was an appropriate in-
strument to use to calculate the utility scores in these
cohorts. There are currently no OBPI-specific instru-
ments and despite being a generic questionnaire, the do-
mains covered by the EQ-5D-5 L, particularly self-care,
usual activities, pain/discomfort and anxiety/depression
were relevant to OBPIs. The best way of measuring and
integrating the ‘spillover’ effects (the impact on care-
givers and family members) of healthcare interventions
into cost-effectiveness analyses is still debated [25] and
generic health status instruments may not fully capture
the ‘spillover’ effects, particularly the potential positive
aspects of caring [25]. Despite this, the EQ-5D question-
naire has been able to detect changes in health-related
quality of life in caregivers of children with major con-
genital anomalies [26] and it appears to be useful in
measuring family members’ quality of life in economic
evaluations [27]. The EQ-5D-5 L questionnaire is also
the preferred health status instrument for NICE [28].
This means that the quality adjusted life years (QALYs)
calculated from these utility scores would be comparable
with the QALYs in other health technology assessments
reviewed by NICE.
We mapped the EQ-5D-5 L responses to an
EQ-5D-3 L valuation set as recommended by NICE
using the eq5dmap command in Stata [19]. The com-
mand is a mapping process based on a system of ordinal
regressions and does not assume that the domains of the
EQ-5D instrument are statistically independent [19, 29].
We used the EuroQoL Group dataset [30, 31] as the ref-
erence for the mapping process. This dataset consists of
a younger population and covers a broader range of dis-
eases compared to the alternative reference dataset avail-
able (National Data Bank for Rheumatic Diseases) [32].
Furthermore, the EuroQoL Group data was generated
from 6 European countries, including England, making
it the more relevant reference dataset to use [30, 31].
The eq5dmap command also adjusts for age and gender
[19].
The inability to stratify utility scores by the severity of
the condition is a limitation of this study. Only a small
proportion of affected adults (28%) and parents (41%)
knew the Narakas classification of the injuries, even
though it is widely used clinically [33]. As a result, a
crude proxy variable was needed and previous OBPI sur-
gery was a reasonable choice. There is some evidence
that having lower Narakas scores (I-II) reduces the likeli-
hood of permanent OBPIs, and hence the need for sur-
gery [34]. Similarly, the presence of Horner’s syndrome,
indicating Narakas score IV, increases the likelihood of
permanent OBPIs and therefore operative management
[34]. Previous OBPI surgery was associated with the af-
fected adult utility score but not with the parent utility
score in this study. In comparison, one previous study
has demonstrated that OBPI surgery had an impact on
the child’s family [12].
We did not attempt to measure the quality of life util-
ity scores of the children with OBPIs. Young children
may not have the cognitive capacity to comprehend or
answer health related questions, and there are few
preference-based, health status instruments derived from
child populations [35, 36]. A small study (n = 18) has
assessed the quality of life of adolescents (aged 10 to
17 years old) with permanent OBPIs using the Child
Health Questionnaire and the Paediatric Outcomes Data
Collection Instrument [37]. Whilst the questionnaire
and instrument quantify health-related quality of life, the
scores cannot be used to calculate QALYs as they are
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not preference-based. There is a youth version of the
EQ-5D questionnaire (EQ-5D-Y) but there are no valu-
ation sets for this at present. Using the EQ-5D adult
values for EQ-5D-Y would misrepresent a child’s health
status [38]. As a result, the EQ-5D-Y cannot generate re-
liable child QALYs for use in economic evaluations.
OBPIs are rare and as such, participants were difficult
to recruit. Collaborating with the Erb’s Palsy Group
allowed access to their membership, the majority of
which would have been eligible to participate in the
study. Despite attempts to maximise publicity and re-
cruitment, the response rates were low. One reason for
this may be because of the perceived lack of benefit in
taking part in the study. The small sample sizes of af-
fected adults and parents of children with permanent
OBPIs limited the extent of our statistical investigations.
As a result, our study had limited statistical power and
we could not confidently detect some true associations.
Moreover, our analyses were sensitive to the changes in
the sample sizes (see additional analyses) and some asso-
ciations were no longer evident in those additional ana-
lyses conducted on marginally larger samples. For
example, previous OBPI surgery went from a positive as-
sociation with the affected adult utility score to no asso-
ciation. This clinical factor was chosen as a proxy for the
severity of OBPIs, but it could be possible that surgery
improves function to the extent that it results in better
quality of life. Further analyses with larger samples are
needed to check whether there are indeed any associa-
tions between the factors identified in this study and the
utility score in these cohorts. Interestingly, mothers of
children with permanent OBPIs had a lower mean utility
score (0.79) compared to fathers (0.89). One possible ex-
planation for this could be that mothers might have a
greater share of the caring responsibility. It is worth not-
ing, however, that this study had a very small cohort of
fathers (8% of the total sample) and an even smaller
number of single fathers (1% of the total sample) to test
this theory. Further research is needed to investigate
whether there is a true difference in the quality of life
between mothers and fathers of children with permanent
OBPIs.
Due to the cross-sectional nature of the study, there
may have been selection biases so the samples in this
study may not be fully representative of all adults in the
UK with OBPIs or parents of children with permanent
OBPIs. Furthermore, as this study was based on ques-
tionnaires, the responses may also have been affected by
recall biases.
Despite the small sample sizes, this is the first study to
directly and robustly assess the quality of life of both
adults with OBPIs and parents of children with perman-
ent OBPIs using a validated health-status instrument.
The findings from this study represent the best available
evidence and provide tailored utility scores that could
now be used as part of cost-utility analyses of interven-
tions related to improving the care, health and wellbeing
of adults affected by OBPIs and parents of children with
permanent OBPIs.
Conclusions
Adults with OBPIs and parents of children with perman-
ent OBPIs reported worse utility scores, and therefore
quality of life, compared to the English general popula-
tion. Previous OBPI surgery, employment status, disabil-
ity benefits status and marital status appeared to
influence the affected adult utility scores. Parental em-
ployment status and the presence of one or more paren-
tal medical condition appeared to have an association
with the parent utility scores. The utility scores in this
study can be used in future economic evaluations related
to OBPIs.
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3.1 Introduction 
National maternity and perinatal reports (5,6,77) frequently recommend training as a 
way of making childbirth safer. The latest National Maternity Review in England 
qualifies this further by stating that training undertaken should be ‘effective in 
improving outcomes or other aspects of quality’ (p.71) (8). This is an important 
distinction as not all training is associated with clinical improvements (106). Two 
reviews of outcomes following training for obstetric emergencies concluded that 
regular, local and multi-professional training for all staff appeared to be the most 
effective model (26,107).  
 
Whilst there have been studies and reviews evaluating the clinical effectiveness of 
training programmes for obstetric emergencies, there is a paucity of information 
regarding the potential cost of their implementation. Despite the recurrent national 
endorsements for training, there have been no accompanying financial considerations. 
The cost of training has consistently been overlooked. Such information would be 
crucial for policymakers in their decision-making and management of limited 
healthcare funds. Furthermore, such costings would be helpful for local departmental 
budgeting and planning.  
 
PRactical Obstetric Multi-Professional Training (PROMPT) was developed in Bristol, 
UK in 2000 and adopts the aforementioned framework for effective training. It is an 
exportable training package consisting of a ‘Course in a Box’, which contains course 
and trainer manuals, and digital training materials that can easily be adapted for local 
use in any maternity setting. All maternity staff (doctors, midwives and healthcare 
support workers) are encouraged to attend local PROMPT courses within the clinical 
areas of their unit. The implementation of PROMPT at Southmead Hospital, Bristol 
has been associated with improvements in perinatal outcomes (93,110,113) as well 
as better safety attitudes and teamwork climate (97). Improvements have also been 
observed outside of the UK (32,100,101). One study attempted to capture the costs of 
PROMPT in a US hospital but did not use any recognised costing techniques (100). 
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The aim of this chapter is to outline the cost of running a standard multi-professional 
simulation training course for obstetric emergencies (PROMPT), or standalone 
shoulder dystocia training for one year at Southmead Hospital.  
 
3.2 Methods 
3.2.1 Southmead Hospital 
Southmead Hospital is a tertiary referral centre, with around 6,500 births per annum. 
There is also an alongside midwifery-led unit and a freestanding midwifery-led unit in 
the community. Annual attendance of PROMPT is mandatory for all maternity staff 
working in the obstetric unit, as well as both midwifery-led units, and also all maternity 
community staff.   
 
3.2.2 Cost references  
Costing information was obtained from a variety of sources. The local PROMPT faculty 
were consulted and different hospital departments were approached, including the 
Human Resources (HR) department, the Finance department, Practice Development, 
Learning and Research (L&R), Facilities, Print Room, Clinical Equipment Services, 
Hospital Ordering System and Pharmacy. Additional information was extracted from 
the British National Formulary (BNF), University of Bristol print services and other 
commercial equipment suppliers. 
 
3.2.3 Cost analysis  
3.2.3.1 General  
A retrospective, micro-costing analysis (pricing down to individual items) was 
performed to assess the cost of implementing ‘Example PROMPT course programme 
3’ (see 3.7 Chapter appendix) from the PROMPT Trainer’s Manual (second edition) 
(193) for one year at Southmead Hospital. Training for shoulder dystocia is one of the 
core components of PROMPT. The cost of implementing standalone shoulder 
dystocia training for one year was therefore also estimated. The costings were divided 
into the initial start-up costs and the variable costs. The start-up costs included the 
purchase of training mannequins and teaching props, ‘in-house’ printing of training 
materials and assembly of emergency boxes (real and training). The variable costs 
consisted of costs related to releasing all maternity staff to attend the training and also 
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other staff to facilitate the training. Administration time, room hire and additional 
printing were also included in the variable costs. The costs were in 2016 UK pounds 
sterling and calculations were performed using Microsoft® Excel for Mac. All final costs 
have been presented to the nearest pence.  
 
3.2.3.2 Additional costs 
There may be additional start-up costs for hospitals without any established training 
in place. These additional costs have been presented separately and possible reasons 
for extra expenses have been described in the relevant sections. 
3.2.3.3 ‘Train the Trainers’ Day  
In order to run PROMPT in another maternity unit, a representative team must first 
attend a PROMPT ‘Train the Trainers’ day, which is usually held in London. Units 
attending this course would need to cover the costs of the team travelling to London 
as well as the costs of attending the day and receiving the PROMPT ‘Course in a Box’. 
PROMPT was developed at Southmead Hospital and therefore, the local faculty would 
not have needed to attend the ‘Train the Trainers’ session. 
3.2.3.4 Printing 
There were nominal printing and lamination charges at Southmead Hospital, with both 
being performed within the department. Pre-course reading booklets only cost £0.40 
each to print. These minimal fees may not be equivalent in all hospitals therefore the 
potential extra costs of printing and laminating materials have been presented using 
the University of Bristol print service prices. 
 
3.2.3.5 Rooms  
PROMPT training should be conducted locally and drills should ideally be run in the 
same locations and using the same equipment as if in a real emergency. At 
Southmead, the simulation sessions were run in a mixture of labour ward or birth 
centre rooms and other ward areas, depending on their availability. As the rooms were 
part of the maternity unit infrastructure and already in use, there was no additional cost 
for using them. The hire of the seminar room was also discounted by 50% as the 
training was for hospital employees.  
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3.2.3.6 Emergency boxes 
The introduction of emergency boxes into clinical practice, each carrying all the 
necessary equipment to manage a specific obstetric emergency (194), meant that 
there needed to be duplicate boxes for use during the training sessions. The only 
differences between the two emergency boxes were that the training boxes had all 
sharps and needles removed, and normal saline ampoules instead of any medication. 
As drill training was well established at Southmead before PROMPT was introduced, 
a lot of the equipment required to run the drills was already available and so there was 
no additional cost. However, the potential cost of stocking real and training emergency 
boxes has also been provided for maternity units without established training. 
3.2.3.7 Staff  
At Southmead Hospital, it has been mandatory for all obstetricians and midwives to 
attend a PROMPT course every year. Whilst not compulsory, it has been highly 
desirable for obstetric anaesthetists to attend as well and further reinforce a multi-
professional approach. As anaesthetic attendance at Southmead has consistently 
been above 80% each year, this cohort has been fully included in the costing exercise 
as this would be considered the ‘gold standard’. Attendance for training was also 
mandated for two operating department practitioners at Southmead, so they too have 
been included in the calculations. In addition, all maternity care assistants attend the 
afternoon drill sessions at Southmead. All maternity staff working in the community 
with an affiliation to the maternity unit were included in this exercise, as were all 
midwifery bank staff, who may be called to cover sickness or staff shortages in the unit 
at any time. This costing analysis was based on training 100% of relevant maternity 
staff over one year. At Southmead, this required seven PROMPT courses per year on 
average and therefore the staff facilitating the training would have been released more 
than once during the year. I estimated that fifty 30-minute sessions (allowing for 
around 10 people to attend each session) of shoulder dystocia training would be 
required to train all maternity staff at Southmead over the course of one year (113).  
The calculation of the annual cost of releasing staff to attend and/or teach PROMPT 
at Southmead was complicated by a number of factors: some staff attended in their 
own personal time or supporting professional activity time, and some members of staff 
used their study leave allowance to attend. In addition, staff could be on different 
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incremental pay scales despite being the same grade or banding. Considering these 
issues, staff costs for PROMPT at Southmead were fully included to give an indication 
of the potential maximum costs of training and therefore minimise underestimation. 
The costs were based on the average salaries per grade for the cohort of maternity 
staff working at Southmead Hospital in 2015-2016. This calculation included the 
salaries of those working less-than-full-time. It was assumed that two less-than-full-
time doctors or midwives had the equivalent cost per day as one full-time 
doctor/midwife. Obstetric and anaesthetic consultants at Southmead often participated 
in the local training during their supporting professional activity time, and this was 
taken into account when calculating the consultant costs for PROMPT at Southmead. 
If locum staff at Southmead were not clearly staying for longer than 12 months they 
were excluded from the calculation. 
The costs per hour and costs per day were calculated assuming the following: 
• Consultants worked 42 weeks a year and 40 hours a week 
• Other doctors worked 44 weeks per year and 40 hours a week 
• Midwifery managers, midwives, operating department practitioners (ODPs) and 
maternity care assistants (MCAs) worked 46 weeks a year and 37.5 hours a 
week 
• A working day for doctors was 8 hours and a working day for midwifery 
managers, midwives, ODPs and MCAs was 7.5 hours 
 
3.2.4 Ethical approval 
As this was a costing analysis and no patients were involved, ethical approval was not 
required. 
 
3.3 Results  
The start-up costs were £4,336 and the variable costs for one year were £111,773 
(Table 3-1 and Table 3-2) The total cost of establishing and running PROMPT at 
Southmead for one year was £116,109. Releasing staff to attend and facilitate training 
accounted for 89% of the total first year costs and 92% of the variable costs. The total 
cost of running PROMPT per year in subsequent years could be modelled on the 
variable costs of the first year. However, the cohort of staff each year will significantly 
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influence this figure. For maternity units without any established training, the additional 
start-up costs could be £5,365 (Table 3-3). The potential costs of printing materials 
and stocking the emergency boxes are included in the 3.7 Chapter appendix. For 
standalone shoulder dystocia training, start-up costs were £2,577 and the variable 
costs for one year were estimated to be £10,256 (Table 3-4).  
In 2015, there were 6,517 births at Southmead Hospital. Therefore, with this birth rate, 
local, multi-professional simulation training for obstetric emergencies at Southmead 
would cost approximately £18,000 per 1,000 births for the first year and around 
£17,000 per 1,000 births in subsequent years. For standalone shoulder dystocia 
training, it would cost around £2,000 per 1,000 births for the first year and 





Items Units Unit cost Total cost Source of data
Mannequins/models
Resusci Anne First Aid 1 £720.00 £720.00 Commercial company
PROMPT Birthing Simulator 1 £2,577.00 £2,577.00 Commercial company
MamaNatalie 1 £510.00 £510.00 Commercial company
Baby Anne 1 £147.60 £147.60 Commercial company
Total for mannequins/models £3,954.60
Teaching props
Magic Trousers 1 PROMPT Faculty
Magic pants 1 PROMPT Faculty
Magic Cushion 1 PROMPT Faculty
Stained pads 4 PROMPT Faculty
Total for teaching props £200.00
Printed materials
Total for printed materials £0.00
Equipment for scenarios
Basic life support
Equipment Already available N/A
Obstetric haemorrhage
Equipment Already available N/A
Emergency box (training) 1 £14.98 £14.98 Box only/ Commercial company
Emergency box (real) 1 £14.98 £14.98 Box only/Commercial company
Large container 1 £14.99 £14.99 Commercial company
Eclampsia
Equipment Already available N/A
Emergency box (training) 1 £14.98 £14.98 Box only/ Commercial company
Emergency box (real) 1 £14.98 £14.98 Box only/ Commercial company
Large container 1 £14.99 £14.99 Commercial company
Sepsis
Equipment Already available N/A
Emergency box (training) 1 £14.98 £14.98 Box only/ Commercial company
Emergency box (real) 1 £14.98 £14.98 Box only/ Commercial company
Large container 1 £14.99 £14.99 Commercial company
Neonatal resuscitation
Equipment Already available N/A
Breech
Equipment Already available N/A
Large container 1 £14.99 £14.99 Commercial company
Total for equipment for scenarios £149.84
Other equipment
Blu-tak 2 £1.99 £3.98 Commercial company
Whiteboard markers (pack of 6) 6 £3.99 £23.94 Commercial company
Paper (200 sheets) 1 £3.99 £3.99 Commercial company
Total for other equipment £31.91
Total start-up costs £4,336.35
Table 3-1 Total start-up costs for PROMPT at Southmead 
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Rooms Sessions Cost/session Total cost Source of data
Seminar room (morning session) 7 £75.00 £525.00 PROMPT faculty/L&R department
Total room cost per year £525.00
Grades Total number Cost/day Total cost Source of data
Consultants 15 £571.43 £8,571.45 HR & Finance departments
Registrars 17 £307.69 £5,230.73 HR & Finance departments
Senior House Officers 28 £225.71 £6,319.88 HR & Finance departments
Total cost of obstetricians per year £20,122.06
Consultants 11 £571.43 £6,285.73 PROMPT faculty/HR & Finance departments
Specialty Doctors 5 £371.95 £1,859.75 PROMPT faculty/HR & Finance departments
Registrars 2 £307.69 £615.38 PROMPT faculty/HR & Finance departments
Senior House Officers 3 £225.71 £677.13 PROMPT faculty/HR & Finance departments
Total cost for anaesthetists per year £9,437.99
Band 8 8 £251.10 £2,008.80 HR & Finance departments
Band 7 54 £224.36 £12,115.44 HR & Finance departments
Band 6 195 £168.36 £32,830.20 HR & Finance departments
Band 5 36 £131.89 £4,748.04 HR & Finance departments
Band 4 (awaiting registration) 1 £117.33 £117.33 HR & Finance departments
Total cost for midwives per year £51,702.48
Band 6 2 £168.36 £336.72 HR & Finance departments
Total cost for ODPs per year £336.72
Band 3 74 £51.80 £3,833.20 HR & Finance departments
Band 2 26 £46.31 £1,204.06 HR & Finance departments
Total cost for MCAs per year £5,037.26
Printing Total number Cost Total cost Source of data
Certificate (Colour) 475 £0.00 £0.00 N/A
Evaulation sheets (2 x B&W) 475 £0.00 £0.00 N/A
Booklets 475 £0.40 £190.00 Hospital Print Room
Total printing (variable) cost per year £190.00
Admin time (Band 8 Midwife) Total days Cost/day Total cost Source of data
Fixed 18 £251.10 £4,519.80 Practice Development midwife
Variable (session dependent)
(2 days per session x 7 sessions) 14 £251.10 £3,515.40 Practice Development midwife
Total admin cost per year £8,035.20
Ice breaker (1 hour) Numbers Cost for 1 hour Total cost
Pratice development midwife (Band 8) 1 £33.48 £33.48 HR & Finance departments
Consultant 1 £71.43 £71.43 HR & Finance departments
Lectures (3 hours) Numbers Cost for 3 hours Total cost
Consultant 1 £214.29 £214.29 HR & Finance departments
Registrar 1 £115.38 £115.38 HR & Finance departments
Midwife Band 7 1 £89.73 £89.73 HR & Finance departments
Pratice development midwife (Band 8) 1 £100.44 £100.44 HR & Finance departments
Total cost for morning £624.75
Scenarios (3.5 hours) Numbers
Cost for 3.5 
hours Total cost
Consultants 3 £250.01 £750.03 HR & Finance departments
Registrars 3 £134.61 £403.83 HR & Finance departments
Midwife Band 6 3 £78.58 £235.74 HR & Finance departments
Midwife band 7 2 £104.69 £209.38 HR & Finance departments
Pratice development midwife (Band 8) 1 £117.18 £117.18 HR & Finance departments
Total cost for afternoon £1,716.16
Total cost of faculty for one day £2,340.91
Total cost of faculty for 1 year (7 days) £16,386.37
Total variable costs £111,773.08
Printing and Admin 







Operating department practitioners (ODPs)
Maternity care assistants (MCAs) (costed per afternoon)
Table 3-2 Total variable costs for PROMPT at Southmead 
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Items Units Unit cost Total cost Source of data
Mannequins/models
PROMPT Birthing Simulator 1 £2,577.00 £2,577.00 Commercial company
Grades Total number Cost per 0.5 hour Total cost Source of data
Consultants 15 £35.71 £535.65 HR & Finance departments
Registrars 17 £19.23 £326.91 HR & Finance departments
Senior House Officers 28 £14.11 £395.08 HR & Finance departments
Total cost of obstetricians per year £1,257.64
Consultants 11 £35.71 £392.81 PROMPT faculty/HR & Finance departments
Specialty Doctors 5 £23.25 £116.25 PROMPT faculty/HR & Finance departments
Registrars 2 £19.23 £38.46 PROMPT faculty/HR & Finance departments
Senior House Officers 3 £14.11 £42.33 PROMPT faculty/HR & Finance departments
Total cost for anaesthetists per year £589.85
Band 8 8 £16.74 £133.92 HR & Finance departments
Band 7 54 £14.96 £807.84 HR & Finance departments
Band 6 195 £11.22 £2,187.90 HR & Finance departments
Band 5 36 £8.79 £316.44 HR & Finance departments
Band 4 (awaiting registration) 1 £7.82 £7.82 HR & Finance departments
Total cost for midwives per year £3,446.10
Band 6 2 £11.22 £22.44 HR & Finance departments
Total cost for ODPs per year £22.44
Band 3 74 £7.40 £547.60 HR & Finance departments
Band 2 26 £6.62 £172.12 HR & Finance departments
Total cost for MCAs per year £719.72
Admin time (Band 8 Midwife) Total days Cost/day Total cost Source of data
Fixed 10 £251.10 £2,511.00 Estimate 
Total admin cost per year £2,511.00
Numbers Cost for 0.5 hour Total cost
Registrars 1 £19.23 £19.23 HR & Finance departments
Midwife Band 7 1 £14.96 £14.96 HR & Finance departments
Total cost of faculty per session £34.19
Total cost of faculty for 1 year (50 sessions) £1,709.50 Allowing for around 10 people per session
Total variable costs of SD training £10,256.25
Maternity care assistants (MCAs) 






Operating department practitioners (ODPs)
Variable costs
Table 3-4 Standalone shoulder dystocia training costs 
Train the Trainers course Units Unit cost Total cost Source of data
Fee (per team of 4) 1 £4,000.00 £4,000.00 Royal College of Obstetricians & Gynaecologists
Travel/accommodation 4 £150.00 £600.00 Estimate
Total for T3 course £4,600.00
Printed materials
Total for printed materials £107.46 See Chapter appendix
Equipment
Obstetric haemorrhage
Emergency box (training) 1 £34.97 £34.97 See Chapter appendix
Emergency box (real) 1 £244.42 £244.42 See Chapter appendix
Eclampsia
Emergency box (training) 1 £30.02 £30.02 See Chapter appendix
Emergency box (real) 1 £237.02 £237.02 See Chapter appendix
Sepsis
Emergency box (training) 1 £30.72 £30.72 See Chapter appendix
Emergency box (real) 1 £80.00 £80.00 See Chapter appendix
Total for equipment £657.15
Total additional start-up costs £5,364.61
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3.4 Discussion 
This is the first study to calculate the cost of multi-professional simulation training for 
obstetric emergencies to this level of detail. This data confirms that training is not 
cheap and does represent a reasonable financial outlay. It is therefore essential that 
maternity units consider the clinical effectiveness of training packages before they 
decide to implement them.  
 
This analysis only focussed on one UK maternity unit so the figures presented may 
not be easily generalisable outside of this context. The calculations were performed to 
provide an indication of how much it would cost to implement PROMPT or standalone 
shoulder dystocia training in the UK. Despite PROMPT’s global reach, this chapter 
has not attempted to investigate the cost of running it in other countries. There are 
also no equivalent courses covering the same breadth of material that could be used 
for meaningful comparison.  
 
The micro-costing analysis was performed with a series of assumptions and therefore, 
the final cost is subject to a degree of uncertainty. Only the average salaries per 
banding scale were used so the actual cost incurred may be different. The costs per 
day and hour were also calculated based on assumptions that each multi-professional 
group worked the same number of weeks and hours per year. In reality, there would 
be range of working patterns within each group, which would affect the final cost. 
Another source of variation is the cost of part-time staff, where two less-than-full-time 
doctors or midwives may actually equate to more than one full time doctor/midwife due 
to training and study requirements. 
 
The cost of releasing staff to attend and teach PROMPT at Southmead may be slightly 
overestimated as some staff may have used their study leave allowance or spare time 
to attend. The staff costs have also been calculated based on the costs of backfilling 
positions during the training courses. In practice, maternity departments, including 
Southmead, may not backfill completely, or at all, and instead choose to function with 
depleted numbers. However, for this analysis, it was important to ensure that the 
potential maximum cost of training was calculated so staff costs (and therefore, the 
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cost of backfilling posts) have been fully quoted, irrespective of possible savings from 
study leave or attendance outside of working hours.  
 
Given that staff costs represent an overwhelming proportion of the total and variable 
costs, the final costs of training will be very dependent on local workforce numbers. A 
recent Care Quality Commission report identified that Southmead maternity unit was 
operating at below the national recommended staffing levels for both obstetricians and 
midwives (195). The costs of training at Southmead may therefore appear to be less 
than the training costs in another maternity unit with a similar birth rate, particularly 
those operating nearer to the nationally recommended staffing levels. 
 
The analysis has been performed assuming that the same course programme is run 
year after year. In reality, maternity units may wish to adapt and change their 
programmes to be locally responsive and to cover a variety of the different obstetric 
emergencies included in the PROMPT package. For example, as PROMPT has been 
running at Southmead for over 10 years, the icebreaker activities have now been 
replaced by poster presentations of local research and audits. This requires more staff 
than a standard icebreaker session and would therefore affect the final cost. Other 
programme changes may also incur small additional expenses. During this analysis, 
it was assumed that the same team of faculty members would teach all the sessions 
throughout the year. In practice however, there may be a different mix and grade of 
faculty for each training day or shoulder dystocia training session, which would also 
affect the final costs. Furthermore, the total number of shoulder dystocia training 
sessions required to train all maternity staff was based on accommodating 10 
attendees per session. Maternity units may choose to provide training in smaller or 
larger groups. This would impact on the number of training sessions needed over the 
course of the year and would therefore affect the variable costs.  
 
With regard to equipment, the costing was based on the minimum number of 
mannequins and teaching props that were needed to effectively implement the course 
or shoulder dystocia training. As this was a retrospective micro-costing analysis, the 
prices for some items may have changed since first purchased. Some prices were 
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The potential, additional start-up costs for maternity units without any established 
training have also been included. Any extra staff costs would clearly represent the 
most significant additional costs. Extra staff would also impact on the number of 
training rooms required, number of sessions needed and the number of certificates, 
evaluation sheets and booklets to be printed. For maternity units without established 
local training, room hire at the full cost may be required. Some of the prices used for 
the contents of the emergency boxes were based on local hospital sources and not 
commercial prices. This may mean that that actual cost of stocking the emergency 
boxes may be different for other maternity units. These local prices, however, are likely 
to be similar across the NHS. Some maternity units without training may already have 
some of the necessary equipment required to stock the emergencies boxes, so they 
may not incur all of these additional costs. 
 
This is the first detailed investigation calculating the cost of local, multi-professional 
simulation training for obstetric emergencies or standalone shoulder dystocia training 
in a UK setting. Local, ‘in-house’ courses are often considered the most economical 
ways of delivering training, but this chapter clearly demonstrates that there is still a 
significant cost to the maternity departments undertaking them. In addition, the 
potential financial savings resulting from running these courses, such as possible 
reductions in litigation, might only be realised outside of the obstetric units delivering 
the training. This may serve as a barrier to the implementation of training programmes, 
with maternity units reluctant to bear the full cost of training for little or no local financial 
benefit. There may be other barriers to implementation too, including institutional 
priorities and departmental motivation, which have not been explored here. 
Policymakers and national agencies should be mindful of the cost implications of 
training and the potential barriers to establishing it. In particular, they should be wary 
of the lack of local monetary reward and find solutions to address this. For example, 
NHS Resolution (formerly known as the NHS Litigation Authority) tried to incentivise 
NHS Trusts in England to provide multidisciplinary, maternity skills and drills training 
through reduced insurance contributions or reimbursements. Originally, this was 
through their Clinical Negligence Schemes for Trusts (CNST) programme (34). More 
recently, a new maternity incentive scheme was introduced that was funded by 
charging each NHS Trust an additional 10% of their insurance contribution (133). 
Maternity units could recoup this money by complying with ten maternity safety 
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actions, which include ensuring that 90% of their maternity staff attended in-situ multi-
professional maternity emergencies training within the last year (133). In another 
example, the Victorian Managed Insurance Authority (VMIA) provided funding to 
support the implementation of PROMPT in health services in Victoria, Australia (32).  
 
In October 2016, the Secretary of State for Health in England announced a £8 million 
Maternity Safety Training Fund as part of a new Safer Maternity Care plan. Each NHS 
Trust in England could apply for at least £40,000 to help support their training of staff 
(196,197). This amount only covers a fraction of the training costs for units similar to 
Southmead but the release of these funds is much needed and a step in the right 
direction.  
 
As alluded to earlier, there are likely to be some cost savings, if not locally, then within 
the health system as a whole, associated with the implementation of training. One US 
unit that delivered PROMPT training estimated that, over 7 years, the costs avoided 
through improved outcomes were US$7.5 million for the prevention of permanent 
obstetric brachial plexus injuries (OBPIs) (15 cases prevented) and US$26.8 million 
for avoided hypoxic-ischaemic encephalopathy (HIE) cases (4 cases prevented) 
(100). The lifetime medical cost of HIE was approximated at US$6.7 million, excluding 
liability costs, and the average lifetime cost of OBPIs (transient and permanent) was 
estimated at US$500,000, which included both medical and negligence costs (100). 
Whilst this chapter has not presented the possible savings related to simulation 
training in obstetric emergencies, an economic evaluation in Chapter 4 will explore 
this in greater detail.  
 
Finally, assuming similar staffing-birth ratios, it might be reasonable to estimate that 
local, multi-professional simulation training for obstetric emergencies could cost 
around £17,000 - £18,000 per annum, per 1,000 births at unit level.  
 
3.5 Conclusions 
Local, multi-professional simulation training for obstetric emergencies is not cheap. 
The cost of training is significant and staff costs potentially represent over 90% of the 
total figure. Rather than discouraging investment in training, this information should 
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instead encourage organisations to carefully review the clinical effectiveness of each 
training package before deciding which one to implement locally.  
 
Whilst there is a growing evidence base for the clinical impact of local, multi-
professional simulation training for obstetric emergencies, the cost implications of 
such training have been generally overlooked until now.  
 
3.6 Publication 
This work was published in Acta Obstetricia et Gynecologica Scandinavica in October 
2016. All costings were presented in Euros at the request of the journal and to make 
the findings more relevant to its European readership. Although shoulder dystocia 
training is an integral part of the PROMPT programme, the costs of standalone 
shoulder dystocia training were not included in this publication. As PROMPT provides 
training for a wide range of obstetric emergencies, I felt that it was better to focus on 
the programme as a whole, instead of individual components. The published article 
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3.7 Chapter appendix  
3.7.1 Example PROMPT course programme 3 
 
        Figure 3-1 Example PROMPT course programme 3 
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Printed materials Units Unitary cost Total cost Source of data
Ice breaker activity 
Animal picture (1 per team) (Colour) 6 £0.17 £1.02 Univesity print services
Teamwork checklist (1 per team) (B&W) 6 £0.05 £0.30 Univesity print services
Lamination 12 £1.00 £12.00 Univesity print services
Subtotal £13.32
Basic life support
Alogirthm (B&W) 6 £0.05 £0.30 Univesity print services
Checklist (B&W) 6 £0.05 £0.30 Univesity print services
Lamination 12 £1.00 £12.00 Univesity print services
Subtotal £12.60
Obstetric Haemorrhage 
Maternity notes (B&W) 1 £0.05 £0.05 Univesity print services
MEOWS chart (Colour) 1 £0.17 £0.17 Univesity print services
Guide to blood loss (Colour) 1 £0.17 £0.17 Univesity print services
Treatment algorithm (colour) 1 £0.17 £0.17 Univesity print services
PPH proforma (B&W) 1 £0.05 £0.05 Univesity print services
Equipment pictures (Colour) 5 £0.17 £0.85 Univesity print services
Checklists (B&W) 4 £0.05 £0.20 Univesity print services
Lamination 14 £1.00 £14.00 Univesity print services
Subtotal £15.66
Vaginal Breech
Maternity notes (B&W) 1 £0.05 £0.05 Univesity print services
CTG (B&W) 1 £0.05 £0.05 Univesity print services
CTG sticker (B&W) 1 £0.05 £0.05 Univesity print services
Checklists (B&W) 4 £0.05 £0.20 Univesity print services
Equipment pictures (Colour) 3 £0.17 £0.51 Univesity print services
Lamination 10 £1.00 £10.00 Univesity print services
Subtotal £10.86
Shoulder dystocia
Maternity notes (B&W) 1 £0.05 £0.05 Univesity print services
Management algorthim (B&W) 1 £0.05 £0.05 Univesity print services
Proforma (B&W) 1 £0.05 £0.05 Univesity print services
Checklists (B&W) 4 £0.05 £0.20 Univesity print services
Equipment pictures (colour) 2 £0.17 £0.34 Univesity print services
Lamination 9 £1.00 £9.00 Univesity print services
Subtotal £9.69
Neonatal resuscitation
Management algorthim (B&W) 1 £0.05 £0.05 Univesity print services
Equipment pictures (Colour) 1 £0.17 £0.17 Univesity print services
Checklist (B&W) 4 £0.05 £0.20 Univesity print services
Lamination 6 £1.00 £6.00 Univesity print services
Subtotal £6.42
Sepsis
Maternity notes (B&W) 1 £0.05 £0.05 Univesity print services
Blood results (B&W) 2 £0.05 £0.10 Univesity print services
SBAR sheet (Colour) 1 £0.17 £0.17 Univesity print services
MEOWS chart (Colour) 1 £0.17 £0.17 Univesity print services
Management algortihm (B&W) 1 £0.05 £0.05 Univesity print services
Checklists (B&W) 4 £0.05 £0.20 Univesity print services
Equipment pictures (Colour) 7 £0.17 £1.19 Univesity print services
Lamination 17 £1.00 £17.00 Univesity print services
Subtotal £18.93
Eclampsia
Maternity notes (B&W) 1 £0.05 £0.05 Univesity print services
Medication chart (colour) 1 £0.17 £0.17 Univesity print services
Partogram (colour) 2 £0.17 £0.34 Univesity print services
MEOWS chart (colour) 1 £0.17 £0.17 Univesity print services
Eclampsia proforama (B&W) 1 £0.05 £0.05 Univesity print services
Magnesium/treatment algorithm (B&W) 3 £0.05 £0.15 Univesity print services
Checklists (B&W) 4 £0.05 £0.20 Univesity print services
Equipment pictures (colour) 5 £0.17 £0.85 Univesity print services
Lamination 18 £1.00 £18.00 Univesity print services
Subtotal £19.98
Total cost of printed materials £107.46
B&W Black and white
Table 3-5 Total costs for printed materials 
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Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commerical company
Cannulae 2 £0.73 £1.46 EROS (Trust ordering system)
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Hartmanns (1L) 2 £0.97 £1.94 EROS (Trust ordering system)
Blooding giving sets 2 £1.08 £2.16 EROS (Trust ordering system)
Syntometrine (5 ampoules) 1 £7.87 £7.87 BNF or Trust Pharmacy
Oxytocin 5 units (5 ampoules) 1 £4.01 £4.01 BNF or Trust Pharmacy
Oxytocin 10 units (5 amps) 1 £4.53 £4.53 BNF or Trust Pharmacy
Hemabate (10 ampoules) 1 £182.01 £182.01 BNF or Trust Pharmacy
Misoprostol (pack of 60) 1 £12.03 £12.03 BNF or Trust Pharmacy
Normal saline (500ml) 1 £0.68 £0.68 BNF or Trust Pharmacy
Giving set for synto infusion 1 £2.99 £2.99 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Labels (roll) 1 - -
Urometer 1 £5.17 £5.17 EROS (Trust ordering system)
Total cost £244.42
Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commerical company
Cannulae 2 £0.73 £1.46 EROS (Trust ordering system)
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Hartmanns(1L) 2 £0.97 £1.94 EROS (Trust ordering system)
Blooding giving sets 2 £1.08 £2.16 EROS (Trust ordering system)
Syntometrine (fake) 2 £0.06 £0.12 BNF or Trust Pharmacy
Oxytocin 5 units (fake) 2 £0.06 £0.12 BNF or Trust Pharmacy
Oxytocin 10 units (fake) 4 £0.06 £0.24 BNF or Trust Pharmacy
Hemabate (fake) 8 £0.06 £0.48 BNF or Trust Pharmacy
Misoprostol (fake) 4 £0.01 £0.04 BNF or Trust Pharmacy
Normal saline (500mL) 1 £0.68 £0.68 BNF or Trust Pharmacy
Giving set for synto infusion 1 £2.99 £2.99 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Labels (roll) 1 - -




Table 3-6 Total costs of obstetric haemorrhage emergency boxes 
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Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commerical company
IV giving sets 2 £0.50 £1.00 EROS (Trust ordering system)
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20 ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Syringes (50ml) 1 £0.30 £0.30 EROS (Trust ordering system)
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Labels (roll) 1 - -
Cannulae (grey) 2 £0.73 £1.46 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Urometer 1 £5.17 £5.17 EROS (Trust ordering system)
Normal saline flushes (10ml) 7 £0.05 £0.35 BNF or Trust Pharmacy
Nifedipine (pack of 84) 1 £12.59 £12.59 BNF or Trust Pharmacy
Hydralazine (5 ampouless) 1 £141.49 £141.49 BNF or Trust Pharmacy
Labetalol (100mg ) pack of 56 1 £4.89 £4.89 BNF or Trust Pharmacy
Labetalol (IV) (5 ampoules) 1 £44.21 £44.21 BNF or Trust Pharmacy
Magnesium sulphate (IV) 50% 10 ampoules 1 £5.39 £5.39 BNF or Trust Pharmacy
Normal saline flushes (10ml) 10 £0.06 £0.60 BNF or Trust Pharmacy
Total cost £237.02
Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commercial company
IV giving sets 2 £0.50 £1.00 EROS (Trust ordering system)
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20 ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Syringes (50ml) 1 £0.30 £0.30 EROS (Trust ordering system)
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Labels (roll) 1 - -
Cannulae (grey) 2 £0.73 £1.46 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Urometer 1 £5.17 £5.17 EROS (Trust ordering system)
Normal saline flushes (10ml) 7 £0.06 £0.42 BNF or Trust Pharmacy
Nifedipine (fake) 10 £0.01 £0.10 Estimate
Hydralazine (fake) 5 £0.06 £0.30 BNF or Trust Pharmacy
Labetalol (fake) 20 £0.01 £0.20 Estimate
Labetalol (fake) 5 £0.06 £0.30 BNF or Trust Pharmacy
Magnesium sulphate (fake) 10 £0.06 £0.60 BNF or Trust Pharmacy
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3.7.5 Total costs of sepsis emergency boxes 
 
Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commerical company
Cannulae 2 £0.73 £1.46 EROS (Trust ordering system)
Cefuroxime (10 vials) 1 £6.48 £6.48 BNF or Trust Pharmacy
Metronidazole 500mg in 100ml 1 £43.00 £43.00 BNF or Trust Pharmacy
Paracetamol 1 £0.66 £0.66 BNF or Trust Pharmacy
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Arterial blood gas syringe 2 - -
Blood culture bottles (set) 1 - -
Micrbiology swabs 2 - -
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Labels (roll) 1 - -
IV Hartmanns (1L) 2 £0.97 £1.94 BNF or Trust Pharmacy
IV giving set 2 £0.50 £1.00 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Urometer 1 £5.17 £5.17 EROS (Trust ordering system)
Speculum 1 £0.48 £0.48 EROS (Trust ordering system)
Normal saline flushes (10ml) 4 £0.06 £0.24 BNF or Trust Pharmacy
Total cost £80.00
Emegency box contents Number Cost Total cost Source of data
Box 1 £14.98 £14.98 Commercial company
Cannulae 2 £0.73 £1.46 EROS (Trust ordering system)
Cefuroxime (fake) 1 £0.06 £0.06 BNF or Trust Pharmacy
Metronidazole (fake) (100ml saline) 1 £0.40 £0.40 BNF or Trust Pharmacy
Paracetamol (fake) (100ml saline) 1 £0.40 £0.40 BNF or Trust Pharmacy
Blood bottles 4 - -
Syringes (10ml) 4 £0.05 £0.20 EROS (Trust ordering system)
Syringes (20ml) 2 £0.08 £0.16 EROS (Trust ordering system)
Arterial blood gas syringe 2 - -
Blood culture bottles (set) 1 - -
Micrbiology swabs 2 - -
Drawing up needles 4 £0.02 £0.08 EROS (Trust ordering system)
Labels (roll) 1 - -
IV Hartmanns (1L) 2 £0.97 £1.94 BNF or Trust Pharmacy
IV giving set 2 £0.50 £1.00 EROS (Trust ordering system)
Catheter 1 £4.15 £4.15 EROS (Trust ordering system)
Urometer 1 £5.17 £5.17 EROS (Trust ordering system)
Speculum 1 £0.48 £0.48 EROS (Trust ordering system)
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Abstract
Introduction. We aim to outline the annual cost of setting up and running a
standard, local, multi-professional obstetric emergencies training course,
PROMPT (PRactical Obstetric Multi-Professional Training), at Southmead
Hospital, Bristol, UK – a unit caring for approximately 6500 births per year.
Material and methods. A retrospective, micro-costing analysis was performed.
Start-up costs included purchasing training mannequins and teaching props,
printing of training materials and assembly of emergency boxes (real and train-
ing). The variable costs included administration time, room hire, additional
printing and the cost of releasing all maternity staff in the unit, either as atten-
dees or trainers. Potential, extra start-up costs for maternity units without
established training were also included. Results. The start-up costs were !5574
and the variable costs for 1 year were !143 232. The total cost of establishing
and running training at Southmead for 1 year was !148 806. Releasing staff as
attendees or trainers accounted for 89% of the total first year costs, and 92%
of the variable costs. The cost of running training in a maternity unit with
around 6500 births per year was approximately !23 000 per 1000 births
for the first year and around !22 000 per 1000 births in subsequent years.
Conclusions. The cost of local, multi-professional obstetric emergencies training
is not cheap, with staff costs potentially representing over 90% of the total
expenditure. It is therefore vital that organizations consider the clinical effec-
tiveness of local training packages before implementing them, to ensure the
optimal allocation of finite healthcare budgets.
Abbreviation: PROMPT, PRactical Obstetric Multi-Professional Training.
Introduction
Improving maternal and perinatal care, and reducing pre-
ventable intrapartum harm in particular, is a global prior-
ity. More and better intrapartum training has frequently
been recommended as a solution by national reports in
the UK, including the recent Maternity Services Review in
England (1–4) and also around the world (5,6). Up until
recently, there has been little guidance or evidence for
effective training and even less information on the
Key Message
Local, multi-professional obstetric emergencies train-
ing is not free. Maternity units should be confident
of the clinical effectiveness of the training packages
that they choose, and policy makers should be
responsive to the cost implications of implementing
training.
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potential costs of implementing training. Two recent
reviews of published outcomes after training for obstetric
emergencies, one in 2009 (7) and another from 2015 (8),
both concluded that regular, local, multi-professional
training for all staff was the most effective model. Local
training may also allow participants to evaluate their own
workplace and identify areas for improvement (9). PRac-
tical Obstetric Multi-Professional Training (PROMPT) is
an example of this model of training and would be a use-
ful vehicle for investigating the cost of training. The
PROMPT package was developed in the UK in 2000 and
consists of a “Course in a Box”, containing Course and
Trainers Manuals, and a DVD of training materials that
can be adapted for local use in any maternity setting.
Doctors, midwives & healthcare support workers all
attend PROMPT training locally within the clinical areas
of the maternity unit. The implementation of PROMPT
at Southmead Hospital, Bristol, UK has been associated
with improvements in perinatal outcomes (10,11) as well
as improvements in safety attitudes and teamwork climate
(12). These results have also been reproduced outside the
UK (13,14). Finally, a recent paper suggests that
the PROMPT program is sustainable, as demonstrated by
the increasing improvements in some perinatal outcomes
after more than a decade of continuous local training
(15).
The latest National Maternity Review in England has
recommended maternity units to adopt localized multi-
professional training packages that have demonstrated
improvements in clinical outcomes and acknowledges
PROMPT as a leading example of such a training pro-
gram (4). This is important as not all local obstetric
emergencies training programs have been associated with
clinical improvements (16): there are programs associated
with no change (17) and, counter-intuitively, other pro-
grams have been associated with increased injury rates
after training (18).
Although there has been useful research investigating
the clinical impact of training programs for obstetric
emergencies, very few studies have considered the finan-
cial implications of their implementation. One paper
discussing the clinical effectiveness of PROMPT in a US
hospital did attempt to capture the costs but did not
use any recognized costing techniques (13). Furthermore,
we are unaware of any publications, including the cur-
rent NHS England Maternity Review (4), that have
attempted to assess the cost of implementing local train-
ing. Such information would be crucial in guiding policy
makers in the appropriate allocation of limited health-
care resources.
The aim of this paper is to outline the cost of setting
up and running a standard course (PROMPT) for 1 year
at its base hospital (Southmead Hospital, Bristol, UK).
Material and methods
A retrospective, micro-costing analysis was performed to
assess the cost of establishing and running “Example
PROMPT Course Programme No. 3” (see Supporting
information, Figure S1)) from the PROMPT Trainer’s
Manual (second edition) (19) for 1 year at Southmead
Hospital, Bristol. Potential, extra start-up costs for mater-
nity units without established training were also included.
The costs were calculated in 2016 UK pounds sterling
and are presented in 2016 euros. As this was a costing
analysis and no patients were involved, ethics approval
was not required.
Southmead Hospital is a tertiary referral center, with
around 6500 births per annum. There is also an alongside
midwifery-led unit and a freestanding midwifery-led unit
in the community (20). The costing was divided into the
initial start-up costs and the variable costs. The start-up
costs included the purchase of training mannequins and
teaching props, “in-house” printing of training materials
and assembly of emergency boxes (real and training). The
variable costs consisted of costs related to releasing all
maternity staff to attend the training and also other staff
to facilitate the training. Administration time, room hire
and additional printing were also included in the variable
costs.
Costing information was obtained from a variety of
sources, including: the local PROMPT faculty, the Trust
Human Resources department and the Finance depart-
ment. Enquiries were also made in other hospital depart-
ments, including practice development, learning and
development, facilities, print room, clinical equipment
services, hospital ordering system and pharmacy. Addi-
tional information was extracted from the British
National Formulary, University of Bristol print services
and other commercial equipment suppliers. Calculations
were performed using MICROSOFT! EXCEL! spreadsheet
software.
For maternity units without any established training,
there may be additional start-up costs. For example, to
run PROMPT in another maternity unit, a representative
team must first attend a PROMPT “Train the Trainers
(T3)” day, which is usually held in London. Therefore,
units attending the T3 course would need to cover the
costs of the team travelling to London as well as the costs
of attending the day and receiving the PROMPT “Course
in a Box” training materials. PROMPT was developed at
Southmead Hospital and therefore, the local faculty did
not need to attend the T3 training.
There were nominal printing and lamination charges at
Southmead Hospital, with both being produced within
the department, including pre-course reading booklets,
which cost !0.51 each to print. These minimal fees may
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not be equivalent in all hospitals therefore the potential
costs of printing and laminating materials have been pre-
sented using the University of Bristol print service prices.
PROMPT should be conducted locally and drills
should ideally be run in the same locations and using the
same equipment as if in the real situation. At Southmead,
the simulation sessions were run in a mixture of labour
ward or birth center rooms and other ward areas,
depending on their availability. As the rooms were part of
the maternity unit infrastructure and already in use, there
was no additional cost for using them. The hire of the
seminar room was also discounted by 50% as the training
was for hospital employees.
The introduction of emergency boxes into clinical prac-
tice, each carrying all the necessary equipment to manage a
specific obstetric emergency (21), meant that there needed
to be duplicate boxes for use during the training sessions.
The only differences between the two emergency boxes
were that the training boxes had all sharps removed and
normal saline ampoules replaced any medication. As drill
training was well established at Southmead before
PROMPT was introduced, a lot of the equipment required
to run the drills was already available and so there was no
additional cost to the department. However, the potential
cost of stocking real and training emergency boxes has been
provided for maternity units without established training.
PROMPT encourages a multi-professional approach to
training and at Southmead, annual attendance of
PROMPT is mandatory for all maternity staff working in
the obstetric unit, as well as both midwifery-led units,
and also all maternity community staff. It is highly desir-
able for obstetric anesthetists to attend and as anesthetic
attendance has consistently been above 80% each year,
this cohort have been fully included in the costing exer-
cise because this would be the “gold standard” for multi-
professional training. Attendance for training was also
mandated for two operating department practitioners at
Southmead, so they too have been included in the calcu-
lations. In addition, all maternity care assistants attend
the afternoon drill sessions at Southmead. The calculation
of the annual cost of releasing staff to attend and/or teach
PROMPT at Southmead was complicated by a number of
other factors: some staff attended in their own personal
time or supporting professional activity time, and some
members of staff used their study leave allowance to
attend. In addition, staff could be on different incremen-
tal pay scales despite being on the same grade or banding.
Considering these issues, we decided to fully include staff
costs for PROMPT at Southmead because this would give
an indication of the potential maximum costs of training
and therefore minimize underestimation. The costs were
based on the average salaries per grade for the current
cohort of maternity staff working at Southmead Hospital.
This calculation included the salaries of those working
less-than-full-time. It was assumed that two less-than-
full-time doctors or midwives had the equivalent cost per
day as one full-time doctor/midwife. Obstetric and anes-
thetic consultants at Southmead often participated in the
local training during their supporting professional activity
time, and this was taken into account when calculating
the consultant costs for PROMPT at Southmead. If
locum staff at Southmead were not clearly staying for
longer than 12 months they were excluded from the cal-
culation. All maternity staff working in the community
with an affiliation to the maternity unit were included in
this exercise, as were all midwifery “bank” staff, who may
be called to cover sickness or staff shortages in the unit at
any time. This costing was based on training 100% of rel-
evant maternity staff over 1 year. At Southmead, this
required seven PROMPT courses per year on average and
therefore the staff facilitating the training may need to be
released more than once during the year.
Results
The start-up costs were !5574 and the variable costs for
1 year were !143 232 (Table 1 and Table 2). The total cost
of establishing and running PROMPT at Southmead for
1 year was !148 806. Releasing staff to attend and facilitate
training accounted for 89% of the total first year costs and
92% of the variable costs. The total cost of running
PROMPT per year in subsequent years could be modeled
on the variable costs of the first year. However, the cohort
of staff each year will significantly influence this figure.
For maternity units without any established training,
the additional start-up costs could be !6759 (Table 3).
The potential costs of printing materials and stocking the
emergency boxes are provided in the Supporting informa-
tion (Tables S1–S4).
In 2015, there were 6517 live births at Southmead
Hospital. Therefore, based on this birth rate, the cost of
local, multi-professional obstetric emergencies training at
Southmead is approximately !23 000 per 1000 births for
the first year and around !22 000 per 1000 births in sub-
sequent years.
Discussion
To our knowledge, this is the first paper that has calculated
the cost of a local, obstetric emergencies training program
to this level of detail. Our data comprehensively confirms
that training is not free, and nor is it cheap. Therefore, it is
vital that maternity units consider the evidence base and
clinical effectiveness of training packages before they decide
to implement them, and policy makers should be respon-
sive to the cost implications of implementing training.
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Similarly, insurers who are best placed to underpin these
costs, should consider the cost effectiveness of training
(22). PROMPT is an established training program that has
been successfully adapted and implemented in the USA,
Australia and also in low-resource settings (13,14,23),
which makes it a useful vehicle for investigation.
This analysis focused on only one UK maternity unit
and we appreciate that these figures may not be easily
generalizable, within or outside the NHS. The costing was
performed with a series of assumptions and therefore, the
final cost is subject to a degree of uncertainty. Only the
average salaries per banding scale were used and
Table 1. Total start-up costs for PROMPT at Southmead.
Units Unitary cost Total cost Source of data
Train the Trainers Course (T3)
Fee (per team of 4) Not applicable
Travel/accommodation 4 Not applicable
Total for T3 course !0.00
Mannequins/models
Resusci Anne First Aid 1 !925.62 !925.62 Commercial company
PROMPT Birthing Simulator 1 !3312.63 !3312.63 Commercial company
MamaNatalie 1 !655.57 !655.57 Commercial company
Baby Anne 1 !189.73 !189.73 Commercial company
Total for mannequins/models !5083.55
Teaching props
Magic Trousers 1 PROMPT Faculty
Magic pants 1 PROMPT Faculty
Magic Cushion 1 PROMPT Faculty
Stained pads 4 PROMPT Faculty
Total for teaching props !257.06
Printed materials
Total for printed materials !0.00
Equipment
Basic life support
Equipment Already available See supporting information, Figure S2
Obstetric hemorrhage
Equipment Already available See supporting information, Figure S2
Emergency box (training) 1 !19.25 !19.25 Box only/Commercial company
Emergency box (real) 1 !19.25 !19.25 Box only/Commercial company
Large container 1 !19.26 !19.26 Commercial company
Eclampsia
Equipment Already available See supporting information, Figure S2
Emergency box (training) 1 !19.25 !19.25 Box only/Commercial company
Emergency box (real) 1 !19.25 !19.25 Box only/Commercial company
Large container 1 !19.26 !19.26 Commercial company
Sepsis
Equipment Already available See supporting information, Figure S2
Emergency box (training) 1 !19.25 !19.25 Box only/Commercial company
Emergency box (real) 1 !19.25 !19.25 Box only/Commercial company
Large container 1 !19.26 !19.26 Commercial company
Neonatal resuscitation
Equipment Already available See supporting information, Figure S2
Breech
Equipment Already available See supporting information, Figure S2
Large container 1 !19.26 !19.26 Commercial company
Total for equipment !192.54
Other equipment needed
Blu-tak 2 !2.56 !5.12 Commercial company
Whiteboard markers (pack of 6) 6 !5.13 !30.78 Commercial company
Paper (200 sheets) 1 !5.13 !5.13 Commercial company
Total for other equipment !41.03
Total start-up costs !5574.18
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Table 2. Total variable costs for PROMPT at Southmead.
Rooms Sessions Cost per
session
Total cost Source of data
Seminar room (morning session) 7 ! 96.10 ! 672.70 PROMPT support manager/Learning
and research department
Total room cost per year ! 672.70
Attending personnel
Obstetricians Total Number Cost per
day
Total Cost Source of data
Consultantsa 15 ! 732.08 ! 10 981.20 HR and Finance departments
Registrarsb 17 ! 394.32 ! 6703.44 HR and Finance departments
Senior House Officersb 28 ! 289.28 ! 8099.84 HR and Finance departments
Total cost for doctors per year ! 25 784.48
Anesthestists Total Number Cost per
day
Total Cost Source of data
Consultantsa 11 ! 732.08 ! 8052.88 PROMPT faculty/HR and Finance departments
Specialty Doctorsb 5 ! 476.72 ! 2383.60 PROMPT faculty/HR and Finance departments
Registrarsb 2 ! 394.32 ! 788.64 PROMPT faculty/HR and Finance departments
Senior House Officersb 3 ! 289.28 ! 867.84 PROMPT faculty/HR and Finance departments
Total cost for anaesthetists per year ! 12 092.96
Midwivesc Total Number Cost per
day
Total Cost Source of data
Band 8 8 ! 321.83 ! 2574.64 HR and Finance departments
Band 7 54 ! 287.48 ! 15 523.92 HR and Finance departments
Band 6 195 ! 215.78 ! 42 077.10 HR and Finance departments
Band 5 36 ! 168.98 ! 6083.28 HR and Finance departments
Band 4 (awaiting registration) 1 ! 150.30 ! 150.30 HR and Finance departments
Total cost for midwives per year ! 66 258.94
Operating department practitioners (ODPs)c
Band 6 2 ! 215.78 ! 431.56 HR and Finance departments
Total cost for ODPs per year ! 431.56
Maternity care assistants (MCAs) c Total Number Cost per
afternoon
Total Cost Source of data
Band 3 74 ! 66.36 ! 4910.64 HR and Finance departments
Band 2 26 ! 59.33 ! 1542.58 HR and Finance departments
Total cost for MCAs per year ! 6453.22
Printing Total number Cost Total Cost Source of data
Certificate (Colour) 475 ! 0.00 ! 0.00 Hospital Print service
Evaulation sheets (2 9 B&W) 475 ! 0.00 ! 0.00 Hospital Print service
Booklets 475 ! 0.51 ! 242.25 Hospital Print service
Total printing (variable) cost per year ! 242.25
Administration time (Band 8) Total days Cost/day Total cost Source of data
Fixed 18 ! 321.83 ! 5792.94 Practice development midwife
Variable (session dependent) 14 ! 321.83 ! 4505.62 Practice development midwife
(2 days per session 9 7 sessions)
Total admin cost per year ! 10 298.56
Faculty
Morning 1 h (ice breaker) Numbers Cost for
morning
Total cost
Pratice development midwife (Band 8) c 1 ! 42.91 ! 42.91 HR and Finance departments
Consultanta 1 ! 91.51 ! 91.51 HR and Finance departments
Remaining lectures 3 h
Consultanta 1 ! 274.53 ! 274.53 HR and Finance departments
Registrarb 1 ! 147.87 ! 147.87 HR and Finance departments
Midwife Band 7c 1 ! 114.99 ! 114.99 HR and Finance departments
Pratice development midwife (Band 8) c 1 ! 128.73 ! 128.73 HR and Finance departments
Total cost for morning ! 800.54
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therefore, the actual cost incurred may be different. The
costs per day and hour were also calculated based on
assumptions that each multi-professional group worked
the same number of weeks and hours per year. In reality,
there would be variation in the time worked within each
multi-professional group, which would affect the final
cost. Other variables to consider are the costs of part-time
staff, where two less-than-full-time doctors or midwives
may actually equate to more than one full time doctor/
midwife due to training and study requirements, so this
too may affect the final costings.
We anticipate that the cost of releasing staff to attend
and teach PROMPT at Southmead may be slightly overes-
timated as some staff may have used their study leave
allowance or spare time to attend and consultants tended
to use their supporting professional activity time to par-
ticipate. However, for this exercise, we felt it was impor-
tant to ensure that the potential maximum cost of
training was calculated and so have quoted fully for all
staff costs, irrespective of potential funding savings from
study leave, personal time or non-attendance.
Given that staff costs represent an overwhelming pro-
portion of the total and variable costs, the final costs of
training will be dependent on local workforce numbers.
A recent Care Quality Commission Report identified
that Southmead maternity unit is operating at below the
national recommended staffing levels for both obstetri-
cians and midwives (24). The costs of training at South-
mead may therefore appear to be less than the training
costs in another maternity unit with a similar birth rate,
particularly those operating nearer to the nationally rec-
ommended staffing levels.
The analysis has been performed assuming that the
same course program is run for the duration of the year.
In reality, units may wish to adapt and change their
programs from year to year to be locally responsive and
to cover a variety of the different obstetric emergencies
included in the PROMPT package (see Supporting Infor-
mation, Figure S3), which may incur small additional
expenses. For example, as PROMPT has been running at
Southmead for over 10 years, the icebreaker activities
have now been replaced by poster presentations of local
research and audits. This requires more staff than a stan-
dard icebreaker session and would therefore affect the
final cost. During this costing, it was assumed that the
same team of faculty members would teach all the
sessions throughout the year. In reality, there may be a
different mix and grade of faculty for each training day,
which would also affect the final costs.
With regard to equipment, the costing was based on
the minimum required mannequins and teaching props
that were needed to effectively implement the course. As
this was a retrospective micro-costing analysis, the prices
for a small number of items may have changed since first
purchased, or they were unavailable at the time of this
costing exercise.
We have tried to include the potential, additional start-
up costs that maternity units without any established
training might incur. Any extra staff costs would clearly
represent the most significant additional costs. Extra staff
would also impact on the number of training rooms
required, number of sessions needed and the number of
certificates, evaluation sheets and booklets to be printed.
For maternity units without established local training,
room hire at the full cost may be required. Some of the
prices used for the components of the emergency boxes
were based on Southmead Hospital sources and not com-
mercial prices: therefore the actual cost to other maternity
units may be different. However, many of these are likely
to be standard across the NHS. Some maternity units
Afternoon 3.5 h Numbers Cost for
afternoon
Total Cost
Consultanta 3 ! 320.29 ! 960.87 HR and Finance departments
Registrarsb 3 ! 172.52 ! 517.56 HR and Finance departments
Midwife Band 6c 3 ! 100.70 ! 302.10 HR and Finance departments
Midwife band 7c 2 ! 134.16 ! 268.32 HR and Finance departments
Pratice development midwife (Band 8) c 1 ! 150.19 ! 150.19 HR and Finance departments
Total cost for afternoon ! 2199.04
Total cost of faculty for one day ! 2999.58
Total cost of faculty for 1 year (7 days) ! 20 997.06
Total variable costs ! 1 43 231.73
The costs per hour and costs per day were calculated assuming:
aConsultants worked 42 weeks a year and 40 h a week
bOther doctors worked 44 weeks per year and 40 h a week
cMidwifery managers, midwives, operating department practitioners (ODPs) and maternity care assistants (MCAs) worked 46 weeks a year and
37.5 h a week.
Working day for doctors is 8 h and working day for midwifery managers, midwives, ODPs and MCAs is 7.5 h.
Table 2. Continued
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without training may already have some of the necessary
equipment required to stock their emergencies boxes, so
they may not incur all of these additional costs.
Our calculations have been performed to provide an indi-
cation of how much it would cost to set up and run
PROMPT in the UK. Although the final costs have also been
presented in euros, we have not attempted to investigate
how much PROMPT would cost to run outside the UK.
As far as we are aware, this is the first detailed inves-
tigation calculating the cost of local, multi-professional
obstetric emergencies training in a UK maternity unit
setting. There is an assumption that local, “in-house”
courses are the most economical methods of delivering
training, but clearly there is still a significant cost to
the maternity departments undertaking them. In addi-
tion, the potential financial benefits of running such
courses, including possible reductions in litigation
claims, are most commonly felt outside the obstetric
units themselves. The lack of an explicit link between
training costs and potential cost savings may be a bar-
rier to the implementation of training because depart-
ment level managers cannot justify the significant,
additional costs incurred locally. There may be many
other barriers to implementation too, including institu-
tional priorities and departmental motivation, which we
have not explored in this paper. The Clinical Negligence
Schemes for Trusts (CNST) was a program, introduced
by the National Health Service Litigation Authority, that
incentivized NHS Trusts in England to provide multi-
professional, maternity skills and drills training through
reduced insurance premiums (25). This CNST assess-
ment has subsequently been halted, but examples of
successful insurer engagement with maternity services
and incentivization can still be found around the world,
such as in Victoria, Australia (14).
A US unit that implemented PROMPT training esti-
mated that, over 7 years, the costs avoided by improved
outcomes associated with PROMPT were $7.5 million for
the prevention of permanent brachial plexus injuries (15
cases prevented) and $26.8 million for avoided hypoxic-
ischemic encephalopathy cases (four cases prevented) (13).
These figures included medical and liability costs but it is
unclear how these sums were calculated. The work for this
paper provides a foundation for a future, robust economic
evaluation of obstetric emergencies training.
Finally, assuming a reasonably narrow range of staffing:
birth ratios, it may be reasonable to estimate that training
will cost at least !22 000 to !23 000 per annum, per 1000
births at unit level.
Conclusions
Local, multi-professional obstetric emergencies training is
not cheap. The cost of training is significant and staff
costs potentially represent over 90% of the total figure. It
is therefore vital that organizations should consider the
evidence base and clinical effectiveness of each training
package before deciding which one to implement locally.
Although there is increasing evidence of the clinical
impact of some local, multi-professional obstetric emer-
gencies training, the potential costs of any training model
also need to be considered when making recommenda-
tions for practice. These could be usefully combined in a
formal economic evaluation that will help guide policy
makers in the prudent and optimal allocation of finite
healthcare resources.
Table 3. Additional start-up costs for maternity units without established training.
Units Unitary cost Total cost Source of data
Train the Trainers Course (T3)
Fee (per team of four) !5124.19 RCOG
Travel/accommodation 4 !192.16 !768.64 Estimate
Total for T3 course !5892.83
Printed materials
Total for printed materials !138.38 See supporting information
Equipment
Obstetric hemorrhage
Emergency box contents (training) 1 !25.70 !25.70 See supporting information
Emergency box contents (real) 1 !294.73 !294.73 See supporting information
Eclampsia
Emergency box contents (training) 1 !19.31 !19.31 See supporting information
Emergency box contents (real) 1 !284.74 !284.74 See supporting information
Sepsis
Emergency box contents (training) 1 !20.19 !20.19 See supporting information
Emergency box contents (real) 1 !83.38 !83.38 See supporting information
Total for equipment !728.05
Total additional start-up costs !6759.26
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Figure S3. Obstetric emergencies included in the
PROMPT package.
Table S1. Breakdown of the cost of the printed
materials.
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training obstetric hemorrhage emergency boxes.
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training eclampsia emergency boxes.
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ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 95 (2016) 1111–1119 1119
C.W.H. Yau et al. The cost of local training
Chapter 4 
 
A cost-utility analysis of multi- professional simulation training for obstetric emergencies 
 120 
 
Chapter 4  
 
A cost-utility analysis of multi- 
professional simulation training 




A cost-utility analysis of multi- professional simulation training for obstetric emergencies 
 121 
4.1 Introduction  
Training is often recommended as a means for improving obstetric care and outcomes 
(5,6,8,76). The implementation and clinical effectiveness of multi-professional training 
programmes for obstetric emergencies has been studied (26,107,198) but up until 
recently (Chapter 3) the cost of running these training programmes has been largely 
ignored. The omission of training costs appears to be widespread within medical 
simulation training in general. In a systematic review investigating cost analyses in 
simulation-based medical education, only 6.1% studies included any cost data (27).  
 
Information on training costs is clearly required to inform policy, commissioners and 
local departmental managers alike. However, the potential monetary savings and 
other benefits from implementing training are equally important (199,200). These 
features could be presented as part of economic evaluations. Only then will decision 
makers be fully informed on the cost, as well as the effect, of training. Although this 
seems obvious, a recent systematic review identified only five full and nine partial 
economic evaluations related to emergency obstetric care training (122). Economic 
evaluation of patient safety initiatives is so infrequent that it has been described as a 
‘neglected necessity’ (p.444) (201).  
 
Economic evaluations are established methods for assessing the costs and impact of 
healthcare interventions (202). A cost-utility analysis – a specific form of economic 
evaluation – compares costs against preference-based health outcomes, such as 
quality adjusted life years (QALYs) (63). A QALY is a generic measure of health benefit 
that incorporates both quantity (mortality) and quality (morbidity) of life (63,72). One 
QALY represents a year in perfect health (203). Cost-utility analyses, with health 
effects expressed in QALYs, are components of health technology assessments 
reviewed by the National Institute for Health and Care Excellence (NICE) in England 
(72) and their use enables comparisons between interventions addressing very 
different health needs. NICE has set a cost-effectiveness threshold of £20,000-
£30,000 per QALY (73). Any health intervention that can gain a QALY for below this 
cost threshold will be deemed cost-effective, and those achieving a QALY for above 
this threshold will not. This cost-effectiveness threshold is not definitive and there are 
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other factors that influence whether an intervention is recommended for use in the 
National Health Service (NHS) (72).  
 
Investment in maternity training has recently been under the policy spotlight in 
England. The introduction of the Maternity Safety Training Fund in 2016 allowed each 
Trust to apply for at least £40,000 to support obstetric training (196,197). However, 
this welcome injection of funds may only cover a proportion of the training costs of 
larger maternity units (Chapter 3). Results from economic evaluations of simulation 
training for obstetric emergencies may help to justify further financial support from the 
macro level of the health system.  
 
In this chapter, I will conduct a model-based cost-utility analysis of a multi-professional, 
simulation-based training programme for obstetric emergencies (PROMPT). Although 
other maternity training programmes exist, PROMPT has been chosen for this 
evaluation as it is the only programme that has been associated with improved clinical 
outcomes across multiple settings (32,93,100,101,110,113). The cost-utility analysis 
will focus on the training programme’s impact on reducing permanent obstetric 
brachial plexus injuries (OBPIs) (113). 
 
4.2 Methods 
A decision model was developed to estimate the cost-utility of adopting annual 
PROMPT (scenario 1a) or just the shoulder dystocia component of PROMPT 
(scenario 1b) in all maternity units in England compared with current practice, where 
only a proportion of English units use the training programme (scenario 2). Scenario 
1 would essentially be scenario 2 plus the additional costs and benefits of training the 
remaining units. The training costs for scenario 1a and 1b were different but the clinical 
impact of both PROMPT and the standalone shoulder dystocia training was assumed 
to be identical, given that shoulder dystocia training is delivered as part of PROMPT. 
Hypothetical cohorts of babies affected by permanent OBPIs were created for all 
scenarios using published background incidence data. Figure 4-1 is a schematic 
representation of the decision model. The analysis was conducted from the 
perspective of the English NHS. Costs were calculated in 2017 UK pounds sterling. 
The time horizon for the model was 30 years, therefore all costs and outcomes after 
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the first year were discounted at an annual rate of 3.5%, as recommended by NICE 
(72).This time horizon was selected to ensure that the final hypothetical cohort of 
individuals with OBPIs were at least 18 years old. Univariate, multivariate and 
probabilistic sensitivity analyses were undertaken to account for uncertainties in the 
inputs for the model. Ethical approval was not required for this study. The Erb’s Palsy 















4.2.1 Model inputs 
The model inputs and their sources are summarised in Table 4-1. 
 
4.2.1.1 Training coverage 
The 2015-2016 Hospital Maternity Activity Provider Level Analysis provided the 
baseline birth rate in England (n=648,107) and births by NHS Trust per year for the 
model (205). For convenience, the birth rate and the annual births per NHS Trust were 
fixed for duration of the model. The number of births covered by PROMPT and the 
duration of the coverage (current practice) were estimated using information regarding 
hospital/NHS Trust attendance at a PROMPT ‘Train the Trainers’ day. Hospitals and 
NHS Trusts that had attended this session were assumed to be running the training 
programme thereafter. Repeat attendances were noted, but PROMPT coverage was 
assumed from the first ‘Train the Trainers’ day. As birthing statistics were at Trust 
level, only those that attended the ‘Train the Trainers’ session as Trusts could be  
Hypothetical cohorts  
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Table 4-1 Summary of model inputs 
 
 
Input Base case Range* Distribution Alpha-Beta
 or 
Standard C Source 
Annual birth rate 648,107 611,337- 671,255 Triangular 0.61 (205,206) 
Births covered by 
PROMPT       
PROMPT for 1 year 38,077  
Births covered by PROMPT to follow 
proportions in base case during 
probabilistic sensitivity analysis 
PROMPT 
data, (205) 
PROMPT for 2 years 18,991  
PROMPT for 3 years 32,269  
PROMPT for 4 years 23,261  
PROMPT for 5 years 31,111  
PROMPT for 6 years 45,093  
PROMPT for 7 years 39,944  
PROMPT for 8 years 8,366  
PROMPT for 15 years 7,386  
Probabilities of permanent 
OBPIs       
Without PROMPT/ 0 years 





1 year after PROMPT 0.000182  
Probabilities of developing permanent 
OBPIs following PROMPT to follow linear 
assumption as per base case during 
probabilistic sensitivity analysis   
Linear 
assumption 
2 years after PROMPT 0.000171  
3 years after PROMPT 0.000161  
4 years after PROMPT 0.000150  
5 years after PROMPT 0.000131  
6 years after PROMPT 0.000113  
7 years after PROMPT 0.000094  
8 years after PROMPT 0.000075  
9 years after PROMPT 0.000056  
10 years after PROMPT 0.000038  
11 years after PROMPT 0.000019  
12 years after PROMPT 0.000000  
Costs       
Discount rate 0.035 Fixed (72) 
Cost of PROMPT per birth 
(first year) £16.91 £13.53-£20.29 Triangular 0.5 
Chapter 3 
Cost of PROMPT per birth 
(subsequent years) £15.56 £12.45-£18.67 Triangular 0.5 
Cost of shoulder dystocia 
training per birth (first year) £1.79 £1.43-£2.14 Triangular 0.5 
Cost of shoulder dystocia 
training per birth 
(subsequent years) 
£1.43 £1.14-£1.71 Triangular 0.5 
Claims inflation 0.10 Fixed NHS 
Resolution, 
(207) 
Mean total litigation cost for 
OBPI £338,879 
£271,103-
£406,654 Triangular 0.5 
Utility scores (means)       
Adult with OBPI 0.56 0.28- 0.84 Beta 6-5 Chapter 2 
Caregiver of child with OBPI 0.80 0.61-0.99 Beta 13-3 
Population norm 0.86 0.62-1.00** Beta 6-1 (166) 
*Plausible ranges were generated by taking the lowest and highest birth rates in the last 10 years, using 
alternative baseline probabilities from an American paper, decreasing and increasing costs by 20% and 
subtracting and adding standard deviations to utility scores 
**Adding a standard deviation to the mean population utility score exceeded the upper threshold of 1.00 
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reliably included in the estimates. However, if all hospitals within a Trust attended 
separately, then the births from this Trust were also considered to be covered by 
PROMPT after the attendance of the final hospital.  
 
Cohorts of births covered by PROMPT were categorised by the number of years that 
the training had been established for as of 2015. This ranged from 1-8 years, with the 
exception of one NHS Trust (North Bristol) which had started training in 2000. The 
proportions of births covered by PROMPT remained fixed throughout the model. 
 
4.2.1.2 Probabilities of permanent OBPIs 
The incidence of OBPIs in the UK and Republic of Ireland was estimated at 0.40 per 
1,000 vaginal births (after excluding vaginal breech and caesarean births) and 48% of 
6-month old infants had partial or no recovery from their OBPIs, suggesting that these 
were permanent injuries (141). Using this data, the incidence of permanent OBPIs in 
the UK was set at 0.192 per 1,000 vaginal births, or 0.192‰ (baseline probability). 
This probability applied to births not exposed to PROMPT and remained constant for 
the duration of the model. 
 
PROMPT has been associated with a reduction in permanent OBPIs (113). After 4 
years of established training (excluding the 1st year of implementation), the incidence 
of permanent OBPIs was 0.15 per 1,000 vaginal births. By the end of 12 years of 
established training, this had fallen to 0‰ (113). The clinical impact of PROMPT 
throughout the model was set to replicate these figures, using a linear assumption to 
determine the probability of permanent OBPIs for each year since the implementation 
of PROMPT. The incidence rate of permanent OBPIs was assumed to be constant at 
0‰ after 12 years of established training.  
 
4.2.1.3 Creating hypothetical cohorts of babies with permanent OBPIs 
Hypothetical cohorts of babies affected by permanent OBPIs were generated for all 
scenarios for each model year. For births not covered by PROMPT, the annual 
permanent OBPI rate was fixed at the baseline probability (0.192‰). The cohorts of 
births covered by PROMPT were combined with the appropriate, extrapolated 
probabilities of permanent OBPIs for each year of the model (Table 4-1). The impact 
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of PROMPT and standalone shoulder dystocia training was assumed to be the same, 
meaning that the cohorts for scenarios 1a and 1b would be identical.  
 
4.2.1.4 Cost data 
Training costs were extracted from a previous micro-costing analysis of PROMPT 
(Chapter 3). Costs were inflated to 2017 UK pounds sterling (208). Using this data and 
the 2015-2016 Hospital Maternity Activity Provider Level Analysis (205), the cost of 
general training per birth was £16.91 in the first year and £15.56 in subsequent years. 
Unit level shoulder dystocia training was estimated to cost £1.79 per birth in the first 
year and £1.43 per birth in subsequent years.  
 
The cost of an OBPI was based on its mean litigation cost. NHS Resolution provided 
10 years’ worth of settled claims relating to shoulder dystocia and/or OBPIs (2006/07-
2016/17). This information included a breakdown of the damages, defence costs and 
claimant costs, all of which are paid for by NHS Resolution. In this period, there were 
376 settled claims, costing a total of £127,418,371.51. The mean cost per OBPI claim, 
and therefore the mean cost of the injury, was £338,878.65. The damages component 
of a claim consists of 3 parts: general damages (including suffering and loss of 
amenity), past losses, and future losses (including loss of earnings, cost of future care 
and cost of home adaptations) (207,209). As such, the mean OBPI litigation cost was 
a suitable proxy for the cost of an injury. Inflation for the damages component of claims 
was 10% per annum (which included a 2.5% personal injury discount rate) (207). This 
was accounted for in the model.  
 
4.2.1.5 Utility scores and Quality Adjusted Life Years (QALYs) 
The mean utility scores for adults with OBPIs and caregivers of children with OBPIs 
were extracted from Chapter 2. The total adult QALYs per model year were calculated 
using the mean utility score for adults with OBPIs, the number of individuals with 
OBPIs and the number of years they would have been adults for by the end of the 
model’s time horizon. Similarly, the total caregiver QALYs per year were calculated by 
using the appropriate utility score, the number of individuals with OBPIs and the 
number of years these individuals would have been children for by the end of the 
model. The adult and caregiver QALYs were then combined (with equal weighting) to 
produce a dyadic QALY. Mean utility scores (population norms) from the 2008 Health 
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Survey for England (166) were used to determine the adult QALYs and caregiver 
QALYs when there were no OBPIs. The QALYs in scenarios 1a and 1b were the same 
as the impact of PROMPT and standalone shoulder dystocia training was assumed to 
be identical.  
 
4.2.2 Model outputs 
Outcomes for the entire simulated period included the following: total costs for 
PROMPT or shoulder dystocia training (including the cost of OBPIs), number of OBPIs 
averted, number of adult/caregiver/dyadic QALYs gained and the incremental cost per 
QALY gained, which is otherwise known as the incremental cost effectiveness ratio 
(ICER). The net monetary benefits (NMBs) for each of the scenarios were also 
calculated by multiplying the number of QALYs gained by the willingness to pay 
thresholds (lower limit of £20,000 and upper limit of £30,000) (72,73) and then 
subtracting the total costs. NICE recommends including the health-related quality of 
life of caregivers in economic evaluations if possible (72). Although three different 
types of QALYs were used, the main outcome measure was therefore the incremental 
cost per dyadic QALY gained. This allowed the quality of life of caregivers to be 
accounted for in the cost-utility analysis.  
 
4.2.3 Sensitivity analyses  
Univariate, multivariate sensitivity and probabilistic sensitivity analyses were 
conducted to account for uncertainties in the model inputs. The lowest and highest 
birth rates in England over the last 10 years were used to create a range of births 
(206). However, as before, the proportion of births covered by PROMPT remained 
fixed throughout the sensitivity analyses. Alternative baseline probabilities for 
permanent OBPIs were taken from an American paper as there were no other UK 
studies investigating the incidence and prevalence of OBPIs – 0.19 per 1,000 vaginal 
births (US rate) and 0.3 per 1,000 vaginal births (rate from other countries) were used 
to create a plausible range of baseline probabilities (142). This enabled the 
extrapolation of alternative probabilities of permanent OBPIs by individual years post 
PROMPT. Costs were decreased and increased by 20% to generate minimum and 
maximum values respectively. The discount rate and claims inflation rate were fixed 
unless specified. The respective standard deviations were subtracted or added to the 
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mean adult, caregiver or general population utility scores to create minimum and 
maximum values. The ranges and assigned distributions for the parameters are 
summarised in Table 4-1. 
 
4.2.3.1 Univariate sensitivity analyses  
Instead of using the reference discount rate of 3.5%, the discount rate was set at 1.5% 
as suggested in NICE guidance (72) for one univariate sensitivity analysis. 
 
For the other univariate analyses, each cohort of births covered by PROMPT, except 
the births covered by PROMPT for 15 years, were reduced by 25% and 75% to 
account for possible suboptimal uptake of training following the ‘Train the Trainers’ 
sessions. North Bristol NHS Trust is the base for PROMPT and has consistently run 
annual training courses since 2000. These births therefore did not need to be altered 
in the univariate analyses.  
 
All three univariate analyses were run independently (Table 4-2). 
 
4.2.3.2 Multivariate analyses 
Input parameters were adjusted simultaneously to create the ‘best case’ and ‘worst 
case’. The best case was generated by altering the following model inputs: 
• Maximum baseline probability for permanent OBPIs (to increase the prevalence 
of the condition) 
• Minimum costs for training 
• Maximum litigation costs 
 
The worst case was created by changing the following model parameters: 
• Minimum baseline probability for permanent OBPIs (to decrease the 
prevalence of the condition) 
• Maximum costs for training 
• Minimum litigation costs 
 
These two multivariate sensitivity analyses were run independently and are 
summarised in Table 4-2. 
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Table 4-2 Univariate and multivariate analyses 
Type of sensitivity analysis Model inputs adjusted 
Univariate analysis 1 Discount rate set at 1.5% 
Univariate analysis 2 PROMPT coverage (except North Bristol births) reduced by 25% 
Univariate analysis 3 PROMPT coverage (except North Bristol births) reduced by 75% 
Multivariate analysis 1 (best case) Maximum baseline probability for permanent OBPIs, minimum training costs, maximum litigation costs 
Multivariate analysis 2 (worst case) Minimum baseline probability for permanent OBPIs, maximum training costs, minimum litigation costs 
 
 
4.2.3.3 Probabilistic sensitivity analysis  
For the probabilistic sensitivity analysis (PSA), the model inputs were assigned 
probability distributions and then repeatedly sampled using Monte Carlo simulation 




4.3.1 Base case 
The key findings for the base case are summarised in Table 4-3. A total 1,753 
permanent OBPIs were avoided when opting for nationwide PROMPT (scenario 1a) 
or national shoulder dystocia training (scenario 1b) over current practice (scenario 2). 
Scenarios 1a and 1b also resulted in increases in adult, caregiver and dyadic QALYs. 
Both scenarios 1a and 1b conferred significant savings (in excess of £1 billion) over 
scenario 2. This led to cost-savings of at least £1 million per QALY gained, irrespective 
of the QALY measure used. Scenarios 1a and 1b were both dominant over scenario 
2, regardless of which QALY was used. National implementation of PROMPT 
(scenario 1a) or shoulder dystocia training (scenario 1b) also resulted in additional 













Base case  Nationwide implementation 
Scenario 2 
(Current practice) Difference 
OBPIs (n) 709 2,462 -1,753 
QALYs (units)    
Adult 44,455,206 44,454,755 451 
Caregiver 146,867,957 146,867,240 717 
Dyadic 191,323,163 191,321,995 1,168 
PROMPT (scenario 1a)    
Costs (£)  £464,530,954 £1,713,783,061 -£1,249,252,107 
ICERs (£)    
Adult QALYs   -£2,768,111 (dominant) 
Caregiver QALYs   -£1,742,410 (dominant) 
Dyadic QALYs   -£1,069,319 (dominant) 
NMBs* (£)    
Using lower threshold £3,825,998,726,927 £3,8224,726,109,438 £1,272,617,489 
Using upper threshold £5,739,230,355,867 £5,737,946,055,688 £1,284,300,179 
Shoulder dystocia 
training (scenario 1b)    
Costs (£)  £289,814,081 £1,648,022,191 -£1,358,208,109 
ICERs (£)    
Adult QALYs   -£3,009,537 (dominant) 
Caregiver QALYs   -£1,894,378 (dominant) 
Dyadic QALYs   -£1,162,582 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,173,443,799 £3,824,791,870,308 £1,381,573,491 
Using upper threshold £5,739,405,072,740 £5,738,011,816,558 £1,393,256,182 
*Net monetary benefits calculated using dyadic QALYs 
Figures rounded up to the nearest whole number. As a result, some of the differences may 
appear to have some discrepancies 
 
 
4.3.2 Sensitivity analyses 
4.3.2.1 Univariate sensitivity analyses  
Running the decision model again using a discount rate of 1.5% produced similar 
results as the base case (Table 4-4). In this univariate analysis, the additional NMBs 
for scenarios 1a or 1b were around £2 billion. Reducing the initial PROMPT coverage 
by 25%, resulted in more permanent OBPIs avoided (n=2,032). However, the ICERs 
Table 4-3 Base case results 
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for scenarios 1a and 1b were very similar to those in the base case. Both scenarios 









(Current practice) Difference 
OBPIs (n) 709 2,462 -1,753 
QALYs (units)    
Adult 47,838,978 47,838,463 515 
Caregiver 177,854,110 177,853,173 937 
Dyadic 225,693,089 225,691,637 1,452 
PROMPT  
(scenario 1a)    
Costs (£) £540,252,955 £2,436,863,322 -£1,896,610,367 
ICERs (£)    
Adult QALYs   -£3,683,281 (dominant) 
Caregiver QALYs   -£2,023,907 (dominant) 
Dyadic QALYs   -£1,306,181 (dominant) 
NMBs* (£)    
Using lower threshold £4,513,321,525,184 £4,511,395,874,267 £1,925,650,917 
Using upper threshold £6,770,252,414,253 £6,768,312,243,062 £1,940,171,191 
Shoulder dystocia 
training (scenario 1b)    
Costs (£) £316,633,148 £2,352,653,848 -£2,036,020,700 
ICERs (£)    
Adult QALYs   -£3,954,020 (dominant) 
Caregiver QALYs   -£2,172,675 (dominant) 
Dyadic QALYs   -£1,402,192 (dominant) 
NMBs* (£)    
Using lower threshold £4,513,545,144,991 £4,511,480,083,742 £2,065,061,249 
Using upper threshold £6,770,476,034,060 £6,768,396,452,536 £2,079,581,524 
*Net monetary benefits calculated using dyadic QALYs 
Figures rounded up to the nearest whole number. As a result, some of the differences may 
appear to have some discrepancies 
 
 
Reducing the starting PROMPT coverage by 75%, resulted in even more permanent 
OBPIs avoided (n=2,557) but again, very comparable ICERs to the base case for 
scenarios 1a and 1b (Table 4-6). As before, both scenarios 1a and 1b were dominant 
Table 4-4 Univariate sensitivity analysis with 1.5% discount rate 
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over scenario 2. The additional NMBs for scenarios 1a or 1b were greater in these 









(Current practice) Difference 
OBPIs (n) 754 2,786 -2,032 
QALYs (units)    
Adult 44,455,107  44,454,573  534 
Caregiver 146,867,918 146,867,084 834 
Dyadic 191,323,025 191,321,657 1,368 
PROMPT (scenario 
1a)    
Costs (£) £482,638,481 £1,929,984,344 -£1,447,345,863 
ICERs (£)    
Adult QALYs   -£2,709,475 (dominant) 
Caregiver QALYs   -£1,735,957 (dominant) 
Dyadic QALYs   -£1,058,059 (dominant) 
NMBs* (£)    
Using lower threshold £3,825,977,854,952 £3,824,503,150,591 £1,474,704,361 
Using upper threshold £5,739,208,101,669 £5,737,719,718,059 £1,488,383,610 
Shoulder dystocia 
training (scenario 1b)    
Costs (£) £307,862,833 £1,880,167,052 -£1,572,304,219 
ICERs (£)    
Adult QALYs   -£2,943,401 (dominant) 
Caregiver QALYs   -£1,885,832 (dominant) 
Dyadic QALYs   -£1,149,408 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,152,630,600 £3,824,552,967,884 £1,599,662,716 
Using upper threshold £5,739,382,877,317 £5,737,769,535,352 £1,613,341,965 
*Net monetary benefits calculated using dyadic QALYs  
Figures rounded up to the nearest whole number. As a result, some of the differences may 



















(Current practice) Difference 
OBPIs (n) 841 3,398 -2,557 
QALYs (units)    
Adult 44,454,916  44,454,243  673 
Caregiver 146,867,842 146,866,793 1,049 
Dyadic 191,322,758 191,321,036 1,722 
PROMPT (scenario 
1a)    
Costs (£) £517,672,708 £2,339,259,835 -£1,821,587,127 
ICERs (£)    
Adult QALYs   -£2,706,604 (dominant) 
Caregiver QALYs   -£1,736,166 (dominant) 
Dyadic QALYs   -£1,057,699 (dominant) 
NMBs* (£)    
Using lower threshold £3,825,937,483,929 £3,824,081,452,464 £1,856,031,465 
Using upper threshold £5,739,165,062,247 £5,737,291,808,613 £1,873,253,634 
Shoulder dystocia 
training (scenario 1b)    
Costs (£) £342,779,508 £2,321,329,698 -£1,978,550,190 
ICERs (£)    
Adult QALYs   -£2,939,828 (dominant) 
Caregiver QALYs   -£1,885,768 (dominant) 
Dyadic QALYs   -£1,148,839 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,112,377,128 £3,824,099,382,601 £2,012,994,528 
Using upper threshold £5,739,339,955,447 £5,737,309,738,750 £2,030,216,697 
*Net monetary benefits calculated using dyadic QALYs  
Figures rounded up to the nearest whole number. As a result, some of the differences may 
appear to have some discrepancies 
 
 
4.3.2.2 Multivariate sensitivity analyses 
The results of the best and worst cases can be found in Table 4-7 and Table 4-8. As 
before, OBPIs were avoided and adult, caregiver and dyadic QALYs were gained 
when adopting scenario 1a or 1b over scenario 2 in both best and worst case analyses. 
Table 4-6 Univariate sensitivity analysis with 75% reduction in initial PROMPT coverage 
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Opting for scenario 1a or 1b over scenario 2 resulted in significant savings of over £2.5 
billion in the best case analysis, and around £1 billion in the worst case analysis. Like 
the base case, this meant that there were considerable cost-savings per QALY gained, 
regardless of the QALY measure used. Scenarios 1a and 1b remained dominant over 
scenario 2 in both multivariate sensitivity analyses. The NMBs were always greater in 
scenarios 1a or 1b in either best or worst cases. However, in the best case analysis, 
the additional NMBs for scenario 1a or 1b were over £2.6 billion, compared to the 
additional NMBs of around £1 billion in the worst case analysis.  
 
 
Best case Nationwide implementation 
Scenario 2 
(Current practice) Difference 
OBPIs (n) 828 3,791 -2,963 
QALYs (units)    
Adult 44,454,789  44,453,669  1,120 
Caregiver 146,867,840 146,866,535 1,304 
Dyadic 191,322,628 191,320,204 2,424 
PROMPT (scenario 1a)    
Costs (£) £530,270,086 £3,118,254,576 -£2,587,984,491 
ICERs (£)    
Adult QALYs   -£2,310,208 (dominant) 
Caregiver QALYs   -£1,984,433 (dominant) 
Dyadic QALYs   -£1,067,482 (dominant) 
NMBs* (£)    
Using lower threshold £3,825,922,299,531 £3,823,285,827,405 £2,636,472,127 
Using upper threshold £5,739,148,584,340 £5,736,487,868,395 £2,660,715,945 
Shoulder dystocia 
training (scenario 1b)    
Costs (£) £390,496,588 £3,065,645,880 -£2,675,149,292 
ICERs (£)    
Adult QALYs   -£2,388,018 (dominant) 
Caregiver QALYs   -£2,051,269 (dominant) 
Dyadic QALYs   -£1,103,436 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,062,073,029 £3,823,338,436,101 £2,723,636,928 
Using upper threshold £5,739,288,357,838 £5,736,540,477,091 £2,747,880,747 
*Net monetary benefits calculated using dyadic QALYs  
Figures rounded up to the nearest whole number. As a result, some of the differences may 
appear to have some discrepancies 
 
Table 4-7 Best case analysis 
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Worst case Nationwide implementation 
Scenario 2 
(Current practice) Difference 
OBPIs (n) 708 2,461 -1,753 
QALYs (units)    
Adult 44,455,209  44,454,758  451 
Caregiver 146,867,958 146,867,241 717 
Dyadic 191,323,167 191,321,999 1,168 
PROMPT (scenario 
1a)    
Costs (£) £448,334,908 £1,399,709,328 -£951,374,420 
ICERs (£)    
Adult QALYs   -£2,108,069 (dominant) 
Caregiver QALYs   -£1,326,942 (dominant) 
Dyadic QALYs   -£814,345 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,015,012,248 £3,825,040,272,447 £974,739,801 




   
Costs (£) £238,674,661 £1,320,796,284 -£1,082,121,623 
ICERs (£)    
Adult QALYs   -£2,397,781 (dominant) 
Caregiver QALYs   -£1,509,303 (dominant) 
Dyadic QALYs   -£926,261 (dominant) 
NMBs* (£)    
Using lower threshold £3,826,224,672,495 £3,825,119,185,491 £1,105,487,004 
Using upper threshold £5,739,456,346,073 £5,738,339,176,378 £1,117,169,695 
*Net monetary benefits calculated using dyadic QALYs  
Figures rounded up to the nearest whole number. As a result, some of the differences may 
appear to have some discrepancies 
 
 
4.3.2.3 Probabilistic sensitivity analysis (PSA) 
The mean probabilistic results are summarised in Table 4-9. Adopting scenario 1a or 
1b over scenario 2 led to 1,733 OBPIs averted and adult QALY gains. There were 
caregiver and dyadic QALY gains too, but the confidence intervals for these were wide, 
indicating the uncertainty in these findings. Implementing national PROMPT (scenario 
1a) or shoulder dystocia training (scenario 1b) resulted in significant cost-savings over 
Table 4-8 Worst case analysis 
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current practice (scenario 2). Like in the base case analysis, both nationwide PROMPT 
and shoulder dystocia training were cost-effective and cost-saving (of at least £1 
million) using any QALY measure in the PSA. Scenarios 1a and 1b remained dominant 
over scenario 2. However, there were large confidence intervals for the ICERs when 
using caregiver or dyadic QALYs. The additional NMBs for scenarios 1a or 1b in the 
PSA were similar to those in the base case analysis and had relatively narrow 
confidence intervals.  
 
The incremental costs for PROMPT (scenario 1a) and shoulder dystocia training 
(scenario 1b) and incremental QALYs (adult, caregiver and dyadic) of each Monte 
Carlo simulation have been plotted on cost-effectiveness planes. For nationwide 
PROMPT, the majority of the simulations lie in the bottom-right quadrant (positive 
effect with decreased costs) when using dyadic QALYs (see Figure 4-2). The same is 
seen in the cost-effectiveness plane for shoulder dystocia training using dyadic QALYs 
(Figure 4-3). These simulations suggest that scenarios 1a or 1b are likely to be more 
effective and less costly than scenario 2 (current practice). 
 
If adult QALYs are used, then all of the simulations can be found in the bottom-right 
quadrants for the cost-effectiveness planes for national PROMPT (scenario 1a) and 
shoulder dystocia training (scenario 1b) (Figure 4-4 and Figure 4-5). These cost-
effectiveness planes suggest that scenarios 1a or 1b will always be more effective and 
less costly than scenario 2. 
 
If caregiver QALYs are used, the cost-effectiveness planes for both nationwide 
PROMPT (scenario 1a) and shoulder dystocia training (scenario 1b) appear similar to 
those when using dyadic QALYs (Figure 4-6 and Figure 4-7). The use of caregiver 
QALYs shifts more of the simulations into the bottom-left quadrant, but just like before, 
the majority of the points lie within the bottom-right quadrant, suggesting that scenarios 
1a or 1b are still more likely to be a better option than scenario 2. 
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Table 4-9 Mean probabilistic results 





OBPIs (n) 703 2,436 -1,733 (-1,800, -1,663) 
QALYs (units)    
Adult 48,314,960 48,314,408 553 (273, 801) 
Caregiver 159,620,746 159,620,357 389 (-1,172, 1,727) 
Dyadic 207,935,706 207,934,764 942 (-771, 2,404) 
PROMPT (scenario 1a)    
Mean costs (£) £461,031,980 £1,696,450,297 -£1,235,418,317 (-£1,476,266,014, -£1,000,227,578) 
Mean ICERs (£)    
Adult QALYs   -£2,426,500 (dominant) (-£4,540,164, -£1,493,377) 
Caregiver QALYs   -£1,383,052 (dominant) (-£27,371,470, £24,652,337) 
Dyadic QALYs   -£2,121,318 (dominant) (-£12,916,818, £5,669,881) 
Mean NMBs* (£)    
Using lower threshold £4,158,253,091,499  £4,156,998,838,614  £1,254,252,885 (£1,014,489,596, £1,490,542,658) 
Using upper threshold £6,237,610,153,239  £6,236,346,483,069  £1,263,670,170 (£1,022,572,313, £1,496,945,736) 
Shoulder dystocia training 
(scenario 1b)    
Mean costs (£) £287,477,566 £1,631,126,959 -£1,343,649,393 (-£1,604,949,235, -£1,088,213,035) 
Mean ICERs (£)    
Adult QALYs   -£2,639,095 (dominant) (-£4,938,559, -£1,625,086) 
Caregiver QALYs   -£1,504,260 (dominant) (-£29,768,033, £26,814,500) 
Dyadic QALYs   -£2,306,803 (dominant) (-£14,046,373, £6,166,821) 
Mean NMBs* (£)    
Using lower threshold £4,158,426,645,914  £4,157,064,161,952  £1,362,483,962 (£1,102,706,771, £1,619,835,367) 
Using upper threshold £6,237,783,707,653  £6,236,411,806,407  £1,371,901,246 (£1,109,787,393, £1,625,638,335) 
*Net monetary benefits calculated using dyadic QALYs  
Figures rounded up to the nearest whole number. As a result, some of the differences may appear to have some discrepancies 
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Incremental effect (dyadic QALYs)
Cost-effectiveness plane for nationwide PROMPT
Figure 4-2 Cost-effectiveness plane for nationwide PROMPT (scenario 1a) using 
dyadic QALYs 
Figure 4-3 Cost-effectiveness plane for nationwide shoulder dystocia training 
























Incremental effect (dyadic QALYS)
Cost-effectiveness plane for nationwide shoulder dystocia training
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Figure 4-5 Cost-effectiveness plane for nationwide shoulder dystocia 
training (scenario 1b) using adult QALYs 
Figure 4-4 Cost-effectiveness plane for nationwide PROMPT (scenario 





















Incremental effect (adult QALYs)




















Incremental effect (adult QALYs)
Cost-effectiveness plane for nationwide shoulder dystocia training
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Figure 4-6 Cost-effectiveness plane for nationwide PROMPT (scenario 1a) 
using caregiver QALYs 
Figure 4-7 Cost-effectiveness plane for nationwide shoulder dystocia training 
























Incremental effect (caregiver QALYs)
























Incremental effect (caregiver QALYs)
Cost-effectiveness plane for nationwide shoulder dystocia training
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Cost-effectiveness acceptability curves were also plotted based on the NMBs. These 
assess the probability that nationwide implementation of PROMPT (scenario 1a) or 
shoulder dystocia training (scenario 1b) will be cost-effective using different cost-
effectiveness thresholds. Figure 4-8 demonstrates that the probability of national 
PROMPT being cost-effective (compared to current practice) is 100% across cost-
effectiveness thresholds from £0 to £100,000.  
 
Similarly, Figure 4-9 indicates that the probability of national shoulder dystocia training 
(scenario 1b) being cost-effective is also 100% across all cost-effectiveness 
thresholds. These cost-effectiveness acceptability curves have been calculated using 
dyadic QALYs. However, the probabilities of both nationwide PROMPT and shoulder 
dystocia training being cost-effective continue to remain at 100% across all cost-













































Cost-effectiveness acceptability curve (dyadic QALYs)
Nationwide PROMPT Current practice
Figure 4-8 Cost-effectiveness acceptability curve for nationwide 
PROMPT (scenario 1a) using dyadic QALYs 
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4.3.2.4 Summary of results 
This cost-utility analysis has shown that national implementation of an established, 
multi-professional simulation training programme for obstetric emergencies 
(PROMPT) (scenario 1a) or shoulder dystocia training (scenario 1b) can be both cost-
effective and cost-saving when considering their impact on OBPIs. Importantly, this 
remained true throughout the sensitivity analyses. Scenarios 1a and 1b were 
consistently dominant over scenario 2 (current practice) during all the sensitivity 
analyses. Furthermore, the probabilistic sensitivity analysis provided strong evidence 
that opting for scenarios 1a or 1b instead of current practice could result in cost-
savings of over £1 billion, savings of over £2 million per adult QALY gained and 
additional NMBs of around £1 billion over 30 years. Although there were still cost-




This work will contribute to the meagre collection of economic evaluations of 
emergency obstetric training that currently exists. A recent systematic review only 
identified five full economic evaluations of emergency obstetric care training and all of 
these were conducted in low- or middle-income countries (122). Whilst it is 






























Cost-effectiveness acceptability curve (dyadic QALYs)
Nationwide SD training Current practice (SD training only)
Figure 4-9 Cost-effectiveness acceptability curve for nationwide 
shoulder dystocia training (scenario 1b) using dyadic QALYs 
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in these countries, money reserved for healthcare expenditure remains a precious 
commodity across the world, including higher-income countries. Detailed economic 
evaluations can help guide decision-makers in making the best use of limited 
healthcare resources. All future studies of training for obstetric emergencies should 
aim to prospectively collect data for use in parallel economic evaluations.  
 
This is the first time that a maternity training package has been economically evaluated 
with QALYs as the health outcome. A previous economic evaluation of simulation-
based training in obstetric emergencies in the Netherlands only investigated the costs 
to prevent adverse obstetric outcomes (124). This study found that multi-professional 
maternity training in a medical simulation centre could be cost-effective if repeated 
sessions are run locally over a year (124). The findings in this chapter also support 
sustained training, but over a number of years.  
 
All economic models are based on a number of assumptions and are dependent on 
the quality of the model inputs. This cost-utility analysis is no different. Firstly, the 
national birth rate and coverage of the training programme remained fixed throughout 
the duration of the model. This was a strong assumption but was made to simplify the 
model. The estimates of births covered by PROMPT were also subject to a degree of 
uncertainty. The number of births covered by the training programme may be 
underestimated as some hospitals (and therefore their births) were discounted due to 
incomplete Trust attendance. This limitation was enforced because the 2015-2016 
Hospital Maternity Activity Provider Level Analysis only presented birth statistics per 
Trust and not individual hospitals. The underlying quality of this Hospital Episodes 
Statistics data has also been questioned previously (210) and the discrepancy 
between the birth rates reported in the Provider Level Analysis (205) and by 
Southmead Hospital (North Bristol NHS Trust) (Chapter 3) suggests possible ongoing 
data issues. For consistency in this economic evaluation, the birth rates in the Provider 
Level Analysis were used even if other information was available. The births covered 
by PROMPT may also be overestimated. Attendance at the ‘Train the Trainers’ course 
may not necessarily lead to established and/or sustained training. However, in the 
univariate analyses, the ICERs for scenarios 1a and 1b were not particularly sensitive 
to changes in the initial level of PROMPT coverage.  
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Although, permanent OBPIs are defined by the presence of symptoms 12 months after 
birth (113), the baseline probability of permanent OBPIs was estimated using clinical 
information at 6 months of age as this was the only data available for the UK (141). 
There is no longitudinal data to support this assumption and this a potential limitation. 
However, one might expect ongoing issues if there are still residual symptoms 6 
months after the injury. The probabilities of permanent OBPIs following the 
introduction of PROMPT were generated using the available incidence data and 
assuming a linear relationship. PROMPT has many of the characteristics of a complex 
intervention – it contains several interacting components, affects a number of 
outcomes and has scope for some flexibility in its delivery (211). Given the complexity 
of the training programme, the clinical effect may not follow a simple linear relationship. 
Furthermore, although we assumed that the incidence of permanent OBPIs had fallen 
to 0‰ after 12 years of training, it may have been possible for this rate to have been 
achieved years earlier. This would have resulted in more OBPIs averted, more QALY 
gains and more cost-savings in our model. For this reason, our findings may be 
relatively conservative. 
 
The clinical effectiveness of PROMPT in preventing OBPIs was based on one 
observational study (113), which remains the best available evidence to date. Any 
interpretation of this cost-utility analysis must also consider the limitations of using 
associated effects, rather than those established by causation. Throughout this 
economic model, the clinical impact of PROMPT was assumed to match the literature 
across all sites. In reality, such results may be difficult to achieve. PROMPT has been 
introduced in a variety of healthcare settings but similar improvements in the rate of 
permanent OBPIs have not yet been reported (32,100,101). A recent ethnographic 
study of Southmead Hospital – the site of the most noteworthy clinical improvements 
associated with PROMPT – highlighted that the intervention (PROMPT) and its 
context shaped and affected each other (212). This finding is an important reminder 
that the success and sustainability of PROMPT may depend on various contextual 
factors that influence the receptivity for service change and quality improvement. 
Examples include environmental pressures, key people leading change, and 
supportive organisational cultures. (213). Furthermore, the dynamic interplay between 
contextual factors within, and between, the different levels of a health system may also 
have an impact on the effectiveness of quality improvement interventions (39). A 
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sensitivity analysis exploring the potential effect of differing training outcomes (i.e. 
probabilities of permanent OBPIs) would have been useful. However, there were 
insufficient data (e.g. no 95% confidence intervals for the observed numbers of 
permanent OBPIs) from the original study to formulate a plausible range of training 
efficacy (113). There were also no suitable data from other PROMPT studies.   
 
Calculating the cost of a permanent OBPI was not attempted. The lifetime cost of an 
OBPI has been estimated to be US$1 million although the basis of this calculation and 
what it incorporates is unclear (214). A more robust measure of the cost is the mean 
litigation cost associated with the injury. The damages sum is determined by a number 
of elements, some of which are directly incurred by the sufferer, such as past losses, 
future cost of care, and adaptations to the home (207,209). However, these are costs 
which are over and above standard NHS care, so costs associated with care provided 
by the NHS, such as hospital clinic appointments or surgery, have not been included 
in this economic evaluation. The mean litigation cost for an OBPI is at the very least a 
partial representation of the cost of the injury to the NHS, which pays for the entirety 
of successful claims. The mean litigation cost served as a useful proxy in the absence 
of any cost of illness data for permanent OBPIs. The recent change in the personal 
injury discount rate from 2.5% to minus 0.75% (215) was not accounted for in the 
model and this is likely to have led to an underestimation of the cost of claims. Rather 
than discounting future claims, the new rate would inflate claims costs in the future. 
The personal injury discount rate is expected to be reset at 0-1% in the next couple of 
years but even then, the claims costs presented here will be underestimated as this 
new rate will still be less than the original 2.5% (207). As such, the cost of OBPIs and 
therefore the potential cost-savings may be greater than the findings suggest.  
There is growing recognition of the effects of illnesses on family members and/or 
caregivers (173,216,217). These effects are expected to be incorporated into 
economic evaluations (72,155) but are still frequently omitted (218). Productivity 
losses as a result of caregiving are less relevant when adopting a health system 
perspective, but carers’ health-related costs and effects are important and should be 
included as health systems, such as the NHS, aim to maximise health benefit from 
their expenditure (218,219).The best way of integrating caregiver outcomes into 
economic evaluations remains unclear (216) but dyadic QALYs have been suggested 
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(173,219,220). In this cost-utility analysis, dyadic QALYs were created by combining 
the QALYs of adults with OBPIs with the QALYs of caregivers of children with OBPIs 
to illustrate the total impact of PROMPT. Child QALYs were not included as there were 
no suitable data in the published literature to construct them.   
The uncertainties surrounding the cost of training have been discussed in Chapter 3. 
One could argue that training costs are usually fixed and independent of births; 
however, training costs were normalised per birth in this analysis to enable training 
costs for a specific maternity unit to be more generalisable.  
 
Extensive sensitivity analyses were conducted to account for the uncertainties in the 
model parameters. The PSA revealed uncertainty in the caregiver and dyadic QALY 
gains as demonstrated by the wide confidence intervals for these figures. The ICERs 
using caregiver and dyadic QALYs also had wide confidence intervals, and this 
uncertainty was reflected in their cost-effectiveness planes, where some of the 
simulations in the PSA fell within the bottom-left quadrant (less effective, less costly). 
This might be explained by the caregiver utility score being higher than the utility score 
for the general population for these simulations, which could be plausible. The other 
confidence intervals were relatively narrow, so there is reasonable evidence that 
national implementation of PROMPT or shoulder dystocia training could lead to 
avoided OBPIs, substantial cost-savings in the region of £1 billion and significant 
money saved per adult QALY gained.  
 
The use of the triangular distribution for the costs and birth rates in the model is a 
limitation of this cost-utility analysis. The role of the triangular distribution in 
probabilistic sensitivity analyses has been questioned (221) but it was the most 
suitable distribution to use in this study given the cost and birth data available. Despite 
the limitations and the assumptions of this cost-utility analysis, the results remained 
consistent throughout the sensitivity analyses.  
 
4.5 Conclusions 
This is the first cost-utility analysis of a multi-professional, simulation-based training 
programme for obstetric emergencies (PROMPT). Nationwide implementation of 
PROMPT or shoulder dystocia training in England appeared to be both cost-effective 
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and cost-saving when evaluating its impact on permanent OBPIs. These findings 
should inform policymakers’ decision-making regarding healthcare expenditure and 
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4.6 Chapter appendix 
4.6.1 Economic evaluations  
Economic evaluations are established methods for assessing the costs and impact of 
alternative healthcare interventions (63). All economic evaluations measure costs but 
the outcome measures chosen to represent the impact of the interventions may vary 
between evaluations (120). The different economic evaluations are therefore defined 
by the outcome measure used. Cost-benefit analyses (CBA) compare the costs of the 
interventions with the monetary consequences, for example, the money saved from 
operations avoided. Cost-effectiveness analyses (CEA) assess the costs against 
clinically relevant units, for example, injuries prevented or number of admissions to 
intensive care (63,222). 
 
Cost-utility analyses (CUA) are essentially cost-effectiveness analyses that use 
generic measures of health gain to capture the impact of healthcare interventions The 
generic health outcome typically used in CUAs is the quality adjusted life year (QALY) 
(63). A QALY incorporates both quantity (mortality) and quality (morbidity) of life 
(63,72). One QALY represents a year in perfect health (203). In the context of CUAs, 
‘utility’ is used to describe the preferences of individuals for a particular set of health 
outcomes and is a way of valuing different health characteristics on a single scale 
(63,223). Utility scores (also known as utility weights) are measured on an interval 
scale from 0 to 1, where 1 is perfect health and 0 represents death, but some health 
profiles may be worse than death and can therefore take negative values (224). As an 
interval scale is used, all intervals should be interpreted equally, for example, an 
increase from 0.1 to 0.2 has the same meaning as an increase from 0.7 to 0.8 (63,223). 
Health utility scores can be measured by direct approaches, such as standard gamble 
(223) and time trade-off (63,225), or indirectly using pre-scored, generic preference-
based instruments (224) such as the EuroQoL EQ-5D (157), Short-Form 6D (SF-6D) 
(226) and the Health Utilities Index (HUI) (227). These utility scores can then be 
combined with the length of living time affected by these health states to generate 
QALYs (63). The use of generic health outcomes, such as QALYs, enables 
comparison between economic evaluations in different areas of healthcare, although 
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An important finding of an economic evaluation is the incremental cost-effectiveness 
ratios (ICER). This is calculated by dividing the difference in costs (incremental costs) 
between the interventions under investigation (e.g. A and B) by the difference in 
outcomes (incremental effects) (120):  
 
ICER = ___Cost A – Cost B______ 
                             Outcome A – Outcome B 
 
The ICER represents the cost per unit of the chosen health measure. Some decision-
makers set a cost-effectiveness threshold – the maximum they would pay for the 
health benefit – as a reference point when interpreting ICERs. Health interventions 
with ICERs exceeding the threshold will not be considered cost-effective. In contrast, 
interventions with ICERs below the cost-effectiveness threshold will be viewed as 
cost-effective and value for money.   
 
The perspective from which the analysis is undertaken is also a critical feature of any 
economic evaluation. There are a variety of different perspectives which could be 
used, ranging from micro viewpoints, such as patient and clinician perspectives, to 
meso/macro perspectives, like hospital, health system (for example, the NHS) or 
societal viewpoints (120). The cost implications and impact of a health intervention will 
vary depending on the viewpoint adopted (117). For example, the costs to a patient to 
receive a flu vaccine at their local NHS hospital may simply be their transport costs 
and opportunity cost – that is what they could be doing with their time instead of 
attending for their vaccine. However, the costs to the hospital for this scenario could 
include the cost of the vaccine, the costs associated with training staff to administer 
the vaccine and the staff salaries. The societal point of view is the broadest 
perspective and takes into account wider costs such as productivity losses from ill 
health (120). A health intervention may seem like an attractive proposition from one 
perspective but may not be the case from other viewpoints (63). Economic evaluations 
may therefore choose to use more than one perspective (120).  
 
Economic models are based on estimates for costs and outcomes which have either 
been directly measured or derived from previously published literature (117). As they 
are estimates, these model inputs will be subject to a degree of uncertainty. Sensitivity 
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analyses can help quantify the uncertainty surrounding the input parameters in 
economic evaluations (117). There are different types of sensitivity analyses available. 
Deterministic sensitivity analyses can be used, which can be divided into univariate 
sensitivity analyses or multivariate sensitivity analyses. As the name would suggest, 
a univariate sensitivity analysis involves varying a single parameter over a plausible 
range and monitoring how this affects the cost-effectiveness of the intervention (63). 
All the parameters can be altered, but only one may be modified each time in 
univariate sensitivity analyses. Multivariate sensitivity analyses allow more than one 
model parameter to be changed at a time. This form of sensitivity analysis is typically 
used for investigating how best and worst case scenarios affect the economic model 
(63). Lastly, probabilistic sensitivity analysis (PSA) is the most sophisticated form of 
sensitivity analysis in economic evaluations. Most, if not all, of the uncertain model 
parameters are assigned probability distributions based on the evidence used to 
generate the estimates (63). The model parameters are then repeatedly sampled, 
often 1,000-10,000 times, in a random fashion using Monte Carlo simulation (63). 
Each sampling iteration will have slightly different input parameters, and therefore 
different incremental costs, incremental health outcomes, and ICERs. This enables 
the mean ICER to be calculated, along with confidence intervals, which are determined 
from the distribution of the sampled estimates. The iterations can also be presented 
visually on a cost-effectiveness plane, with incremental costs plotted on the y-axis and 
incremental health effects on the x-axis (Figure 4-10) (228).  
 
If the majority of the sampling iterations fall within the top left quadrant (quadrant A in 
Figure 4-10), this would suggest that the health intervention is less effective but more 
expensive than its comparator. This intervention is said to be dominated or not cost-
effective. However, if most of the iterations lie within the bottom right quadrant 
(quadrant D), then this would suggest that the health intervention is more effective but 
less costly than the alternative intervention – in this case the intervention is dominant 
or cost-effective. Iterations that mostly congregate in the top right quadrant (quadrant 
C) indicate that the intervention is more effective and more expensive, and iterations 
that tend to lie in the bottom left quadrant (quadrant B) suggest that the intervention is 




















A line representing the cost-effectiveness threshold can be added to the cost-
effectiveness plane to help with the interpretation of the iterations lying in the bottom 
left or top right quadrant, where there will be trade-offs between cost and effectiveness 
(228). If most of the iterations fall below (or to the right of) the cost-effectiveness 
threshold, then the intervention would appear to be cost-effective. If however, the 
majority of the iterations are above (or to the left) of the cost-effectiveness threshold, 
then the health intervention would not seem to be cost-effective in comparison to the 
alternative (228). Cost-effectiveness acceptability curves (CEACs) can also be used 
to illustrate the probabilities of an intervention being cost-effective at different cost-

















































Figure 4-10 Example of cost-effectiveness plane 
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4.6.2 Consolidated Health Economic Evaluation Reporting Standards 
(CHEERS) 
 




















































Items to include when reporting economic evaluations of health interventions 
 
The ISPOR CHEERS Task Force Report, Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluations 
Publication Guidelines Good Reporting Practices Task Force, provides examples and further discussion of 
the 24-item CHEERS Checklist and the CHEERS Statement.   It may be accessed via the Value in Health or 







on page No/ 
line No 
Title and abstract 
Title 1 Identify the study as an economic evaluation or use more 
specific terms such as “cost-effectiveness analysis”, and 
describe the interventions compared.  
Abstract 2 Provide a structured summary of objectives, perspective, 
setting, methods (including study design and inputs), results 





3 Provide an explicit statement of the broader context for the 
study. 
 
Present the study question and its relevance for health policy or 
practice decisions.  
Methods 
Target population and 
subgroups 
4 Describe characteristics of the base case population and 
subgroups analysed, including why they were chosen.  
Setting and location 5 State relevant aspects of the system(s) in which the decision(s) 
need(s) to be made.  
Study perspective 6 Describe the perspective of the study and relate this to the 
costs being evaluated.  
Comparators 7 Describe the interventions or strategies being compared and 
state why they were chosen.  
Time horizon 8 State the time horizon(s) over which costs and consequences 
are being evaluated and say why appropriate. 
 
 
Discount rate 9 Report the choice of discount rate(s) used for costs and  
outcomes and say why appropriate.  
Choice of health 
outcomes 
10 Describe what outcomes were used as the measure(s) of 
benefit in the evaluation and their relevance for the type of 
analysis performed.  
Measurement of 
effectiveness 
11a Single study-based estimates: Describe fully the design 
features of the single effectiveness study and why the single 
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11b Synthesis-based estimates: Describe fully the methods used for 
identification of included studies and synthesis of clinical 
effectiveness data.  
Measurement and 
valuation of preference 
based outcomes 
12 If applicable, describe the population and methods used to 




13a Single study-based economic evaluation: Describe approaches 
used to estimate resource use associated with the alternative 
interventions. Describe primary or secondary research methods 
for valuing each resource item in terms of its unit cost. 
Describe any adjustments made to approximate to opportunity 
costs.  
13b Model-based economic evaluation: Describe approaches and 
data sources used to estimate resource use associated with 
model health states. Describe primary or secondary research 
methods for valuing each resource item in terms of its unit 
cost. Describe any adjustments made to approximate to 
opportunity costs.  
Currency, price date, 
and conversion 
14 Report the dates of the estimated resource quantities and unit 
costs. Describe methods for adjusting estimated unit costs to 
the year of reported costs if necessary. Describe methods for 
converting costs into a common currency base and the 
exchange rate.  
Choice of model 15 Describe and give reasons for the specific type of decision-
analytical model used. Providing a figure to show model 
structure is strongly recommended.  
Assumptions 16 Describe all structural or other assumptions underpinning the 
decision-analytical model.  
Analytical methods 17 Describe all analytical methods supporting the evaluation. This 
could include methods for dealing with skewed, missing, or 
censored data; extrapolation methods; methods for pooling 
data; approaches to validate or make adjustments (such as half 
cycle corrections) to a model; and methods for handling 
population heterogeneity and uncertainty.  
Results 
Study parameters 18 Report the values, ranges, references, and, if used, probability 
distributions for all parameters. Report reasons or sources for 
distributions used to represent uncertainty where appropriate. 
Providing a table to show the input values is strongly 
recommended.  
Incremental costs and 
outcomes 
19 For each intervention, report mean values for the main 
categories of estimated costs and outcomes of interest, as well 
as mean differences between the comparator groups. If 
applicable, report incremental cost-effectiveness ratios.  
Characterising 
uncertainty 
20a Single study-based economic evaluation: Describe the effects 
of sampling uncertainty for the estimated incremental cost and 



























of methodological assumptions (such as discount rate, study 
perspective). 
20b Model-based economic evaluation: Describe the effects on the 
results of uncertainty for all input parameters, and uncertainty 
related to the structure of the model and assumptions.  
Characterising 
heterogeneity 
21 If applicable, report differences in costs, outcomes, or cost-
effectiveness that can be explained by variations between 
subgroups of patients with different baseline characteristics or 
other observed variability in effects that are not reducible by 






22 Summarise key study findings and describe how they support 
the conclusions reached. Discuss limitations and the 
generalisability of the findings and how the findings fit with 
current knowledge.  
Other 
Source of funding 23 Describe how the study was funded and the role of the funder 
in the identification, design, conduct, and reporting of the 
analysis. Describe other non-monetary sources of support.  
Conflicts of interest 24 Describe any potential for conflict of interest of study 
contributors in accordance with journal policy. In the absence 
of a journal policy, we recommend authors comply with 
International Committee of Medical Journal Editors 
recommendations.  
 
For consistency, the CHEERS Statement checklist format is based on the format of the CONSORT 
statement checklist 
 
The ISPOR CHEERS Task Force Report provides examples and further discussion of the 24-item 
CHEERS Checklist and the CHEERS Statement.   It may be accessed via the Value in Health link or via the 
ISPOR Health Economic Evaluation Publication Guidelines – CHEERS: Good Reporting Practices 
webpage: http://www.ispor.org/TaskForces/EconomicPubGuidelines.asp 
 
The citation for the CHEERS Task Force Report is: 
Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards 
(CHEERS)—Explanation and elaboration: A report of the ISPOR health economic evaluations publication 
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5.1 Introduction  
Preventable harm in maternity care is not only a tragedy for affected patients and their 
families, but with rising litigation costs, it is a significant drain of financial resources 
from a health system. The NHS Litigation Authority (NHSLA), who provide indemnity 
cover for all obstetric units in England, estimated that avoidable harm in maternity 
services from 2000-2010 cost the NHS £3.1 billion (1). Between April 1995 and March 
2011, obstetrics and gynaecology accounted for 20% of the clinical negligence claims 
handled by the NHSLA but 49% of the total value of claims (1). This heavy litigation 
burden associated with maternity services is not just isolated to England. In Scotland, 
obstetric claims accounted for 16% of total claims but 43% of the total value from 
2013-2016. In the state of Victoria, Australia, obstetric claims represented over 25% 
of medical indemnity claims in a 10-year period (July 2006 to June 2016), with a value 
of A$201million. Worryingly, the cost of clinical negligence claims continues to 
escalate. In 2017/18, £2.2 billion was paid out for all medical malpractice claims in 
England. Legal fees alone amounted to around £596 million in the same period. The 
value of obstetric claims received in England in 2017/18 alone is expected to reach £2 
billion (21). 
 
These are payments that no one wants to pay or receive. They represent money lost 
to a health system and a diversion of resources away from patient care. However, the 
prevention of these underlying incidents may be a significant driver for cost-savings 
and quality improvement within maternity care. One English maternity unit reported a 
91% reduction in maternity-related litigation (29) following the introduction of 
simulation training for obstetric emergencies and subsequent improvements in a range 
of clinical outcomes (93,113). A hospital in the United States observed a reduction in 
perinatal adverse events and compensation payments following the implementation of 
a comprehensive obstetric patient safety programme (229). For this hospital, average 
compensation payments decreased from around US$27.5 million between 2003-2006 
to roughly US$2.5 million between 2007-2009 (229). Yale-New Haven Hospital in 
Connecticut, USA was also able to demonstrate a decrease in adverse events and a 
drop in median annual compensation payments per 1,000 deliveries from 
US$1,141,638 to US$63,470 following the introduction of an obstetric patient safety 
programme (230,231). Whilst it may be difficult to prove direct causality between these 
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interventions and the improvements in clinical outcomes and litigation rates, these 
examples offer some evidence that improving care and reducing preventable harm 
could save money. Replicating these results would not only reduce injuries to patients 
but could also release substantial funds that could be reinvested and replenish health 
systems facing perpetual financial constraints. 
 
Medical indemnifiers are not responsible for patient safety but they can have a role in 
avoiding preventable harm and litigation (28,29). For example, a private insurer 
(Hospitals Insurance Company) in New York provided staff, resources and funding to 
support quality improvement initiatives across four obstetric units (30). There are also 
some notable examples of state-based medical indemnifiers (MIs) working together 
with clinicians to try to improve maternity services. The Victorian Managed Insurance 
Authority (VMIA) in Australia funded quality improvement initiatives for maternity units 
across the state of Victoria (32). Landstingens Ömsesidiga Försäkringsbolag (LÖF), 
Sweden’s mutual insurance company, supported the Perinatal Patient Safety 
Program, which has been associated with a downward trend in settled claims 
regarding severe delivery related asphyxia (33).  
 
Although there is evidence of involvement in patient safety initiatives by private and 
state-based MIs, there has been little empirical research to investigate strategies 
employed by state MIs to engage clinical teams. A better understanding of the different 
ways state-based MIs can interact with clinical staff could be useful in informing future 
practice. In this chapter, I examine the work of six state-based MIs in Europe and 
Australia and explore how they engage with clinical staff to improve outcomes and 
prevent harm, particularly within maternity services. In addition, I will consider how 
engagement between clinical staff and MIs could be more effective.   
 
5.2 Methods 
5.2.1 Recruitment of medical indemnifiers (MIs) 
The following state-based MIs were invited to participate:  
● NHS Litigation Authority (NHSLA) – England 
● Welsh Risk Pool Services (WRPS) – Wales 
● Central Legal Office (CLO) – Scotland 
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● State Claims Agency (SCA) – Republic of Ireland 
● Landstingens Ömsesidiga Försäkringsbolag (LÖF) – Sweden 
● Victorian Managed Insurance Authority (VMIA) – Victoria, Australia 
 
These MIs were chosen to compare current practice in England, Wales, Scotland and 
the Republic of Ireland. Sweden was chosen to enable comparison with an 
administrative, ‘no-fault’ compensation scheme, which is distinct from the liability 
system. The VMIA was included as it has funded quality improvement initiatives in 
maternity units across Victoria (32). All of the state-based MIs agreed to participate. 
 
5.2.2 Definitions 
In insurance, there are usually formal contracts between the organisation providing 
insurance and the party being insured. If using this defining feature, only LÖF and the 
VMIA could be classified as insurers. As some of the remaining participants did not 
identify with the term insurer, the more general term of medical indemnifier (MI), was 
used to describe these agencies dealing with medical malpractice and compensation. 
Engagement was defined as any sort of interaction specifically focussed on improving 
safety and patient outcomes.   
 
5.2.3 Interviews and focus groups 
The MIs were asked to identify staff with experience of engagement with clinical teams 
(particularly maternity teams) to take part in face-to-face, semi-structured interviews 
or focus groups. In order to maintain confidentiality, the names of the participants and 
their affiliations have not been provided. However, the roles of the participants from all 
six state-based MIs have been listed in Table 5-1. 
 
Interviews (with one participant) or focus groups (with more than one participant) were 
arranged depending on time schedules and preferences. These took place at their 
offices and occurred between August 2016 and February 2017. There were two 
interviews with NHSLA, one focus group (three participants) with the WRPS, one focus 
group (three participants) with the CLO, one focus group (two participants) with the 
SCA, one focus group (two participants) with LÖF, and two focus groups (one with 
three participants, the other with two) with the VMIA. 
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The interviews/focus groups were conducted by myself and Dr Oliver Quick, who is a 
Reader in Law with an interest in the role of law and regulation in improving safety in 
healthcare. The only exception was for the VMIA, where I facilitated the focus groups 
on my own.  
 


















A semi-structured approach, with a basic topic guide (see 5.8 Chapter appendix), 
enabled us to cover key areas but also offered participants the opportunity to share 
important experiences and information that we may not have previously considered to 
be relevant (232). The interview format permitted participants to speak freely and 
without judgement from colleagues. In comparison, the focus groups allowed us to 
explore collective views and the dynamics within these often encouraged discussion, 
resulting in richer responses (232). The same basic topic guide was used for both 
interviews and focus groups. All interviews and focus groups were audio-recorded 
when permission was given (all except one) and were professionally transcribed.  
Role of participant 
Head of clinical risk 
General manager of medical indemnity 
Chief medical officer 
Head of business development 
Risk management assessor 
Director 
Head of litigation 
Senior risk advisor 
Head of clinical claims 
Deputy chief executive officer 
Actuarial analyst 
Manager of health informatics 
Director of safety and learning 
Medical indemnity portfolio manager 
Scheme manager 
Table 5-1 Summary of participant roles 
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5.2.4 Analysis  
The approach to the interviews/focus groups and data analysis was based on 
grounded theory – generating theory from the data rather than approaching the 
research with any preconceptions or a fixed framework of analysis (233). However, 
this approach was also complemented by an a priori, semi-structured topic guide. The 
transcripts were analysed independently by both researchers before observations 
were compared. In addition to exploring different models of engagement between 
clinical staff and MIs, transcripts and field notes were analysed for themes. A one-day 
workshop was held to present the findings to senior representatives from all the 
participating MIs except for the WRPS (who were unavailable). The representative 
from the SCA missed the workshop but we were still able to share our findings with 
them once they had arrived. Our observations for each MI were shared with all 
attendees. The workshop allowed for feedback, clarification and discussion. Detailed 
notes from the workshop also informed the analysis. The workshop was held just 
before the PROMPT Symposium (an international maternity safety conference) that 
some of the MIs were already attending.   
 
5.2.5 Ethical approval and consent  
Ethical approval was obtained from the University of Bristol Faculty of Health Sciences 
Research Ethics Committee (33681). Participants were issued with information 
leaflets regarding the study and written consent was obtained prior to the 
interviews/focus groups.  
 
5.3 Contexts  
Comparison and analysis of the different models of engagement could not be 
performed without taking into account the contextual background for each state-based 
MI. The key features of each MI and the circumstances in which they operate are now 
described prior to exploring their examples of engagement.  
 
5.3.1 NHS Litigation Authority (NHSLA) – England 
In England, the population is just over 55 million (234) and NHS England is responsible 
for providing healthcare. Since the NHS and Community Care Act 1990 there has 
been an internal market where NHS Trusts compete with each other for contracts from 
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purchasers of health (235). The NHSLA was established in 1995 and provides 
indemnity cover for legal claims made against the NHS in England. It also provides 
other legal and professional services, such as advising on equal pay issues and 
resolving contract disputes between health practitioners (236). The NHSLA is 
answerable to the Secretary of State for Health.  
 
The NHSLA operates the Clinical Negligence Scheme for Trusts (CNST), which is a 
voluntary, pay-as-you-go and risk pooling scheme that handles all medical malpractice 
claims against NHS bodies. Despite being voluntary, all NHS Trusts are members of 
the scheme. Membership contributions are collected each year to match the projected 
total cost of claims calculated for that year (237). Individual member contributions are 
determined by staffing and activity levels, past claims experience in the last 5 years 
and outstanding claims (238). 
 
In April 2017, the NHSLA was rebranded as NHS Resolution. This change in name 
aimed to reflect the organisation’s focus on prevention, learning and early intervention. 
However, for consistency within this chapter, the state-based MI for England will 
continue to be referred to as the NHSLA.  
 
5.3.2 Welsh Risk Pool Services (WRPS) – Wales 
Wales has a population of around 3 million (234) and a devolved government. NHS 
Wales delivers healthcare through seven local Health Boards and three NHS Trusts 
(239). Welsh Risk Pool Services (WRPS) was set up in the early 1990s and is part of 
the NHS Shared Services Partnership in Wales. The Shared Services Partnership is 
owned and directed by NHS Wales. WRPS funding comes centrally from the Welsh 
Government, via the NHS Shared Services Partnership in Wales. There is no premium 
pool, despite the name. Hospitals are allocated resources in accordance with the 
population that they serve. However, before the transfer of funds, some of their 
designated money gets diverted to the WRPS. In 2015/16, the budget for the WRPS 
was £75 million (240). The WRPS is accountable to the Shared Services Committee.  
 
The ‘Putting Things Right’ scheme (since 2011) is an alternative to the litigation system 
in Wales. It is a redress package composed of the following: 
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● Compensation (<£25,000) 
● Apology 
● Explanation 
● Demonstration that actions have been implemented to prevent recurrence 
(241) 
 
Under this scheme, concerns regarding clinical services provided by NHS Wales are 
reported to the hospital. If there is a suggestion of a patient suffering from harm, the 
hospital has to carry out an investigation to determine whether there is qualifying 
liability under the well-known Bolam test (242). If qualifying liability is demonstrated, 
the hospital has a responsibility to consider the value of financial compensation. If the 
value is less than £25,000, then the hospital can offer compensation directly to the 
patient as part of the ‘Putting Things Right’ scheme. The Welsh government can then 
reimburse this fee. At the time of the focus group, £1.3 million had been paid for 193 
cases under this scheme. Patients waive their right to file a legal claim by accepting 
this redress package. Whilst the WRPS oversee the learning from this scheme, they 
are not directly involved in this redress arrangement. Questions have been raised 
about whether the scheme is sufficiently neutral and also whether hospital staff 
reviewing the cases have the appropriate legal expertise (241). 
 
The WRPS become involved in the following instances: 
● A formal claim is made 
● Valuation of compensation exceeds £25,000 in ‘Putting Things Right’ scheme 
● Patient/solicitor is unhappy with the ‘Putting Things Right’ process 
 
If a claim is settled, the hospital pays the settlement first, before applying to the WRPS 
for reimbursement. The hospitals are only reimbursed if an adequate learning plan has 
been implemented and WRPS has the power to delay or even refuse reimbursement.   
 
5.3.3 Central Legal Office (CLO) – Scotland 
Scotland has a devolved government and a population of just under 5.5 million (234). 
Healthcare is delivered by NHS Scotland, which consists of 14 regional Health Boards. 
There are also 7 special Health Boards and one public health agency that support the 
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regional boards (236). The CLO was created in the 1970s and is one of the 6 strategic 
business units of NHS National Services Scotland (NSS), which is one of the 
aforementioned special Health Boards and a non-departmental public body (243). The 
CLO can be considered to be the ‘in-house’ solicitors for Scotland’s public sector. They 
cover a number of areas including litigation, employment, commercial contracts and 
commercial property (236). The litigation department is split into regional teams and 
currently consists of around 30 lawyers. The CLO is answerable to the internal auditors 
of NSS but also has to meet certain targets as defined in Service Level Agreements 
with the Scottish government.  
 
The Clinical Negligence and Other Risks Indemnity Scheme (CNORIS) is a risk and 
financial pooling scheme which was established in 1999. It is managed by NSS as a 
whole, but legal advice is provided by the CLO (244). Health boards are mandated to 
be members of the scheme. Member contributions are taken annually and are 
calculated based on a number of factors, including previous claims history and risk 
management practices. There are caps to protect smaller authorities. Claims are 
settled by the CLO and paid for by the Health Board. The Health Board can then apply 
to be reimbursed by the Scottish government. Only claims greater than £25,000 are 
eligible for reimbursement and any claim over £250,000 requires authorisation from 
the Scottish government.  
 
5.3.4 State Claims Agency (SCA) – Republic of Ireland 
The population in the Republic of Ireland is around 4.7 million (245). The Health 
Service Executive (HSE) is responsible for providing public healthcare. Residents in 
the Republic of Ireland are entitled to hospital care free of charge; however, there are 
some fees designed to act as deterrents against the misuse of services. For example, 
there is an attendance charge for patients presenting to the Emergency Department 
without being referred by their general practitioner. These fees are retrospectively 
collected and not rigorously enforced. Patients have to pay for community care and 
medication, unless they meet the eligibility criteria for a medical card, which enables 
free access. 
 
The management of personal injury and property damage claims against the State 
was delegated to the National Treasury Management Agency (NTMA) after the 
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National Treasury Management Agency (Amendment) Act in 2000. When dealing with 
claims, the NTMA is known as the State Claims Agency (SCA) (246). Following the 
introduction of the Clinical Indemnity Scheme in 2002, the SCA also took full 
responsibility for the indemnification and management of all clinical negligence claims 
against the State (247). The SCA is funded by taxation so there is no risk pool. It is 
therefore accountable to the Minister for Finance and public accounts auditors.  
The SCA has a clinical risk team, made up of 14 members, including doctors, 
midwives, pharmacists and physiotherapists, to assist in the investigation and risk 
management of clinical negligence claims. In addition, the reporting of any adverse 
healthcare incidents to the SCA is statutory. This is done via the online National 
Incident Management System (NIMS). Any local investigations or recommendations 
resulting from the incident can also be uploaded with the report. This database of 
adverse events serves as a resource for learning and guides risk mitigation strategies. 
Furthermore, this information can be used as part of a subsequent investigation if the 
incident leads to a claim (248). Although the process of reporting adverse incidents is 
statutory, there is no formal penalty for non-compliance. However, if a claim is not 
preceded by an incident report, the SCA can decline to cover the cost of the claim and 
the hospital would have to pay out itself.  
 
5.3.5 Landstingens Ömsesidiga Försäkringsbolag (LÖF) – Sweden  
Sweden has a population of around 10 million and the country is made up of 21 
autonomous counties and regions. Since 1975, liability and compensation have been 
handled separately in Sweden. In 1992, the Patient Insurance Investigation stated that 
healthcare providers had a responsibility to compensate and that the purchase of 
insurance was mandatory. Prior to this, insurance for hospitals was voluntary. The 
Patient Injury Act, which was introduced in 1997, reaffirmed healthcare providers’ 
obligation to be insured and established the right for patients to be compensated for 
avoidable injury. From 2011, the Patient Safety Act compelled healthcare 
professionals to inform patients of their rights to compensation and potential eligibility. 
 
Landstingens Ömsesidiga Försäkringsbolag (LÖF) translates as the ‘county councils’ 
mutual insurance company’ and compensates patients’ claims. As the name suggests, 
LÖF is owned by the Swedish county councils and regions and is accountable to its 
owners. Unlike some of the other MIs described, there is an insurance contract 
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between LÖF and the public healthcare providers. As part of this contract, LÖF has 
the right to request and access any material from the healthcare provider which is 
required to settle a claim on behalf of the patient. LÖF functions like any other 
insurance company in Sweden and is subject to financial inspection. It is funded 
through the county council tax system instead of member contributions. The cost per 
resident equates to around €13 per year. This is a relatively modest fee compared to 
other forms of insurance.  
 
The laws mentioned previously enable LÖF to operate an administrative patient 
compensation scheme. This is a ‘no blame’ system which assesses claims based on 
whether healthcare related injuries are avoidable rather than due to negligence. 
Treatment is judged against the standards of an ‘experienced professional’. 
Compensation awarded is based on actual or expected financial loss. The maximum 
award is capped at €1 million and there is a €250 deductible fee. There is no punishing 
or deterrence component to this form of compensation. Around €65 million is spent on 
compensation per annum. This scheme complements the welfare system and covers 
what the social insurance system does not. The compensation scheme is much faster 
than the judicial process. Only around 20 claims reach the court system per year. 
There is separate liability insurance for negligent cases and this system allows 
compensation to go over the €1 million cap.  
 
5.3.6 Victorian Managed Insurance Authority (VMIA) – Victoria, Australia  
Australia has 3 levels of government: federal, state/territory and local (249). State 
governments are responsible for some aspects of healthcare provision, such as 
running hospitals (208). The state of Victoria has 149 public, acute hospitals looking 
after a population of around 6 million.  
 
The VMIA was established in 1996 by the Victorian Managed Insurance Authority Act. 
It is a statutory authority in Victoria. The VMIA is an independent organisation but is 
accountable to the Department of Finance and Minister for Finance. The VMIA is 
responsible for providing risk advice and insurance services for the Victorian 
government, as well as hospitals, health centres, community service organisations 
and national parks (250). Medical indemnity makes up almost 50% of the insurance 
work, with roughly 250 clinical negligence claims made annually.  
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The premium pool is calculated each year by external actuaries based on occurrence 
of claims in the projected 12 months. Public hospitals would contribute towards 98% 
of the pool, with the remaining 2% from rural general practitioners, community health 
centres and the ambulance services. The hospitals are charged a premium which is 
based on a blended model: 75% exposure model and 25% experience model. For the 
exposure model, all clinical work is divided into 8 broad specialty groups. Obstetrics is 
one of these specialty groups. The premium pool is then divided between the specialty 
groups based on historical claims. The premium allocation per specialty group is then 
split between hospitals based on expected activity over the next 12 months. For 
example, a hospital expecting to undertake 10% of the obstetric activity for Victoria 
will have to pay 10% of the obstetric premium under this model. For the experience 
model, the premium is calculated using the last 10 years of incurred claims costs 
(including paid and outstanding amounts) per hospital or health service. 
 
5.4 Results  
The MIs were involved in a wide variety of engagement activities. Some of these were 
not restricted to maternity teams, or even clinical staff. For this reason, examples of 
engagement have been grouped into the following subcategories: general 
engagement, clinical engagement and research and collaborations.  
 
5.4.1 NHS Litigation Authority (NHSLA) – England  
5.4.1.1 General engagement 
Each year, the NHSLA issues each NHS Trust with a score card, which provides an 
overview of claims, broken down by speciality, over the previous 5 years. The aim of 
the score card is to increase awareness of claims, particularly their monetary value. 
Information leaflets on NHSLA services are also available to the Trusts. The NHSLA 
liaises and works with other organisations such as NHS Improvement and NHS 
England. The Sign up to Safety Campaign, an independent, national initiative for 
locally led improvement in safety, is hosted by the NHSLA (35). Other general 
engagement activities include signposting to good practice and obtaining feedback 
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5.4.1.2 Clinical engagement  
The NHSLA’s main form of clinical engagement was through the Sign up to Safety 
Incentivisation Scheme in 2015. This was an idea from the Secretary of State for 
Health and was managed by the NHSLA. A one-off financial incentive, up to 10% of 
the value of their CNST contributions, was available to NHS Trusts who could prove 
that their local patient safety initiatives could address areas relating to higher value 
and/or higher volume claims (35). The NHSLA received a total of 249 bids and 
approved and funded 67 of these. Twenty-eight maternity units were given a total of 
£8.6 million to try to reduce intrapartum harm and £0.8 million was allocated to 
Emergency Departments aiming to reduce missed fractures (35). In addition to 
funding, successful NHS Trusts were given complete autonomy in choosing their 
interventions or patient safety initiatives. A one year evaluation found no reduction in 
intrapartum harm (135).  
 
5.4.1.3 Research and collaborations 
Learning from claims data and research in this area has been encouraged by the 
NHSLA (251). ‘Deep dives’ into the organisation’s claims data are sometimes 
supported by the NHSLA’s panel firms. The NHSLA has also been working with other 
organisations such as the Department of Health, NHS Improvement, NHS England, 
the Royal College of Obstetricians and Gynaecologists (RCOG) and the PROMPT 
Maternity Foundation to develop maternity indicators that could potentially be used for 
incentivisation (238).  
 
5.4.2 Welsh Risk Pool Services (WRPS) – Wales  
5.4.2.1 General engagement 
The WRPS undertake claims reviews and audits. These ensure that learning plans 
are in place following a claim or the ‘Putting Things Right’ scheme. The WRPS identify 
a specialty to review based on worrying trends in claims. This forms the starting point 
for themed reviews which will be described in the next section. Networks for concerns 
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5.4.2.2 Clinical engagement 
Once a specialty has been identified for a themed review, the WRPS liaise with clinical 
experts in that field to decide on best practice. The specialty is then reviewed in each 
hospital in Wales and current practice is assessed against the agreed standards. 
Following the themed review, a report is produced for each hospital with 
recommendations regarding risk management. WRPS has facilitated the formation of 
a national maternity network, which is represented by each maternity unit. This 
network meets every 3 months and acts as a multi-professional forum for discussing 
patient safety and improvement in obstetric and midwifery care. Teaching sessions 
and courses on claims and risk management are also organised by the WRPS for 
clinical staff. 
 
5.4.2.3 Research and collaborations 
The WRPS analyse their own claims data to identify trends and specialties for themed 
reviews. There is an informal relationship with the 1,000 Lives Campaign, a national 
improvement programme in Wales. The WRPS liaises with Health Inspectorate Wales 
(the national regulator) to avoid duplicating audits.  
 
5.4.3 Central Legal Office (CLO) – Scotland 
5.4.3.1 Engagement  
The CLO focusses primarily on providing legal advice to its members. Their main point 
of contact in a Health Board or hospital will be the Claims Contact. There is some 
engagement with the Health Boards at an executive level but little engagement with 
frontline clinical staff beyond providing lectures and conference presentations.  
 
Data is shared with the Health Boards but the CLO recognises that more data could 
be shared, particularly with clinicians, to improve learning from claims. 
 
5.4.4 State Claims Agency (SCA) – Republic of Ireland 
5.4.4.1 General engagement 
The SCA conducts biannual or annual claims reviews for each hospital and presents 
the findings to the Claims Managers and Chief Executives. The data from incident 
reporting is presented in hospital dashboards and analysed. If a worrying trend is 
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identified in a hospital, the SCA alerts the hospital’s risk advisors. The SCA also hosts 
a Quality, Patient Safety and Clinical Risk Conference, which was first held in 2016.  
 
5.4.4.2 Clinical engagement  
The SCA provides clinical risk courses at undergraduate and postgraduate levels. It 
also sets some questions in undergraduate examinations. Teaching on topics such as 
open disclosure, documentation and incident reporting is also available for hospital 
staff. Claims reviews are sometimes delivered to clinical teams at Grand Rounds, in 
addition to sessions on preparing statements for the coroner’s court. The clinical risk 
team of the SCA meets with departmental or speciality leads annually. These allow 
face-to-face discussions to identify areas of risk.  
 
5.4.4.3 Research and collaborations 
There are a number of projects that the SCA has worked on. The Affinity project was 
a collaboration with the HSE aimed at reducing falls. The Head Injuries Management 
Pathway was established following discussion with the HSE. The SCA has also been 
involved in formulating the national maternity and gynaecology strategy. There are 
plans to develop a national neonatal encephalopathy register.  
 
The SCA has been a co-applicant for several research grants. There is an aspiration 
to expand this research profile in the future and eventually lead on such endeavours.  
 
5.4.5 Landstingens Ömsesidiga Försäkringsbolag (LÖF) – Sweden  
5.4.5.1 General engagement 
LÖF has hosted national conferences on patient safety. Its main forms of engagement 
though, are clinical and research based.  
 
5.4.5.2 Clinical engagement 
Educational courses, such as leadership for patient safety, and lectures are organised 
for Chief Medical Officers and doctors. LÖF also arranges hospital site visits to meet 
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LÖF has been proactive in coordinating patient safety initiatives which are targeted at 
problematic areas, as highlighted by its claims data. Healthcare professionals are 
approached by LÖF via their professional organisations. The role of LÖF in these 
projects is solely to provide financial and administrative support. Its aim is to facilitate 
multi-disciplinary teams developing and implementing best practice. LÖF pays the 
participating individuals’ hospitals for their time and also any expenses incurred. It is 
cost neutral for all those involved. These patient safety initiatives often foster a sense 
of professional pride, which is something that LÖF is keen to encourage and harness. 
There have been 5 large, national projects that LÖF has supported:  
• Perinatal Patient Safety Program  
• Prosthesis Related Infections Should be Stopped 
• Safe Abdominal Surgery 
• Safe Use of Drugs in Primary Care 
• Safe Trauma Care 
An online, interactive educational programme for cardiotocography (CTG) 
interpretation was developed as part of the Perinatal Patient Safety Program. An 
evaluation of this project found no improvement in outcomes. Despite this, a downward 
trend in claims for avoidable birth injuries was observed during the evaluation period 
(33).  
 
5.4.5.3 Research and collaborations 
LÖF has a database of over 170,000 claims which can be easily matched to clinical 
records. This is a significant learning resource and LÖF often allows postgraduate 
researchers and other academics access to its database for research purposes. LÖF 
is also committed to supporting early research into patient safety. This tends to serve 
as a foundation for future grant applications.  
 
5.4.6 Victorian Managed Insurance Authority (VMIA) – Australia  
5.4.6.1 General engagement 
The VMIA organises presentations for hospitals boards. It often presents information 
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5.4.6.2 Clinical engagement 
The VMIA mainly engages with clinical staff through supporting patient safety 
initiatives in financial and/or administrative capacities. Supporting the implementation 
of a multi-professional training programme for obstetric emergencies throughout 
Victoria is a good example (32). The VMIA provided each participating unit with 
funding: an initial A$50,500 and then a further A$15,000 in 2 instalments. Regular 
meetings are held between the VMIA and the training programme leads across the 
state.  
 
The fetal surveillance project in Victoria was jointly funded by the VMIA, the 
Department of Health and Human Services, and the Royal Australian and New 
Zealand College for Obstetricians and Gynaecologists (RANZCOG). This was a 
collaboration with clinicians to develop fetal surveillance guidelines and an education 
programme.  
 
The VMIA also hosts roundtable discussions with clinical experts to agree on areas to 
focus investigation and action. These discussions often result in tenders for projects 
that clinical teams can apply for. Ideas for local improvement have been supported by 
the VMIA too; for example, the VMIA supported one hospital running the training 
programme for obstetric emergencies in trialling it outside of the maternity unit and in 
the Emergency Department.  
 
5.4.6.3 Research and collaborations 
The VMIA is committed to encouraging and supporting research. It is keen on 
translational research which can be applied in various settings across Victoria. An 
internal health informatics team was recently formed; this team is responsible for using 
data to develop ideas and projects that can improve patient care and reduce harm. 
Some of the patient safety initiatives supported by the VMIA also have a research 
component. The VMIA collaborated with a UK charity (PROMPT Maternity 
Foundation) to investigate the impact of the training programme for obstetric 
emergencies in the participating hospitals. Some of the findings of this evaluation will 
feature in the next chapter. At the time of the focus groups, the VMIA were looking to 
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establish a formal, 3-year partnership with an external academic team, further 
reinforcing its research ambitions.  
 
The VMIA also works closely with other organisations. It collaborates with RANZCOG 
in implementing the training programme for obstetric emergencies and distributing 
teaching material. The VMIA developed the blended premium model with the 
Department of Health and Human Services. It aims to work more closely with the 
Department in the future. 
 
Table 5-2 summarises all of the different engagement activities that were discussed 
in the interviews or focus groups into themes.  
 
General engagement Clinical engagement 
Research and 
collaborations 















available for research 
purposes 
Obtaining feedback from 
members 
Training for clinical staff Supporting early research 
Signposting to good 
practice 
Performing site visits 
Internal health informatics 
team 
Liaising with other 
organisations 
Providing financial and/or 
administrative support for 
patient safety initiatives 
Research components to 
safety initiatives 











Hosting conferences   
Table 5-2 Thematic summary of engagement activities 
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This chapter has demonstrated that state-based medical indemnifiers (MIs) 
participated in a wide range of general, clinical and research/collaborative 
engagement activities. There were many models of engagement between clinical staff 
and MIs but there was a strong sense that this relationship could be improved further. 
The analysis of the responses allowed the identification of the following themes which 
appear to be centrally important for effective clinical-MI engagement: the welfare 
system and medico-legal environment, insurer identity and size, the hospital-MI 
relationship, MIs’ use of data and commitment to research, and how MIs attempt to 
incentivise improvement and integrate the system. Supporting quotations from the 
interviews/focus groups are presented anonymously.  
 
5.5.1 The welfare system and medico-legal environment  
 
“It’s intended to be a complement to the social insurance system”. 
 
When considering and comparing the features of the MIs described in this chapter, it 
is important not to forget the underlying welfare systems in which they function. 
Countries with higher taxation are more likely to have social insurance systems that 
can support patients over and above the level of compensation that they receive. In 
Sweden, the National Insurance Act creates a system which covers basic wage loss 
due to injury or illness, regardless of cause (252). This is in addition to the Swedish 
patient compensation scheme. Higher tax countries may also be more likely to have 
better funded healthcare systems and perhaps as a result, better clinical care.  
 
“From the beginning of this system, the liability system was separated from the 
compensation issue, and I think that is important to keep in mind”. 
 
 
“We have got… our own complaints system which is different from any of the 
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Each MI will also operate within different medico-legal contexts. England, Scotland, 
Republic of Ireland and Australia all have a fault-based liability system and 
compensate when negligence has been proven. Whilst Sweden still has a liability 
system, it also has another framework for compensation. Its administrative 
compensation scheme works on a no-fault basis for avoidable injuries. The best 
medico-legal system (fault versus no-fault liability) for encouraging safer patient care 
remains unclear (253), although it is acknowledged that no-fault systems may promote 
the openness and transparency required for optimal learning from medical errors 
(252). Scotland has explored the possibility of offering no-fault compensation but has 
(so far) decided against doing so (254). In Wales, there is a redress package available 
for cases worth less that £25,000. The Department of Health in England has recently 
consulted on a ‘rapid resolution and redress scheme’ for severe, avoidable birth 
injuries (255) and the NHSLA has since introduced the Early Notification Scheme, 
which requires NHS Trusts to notify all incidents of potentially severe brain injuries (in 
line with the Each Baby Counts criteria from the Royal College of Obstetricians and 
Gynaecologists) (19). This scheme is an alternative to the litigious system, and in 
cases of substandard care provides families with a written apology and timely 
compensation, as well as support for the staff involved (256). 
 
Even within the fault-based system in the UK, there are variations in how claims are 
paid. In England, the NHSLA is responsible for paying all compensation and legal fees. 
In comparison, individual hospitals in Wales pay any agreed settlements first, before 
applying for reimbursement. The WRPS can delay or even refuse reimbursement 
depending on whether an acceptable learning plan has been executed.  
 
5.5.2 Identity and scale  
 
“We are not an insurance company, we are simply managing a pot of money”. 
 
“It’s not an insurance scheme; it’s a cost recovery scheme”.  
 
As mentioned earlier in the chapter, many of the organisations did not regard 
themselves as insurers. Only LÖF and VMIA can be classed as traditional insurers 
with contractual obligations. The others provide indemnity cover or reimbursement. 
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The identity and mind-set of an organisation will direct its approach to resource use 
and prioritisation.  
 
“I think it’s also important to stress that we always try, if it’s possible, to find a 
way to compensate. That’s how we work. We are not here to save money. 
That’s important to save money. We just want to make sure that if we can pay 
compensation we should do that and try to find a possibility. So, we don't want 
to be this ugly insurance company that just wants to fool everyone. We really 
want to help people.” 
 
“They’re not really our customers but still we want to treat them like customers 
because we want to have that relationship with the injured people so they feel 
that we are really taking care of them, they are important to us”. 
 
Should MIs only be involved with claims management and providing legal advice? Or 
should they also have a role in quality improvement and harm prevention?  
 
“A dollar's a dollar at the end of the day but if we're preventing harm/saving 
lives it's a whole different story and I think it generates more enthusiasm for all 
of us knowing that we're looking for something that's going to help.” 
 
“Yeah, we’re insurers and we’re there to make sure that the clients are well 
looked after when things go wrong but, at the same time, we see our role to 
prevent that harm happening in the first place.” 
 
The state-based MIs have a responsibility to protect their members or clients but also 
have a duty to compensate patients appropriately when negligence or avoidable harm 
has occurred. Furthermore, they must perform these roles whilst attempting to 
minimise costs to the state. Satisfying all these different stakeholders may be 
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“From the point of view of claims management, it’s easier in a smaller place 
where you have only about 10% number of the claims and just geographically, 
it seems easier to manage”. 
 
Scale refers to the size of the different countries and their respective health systems 
and how this may impact on the MIs’ engagement activities. Logically, one would 
expect engagement to be easier in smaller countries and health systems. This was 
confirmed by some responses from the focus groups. A smaller health system also 
encourages the development of more personable relationships between MIs and key 
clinical personnel. Dividing more populous countries into smaller, manageable regions 
may improve engagement efforts.  
 
5.5.3 The hospital-MI relationship 
 
“We don't ask the hospitals, ‘can we?’ we say, ‘we’re going to do this’”.  
 
“The clients are beginning to realise that we’re there to help them through that 
process”. 
 
“I think we need the membership to help us”. 
 
“Anywhere that you’re trying to influence health services around a clinical 
practice change, or around an education programme… our role in some ways 
is about pointing to where it’s done really well”. 
 
This interesting dynamic could be considered to be a continuum of two extremes: total 
dependency on the MI to complete autonomy of the hospital. Ideally, MIs should aim 
to strike a perfect balance between the extremes. They should guide and be 
supportive, in addition to affording some degree of autonomy and flexibility. However, 
some hospitals will be more autonomous than others. This needs to be reflected in the 
hospital-MI relationship, as MIs will need different relationships with different units. 
Other hospital factors may influence the hospital-MI relationship. Some hospitals may 
have a greater risk profile than others because of the complexity of the patients they 
look after (e.g. pregnant women with high-risk cardiac conditions). Some hospitals 
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may be underperforming and have poorer clinical outcomes compared to others. Such 
factors may not only affect the hospital-MI relationship but might also help MIs 
prioritise when a more pragmatic approach to clinical engagement is needed due to 
limited resources. 
 
There was a sense that the connection between a MI and a hospital should be more 
symbiotic and that there should be more learning from both parties. MIs have 
experience with claims analyses and management, whereas hospitals have the 
clinical expertise. Based on the responses from the interviews and focus groups, MIs 
and hospitals could benefit more from their relationships and take advantage of their 
strengths. 
 
5.5.4 Data and research  
 
“We have a very little bit of information when we talk about claims, but we 
have to work with the sector to understand what else is going on”. 
 
“We want our patient safety activities to be data-driven. Targeted work, we 
can’t work with everything, so we have to be selective”. 
 
Some MIs have been using their claim analyses to direct improvement efforts towards 
problematic areas but claims data could still be better utilised as a learning resource. 
One limitation of claims data is that it is collected for legal purposes and therefore 
gives a narrow perspective.  
 
“We’ve got the claims data but that’s just a small piece of the data puzzle”. 
 
“Data is only going to start to signpost you to look at which stone you might 
want to turn over. It’s not going to tell you how to fix those problems 
necessarily.” 
 
Nevertheless, claims data does offer a different viewpoint and would complement 
clinical data, thereby improving our potential learning from harm that has occurred. 
Combining clinical and claims data will be difficult. The myriad of competing databases 
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needs to be overcome by a system that integrates both sets of data. MIs and clinicians 
should work in partnership to carefully design an accessible system that will facilitate, 
rather than impede, the analysis of claims and clinical data together. This would result 
in more data being converted into meaningful information. Furthermore, a consensus 
on the terminology to be used between MIs and clinicians worldwide would encourage 
data sharing and the formation of larger datasets. This would increase opportunities 
for learning and foster a greater sense of collaboration.     
 
“We just need to be able to show people that we’re a vehicle to help them 
have their research make a difference”. 
 
In addition to developing a better way of using data, MIs could work more closely with 
clinical experts and other academics in research related to patient safety. MIs could 
fund collaborative research projects as part of their risk mitigation initiatives (32,33). 
The focus should be on translational research to maximise impact in a variety of 
healthcare settings. The key to success in these joint endeavours is taking full 
advantage of the different expertise available.  
 
5.5.5 Incentivising improvement  
 
“This is more the carrot rather than the stick. We want them to do it because 
we believe it's going to have a long-term improvement in reducing harm and 
future cost of claims”. 
 
Institutional-level incentives can play an important role in encouraging improvement 
but there is no agreement on the perfect model for this. Though not formal regulators, 
MIs can have some regulatory influence by setting targets (such as adopting evidence-
based patient safety programmes) linked with powerful monetary and administrative 
incentives (44). Other financial incentives could be in the form of premium discounts 
or reimbursements subject to fulfilling certain assessment criteria. The NHSLA 
previously offered discounts of up to 30% on the maternity element of hospitals’ 
premiums if their maternity clinical risk management standards (process measures) 
were met (34). These discounts and standards were eventually stopped as there was 
no clear correlation between compliance with these standards and better outcomes 
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(132,257). Eligibility for discounts on premiums, therefore, should include assessment 
of both processes and clinical outcomes.  
 
Maternity claims often have a considerable time lag between the incident occurring 
and settlement, usually due to the time needed for a diagnosis and long-term 
prognosis to be made. As a result, premiums charged to maternity units may still be 
influenced by previous events, even if care has significantly changed since they 
occurred. There is an argument that premiums are too backward-looking and do not 
reward current good practice.  
 
“One of the often criticisms you hear about this scheme is it’s backward-looking, 
not forward-looking”.  
 
Future pricing strategies should take this into consideration. Clinical indicators that can 
reliably predict litigation may be useful additions to existing pricing methodologies. 
These indicators, if identified, would allow premiums to be more responsive to current 
performance and incentivise improvement. The possibility of using such indicators is 
being explored in England (238) and Chapter 7 in this thesis will contribute to this 
process.  
 
Non-financial measures could be very powerful alternatives and could include 
releasing performance data for regional/national benchmarking. There is mixed 
evidence to support public reporting of performance results to improve patient 
outcomes; however, data released in this way does appear to stimulate improvement 
activities (258). Public reporting of data for benchmarking and other non-monetary 
options, such as promoting professionalism, could be considered to be universal 
incentives that are not reliant on pricing strategies or premiums. However, it is worth 
noting that performance data can be affected by confounding measures and also be 
misinterpreted. For example, a surgeon’s post-operative mortality rate will be 
influenced by post-operative care and medical comorbidities as well as the procedure 
itself. Some clinicians/hospitals might therefore suggest that it would be more 
appropriate for performance results to be released to regulatory organisations, such 
as the Care Quality Commission (CQC), who are more adept at interpreting such data, 
instead of public reporting.  
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“It is a sanction that is used so they know it is used” [on discussing the 
possibility that hospitals may not be reimbursed after paying a claim].  
 
Negatively focused incentives such as imposing penalties on substandard care may 
also be adopted. These measures, however, may perpetuate poor care by punishing 
the hospitals that need help in improving.  
 
Further exploration of different incentive models, including their evaluation and 
implications for policy, is clearly required. MIs have the financial resources and 
administrative capacity to help develop and run incentive schemes. Crucially, from 
these interviews and focus groups at least, there appears to be a growing appetite for 
new and better incentive plans. MIs, hospital staff (both clinical and managerial) and 
other key agencies in a health system should all be involved in the co-design of future 
incentive models. This would ensure system-wide coherence of objectives.  
 
5.5.6 System integration 
 
“I don’t think we’re the main part. I think we have a role”. 
 
“What we’re looking to do is connect the system up so that if you’re an 
organisation you haven’t got a visit from five or six…bodies plus a Royal 
College visit”. 
 
Many people and agencies in a health system contribute towards patient safety. 
However, an overcrowded system has been suggested to hinder rather than enhance 
quality improvement efforts. Poor communication and inadequate sharing of 
information between clinical teams or organisations may lead to time wasted on 
reinventing solutions that already exist elsewhere (11). The existence of too many 
local processes creates more variability within a health system, which may perversely 
undermine patient safety (11). The regulatory sector is similarly congested. Many 
regulators have overlapping roles and often duplicate data requests unnecessarily. 
This bureaucratic burden wastes time and resources for both the regulators and those 
being regulated (12). A more co-ordinated approach will help to align the aims 
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throughout a health system. Patient safety and quality of care are more likely to 
improve if all the drivers in the system – for example, policy, training, incentivisation, 
and regulation – are pointing to the same objectives (10). A medical indemnifier (MI) 
is only one stakeholder, amongst many others, in the pursuit for safer patient care. 
Despite this, MIs may be ideally placed to facilitate system integration through their 
multi-level contacts and financial power. MIs could work together and liaise with other 
organisations in the macro level of the health system whilst also maintaining 
relationships at the meso and micro levels.  
 
This work is subject to some limitations. A limitation of this work is the omission of 
private MIs from the analysis. Private MIs have different economic priorities and 
resources to state-based MIs. Despite this, there is evidence of clinical-MI partnership 
in patient safety initiatives in the private sector in the US (30,31). One physician-
sponsored malpractice indemnifier in Colorado offered financial incentives for 
adopting effective practices (259), which is similar to the VMIA’s approach to obstetric 
training. There are also some MIs in America that have a proactive approach to risk 
management, which includes engaging with clinical staff (259). Such a mentality 
appears increasingly necessary to combat the escalating costs of avoidable harm. 
Many of the state-based MIs that were interviewed echo this. The recent rebranding 
of NHS Resolution, with its focus on learning and prevention, is evidence of this. There 
are clearly opportunities to learn from private MIs and future research should consider 
exploring the engagement strategies used in the private sector.  
 
The study design only focussed on the perspectives of MIs and did not account for the 
viewpoints of clinical teams and managers. As the state-based MIs were purposefully 
chosen, there will be an element of selection bias and the findings here may not be as 
representative as they could be. The number of interviews, focus groups and 
participating MIs were limited by the time and resources assigned to this work. Data 
saturation was also unlikely to have been achieved through interviewing 17 
participants from the small sample of six state-based MIs. However, there has been 
little, if any, research in this area previously and in spite of the limitations, this work 
offers preliminary insights into how some state-based MIs currently engage with 
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5.6 Conclusion and recommendations 
This chapter has identified different models of clinical-MI engagement, which include 
training clinical staff on claims and risk management, hospital site visits, facilitating 
multi-professional network meetings and working with clinical experts to develop best 
practice recommendations. Some of the state MIs interviewed, notably the VMIA and 
LÖF, have mainly engaged with frontline clinical teams through collaborative patient 
safety initiatives. These projects were supervised by clinical experts from the start and 
some appear to have had beneficial effects on outcomes (32) or litigation (33).  
 
Analysing the different ways that MIs currently work has allowed the development of 
some recommendations for how state-based MIs could have a more effective role 
within the healthcare system and how they may use different levers to influence patient 
care and safety. State-based medical indemnifiers could:  
 
● Improve integration of the health system: 
○ By using their system-wide contacts and influence to coordinate and 
prioritise health-related initiatives 
○ By signposting members to possible solutions or directing them to 
relevant contacts 
 
● Collaborate more closely with clinical experts and other academics in the 
following: 
○ To create systems to combine clinical and claims data 
○ Implementing safety initiatives with proven clinical effectiveness 
○ Undertake translational research together, with the aim of applying this 
to multiple settings 
 
● Use their resources to help improve patient care: 
○ By providing administrative and financial support in collaborative 
projects 
○ By identifying problematic areas to focus on through their claims 
analyses 
○ By supporting collaborative research 
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● Utilise incentives to encourage improvement: 
○ By providing monetary support/incentives for safety initiatives with 
proven clinical effectiveness 
○ By providing premium discounts (where applicable) when certain 
assessment criteria are met 
○ By adjusting their premium models (where applicable) to influence 
current practice 
○ By supporting regional and national benchmarking 
○ By re-affirming professional pride and professionalism 
 
● Share learning and good practice with other medical indemnifiers:  
○ By hosting international meetings and forums 
 
It would be important to evaluate these recommendations before they are widely 
adopted so that they can be prioritised according to their impact. Whilst this chapter 
primarily focussed on maternity care, these recommendations may also be relevant in 
other medical specialities. State-based medical indemnifiers and clinical staff could 
and should collaborate more closely to achieve their common goals: improving patient 
outcomes and reducing the money that no one wants to have to receive or pay. 
 
5.7 Publication 
The work from this chapter was condensed and published in the Journal of Patient 
Safety and Risk Management in April 2018. The state-based medical indemnifiers 
were referred to as state insurers in this article. The publication has been included in 
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5.8 Chapter appendix 
5.8.1 Topic guide 
 
Background 
What is your job title? What does that entail? 
Could you explain a bit about your organisation?  
How is it funded?  
 
Management 
Could you talk about the claims management process?  
What happens when a claim is received? 
 
Communication 
How do communication channels open up with different professional groups? Who 
initiates contact? 
What is your approach to communicating with different professional groups?  
PROMPT if needed:  
- clinicians in general 
- maternity teams 
- researchers 
- other personnel 
 
Engagement and incentives (maternity) 
How does your organisation engage with maternity teams? 
Do you offer any incentives and could you give some examples?  
What has worked well? 
What has worked less well?  




What do you think would be the ideal way of engaging and collaborating with 
healthcare organisations/teams?  
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Clinical–insurer engagement to improve
maternity safety in the UK, Ireland,
Sweden and Australia
Christopher W H Yau1,2 , Oliver Quick3 and
Timothy Draycott1
Abstract
Objective: To explore different models of clinical–insurer engagement around maternity safety and to understand how
state insurers could and should engage with clinical staff to improve outcomes and reduce harm.
Design: Semi-structured interviews and focus groups were conducted with senior representatives from state insurers.
Transcripts were analysed to identify different models of engagement. Themes were also elicited from the transcripts. A
further one-day focus group allowed for clarification and elaboration of these themes.
Participants: Senior representatives from state insurers in England, Scotland, Wales, Republic of Ireland, Sweden and
Victoria, Australia.
Results: A variety of clinical engagement activities were undertaken by the insurers. These included training on claims
and risk management, hospital site visits, facilitating multi-professional network meetings and working with clinical
experts to develop best practice recommendations. Some insurers engaged with frontline clinical staff through collab-
orative patient safety programmes. The themes (identity and size, data and research, incentivising improvement and
system integration) were important for considering the role of state insurers within health systems and how insurers
could engage with clinical teams.
Conclusions: This study identified different examples of clinical–insurer engagement. Whilst this was encouraging, the
relationships between insurers and clinical teams could be developed further. Insurers and clinical staff could still
collaborate more closely and work together in improving patient outcomes. Whilst not specifically their domain,
insurers do have a role in patient safety. Closer clinical collaboration may strengthen this contribution.
Keywords
Clinical negligence, international perspectives, risk management, obstetrics
Introduction
Across the world, birth is not as safe as it could and
should be. Preventable harm is not only a tragedy for
the families affected, but with rising treatment and
litigation costs, it is a significant drain of financial
resources from healthcare systems. In 2016–17, the
English National Health Service Litigation Authority
paid out £1.7 billion in compensation and fees for
clinical negligence claims. Alarmingly, the value of
the obstetric claims received in 2016/17 is expected
to reach £2 billion.1 These are claims that no one
wants to receive or pay. It is money lost to the health-
care service and patient care. However, these pay-
ments, and in particular the prevention of the
underlying incidents, may help to drive improvement
in health systems. Agencies that provide indemnity
insurance for clinical negligence are not patient
safety organisations but can have a role in preventing
harm and avoiding litigation.2,3 Whilst there is evi-
dence of involvement by both private and state insur-
ers in patient safety initiatives,4–7 there has been little
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empirical research to understand the strategies
employed by state insurers to engage with clinical
teams. A better understanding of the different ways
state insurers interact with clinicians could be useful in
informing future practice. In this study, we explored
different models of engagement by examining the
work of six state insurers in Europe and Australia.
We focused on maternity care given its disproportion-
ate litigation burden – in England, obstetric cases rep-
resent 10% of the number of claims but constitute
50% of the total value.1 Our aim was to describe
how different state insurers engage with clinical staff
to improve outcomes and prevent harm, and explore
how such engagement can be more effective.
Methods
We examined different models of insurer engagement
with clinical providers (clinical–insurer engagement) at
the following six state insurers:
• NHS Litigation Authority (NHSLA) – England
• Welsh Risk Pool Services (WRPS) – Wales
• Central Legal Office (CLO) – Scotland
• State Claims Agency (SCA) – Republic of Ireland
• Landstingens !Omsesidiga F!ors!akringsbolag (L!OF) –
Sweden
• Victorian Managed Insurance Authority (VMIA) –
Victoria, Australia
These insurers were chosen to compare current practice
in England, Wales, Scotland and the Republic of
Ireland. Sweden was included to enable comparison
with an administrative ‘no-fault’ compensation
scheme run by a national mutual insurance company
(L!OF). The VMIA was included as it has funded qual-
ity improvement initiatives for maternity units across
Victoria.6 The key features of each insurer and the con-
text in which they operate are summarised in Figure 1.
Many of the participants did not identify with the term
insurer as there are no formal insurance contracts
between their organisation and their clients.
Indemnifier or reimburser are thus more accurate
terms to describe some of these organisations.
However, for ease of reference, we refer to all agencies
that manage clinical negligence claims and provide
compensation as insurers. We defined engagement to
include any sort of partnership or relationship which
is specifically focussed on improving safety and
outcomes.
We carried out semi-structured interviews (with one
participant) or focus groups (with more than one par-
ticipant) with senior representatives from each insurer.
To maintain confidentiality, the names of the partici-
pants and their affiliations have not been provided.
However, the roles of the participants from all six
state insurers have been listed in Table 1. The inter-
views/focus groups took place between August 2016
and February 2017 and were conducted by OQ
(Reader in Law) and CY (Obstetric Registrar and
Research Fellow). The exception was for the VMIA,
where CY facilitated focus groups. A basic topic guide
(see Appendix 1) was utilised at each interview/focus
group. All interviews/focus groups were audio-
recorded when permission was given (all except one)
and were transcribed. Analysis was supported by a
one-day focus group with all participants who provided
feedback on our preliminary analysis of the data and
an opportunity for collective reflection on the emerging
themes.
We followed a Grounded Theory approach, defined
as the ‘discovery of theory from data systematically
obtained from social research’.8 This approach is well
suited to investigating areas such as this where there is
limited existing research. The transcripts and field notes
were analysed independently by both researchers before
observations were compared and themes identified.
There was a high degree of similarity in terms of our
observations and no disagreements within the research
team in identifying themes from the data. We employed
deviant case analysis (i.e. whenever a theme or catego-
risation was identified within the data, each interview
was re-examined for counter-examples and disconfirm-
ing data). This afforded greater confidence that the iden-
tification of themes was trustworthy and reduced bias.
Ethical approval was obtained from the University of
Bristol Faculty of Health Sciences Research Ethics
Committee. Participants were provided with informa-
tion leaflets regarding the study and written consent
was obtained prior to the interviews/focus groups.
Results
Insurers were involved in a wide variety of engage-
ment activities. We classified these into ‘general’, ‘clin-
ical’ and ‘research’ engagement. All insurers
participated in general engagement activities, for
example providing claims data to hospitals, conduct-
ing claims reviews, and hosting quality and safety
conferences. There were also a range of initiatives
and projects whereby insurers attempted to engage
with clinical staff and also support research activity.
All engagement activities discussed by the insurers are
summarised in Table 2.
There was no consensus amongst respondents on
the best way of ensuring effective clinical–insurer
engagement. Whilst there was no lack of activity,
there was an acknowledgement that engagement
with frontline clinicians (as opposed to managers) is
challenging and somewhat under developed. This was
2 Journal of Patient Safety and Risk Management 0(0)
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reflected in the following quotes from respondents at
the NHSLA:
"What do we need to do to be engaging with the clini-
cians on the ground? How can we best develop and
start to move things forward?"
"I think in an ideal world we would have really pulled
off much closer clinical engagement, and if I’m being
realistic, I’m not sure we’d do it at hospital level but
there’s the potential to do it at speciality level."
L!OF appeared to have been successful in engaging with
specialists by collaborating with their professional
organisations. It has provided financial and adminis-
trative support for safety improvement projects focus-
sing on perinatal care, prosthesis-related infections,
abdominal surgery, trauma care and the use of drugs
NHS Litigation Authority (NHSLA) - England  
• The English NHS covers a population of 54 million and operated a budget of 
£101.3 billion in 2015-16.  
• The NHSLA was established in 1995 in order to provide indemnity cover for 
legal claims against the NHS. 
• It was rebranded as NHS Resolution in April 2017.  
• The Clinical Negligence Scheme for Trusts (CNST) is a risk pooling scheme 
made up of 530 NHS Trust members which operates on a not-for-profit and 
pay-as-you-go basis, with no limits or excesses.  
• The scheme collects annual membership subscriptions from each Trust to 
cover the projected costs of the scheme in that year, and these are calculated 
based on three factors: 
I. A risk-based element (staffing size and activity levels). 
II. Claims experience over past 5 years. 
III. Known outstanding claims 
Welsh Risk Pool Services (WRPS) - Wales 
• Wales has a population of around 3 million and NHS Wales delivers healthcare 
through seven local Health Boards and three NHS Trusts.  
• Welsh Risk Pool Services (WRPS) was set up in the early 1990s 
• WRPS funding comes centrally from the Welsh Government, via the NHS 
Shared Services Partnership in Wales.  
• Hospitals are allocated resources in accordance with the population that they 
serve, a proportion of which gets diverted to the WRPS beforehand. 
State Claims Agency (SCA) - Republic of Ireland 
• In Ireland, the Health Service Executive (HSE) is responsible for providing 
public healthcare for a population of around 5 million.  
• Residents are entitled to hospital services free of charge, however, there are 
some fees designed to act as deterrents for the misuse of services.  
• The SCA manages all clinical negligence claims against the State.  
• It is funded by taxation so there is no risk pool.  
• The SCA has a multi-professional clinical risk team, made up of 14 members, 
to assist in the investigation and risk management of clinical negligence claims.  
Central Legal Office (CLO) - Scotland 
• The CLO was created in 1974 and forms part of National Services Scotland, a 
non-departmental public body which is part of the NHS.  
• It handles legal claims brought against the health service and all work is 
handled in house by a team of 30 solicitors.   
• The Clinical Negligence and Other Risks Indemnity Scheme (CNORIS), akin to 
the English CNST, is a risk and financial pooling scheme which was 
established in 1999.  
• Health Boards are mandated to join the scheme, which is managed by NHS 
National Services Scotland, and overseen by the Scottish Government, which 
is required to approve claims in excess of £250,0000.  
• The CLO focuses exclusively on providing legal advice and guidance to its 
members in relation to negligence claims.  
Figure 1. Key features and context of insurers.
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in primary care. They were able to cite numerous exam-
ples of effective engagement with clinicians:
"We work with midwives, infectious specialists, obste-
tricians, primary GPs. We reach them via their
professional organisations, and our role here is to
administer and support financially. Then hopefully we
get the perfect marriage here."
A strong feature of the approach of L!OF was its
emphasis on inspiring appropriate professional norms
around learning and improvement as opposed to being
overly prescriptive:
"We’re quite cautious about telling – it’s not that we
say, for instance, 'L!OF does not say that you should do
it this way.' We don’t say that. We say that we have
helped the professionals to find the best practice to do
it and we have supported them. . .So, what we actually
work with there are professional norms. 'We help the
professions to develop their professional norms. ‘It’s
okay to do it this way. It’s not okay to do it this
way.' "
It should be noted that Sweden operates an adminis-
trative scheme for compensating patients for avoidable
harm. This is different to the fault-based systems in the
UK, Republic of Ireland and Australia. In Sweden,
claims are assessed with reference to whether injuries
are ‘avoidable’ rather than being caused by negligence,
Figure 1. Continued.
Table 1. Summary of participant roles.
Roles of participants
Head of clinical risk
General manager of medical indemnity
Chief medical officer





Head of clinical claims
Deputy chief executive officer
Actuarial analyst
Manager of health informatics
Director of safety and learning
Medical indemnity portfolio manager
Scheme manager
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and care is assessed by reference to the ‘experienced
professional standard’ rather than the standard of the
‘reasonable practitioner’ as it is in fault-based systems.
The Swedish Patient Injury Act, introduced in 1997,
establishes the right for patients to be compensated for
avoidable injury. This results in around a third of all
claims being compensated within eight months of the
injury being reported.9 Within this system, the insurer
is predisposed to offer compensation wherever possible:
"I think it’s also important to stress that we always try,
if it’s possible, to find a way to compensate. That’s how
we work. We are not here to save money. That’s impor-
tant to save money. We just want to make sure that if
we can pay compensation we should do that and try to
find a possibility. So, we don’t want to be this ugly
insurance company that just wants to fool everyone.
We really want to help people."
The Scottish Government has considered introducing
no-fault liability but has (so far) decided against doing
so.10 The UK Department of Health has recently con-
sulted on creating a ‘Rapid Resolution and Redress
Scheme’ for obstetric cases which is modelled on the
Swedish system.11 This scheme proposes to offer earlier
support and financial redress for children with birth-
related brain injuries in England. Ahead of this, the
NHSLA introduced an Early Notification Scheme in
April 2017 which requires Trusts to notify them of all
maternity incidents involving severe brain injury and
which allows families to be compensated without issu-
ing legal proceedings.12 Interestingly, the Welsh
Government has introduced a system of redress for
low-value cases (under £25,000). Under this ‘Putting
Things Right’ Scheme, concerns regarding clinical serv-
ices provided by NHS Wales are reported to the hos-
pital. If there is a suggestion of medical harm, the
hospital has to carry out an investigation to determine
whether there is qualifying liability under the well-
known Bolam test for assessing negligence.13 If quali-
fying liability is demonstrated, the hospital has a
responsibility to consider the value of financial com-
pensation. If the value is less than £25,000, then the
hospital can offer compensation directly to the patient
as part of this Scheme. The Welsh government can then
reimburse this fee. Patients waive their right to file a
legal claim by accepting this redress package.
Even within the fault-based system in the UK, there
were important differences in terms of the mechanics of
paying for claims. In England, Hospital Trusts pay a
premium to be members of an indemnity scheme (the
Clinical Negligence Scheme for Trusts) which is admin-
istered by the NHSLA. This means that the NHSLA
takes responsibility for managing claims and paying
out compensation. Whereas in Wales, if a settlement
is agreed, the hospital pays the settlement first, before
applying to the WRPS for reimbursement. Hospitals
are only reimbursed if an adequate learning plan has
been implemented and WRPS has the power to delay
or even refuse reimbursement at its discretion.
"It is a sanction that is used so they know it is used" (on
discussing the possibility that hospitals may not be
reimbursed after paying a claim).
In the Republic of Ireland, the reporting of any
adverse healthcare incidents to the SCA is a statutory
requirement. Whilst there is no formal penalty for non-
compliance, if a claim is not preceded by an incident
report, the SCA can decline to cover the cost of the
claim and the hospital would have to pay out
themselves.
Engagement appeared to be easier in smaller health
systems. Respondents from Wales made repeated
Table 2. Summary of engagement activities.
General Clinical Research
Providing leaflets on services Operating incentive schemes Learning from claims data
Claims reviews/audits Performing themed reviews Co-applicants for research grants
Hosting national safety campaigns Facilitating national maternity network Claims database available for
research purposes
Obtaining feedback from members Training for clinical staff Supporting early research
Signposting to good practice Performing site visits ‘In-house’ health informatics team
Liaising with other organisations Providing financial and/
or administrative support for
patient safety initiatives
Research components to safety initiatives
Organising networks for claims managers Developing educational programmes Seeking formal research partnerships
Presentations at executive level Facilitating expert discussions
Hosting conferences
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reference to the relatively small size of their health sys-
tems and their ability to get to know key clinical
personnel.
"I think because Wales is smaller we’ve been able to
have a better handle on the risk management and the
training and the lessons that come out of the claims."
"From the point of view of claims management, it’s
easier in a smaller place where you have only about
10% number of the claims and just geographically, it
seems easier to manage."
All insurers possess a significant amount of claims
data. However, there was recognition that merely pos-
sessing the data does not ensure improvement:
"Data is only going to start to signpost you to look at
which stone you might want to turn over. It’s not going
to tell you how to fix those problems necessarily."
"So, we can capture more and more data if we want, we
can capture more and more granular data but is it
going to necessarily take us that further forward in
terms of actually supporting and engaging with people
on the ground to improve? It might give them more
tools but more information about what they already
know is an issue isn’t helping them solve that issue
whereas the provision of potential support [or] interven-
tion. . .to help them get past that would be, I think, a
really positive step towards that improvement."
Some have been using their claim analyses to direct
improvement efforts towards problematic areas.
"We want our patient safety activities to be data-
driven. Targeted work, we can’t work with everything,
so we have to be selective."
Finally, many of the insurers seemed to take a pro-
active approach to risk management and the recent
rebranding of the NHSLA to NHS Resolution,12
with its focus on learning and prevention, is evidence
of this.
"Yeah, we’re insurers and we’re there to make sure that
the clients are well looked after when things go wrong
but, at the same time, we see our role to prevent that
harm happening in the first place."
"So, all of the players, whether you’re the national lead
for maternity for NHS England or you’re in improve-
ment or you’re here, we’ve all got the same aim. . .what-
ever we can possibly do in a combined way to reduce
harm."
"A dollar’s a dollar at the end of the day but if we’re
preventing harm/saving lives it’s a whole different story
and I think it generates more enthusiasm for all of us
knowing that we’re looking for something that’s going
to help."
Discussion
This study demonstrated that state insurers participat-
ed in a wide range of general, clinical and research
engagement activities. There were many models of clin-
ical–insurer engagement but there was a strong sense
that this relationship could be improved further. Our
analysis of the responses allowed us to identify the fol-
lowing themes which appear to be centrally important
for effective clinical–insurer engagement: insurer iden-
tity and size, their use of data and commitment to
research and how they attempt to incentivise improve-
ment and integrate the system.
Insurer identity and size
A fundamental question surrounds the identity of each
insurer and what they regard as their main priorities.
Whilst all the insurers are responsible for protecting the
interests of their members, both financial and reputa-
tional, they must also compensate patients for negligent
or avoidable harm. This raises the significant challenge
of how insurers can satisfy all of these different stake-
holders whilst maintaining their trust and confidence.
Balancing the interests of patients (particularly those
who bring claims) whilst defending the financial inter-
ests of the health system is particularly challenging.
Apart from L!OF, which operates within a system
which provides an entitlement to compensation for
avoidable harm, the other insurers have operated
within systems which have (historically) been focused
on denying or defending claims. It is important not to
overlook the impact of these different systems on how
insurers identify themselves and what they consider to
be their main priority. For example, L!OF functions as
an insurance company which essentially regards
patients as its customers and attempts to resolve
claims to their satisfaction. This contrasts with the
approach of insurers in fault-based systems which
have tended to focus on satisfying its clinical provider
members. We would tentatively suggest that no-fault
systems, with an emphasis on efficient resolution of
claims and a less adversarial approach, are more con-
ducive to effective clinical–insurer engagement.
Effective engagement also appeared to be easier in
smaller health systems. It was a foreground assumption
of this research that engagement might be easier in
smaller health systems, and the responses appear to
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confirm this. One of the explanations for the positive
examples of engagement in Sweden and Victoria is the
relatively small size of their health systems. This
presents challenges for such engagement in bigger
health systems such as the English NHS and raises
the possibility of larger insurers operating at regional
level in order to help facilitate more effective
engagement.
Data and research
Claims data can complement clinical data and improve
the potential learning from harmful events. However,
data collected for claims purposes are limited in a
number of ways. First, it presents a skewed picture in
only focusing on failure rather than success. Second,
given the time lag between the incident date and the
claim date, it may not accurately reflect the safety of
current care being delivered. Third, such data are col-
lected for narrower legal rather than much broader
clinical purposes. Combining clinical and claims data
would be challenging given the need to integrate many
different databases. Insurers and clinicians should
work in partnership to carefully design an accessible
system that will facilitate, rather than impede, the anal-
ysis of claims and clinical data together. This would
result in more data being converted into meaningful
information. Furthermore, a consensus on the taxono-
my to be used between insurers and clinicians world-
wide would encourage data sharing and the formation
of larger datasets. This would increase opportunities
for learning and foster a greater sense of collaboration.
In addition to developing a better way of using data,
insurers could work more closely with clinical experts
and draw on academic expertise in designing patient
safety research. In particular, insurers could fund col-
laborative research projects as part of their risk miti-
gation initiatives.6,7 The VMIA has supported the
implementation of a multi-professional obstetric emer-
gencies training programme (PROMPT) throughout
Victoria. Each participating unit received funding
from the VMIA to help with training costs. An initial
analysis found that the programme was associated with
improvements in staff attitudes towards safety, team-
work and perception of management. There were also
significant improvements in some clinical outcomes
during or after training.6 The VMIA is currently col-
laborating with a UK charity (PROMPT Maternity
Foundation) to evaluate the state-wide impact of this
training package.
Incentivising improvement
Incentives can play an important role in encouraging
improvement but there is no agreement on the perfect
model for this. Though not formal regulators, insurers
can exert some regulatory influence by setting targets
(such as adopting evidence-based patient safety pro-
grammes) linked with monetary and administrative
incentives.14 Other financial incentives could be in the
form of premium discounts or returns subject to certain
assessment criteria. The NHSLA previously offered
discounts of up to 30% on hospitals’ premiums if
their standards were met. These were process measures
covering governance, learning, workforce, environ-
ment, training and procedures.15 These discounts and
standards were eventually stopped as there was no clear
correlation between compliance with standards and
better outcomes.16,17 Eligibility for discounts on premi-
ums, therefore, should include assessment of both pro-
cesses and clinical outcomes.
There is a considerable time lag in maternity claims
between the incident and settlement, usually due to the
time needed for a diagnosis and long-term prognosis to
be made. As a result, premiums charged to maternity
units may still be influenced by previous events, even if
care has significantly changed since they occurred.
There is an argument that premiums are too backward
looking and do not reward current, good practice.
Future pricing strategies should take this into
consideration.
Non-financial incentives can also be very powerful
and could include releasing data for regional/national
benchmarking or promoting professionalism. Such
incentives could be considered universal and not reliant
on pricing strategies or premiums. Negatively focused
incentives such as imposing penalties on substandard
care may also be utilised. These measures, however,
may perpetuate poor care by punishing those that
need help in improving.
Further exploration of different incentive models,
including their evaluation and implications for policy,
is clearly required. Insurers have the financial resources
and administrative capacity to help develop and run
incentive schemes. Crucially, from these interviews
and focus groups at least, there appeared to be a grow-
ing appetite for new and better incentive plans, as dem-
onstrated by proposals in England to introduce a new
discount scheme in 2018/19.18 Insurers, hospital staff
(both clinical and managerial) and other key agencies
in the health system should all be involved in the co-
design of future incentive models. This would ensure
system-wide coherence of objectives, which are realistic
and relevant to frontline services.
System integration
Many people and agencies in a health system contrib-
ute towards patient safety. However, an overcrowded
system may hinder rather than enhance quality
Yau et al. 7
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improvement efforts. Poor communication and inade-
quate sharing of information between clinical teams or
organisations may lead to time wasted on reinventing
solutions that already exist elsewhere.19 The existence
of too many local processes creates more variability
within a health system, which may perversely under-
mine patient safety.19 The regulatory sector is similarly
congested. Many regulators have overlapping roles and
often duplicate data requests unnecessarily. This
bureaucratic burden wastes time and resources for
both the regulators and those being regulated.20
A more co-ordinated approach would help to align
the aims throughout a health system. Patient safety and
quality of care are more likely to improve if all the
drivers in the system – for example, policy, training,
incentivisation and regulation – are pointing to the
same objectives.21 An insurer is only one stakeholder,
amongst many others, in the pursuit for safer patient
care. Despite this, insurers may be ideally placed to
facilitate system integration through their multi-level
contacts and financial power. Insurers could work
together and liaise with organisations at all levels of
the health system.
This research is subject to some limitations. The
study design was limited to understanding engagement
from the perspective of key personnel at insurers. No
account was taken here of the perspectives of clinicians
or managers. Another limitation is the small sample
size of state insurers we selected to participate in this
study. As the insurers were purposefully chosen, there
will be an element of selection bias and our findings
may not be as representative as they could be. Data
saturation was also unlikely to have been achieved
through interviewing six state insurers, though our
sample size was limited by the time and resources
assigned for this work. Despite the limitations, there
has been little, if any, research in this area previously
so this work offers preliminary insights into how some
state insurers currently engage with clinical teams,
which other insurers may find helpful.
Conclusion
To conclude, this study identified different models of
clinical–insurer engagement, which include training
clinical staff on claims and risk management, hospital
site visits, facilitating multi-professional network meet-
ings and working with clinical experts to develop best
practice recommendations. Some insurers, notably the
VMIA and L!OF, have mainly engaged with frontline
clinical teams through collaborative patient safety ini-
tiatives. These projects were supervised by clinical
experts from the start and some appear to have had
beneficial effects on outcomes6 or litigation.7 Whilst it
was encouraging that many examples of clinical–
insurer engagement were elicited, there is scope for
this dynamic to be developed further.
Analysing the way that different insurers currently
work has allowed us to develop recommendations for
how state insurers could play a more effective role
within the healthcare system and how they may use
different levers to affect patient care and safety.
These recommendations fall within the categories
listed below. Insurers could:
• Improve integration of the health system:
! By using their system-wide contacts and influence
to coordinate and prioritise health-related
initiatives
! By signposting members to possible solutions or
directing them to relevant contacts
• Collaborate more closely with clinical experts and
other academics in the following:
! To create ways to combine clinical and claims data
! Implement safety initiatives with proven clinical
effectiveness
! Undertake translational research together, with the
aim of applying this to multiple settings
• Use their resources to help improve patient care:
! By providing administrative support in collabora-
tive projects
!By identifying problematic areas to focus on
through claims analyses
! By supporting collaborative research
• Utilise incentives to encourage improvement:
! By providing monetary support/incentives
for safety initiatives with proven clinical
effectiveness
! By providing premium discounts (where applica-
ble) when certain assessment criteria are met
! By adjusting their premium models (where appli-
cable) to influence current practice
! By supporting regional/national benchmarking
! By reaffirming professional pride and
professionalism
• Share learning and good practice with other insurers
Whilst this study primarily focussed on maternity
care, these recommendations may also be relevant in
other medical specialties. Insurers and clinical teams
could and should collaborate more closely to achieve
their common goals: improving patient outcomes and
reducing costly payouts.
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Appendix 1. Topic guide
Background
What is your job title? What does that entail?
Could you explain a bit about your organisation?
How is it funded?
Yau et al. 9
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Could you talk about the claims management process?
What happens when a claim is received?
Communication
How do communication channels open up with differ-
ent professional groups? Who initiates contact?
What is your approach to communicating with differ-
ent professional groups?
PROMPT if needed:




Engagement and incentives (maternity)
How does your organisation engage with maternity
teams?
Do you offer any incentives and could you give some
examples?
What has worked well?
What has worked less well?
• are there any administrative/organisational/legal
barriers to engaging with maternity teams?
Ideal standard
What do you think would be the ideal way of engaging
and collaborating with healthcare organisations/teams?
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6.1 Introduction 
Birth injuries can have devastating and lifelong consequences. In addition to the harm 
caused to patients and their families, the litigation costs associated with poor obstetric 
care can be substantial. Preventable harm in English maternity services cost the NHS 
£3.1 billion from 2000-2010. The value of individual claims can also be significant; in 
the UK, the record damages ever awarded for a birth injury was £19.8 million (260). 
Alarmingly, these litigation costs appear to be increasing, with all English obstetric 
claims from 2017/18 alone expected to cost around £2 billion (21). This rise in litigation 
costs in maternity care is a global issue (2). 
 
These maternity-related litigation costs may reduce funding for patient care. Improving 
outcomes would benefit both individuals and system level funding for care. Different 
strategies have been proposed to control litigation costs in obstetrics, such as no-fault 
approaches, communication and resolution, and caps on compensation and legal fees 
(261). However, improving maternity care and reducing preventable harm should be 
the primary aims of initiatives to reduce obstetric-related litigation. There are examples 
of maternity safety initiatives that have been associated with a reduction in malpractice 
claims. One maternity unit in England reported a 91% reduction in litigation payments 
following improved outcomes after the introduction of a training programme for 
obstetric emergencies (29,93). A hospital in the United States also reported a 
decrease in perinatal adverse events and compensation payments following the 
implementation of a comprehensive obstetric patient safety programme – average 
annual compensation payments decreased from US$27.6 million between 2003-2006 
to US$2.6 million between 2007-2009 (229). As these figures illustrate, the potential 
cost-savings to a health system from avoiding maternity litigation are considerable. 
 
Medical indemnifiers (MIs) are responsible for managing malpractice claims, and 
although they are not patient safety organisations, they do have a responsibility to 
reduce litigation (28,29). MIs can and do support patient safety initiatives aiming to 
reduce litigation costs (Chapter 5). There are a number of examples of MI-supported 
maternity improvement projects that have been associated with better clinical 
outcomes (30), reduced litigation (33,262) or both (230,231). For example, the 
Hospitals Insurance Company in New York provided staff, resources and funding to 
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support quality improvement initiatives across four obstetric units, and a 42% 
decrease in overall adverse outcomes (10.7% to 6.2%, p <0.001) was reported 
following this (30).  
 
In Sweden, Landstingens Ömsesidiga Försäkringsbolag (LÖF), the national mutual 
insurance company, provided administrative and financial support to implement a 
nationwide Perinatal Patient Safety Program, which consisted of peer-reviewed local 
interventions and an online training programme for cardiotocography (CTG) 
interpretation. The Perinatal Patient Safety Program did not demonstrate any direct 
improvements in patient outcomes but was associated with a reduction in settled 
claims related to severe delivery-related asphyxia (33).  
 
The American Excess Insurance Exchange partially funded a collaborative, multi-state 
quality improvement project that involved standardising care, multi-professional team 
training and clinical education with performance feedback. Following this improvement 
project, the total maternity litigation costs (inclusive of legal fees) fell by 77.6% (262).  
 
MCIC Vermont provided partial financial support for an obstetric patient safety 
program that was associated with a reduction in adverse events and a parallel 
reduction in median annual compensation payments per 1,000 deliveries from 
US$1,141,638 to US$63,470 (230,231).  
 
Multi-professional simulation training for obstetric emergencies (PROMPT) has been 
implemented in maternity units in Victoria, Australia with the support of the state MI, 
the Victorian Managed Insurance Authority (VMIA) (32). PROMPT was endorsed by 
the VMIA (263) following early evidence of clinical impact in multiple settings 
(93,100,101,113). An initial evaluation of the first eight participating units 
demonstrated improvements in attitudes to teamwork, safety and perception of 
management. Some clinical outcomes also improved following PROMPT, with 
significant reductions in the number of babies with Apgar scores <7 at 1 minute and 
the number of babies born with poor umbilical cord lactates (32). However, the effect 
of this patient safety initiative on maternity litigation was not evaluated. This chapter 
aims to investigate the impact of multi-professional simulation training for obstetric 
emergencies (PROMPT) on maternity-related claims frequency (claim rate) and costs 
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6.2.1 Ethical approval 
Monash Health (Victoria, Australia) approved this study as part of a wider evaluation 
of PROMPT in Victoria (Monash Health Human Research Ethics Committees Ref: 
16164L).    
 
6.2.2 Health service/hospital groups 
The VMIA supported the phased implementation of PROMPT in 22 Victorian health 
services/hospitals (approximately 46% of health services providing intrapartum care). 
An interrupted time series model was used for evaluation; there was a pre-PROMPT 
period, an initial training period and a post-PROMPT implementation period for each 
unit. The health services/hospitals were divided into 4 groups according to their initial 
training periods. Group I’s initial training period was from January 2010 to December 
2010 (1 year in duration). Group I also represented all the maternity units in the original 
pilot study (evaluation period from July 2008 to December 2011) (32). Group II’s initial 
training period was from March 2013 to May 2014 (1 year and 2 months in duration). 
The initial training period for Group III was May 2014 to July 2015 (1 year and 2 months 
in duration). Group IV’s (Northwest and Wodonga) initial training period was from 
November 2014 to November 2015 (1 year and 1 month in duration). As there was 
only a 6-month difference between the start of the initial training periods for Groups III 
and IV, it was decided prior to the analyses to combine Northeast and Wodonga 
(Group IV) with health services/hospitals in Group III (at the request of the VMIA). All 
pre-PROMPT periods consisted of the 3 years preceding the initial training periods. 
Health services and hospitals were assumed to have continued PROMPT after their 
initial training periods as regular, multi-professional training is considered the most 
effective training model for the management of obstetric emergencies (26, 107). The 
post-PROMPT implementation period for Group I was 6 years and 6 months (January 
2011 to June 2017). For Group II, the post-PROMPT implementation period was 3 
years and 1 month (June 2014 to June 2017). The post-implementation periods for  
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Group III and Northeast/Wodonga were 1 year and 11 months (August 2015 to June 
2017) and 1 year and 7 months (December 2015 to June 2017) respectively. Table 
6-1 summaries the groups, the different periods and the corresponding births.  
 
































January 2011 to 
June 2017 
(6 years 6 
months) 
 













March 2013 to 
May 2014 
(1 year 2 
months) 
June 2014 to 
June 2017 
(3 years 1 
month) 
 
39,137 births 17,767 births 53,374 births 
110,278 births 
(+2 births with 















May 2011 to 
April 2014 
(3 years) 
May 2014 to 
July 2015 
(1 year 2 
months) 
August 2015 to 
June 2017 
(1 year 11 
months) 
 
34,671 births 12,979 births 27,408 births 
75,058 births 
(+1 birth with 













(1 year 1 
month) 
December 2015 
to June 2017 
(1 year 7 
months) 
 
15,541 births 10,824 births 5,832 births 32,197 births 
     
366,290 births 
(+3 births with 
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6.2.3 Data management 
In Victoria, it is mandatory for all maternity units to report any information regarding 
conditions, procedures and outcomes for every birth to a state-based birth registry 
(Victorian Perinatal Data Collection) (264). Electronic data collection started in Victoria 
in 2009 and the majority of maternity units in Victoria (96%) use the Birthing Outcomes 
System (BOS) to input this data (265). Anonymised birth data (from 2009-2017) for 
the health services/hospitals under investigation were obtained through BOS and 
transferred via the VMIA. Anonymised details of all (100%) maternity claims occurring 
in the health services/hospitals with incident dates between July 2003 and June 2017 
were provided by the VMIA. Data for 1,163 claims and 366,293 births were received. 
All data were transferred as password-protected files and stored securely on 
University of Bristol computers. The birth and claims data were divided into two 
evaluation periods to investigate the impact of PROMPT: pre-PROMPT (which 
included the initial training period) and post-PROMPT implementation. The initial 
training period was included as part of the pre-PROMPT period as a previous study 
only observed improvements following PROMPT at least a year after the 
implementation of training (93).  
 
6.2.3.1 Costs and claims definitions 
All data regarding total costs paid, total outstanding costs and net incurred costs for 
each maternity claim were received. However, we focused on the gross incurred costs 
– defined as the total costs paid to date plus any outstanding costs (usually based on 
estimates). Information on claims status (i.e. whether claims were open or closed) was 
also provided, as well as brief incident descriptions. Analysing the gross incurred costs 
meant that the full value of each claim could be accounted for, regardless of whether 
it was open or closed. All costs were in Australian dollars. The following definitions 
were employed for the analyses after discussion with the actuarial team at the VMIA.  
 
Open claim with no gross incurred costs 
An incident (reported by a health service/hospital) that may result in a claim. However, 
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Open claim with gross incurred costs 
A claim that has been made, but not yet settled. An open claim with gross incurred 
costs ≤A$10,000 represents a high-risk incident that is more likely to become a claim 
and would benefit from some preparatory legal work (thereby incurring costs 
≤A$10,000) in case a claim is made. The VMIA decide which incidents are more likely 
to result in a claim.  
 
Closed claim with no gross incurred costs 
An incident (reported by a health service/hospital) that did not result in a claim or any 
incurred costs. 
 
Closed claim with gross incurred costs 
A claim that has been settled and incurred costs. 
 
6.2.3.2 Exclusion criteria 
Figure 6-1 summaries the exclusion process for the claims data. Claims data from 35 
health services/hospitals were received.  
 
Claims from 13 non-participating health services/hospitals were excluded (n=59). Only 
claims with gross incurred costs, regardless of whether they were open or closed, 
were included for the analyses. Closed claims with no gross incurred costs (n=461) 
and open claims with no gross incurred costs (n=162) were therefore excluded. 
Incident descriptions of cases that were classified as neonatology claims were 
reviewed by myself and a consultant obstetrician. Any neonatology claims that were 
clearly related to neonatal care only were excluded (n=13). Neonatology claims that 
were ambiguous or related to obstetric care were retained. One claim was removed 
as it was concerning a non-related condition (n=1) (condition anonymised to maintain 
patient confidentiality). 
 
No birth data were received from South West Healthcare (as it did not use BOS) so 
these claims were excluded (n=4). Claims from Healesville (n=1) and Alfred Health 
(n=11) were also excluded as both had intervals of missing birth data within their 
respective evaluation periods. Claims outside of the evaluation periods were excluded. 
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As electronic data collection only started in Victoria in 2009, no birth data were 
received for Group I from January 2007 to December 2008. Claims during this time 
period for Group I were therefore excluded. After the exclusion process, a total of 181 
claims with incident dates between January 2009 to May 2017 were available for the 
analyses. 
 
Figure 6-2 summarises the exclusion process for the birth data. Births with missing 
date of delivery were excluded (n=3). After the exclusion process for the claims data, 
1,163 claims 
received 
1,104 claims  
Excluded due to: 
• Non-PROMPT health services/hospitals (n=59) 
 
Excluded due to: 
• Closed claims with no gross incurred costs 
(n=461) 




Excluded due to: 
• Non-related condition (n=1) 
• Neonatal related (n=13) 
451 claims 
Excluded due to: 
• South West Healthcare claims (n=4)* 
• Healesville claims (n=1)** 
• Alfred Health claims (n=11)** 
181 claims for 
analysis 
Excluded due to: 
• Outside of evaluation period or no 
corresponding birth data received (Jan 
2007-Dec 2008) for Group I (n=110) 
• Outside of evaluation period for Group II 
(n=54) 
• Outside of evaluation period for Group III 
(n=106) 
 
Figure 6-1 Exclusion process for claims data  
*South West Healthcare claims excluded as no birth data received 
**Healesville and Alfred Health claims excluded as intervals of missing birth data present 
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only claims with incident dates up to and including May 2017 were available. As a 




















As there were intervals of missing birth data for Healesville and Alfred Health, all births 
from these two health services/hospitals were removed. Finally, any births outside of 
the evaluation periods were excluded (n=7,303). A total of 323,802 births remained 
for the analyses. 
 
All exclusions were performed so that both the birth and claims data were from the 
same time periods. In other words, this ensured that we analysed each preceding 
incident and claim together, rather than capturing data for one without the other.  
 
6.2.4 Outcomes and statistical models 
Aggregated births and claims data by group and evaluation period were used to derive 
the following outcomes:  
366,293 births 
received 
Excluded due to: 
• Births occurring after available claims data (post 
May 2017) (n=29,369) 
Excluded due to: 
• Missing/incomplete births data from Healesville 
(n=170)* 
• Missing/incomplete births data from Alfred 
Health (n=5,646)* 
336,921 births 
Excluded due to: 
• Outside of evaluation periods for Groups I, II and 
III (n=7,303) 
331,105 births 
323,802 births for 
analysis 
Figure 6-2 Exclusion process for birth data 




Excluded due to: 
• Births missing date of births (n=3) 
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• Rate of claims per 10,000 births per month 
• Mean cost per claim 
• Mean monthly litigation cost 
 
The impact of PROMPT was assessed by comparing these outcomes between the 
pre-PROMPT periods (inclusive of the initial training periods) and the post-PROMPT 
implementation periods. For all subsequent statistical tests, p-values around 0.05 
were assumed to represent weak evidence against the null hypothesis and p-values 
<0.001 as strong evidence (171). All statistical tests and models were performed using 
R statistical software. 
 
6.2.4.1 Claims frequency 




= 	6&#")	47+2$.	&'	$)*8*2)$	()"*+,	*4	8*9$4	+&4#ℎ6&#")	47+2$.	&'	2*.#ℎ,	*4	8*9$4	+&4#ℎ 	× 	10,000 
 
Descriptive statistics were used to describe the changes in the rate of claims. In 
addition, a Poisson regression model was used to model the claim rates. As the 
numerator of the outcome variable (rate of claims) was a count variable, a Poisson 
model was the most appropriate choice (266). The rate of claims needed to follow a 
Poisson distribution (i.e. the mean should be equal to the variance) for the Poisson 
regression model to be valid. There was increased variance in the claim rates, 
resulting in an over-dispersion of the claim counts. A quasi-likelihood method was 
therefore required to modify the model and take this over-dispersion into account 
(quasi-Poisson model). The outcome variables must also be independent for the 
Poisson model to remain valid and unbiased. The assumption that claim rates were 
independent (i.e. the claim rate in a given month did not influence the claim rate in the 
following month) was checked using visual (autocorrelation function plots) and 
statistical (Ljung-Box test) checks. When a significant correlation was detected (i.e. 
claim rates were not independent from one month to another), a regression model with 
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autoregressive integrated moving average (ARIMA) errors was employed as a 
sensitivity analysis to check the results from the quasi-Poisson model.  
 
The quasi-Poisson model provided estimates of the claim rate ratios (between the pre-
PROMPT and post-PROMPT implementation periods) whereas the ARIMA model was 
used to identify the differences in the claim rates between the two periods. The quasi-
Poisson model was also adjusted for time (in months) to eliminate the effect of time 
on the results.  
 
6.2.4.2 Claims costs 
The duration of the pre-PROMPT and post-PROMPT implementation periods varied 
between groups so simply comparing the pre- and post- litigation costs was 
inappropriate. We derived the mean cost per claim and the mean monthly litigation 
cost using the following formulae: 
 
;$"4	)*#*8"#*&4	(&,#	-$.	()"*+
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Descriptive statistics were used to describe the changes in mean cost per claim and 
mean monthly litigation cost before and after PROMPT was implemented. A 
generalised linear model (GLM) with gamma distributed errors was used to model the 
mean cost per claim as well as the mean monthly litigation cost between evaluation 
periods. The gamma distribution of errors was the most suitable choice as the data 
were continuous, had positive values and had positively skewed distributions. The 
gamma distribution has also been recommended for modelling cost data (267). Time 
(in months) was included as a covariate in this model to adjust for the effect of time on 
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All open claims with gross incurred costs ≤A$10,000 represented high-risk incidents 
that were more likely to become formal claims, so had some preparatory legal work 
undertaken (thereby incurring costs). In total, there were 55 of such claims (17 in the 
pre-PROMPT periods and 38 in the post-PROMPT implementation periods). 
Sensitivity analyses were performed where these high-risk incidents were treated as 
formal claims and the GLMs were rerun. These worst-case analyses would give an 
indication of the potential financial impact if these incidents all became claims. In the 
first sensitivity analysis, high-risk incidents were converted to formal claims by 
substituting the ≤A$10,000 gross incurred costs of the high-risk incidents with the 
median cost of all the remaining claims from the relevant evaluation period. The 
median cost was selected as this was a better figure to summarise the data that were 
highly, positively skewed. 
 
In the second sensitivity analysis, the ≤A$10,000 gross incurred costs of the high-risk 
incidents were substituted with the median cost of the remaining claims of a similar 
nature. All high-risk incidents were categorised according to the incident descriptions 
provided. The incident descriptions of the remaining open or closed claims were then 
reviewed and classified using the same taxonomy. Category specific median costs 
were used to replace the ≤A$10,000 gross incurred costs to model the potential 
financial implications if these high-risk incidents became formal claims. Median costs 
were used as the data were skewed.     
 
6.3 Results  
Figure 6-3 illustrates the number of births per health service/hospital per year, with the 
vertical dotted lines demarcating the pre-PROMPT, initial training and post-PROMPT 
implementation periods.  
 
Table 6-2 summarises the claims by their status, evaluation period and group. There 
were 181 claims related to 323,802 births between 2009-2017. Of these, 101 occurred 
in the pre-PROMPT period and 80 in the post-PROMPT implementation period. The 
majority of claims in all post-PROMPT implementation periods were open claims with 






































Figure 6-3 Births per health service/hospital per year (dotted lines demarcate the pre-




















6.3.1 Claims frequency  
Table 6-3 presents the claim rates and unadjusted and adjusted rate ratios between 
the pre-PROMPT and post-PROMPT implementation periods. Overall, the claim rate 
decreased from 6.65 claims per 10,000 births to 4.65 claims per 10,000 births following 
the introduction of PROMPT. The claim rate also decreased in each group after the 
implementation of PROMPT. Group I had the highest rate of claims (10.7 per 10,000 
births) in the pre-PROMPT period, whereas Group III had the lowest rate (5.57 per 
10,000 births). After PROMPT was introduced, Group I still had the highest rate of 
claims (4.93 per 10,000 births) but Group II had the lowest rate (4.02 per 10,000 
births). 
 
A 53% (95% confidence interval (CI) 18%, 73%, p=0.008) reduction in the overall rate 
of claims following the implementation of PROMPT was found in the adjusted quasi-
Poisson model. This effect was confined to Group I with a 70% reduction (95% CI 
29%, 88%, p=0.007) and there was no evidence that the claim rates had decreased 











































Overall 323,802 181 101 51 (51) 50 (49) 80 9 (11) 71 (89) 
         
Group I 138,226 86 33 27 (82) 6 (18) 53 8 (15) 45 (85) 
         
Group II 94,460 47 31 12 (39) 19 (61) 16  1 (6) 15 (94) 
         
Group III 91,116 48 37 12 (32) 25 (68) 11  0 (0) 11 (100) 
Closed claim with gross incurred costs – a claim that has been settled and incurred costs 
Open claim with gross incurred costs – a claim that has been made but not yet settled or a high-risk incident that is 
more likely to become a claim and would benefit from some preparatory legal work (thereby incurring costs) in case a 
claim is made. 
Table 6-2 Claims by status, evaluation period and group 
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Table 6-3 Claim rates, unadjusted ratios and adjusted rate ratios for claims 
* Adjusted for time (in months) 
 
There was evidence of significant correlation in the overall claims data from one 
evaluation period to another. This meant that the overall adjusted quasi-Poisson 
model may have produced a biased result. An ARIMA model was therefore applied as 
a sensitivity analysis to check the results of the overall adjusted quasi-Poisson model. 
The ARIMA model results were similar with a 4.52 reduction (95% CI 1.06, 7.98, p= 
0.01) in the claim rate between the pre-PROMPT period and the post-PROMPT 
implementation period (Table 6-4). This equated to an overall 59% reduction in the 
claim rate ((4.52/7.64) x 100). Although there was no correlation between claims data 
from one evaluation period to another within groups, ARIMA models for each group 
have been included for completeness (Table 6-4). These demonstrate similar results 
to the adjusted quasi-Poisson models, with evidence of a 69% reduction ((7.70/11.15) 
x 100) in the claim rate in Group I (p=0.003) and no evidence of reductions in the claim 





Claim rate in 
pre-PROMPT 
period 





 (95% CI) 
P-value 
Overall 7.64 3.11 4.52 (1.06, 7.98) 0.01 
Group I 11.15 3.45 7.70 (2.54, 12.85) 0.003 
Group II 6.41 3.51 2.90 (-3.33, 9.13) 0.64 
Group III 4.86 4.66 0.21 (-4.71, 5.14) 0.93 
 
 Pre-PROMPT period Post-PROMPT implementation period Crude 
Quasi-Poisson 
Model* 









































Table 6-4 ARIMA models 
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6.3.2 Claims costs 
Table 6-5 summaries the mean litigation cost per claim by evaluation period and 
group. The VMIA paid approximately A$69 million for the 181 claims, averaging nearly 
A$400,000 per claim. The mean cost per claim in the pre-PROMPT period was around 
A$500,000, compared to A$250,000 after PROMPT was introduced. The mean cost 
per claim in each group was also lower in the post-PROMPT implementation periods. 
Group I had the highest mean cost per claim pre-PROMPT (A$606,018) but the lowest 
mean cost per claim post-PROMPT (A$229,159). Group II had the highest mean cost 
per claim following PROMPT (A$319,835).  
 
Table 6-5 Mean litigation cost per claim (A$) 
 
 
Table 6-6 summarises the mean monthly litigation cost by evaluation period and 
group. During the whole evaluation period, VMIA spent around A$430,000 per month 
on maternity-related litigation costs. The overall mean monthly expenditure on 
litigation before PROMPT was around A$600,000 and this dropped to about 
A$260,000 following the introduction of PROMPT. The mean monthly litigation cost in 
each group was lower in the post-PROMPT implementation periods. Group I had the 
highest mean monthly litigation cost pre-PROMPT (A$833,275) but also the highest 
mean monthly litigation cost post-PROMPT (A$157,733).  
Overall 
 Claims Total cost Mean cost SD Q1 Q3 
Overall 181 $69,444,096 $383,669 $1,048,076 $10,000 $263,740 
Group I 86 $32,144,057 $373,768 $1,057,999 $10,000 $220,187 
Group II 47 $22,543,472 $479,648 $1,336,947 $10,000 $322,237 
Group III 48 $14,756,567 $307,429 $646,358 $10,000 $282,784 
Pre-PROMPT period 
 Claims Total cost Mean cost SD Q1 Q3 
Overall 101 $49,513,178 $490,230 $1,259,760 $10,000 $280,406 
Group I 33 $19,998,606 $606,018 $1,506,506 $8,658 $200,365 
Group II 31 $17,426,118 $562,133 $1,492,465 $10,000 $342,270 
Group III 37 $12,088,454 $326,715 $700,358 $10,000 $277,491 
Post-PROMPT implementation period 
 Claims Total cost Mean cost SD Q1 Q3 
Overall 80 $19,930,917 $249,137 $679,065 $10,000 $230,000 
Group I 53 $12,145,450 $229,159 $614,434 $10,000 $225,000 
Group II 16 $5,117,354 $319,835 $992,591 $10,000 $51,399 
Group III 11 $2,668,113 $242,556 $437,895 $10,000 $310,434 
SD Standard deviation, Q1 First quartile, Q3 Third quartile 
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Table 6-7 summarises the results from the generalised linear models (GLMs) for both 
the mean cost per claim and the mean monthly litigation cost. Overall, there was weak 
evidence of a 49% reduction ((1-0.51) x 100) in the mean cost per claim after the 
implementation of PROMPT (95% CI 2%, 74%, p=0.045). There was also some weak 
evidence that monthly spending on maternity litigation had reduced by 57% ((1-0.43) 
x 100) after PROMPT implementation (95% CI 0%, 82%, p=0.05). This decrease was 
specifically identified in Group I with an 81% ((1-0.19) x 100) fall in the mean monthly 
litigation cost (95% CI 20%, 96%, p=0.02) but not in the other groups.  
 
 
GLMs with gamma distributed errors 
 
Ratio of the mean cost per claim 
(Post-PROMPT implementation/Pre-
PROMPT) 
Ratio of mean monthly cost 
(Post-PROMPT implementation/Pre-
PROMPT) 
 Estimate (95% CI) P-value Estimate (95% CI) P-value 
Overall 0.51 (0.26,0.98) 0.045 0.43 (0.18,1.01) 0.05 
Group I 0.55 (0.22,1.34) 0.19 0.19 (0.04,0.80) 0.02 
Group II 0.42 (0.08,2.07) 0.30 0.41 (0.07,2.34) 0.32 
Group III 0.60 (0.22,1.62) 0.32 0.67 (0.15,2.94) 0.60 
 
The analyses above included high-risk incidents (open claims with ≤A$10,000 gross 
incurred costs) that were more likely to become claims and therefore incurred some 
Overall 
 Mean monthly cost SD Q1 Q3 
Overall $434,026 $1,223,422 $0 $287,034 
Group I $318,258 $1,099,243 $0 $39,750 
Group II $259,120 $1,016,227 $0 $10,000 
Group III $202,145 $573,921 $0 $56,220 
Pre-PROMPT period 
 Mean monthly cost SD Q1 Q3 
Overall $596,544 $1,519,541 $0 $336,667 
Group I $833,275 $1,994,426 $0 $305,604 
Group II $341,689 $1,202,360 $0 $15,000 
Group III $219,790 $629,704 $0 $68,009 
Post-PROMPT implementation period 
 Mean monthly cost SD Q1 Q3 
Overall $258,843 $761,674 $0 $73,532 
Group I $157,733 $525,602 $0 $30,000 
Group II $142,149 $669,540 $0 $10,000 
Group III $148,229 $362,490 $0 $10,000 
SD Standard deviation, Q1 First quartile, Q3 Third quartile 
Table 6-7 GLMs for maternity-related litigation costs 
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preparatory legal costs. Table 6-8 focusses only on the high-risk incidents by Group 
and period. Overall, there were more high-risk incidents in the post-PROMPT period. 
Additionally, high-risk incidents made up over 50% of open claims with gross incurred 
costs for each Group in the post-PROMPT period.   
 
Table 6-8 Number of high-risk incidents  
Number of high-risk incidents (open claims with ≤A$10,000 gross incurred costs) 















Group I 1 (17) 6 24 (53) 45 
Group II 7 (37) 19 9 (60) 15 
Group III 9 (36) 25 6 (55) 11 
 
Two worst-case sensitivity analyses were performed to see if the results differed if 
these high-risk incidents were treated as formal claims. In the first sensitivity analysis, 
the ≤A$10,000 gross incurred costs were substituted with group and period specific 
median costs of all the other remaining claims (Table 6-9). 
 
Table 6-9 Group and period specific median costs (A$) 
 Substituted median costs (A$) 
 Pre-PROMPT period Post-PROMPT implementation period 
Group I $31,207 $205,747 
Group II $261,730 $75,000 
Group III $205,278 $370,867 
 
Table 6-10 summarises the results from the generalised linear models with substituted 
group and period specific median costs. Unlike the original models, there was no 
evidence to suggest that the mean cost per claim decreased following the 
implementation of PROMPT (p=0.61). Overall, there was also no evidence of a 
reduction in the mean monthly litigation cost either. However, like the original models, 
there was weak evidence of a fall in the mean monthly litigation cost in Group I after 
PROMPT. This decrease was more modest though at 74% ((1-0.26) x 100) (95% CI 
20%, 91%, p=0.02), compared to the original 81% reduction (95% CI 20%, 96%, 
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Table 6-10 GLMs with substituted group and period specific median costs 
GLMs with gamma distributed errors and substituted Group and period specific median costs 
 
Ratio of the mean cost per claim 
(Post-PROMPT implementation/Pre-
PROMPT) 
Ratio of mean monthly cost 
(Post-PROMPT implementation/Pre-
PROMPT) 
 Estimate (95% CI) P-value Estimate (95% CI) P-value 
All 0.88 (0.49, 1.57) 0.61 0.55 (0.26, 1.16) 0.12 
Group I 1.01 (0.47, 2.14) 0.98 0.26 (0.09, 0.80) 0.02 
Group II 0.53 (0.16, 1.83) 0.32 0.42 (0.09, 1.99) 0.27 
Group III 1.23 (0.57, 2.65) 0.60 1.06 (0.30, 3.69) 0.91 
 
In the second sensitivity analysis, the ≤A$10,000 gross incurred costs of the high-risk 
incidents were substituted with the median costs of the remaining claims with similar 
themes. The high-risk incidents were divided into 20 categories based on their incident 
descriptions (Table 6-11). All remaining claims were then classified using the same 
taxonomy. The ≤A$10,000 gross incurred costs of the high-risk incidents were then 
substituted with the category specific median costs of the remaining claims. Table 6-11 
summarises the different categories of the high-risk incidents and the category specific 
median costs of the remaining claims. If there was only one remaining claim in a 
category, the cost of this claim was used for substitution. If there were no remaining 
claims in a category, the median cost of the remaining miscellaneous claims was used.  
 
Table 6-12 summarises the results from the generalised linear models with substituted 
category specific median costs. There was no evidence to suggest that the mean cost 
per claim decreased following the implementation of PROMPT (p=0.55). There was 
also no evidence of a reduction in the overall mean monthly litigation cost either 
(p=0.10). However, like the original analyses, there was weak evidence of a fall in the 
mean monthly litigation cost in Group I after PROMPT. Again, this decrease was more 
modest at 72% ((1-0.28) x 100) (95% CI 15%, 90%, p=0.03), compared to the original 
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median costs of 
remaining claims (A$) * 
Born in poor condition 2 1 $24,349 
Brain injury 14 28 $736,888 
Postpartum haemorrhage 1 2 $2,626 
Neonatal death/stillbirth 13 41 $223,900 
Post-delivery symptoms 2 7 $294,789 
Obstetric brachial plexus injury 
(OBPI)/shoulder dystocia 
3 3 $34,618 
Maternal cardiac arrest and 
neonatal brain injury 
1 0 As per miscellaneous 
Maternal and neonatal death 1 0 As per miscellaneous 
Neonatal cardiac arrest 1 0 As per miscellaneous 
Preterm birth 2 0 As per miscellaneous 
Subgaleal haemorrhage 1 0 As per miscellaneous 
Neonatal seizures 2 1 $24,226 
Hysterectomy 1 4 $164,975 
4th degree tear 2 4 $289,534 
Wrongful birth 3 7 $191,441 
Maternal death 2 4 $25,294 
Missed diagnosis 1 0 As per miscellaneous 
Dissatisfaction with care 1 4 $11,633 
Developmental delay 1 0 As per miscellaneous 
Miscellaneous 2 19 $21,259 
* If only one remaining claim in a category, the cost of this claim was used for substitution. If no remaining claims in a 
category, the median cost of the remaining miscellaneous claims was used.  
 
Table 6-12 GLMs with substituted category specific median costs 
GLMs with gamma distributed errors and substituted category specific median costs 
 
Ratio of the mean cost per claim 
(Post-PROMPT implementation/Pre-
PROMPT) 
Ratio of mean monthly cost 
(Post-PROMPT implementation/Pre-
PROMPT) 
 Estimate (95% CI) P-value Estimate (95% CI) P-value 
All 1.17 (0.69, 1.99) 0.55 0.55 (0.27, 1.19) 0.10 
Group I 0.90 (0.42, 1.96) 0.80 0.28 (0.10, 0.85) 0.03 
Group II 1.55 (0.47, 5.17) 0.48 0.49 (0.11, 2.05) 0.33 




In this chapter, I examined the impact of multi-professional simulation training for 
obstetric emergencies on maternity-related claims frequency (claim rate) and costs 
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(mean cost per maternity claim and mean monthly maternity litigation cost) across 
Victoria using robust and appropriate statistical methods.  
 
The implementation of PROMPT was associated with a 53% reduction in the overall 
maternity claim rate, as well as a 70% reduction in obstetric claims in Group I – the 
group of health services/hospitals with the longest exposure to the patient safety 
initiative. Other studies investigating the impact of obstetric safety initiatives on 
litigation have also reported decreases in the maternity claim rate (33,231,262). 
However, only one of these studies used robust statistical methods to account for the 
effect of time on their data.  
 
Luthander et al. used a segmented logistic regression model to explore the changes 
in an interrupted time series of settled claims due to severe delivery-related asphyxia 
(33). This method was able to incorporate the impact of time on the data. The model 
also assumed independence of the outcome measure (settled claim rate). Whilst not 
explicitly checked, the settled claim rate appeared to be independent on visualisation 
of the data, so the statistical model was valid.  
 
Riley and colleagues suggested that their analytical approach helped to control for 
historical claim patterns but the authors only accounted for claims lag by selectively 
analysing claims data to allow at least 5 years for claims to be filed and settled (262). 
Whilst this approach would have maximised the number of settled claims for analysis, 
it would not have assessed the effect of time on their data. Riley et al. simply used 
paired t-tests to assess the differences in the claims made, claims paid and liability 
spending pre-and post-intervention (262). However, paired t-tests still do not assess 
trends in time and the authors did not test for independence in their outcomes. 
 
Pettker et al. also purposefully set their study period to allow enough time for open 
claims to fully resolve but did attempt to account for time by using Poisson regression 
to analyse the overall trend in their annual claims data (231). However, this model 
assumed independence of the annual claim rate but this was not checked or proven. 
The data did not appear to be independent on visualisation. Moreover, it might have 
been more appropriate for the authors to have performed an interrupted time series 
analysis and compared the regression lines pre- and post-intervention.  
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Time was adjusted for in all of the statistical models in this chapter. Model assumptions 
were also checked and sensitivity analyses were performed when required. For 
example, when there was evidence of correlation between claims from one evaluation 
period to another (i.e. a breach in the model assumptions), a sensitivity analysis was 
conducted to ensure the inferences from the original model were still correct and valid. 
The mean cost per maternity claim and the mean monthly maternity litigation spending 
across all health services/hospitals in the post-PROMPT implementation periods were 
lower than the mean costs observed prior to the intervention. These findings are 
comparable with other maternity safety programmes.  
An obstetric patient safety programme in Connecticut, US was associated with a 94% 
reduction in median annual compensation payments per 1,000 deliveries from 
US$1,141,638 to US$63,470 (231). Grunebaum et al. observed a 90% decrease in 
average compensation payments after a comprehensive obstetric patient safety 
programme was implemented (229). PROMPT has previously been associated with a 
91% reduction in litigation costs in an English maternity unit (106). However, these 
findings are purely observational and furthermore, Grunebaum et al. did not employ 
any statistical tests in their analyses at all (229).  
The analyses in this chapter employ robust statistical modelling to demonstrate that 
the implementation of PROMPT was associated with an overall 49% reduction in the 
mean cost per maternity claim, and an 81% decrease in the mean monthly maternity 
litigation cost for Group I.  
High-risk incidents (open claims with ≤A$10,000 gross incurred costs) were included 
in the analyses. There were more high-risk incidents in the post-PROMPT 
implementation period (n=39, 49%) compared to the pre-PROMPT period (n=17, 
17%). This was an anticipated finding as one would expect more open claims (and 
therefore high-risk incidents) in the post-PROMPT implementation period as there 
would have been less time for these to be settled compared to claims from the pre-
PROMPT period. This discrepancy in high-risk incidents may have resulted in biased 
towards cost savings for the post-PROMPT implementation period compared to the 
pre-PROMPT period. To address this bias, two sensitivity analyses were conducted 
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and treated all these high-risk incidents as eventual claims by substituting in median 
litigation costs that were either group and period specific, or category specific. 
Specifying median costs by group allowed differences in the services provided 
between the groups to be accounted for. This is important as the complexity in the 
care provided might impact on the severity of any adverse events and therefore the 
litigation costs. Specifying median costs by period enabled potential differences in the 
nature of adverse outcomes before and after PROMPT to be accounted for. For 
example, adverse events occurring post-intervention may be less severe than those 
that happened pre-intervention and this might be reflected in less costly claims. 
However, not all of the data supports this premise, as there were higher median 
litigation costs in the post-PROMPT implementation periods for Groups I and III. Unlike 
the original analyses, there was no evidence of any decrease in the overall mean cost 
per maternity claim or mean monthly litigation cost when using substituted group and 
period specific median costs. However, despite the higher median litigation costs 
following PROMPT in Group I, a reduction in the mean monthly maternity litigation 
cost was still observed in this group.  
 
In the second sensitivity analysis, median costs of similar claims (category specific) 
were used instead of the ≤A$10,000 gross incurred costs. Broad categories were 
chosen to classify the high-risk incidents and remaining claims. As a result, there was 
still scope for variation within categories, especially with the severity of the condition 
or outcome. Some high-risk incidents or claims may also have had more than one 
contributing factor so these broad categories would not have captured this level of 
detail. Like the first sensitivity analysis, there was no evidence of any decrease in the 
overall mean cost per maternity claim or mean monthly litigation cost when using 
category specific median costs. However, a reduction in the mean monthly maternity 
litigation cost was still present in Group I. 
 
Of the two sensitivity analyses regarding the cost of claims, the one using substituted 
category specific median costs is likely to be more representative of the possible 
financial implications if all high-risk incidents became claims. However, it is worth 
remembering that these sensitivity analyses only provide a crude estimate of the 
potential costs. Some of these high-risk incidents may never materialise as claims 
whilst some may become claims that have gross incurred costs much lower or much 
Chapter 6 
 
The impact of multi-professional simulation training for obstetric emergencies on litigation 
 218 
higher than the substituted median costs. It is therefore very difficult to predict the 
impact of high-risk incidents turning into claims. An alternative way of imputing costs 
for the high-risk incidents could be to develop statistical models based on the closed 
claims data. Patient-level data would be needed to design such models. Unfortunately, 
we did not have the necessary permissions to obtain individualised clinical notes and 
claims data. A cleaner analysis may have been to disregard all open claims entirely 
and solely focus on the claims that had already been settled. However, this was not 
possible with the data available where the majority of the post-PROMPT 
implementation claims were open (89%). Open claims with gross incurred costs were 
included to ensure that there were claims in the post-PROMPT implementation 
periods for all groups. Furthermore, high-risk incidents (open claims with ≤A$10,000 
gross incurred costs) were retained to avoid losing almost 50% of the post-PROMPT 
data.  
 
An additional sensitivity analysis was conducted where data from the initial training 
period were excluded and the statistical models rerun (see additional sensitivity 
analyses in 6.6 Chapter appendix). The inferences were broadly similar to the original 
analyses with evidence of reductions in the rate of claims overall and in Group I, as 
well as evidence of a decrease in the overall mean cost per claim. Data from the initial 
training period was included as part of the pre-PROMPT period as a previous study 
only observed improvements following PROMPT at least a year after the 
implementation of training (93). Including this data also meant that 26% of claims data 
and 34% of births could be retained for the analyses.  
 
A formal cost-benefit analysis was not performed as a more comprehensive cost-utility 
analysis of multi-professional simulation training for obstetric emergencies was 
conducted in Chapter 4. However, a simple return on investment can still be 
calculated. The VMIA allocated each health service with A$65,500 funding to help with 
implementing PROMPT (Chapter 5). The VMIA spent a total of A$1,244,500 
supporting the implementation of PROMPT in 19 health services/hospitals. PROMPT 
in Victoria was associated with an overall saving of A$29,582,261 in maternity litigation 
costs. Using these figures, a substantial return on investment for the VMIA (in the 
order of 24:1) could be anticipated. In other words, the VMIA were able to make 
substantial cost savings with a relatively modest investment in PROMPT.  
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The fall in the overall claim rate and mean cost per maternity claim cannot be solely 
attributed to PROMPT. The reductions are likely to be multifactorial and it is possible 
that maternity claims were falling before PROMPT was even implemented. The 
models used only adjusted for time and there may be other unaccounted factors. 
Australian tort law reforms in 2002-2006, which predate PROMPT, introduced 
statutory limits such as thresholds and caps on damages (268,269). These factors are 
likely to have contributed to the decreases in the cost of claims. The tort law reforms 
may also have affected the maternity claim rate. However, these reforms were 
instigated before the pre-PROMPT evaluation periods, and any effects that they may 
have had on the claim rate or cost of claims are likely to be equally applicable to both 
the pre-PROMPT and post-PROMPT implementation data. This means that although 
the tort law reforms may have contributed to reductions in claims or costs overall, they 
are less likely to explain the differences observed between our evaluation periods.  
The Fetal Surveillance Education Program was also introduced in 2004 in over 80% 
of Victoria’s public and private hospitals in 2005 alone (270). As this programme was 
established before PROMPT, it is possible that it was run alongside or instead of the 
fetal monitoring components of PROMPT during the evaluation periods. As a result, 
the Fetal Surveillance Education Program may also have had an impact on clinical 
care and the maternity litigation rate.  
The VMIA use a 3% claims inflation factor (per annum) when calculating each annual 
premium pool. However, using the available data, it was difficult to determine whether 
this inflation factor actually translated to the settlements in this evaluation. Litigation 
costs in this evaluation are likely to have been influenced by some element of inflation 
but it was not possible to confidently account for this in the statistical models. Despite, 
probable inflationary effects, there was still some evidence to suggest there was a 
reduction in the overall mean cost per maternity claim following the implementation of 
PROMPT.  
The pre-PROMPT claim rates for Groups II and III (6 claims per 10,000 births) were 
lower than for Group I (11 claims per 10,000 births). As the pre-PROMPT periods for 
Groups II and III were more recent, this might suggest that maternity claims were 
already heading in a downwards trajectory due to factors independent of PROMPT. 
These differences might also have been reflective of the different services provided 
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between the groups or due to data contamination. Alternatively, Groups II and III may 
simply have had lower claim rates than Group I in general, perhaps because of better 
clinical performance. There was evidence of a 70% reduction in claims in Group I 
following the implementation of PROMPT (p=0.007), but there was no evidence of 
reduction in Groups II and III. As the pre-PROMPT claim rates for Groups II and III 
were already relatively low, there may have been less scope for improvement. This 
may be particularly true if the minimum rate for maternity claims is 4 or 5 claims per 
10,000 births. For example, a high performing maternity unit in England still had a 
claim rate of 4 per 10,000 births (see feasibility study of maternity litigation indicators 
in the Thesis appendix).  
Moreover, the limited post-PROMPT implementation periods must be acknowledged, 
particularly for Groups II and III. Although clinical outcomes appear to improve as early 
as one year after PROMPT is introduced (93), the full benefits of the programme may 
require up to 12 years of sustained training (113). Group I had a 6.5 year post-
implementation period which is a reasonable timeframe for evaluation. Groups II and 
III had much shorter post-implementation periods of 3 years and nearly 2 years 
respectively. The full effect of PROMPT in Victoria may not have been achieved by 
the time of these analyses. As a result, the impact of PROMPT on maternity litigation 
rates and costs may have been underestimated. It would be worthwhile to evaluate 
again with a longer follow-up period (aiming for at least 12 years post-PROMPT) to 
see whether this would affect the presented results. The differences in duration of the 
post-PROMPT implementation periods might also explain why improvements in the 
maternity claim rate and mean monthly litigation cost were identified in Group I but not 
Groups II and III. An additional sensitivity analysis was performed to explore this (see 
additional sensitivity analyses in 6.6 Chapter appendix). Data from the post-PROMPT 
implementation periods for Groups I and II were constrained to match the shortest 
follow-up period (Group III) to allow for a like-for-like comparison. In this additional 
sensitivity analysis, the previously seen reductions in claim rate and mean monthly 
cost were no longer observed for Group I. This suggests that the duration of the post-
PROMPT implementation period did influence the findings and that a longer follow-up 
period for Groups II and III may yield different results. Interestingly, with the 
constrained post-PROMPT data, there was now evidence of an 87% reduction in the 
mean cost per claim (95% CI 14%, 98%, p=0.04) and a 93% reduction in mean 
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monthly cost (95% CI 59%, 99%, p=0.005) in Group II. However, given the substantial 
loss of data (69% of claims data and 61% of births) and the low number claims in the 
post-PROMPT implementation period, it would be difficult to confidently draw any valid 
inferences from this sensitivity analysis.  
 
Finally, the findings in this chapter should be interpreted with knowledge of the typical 
time frame for a maternity claim. In Victoria, there is an average lag of around 3 years 
between the incident occurring and a claim being made. Some claims in this evaluation 
may not yet have materialised because of this lag in reporting, although some may 
have been captured as high-risk incidents. Furthermore, there is lag of 8-10 years 
between the incident date and claim settlement. However, the use of gross incurred 
costs meant that the full value of each open claim could be accounted for, thereby 
mitigating against the long lag between incident and settlement.  
 
6.5 Conclusions 
The implementation of multi-professional simulation training for obstetric emergencies 
(PROMPT) in Victoria was associated with a decrease of 53% in the overall maternity 
claim rate and a fall in the overall mean cost per maternity claim by 49%. Although the 
primary objective of patient safety initiatives is first and foremost to improve care, those 
that appear to be associated with a tangible reduction in claims frequency and litigation 
costs may also be worth consideration. Some policymakers may choose to fund 
patient safety programmes with relatively modest clinical benefits if there are also likely 
to be cost savings. Presenting both the clinical and financial impact of patient safety 
initiatives will help macro organisations, such as medical indemnifiers, decide which 
quality improvement programmes to support. Although there are likely to be other 
contributing factors, the work in this chapter suggests that training programmes (such 
as PROMPT) could usefully be incentivised to reduce maternity-related claims and 
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6.6 Chapter appendix 
 
6.6.1 Additional sensitivity analyses  
 
The statistical models were rerun after excluding births and claims from the initial 
training period. Table 6-13 presents the claim rates and unadjusted and adjusted rate 
ratios between the pre-PROMPT and post-PROMPT implementation periods after 
exclusion of initial training period data. A 64% (95% CI 36%, 80%, p=0.0007) reduction 
in the overall rate of claims following the implementation of PROMPT was found in the 
new adjusted quasi-Poisson model, with a 79% reduction (95% CI 50%, 92%, 
p=0.001) in claims in Group I. These inferences are similar to the original analyses.  
 
Table 6-13 Claim rates, unadjusted ratios and adjusted rate ratios for claims after 
excluding initial training period data 
 
 
Table 6-14 summarise the results from the generalised linear models (GLMs) for both 
the mean cost per claim and the mean monthly litigation cost after excluding initial 
training period data. Overall, there was evidence of a 56% reduction in the mean cost 
per claim after the implementation of PROMPT (95% CI 10%, 79%, p=0.03). Again, 
this inference is similar to the original analyses. Unlike the original analyses, there was 
 Pre-PROMPT period Post-PROMPT implementation period Crude 
Quasi-Poisson 
Model* 




















Overall 75 100,045 7.50 80 172,028 4.65 0.62 (0.45,0.84) 0.003 
0.36 
(0.20,0.64) 0.0007 
Group I 22 15,227 14.45 53 107,490 4.93 0.34 (0.21,0.56) 0.0001 
0.21 
(0.08,0.50) 0.001 
Group II 23 37,798 6.08 16 39,803 4.02 0.67 (0.35,1.25) 0.20 
0.41 
(0.10,1.56) 0.20 
Group III 30 47,020 6.38 11 24,735 4.45 0.70 (0.34,1.39) 0.32 
0.60 
(0.21,1.73) 0.34 
*Adjusted for time (in months) 
Chapter 6 
 
The impact of multi-professional simulation training for obstetric emergencies on litigation 
 223 
no longer any evidence of a decrease in the mean monthly cost overall (p=0.12) or for 
Group I (p=0.13) following the introduction of PROMPT.  




Another additional sensitivity analysis was performed to explore the effect of the 
follow-up time in the post-PROMPT implementation period. Data from the post-
PROMPT implementation periods for Groups I and II were constrained to match the 
shortest follow-up period (Group III) and the statistical models rerun. Table 6-15 
presents the claim rates and unadjusted and adjusted rate ratios between the pre-
PROMPT and post-PROMPT implementation periods with the constrained post-
PROMPT data. 
 
Table 6-15 Claim rates, unadjusted ratios and adjusted rate ratios for claims with 
constrained post-PROMPT data 
 
There was a 50% reduction in the overall claim rate following the introduction of 
PROMPT (95% CI 6%, 74%, p=0.04). This inference is similar to the original analyses. 
GLMs with gamma distributed errors 
 
Ratio of the mean cost per claim 
(Post-PROMPT implementation/Pre-
PROMPT) 
Ratio of mean monthly cost 
(Post-PROMPT 
implementation/Pre-PROMPT) 
 Estimate (95% CI) P-value Estimate (95% CI) P-value 
Overall 0.44 (0.21,0.90) 0.03 0.47 (0.19,1.21) 0.12 
Group I 0.50 (0.17,1.45) 0.20 0.21 (0.03,1.55) 0.13 
Group II 0.34 (0.08,1.57) 0.18 0.30 (0.05,1.93) 0.21 
Group III 0.57 (0.17,1.82) 0.35 0.57 (0.13,2.57) 0.47 
 Pre-PROMPT period Post-PROMPT implementation period Crude 
Quasi-Poisson 
Model* 




















Overall 101 151,774 6.65 25 67,638 3.70 0.55 (0.36,0.86) 0.007 
0.50 
(0.26,0.94) 0.04 
Group I 33 30,736 10.7 7 23,250 3.01 0.28 (0.12,0.63) 0.001 
0.56 
(0.13,2.40) 0.44 
Group II 31 54,657 5.67 7 19,653 3.56 0.62 (0.28,1.42) 0.35 
0.58 
(0.16,2.06) 0.40 
Group III 37 66,381 5.57 11 24,735 4.45 0.80 (0.41,1.56) 0.63 
0.99 
(0.37,2.60) 0.56 
*Adjusted for time (in months)    
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With the constrained post-PROMPT data, there was no longer any evidence for a 
decrease in the claim rate for Group I (p=0.44).  
 




Table 6-16 summarises the GLMs for the mean cost per claim and mean monthly cost 
with the constrained post-PROMPT data. In this sensitivity analysis there is no longer 
any evidence of a decrease in the mean cost per claim overall (p=0.33) or a reduction 
in the mean monthly cost for Group I (p=0.054) like in the original analyses. However, 
there is now strong evidence for a 81% reduction in the overall mean monthly cost 
(95% CI 51%, 92%, P<0.001) and interestingly, also evidence of a 87% reduction in 
the mean cost per claim (95% CI 14%, 98%, p=0.04) and a 93% reduction in mean 





GLMs with gamma distributed errors 
 
Ratio of the mean cost per claim 
(Post-PROMPT implementation/Pre-
PROMPT) 
Ratio of mean monthly cost 
(Post-PROMPT implementation/Pre-
PROMPT) 
 Estimate (95% CI) P-value Estimate (95% CI) P-value 
Overall 0.64 (0.26,1.57) 0.33 
0.19 
(0.08,0.49) <0.001 
Group I 2.13 (0.55,8.24) 0.28 
0.20 
(0.04,0.98) 0.054 
Group II 0.13 (0.02,0.86) 0.04 
0.07 
(0.01,0.41) 0.005 
Group III 0.60 (0.22,1.62) 0.32 0.67 (0.15,2.94) 0.60 
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7.1 Introduction 
Injured at birth is often injured for life and this regrettable truth is reflected in the high 
value litigation claims associated with poor maternity care (271). There are many 
reasons underpinning patients and/or relatives pursuing litigation in healthcare such 
as compensation, need for information or explanation, desire for accountability or 
simply being advised to do so (272-274). The lack of a clear connection between 
negligent adverse events and claims undermines one of the social goals of malpractice 
litigation: to deter unsafe practices (275). Furthermore, when a medical error and 
ensuing claim does occur, a hospital’s ability to externalise most of the costs of the 
injury weakens any deterrent effect and also diminishes any incentive to improve 
patient care (139). 
 
In the absence of any substantial empirical evidence, the establishment of a robust 
statistical link between adverse medical events and litigation claims would be of 
significant interest to policymakers (137). Some studies have sought to identify an 
association. Greenberg and colleagues were the first to report a highly significant 
correlation between the frequency of adverse events and litigation claims in California, 
USA (137). More recently, Black et al. demonstrated a strong, positive relationship 
between a pooled measure of 17 avoidable adverse events and malpractice claims in 
hospitals in the Florida, USA (138). Furthermore, the authors found a significant 
positive association between a pooled measure of childbirth-related events (including 
injuries to the baby and injuries to the mother during an instrumental delivery or vaginal 
delivery) and childbirth litigation claims (138). In addition, Black et al. also investigated 
the associations between individual adverse outcomes, such as post-operative sepsis 
and pressure ulcers, and malpractice claims (138). These links suggest that an 
underlying relationship between preventable harm and litigation exists. This is 
important to policymakers as it suggests that hospitals might be able to attenuate their 
malpractice risk by improving safety (137,138). Although not directly concerning 
adverse outcomes, Lovaglio analysed administrative records and claims data in 
Lombardy, Italy and has also identified certain hospital processes (such as high 
utilisation of operating theatres and high proportions of oncology patients) that were 
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Greenberg et al. and Black et al. have begun to establish a connection between 
adverse clinical outcomes and litigation, and also start to explore which specific 
adverse clinical events to target. However, there are opportunities to expand this work 
and develop its practical use in promoting patient safety. Although previous studies 
have demonstrated that adverse events (137), composite outcomes (138) and hospital 
processes (276) can be associated with increases in the likelihood of claims, no study 
has investigated the predictive capability of specific clinical indicators for litigation. For 
example, could the current rate of a particular quality indicator be used to predict the 
rate of malpractice claims in the future? If such a litigation indicator exists, then it could 
potentially be a feature of new incentivisation models and be incorporated into 
premium modelling schemes by medical indemnifiers. Given the focus of this thesis 
and the disproportionate litigation burden of maternity care, this chapter aims to 
contribute to the growing body of research associating adverse clinical outcomes with 
malpractice claims by identifying whether core maternity and neonatal clinical 
indicators (including some adverse events) can potentially be used to predict future 
litigation claims, i.e. maternity and neonatal litigation indicators.  
 
7.2 Methods 
7.2.1 Ethical approval 
Monash Health (Victoria, Australia) approved this study as part of a wider evaluation 
of multi-professional simulation training for obstetric emergencies in Victoria (Monash 
Health Human Research Ethics Committees Ref: 16164L).  
 
7.2.2 Data source and management 
The same data from Chapter 6 were used. As before, anonymised births data from 
2009-2017 for 22 Victorian health services/hospitals (approximately 46% of health 
services providing intrapartum care) were extracted from the state-based birth registry 
(Victorian Perinatal Data Collection) through the Birthing Outcomes System (BOS) 
(264,265). Anonymised details of all maternity claims (100%) occurring in the same 
22 health services/hospitals with incident dates between July 2003 to June 2017 were 
also provided. The Victorian Managed Insurance Authority (VMIA) transferred both 
births and claims data using password encrypted files. These files were stored 
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securely on University of Bristol computers. Data for 366,293 births and 1,163 claims 
were received.  
 
An initial review of the births data demonstrated two periods where discrepancies in 
the number of births did not fit the overall trend of the data (Figure 7-1). There were 
sharp rises in the birth rate around January 2010 and April 2011. It was impossible to 
determine if there were any clinically plausible reasons for these sudden increases in 
the number of births; however, incomplete or missing data from the BOS extraction 
process were possible explanations. As the monthly rates of core clinical indictors and 
maternity claims were being calculated using total births per month as the denominator 
(see later), it was essential that this denominator was consistently complete 
throughout the proposed evaluation period to ensure accurate rate calculations. As 
the completeness of the births data before May 2011 could not be guaranteed, these 
data were excluded (births in the red box in Figure 7-1, n=64,094) and the following 
analyses focused on May 2011 onwards. After the exclusion process for the claims 
data (see later), only claims with incident dates up to and including May 2017 were 
available. As a result, births occurring after May 2017 (n=28,433) were also excluded, 
















Figure 7-1 Number of births between Jan 2009 and June 2017 in 22 
health services/hospitals across Victoria, Australia 
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Figure 7-3 summarises the exclusion process for the claims data. Claims that were 
not from the 22 health services/hospitals were excluded (n=59). Only claims (open or 
closed) with gross incurred costs – defined as the total costs paid to date plus any 
outstanding costs – were retained for the analyses. Any claims (open or closed) with 
no gross incurred costs were excluded (n=623).  
 
Neonatal and gynaecology related claims were also discounted (n=14). As per 
Chapter 6, no birth data were received from one health service/hospital (as it did not 
use BOS) and there were periods of missing birth data from two others. Claims from 
these health services/hospitals were therefore excluded (n=16). Finally, a further 307 
claims with incident dates preceding May 2011 were removed. There were 144 
maternity claims with incident dates between May 2011 and May 2017 which were 
available for analysis. All exclusions were performed to ensure that births and claims 






Figure 7-2 Exclusion process for birth data 
366,293 births 
Excluded due to: 
• Data quality concerns between January 2009 to 





Excluded due to: 
• Births occurring after available claims data (post 
May 2017) (n=28,433) 
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7.2.3 Outcome measures 
Table 7-1 summarises the core maternity and neonatal clinical indicators that were 
available through BOS and selected for investigation. Eleven of these indicators are 
part of a core set which have been recommended by an expert UK panel as suitable 
metrics for assessing intrapartum care (277). These indicators are routinely collected 
as part of standard care in most maternity units around the world. Shoulder dystocia 
and brachial plexus injuries were included as indicators as these are associated with 
high litigation costs (1). In addition to the core maternity and neonatal clinical 





1,104 claims  
Excluded due to: 
• Claims from other health services/hospitals 
(n=59) 
 
Excluded due to: 
• Claims (open or closed) with no gross 
incurred costs (n=623) 
481 claims 
467 claims 
Excluded due to: 
• Neonatal/gynaecology related claims (n=14) 
451 claims 
Excluded due to: 
• No data or incomplete birth data from health 
services/hospitals (n=16) 
144 claims for 
analysis 
Excluded due to: 
• Claims with incident dates preceding May 
2011 (n=307) 
 
Figure 7-3 Exclusion process for claims data 
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Core clinical indicators 
Induction of labour (IOL)* 
Preterm births (≥34 weeks gestation and ≤37 weeks gestation)* 
Multiple births* 
Instrumental vaginal deliveries* 
Caesarean sections* 
Intensive care unit (ICU) admissions from obstetrics* 
3rd and 4th degree tears* 
Term babies (≥37 weeks’ gestation) with 5-minute Apgar scores <7* 
Postpartum haemorrhage (PPH) ≥1000ml* 




Brachial plexus injury 
*recommended by Sibanda et al. (277) 
 
7.2.4 Statistical methods 
7.2.4.1 Calculation of rates 
Monthly rates of the core maternity/neonatal clinical indicators were calculated using 
the following formula:  
 
!"#$	&'	(&.$	()*4*(")	*4<*("#&.	-$.	8*9$4	+&4#ℎ
= 6&#")	47+2$.	&'	+&#ℎ$.,	&.	2"2*$,	>*#ℎ	(&.$	()*4*(")	*4<*("#&.	-$.	8*9$4	+&4#ℎ6&#")	47+2$.	&'	2*.#ℎ,	-$.	8*9$4	+&4#ℎ  
 
The monthly rate of maternity claims was calculated using the following formula: 
 
!"#$	&'	+"#$.4*#=	()"*+,	-$.	8*9$4	+&4#ℎ
= 6&#")	47+2$.	&'	+"#$.4*#=	()"*+,	-$.	8*9$4	+&4#ℎ6&#")	47+2$.	&'	2*.#ℎ,	-$.	8*9$4	+&4#ℎ  
 
Table 7-1 Core clinical indicators under investigation 
Chapter 7 
 
Maternity and neonatal litigation indicators: can core clinical indicators predict litigation? 
 232 
7.2.4.2 Time series and standardisation  
The monthly rates of the core clinical indicators and maternity claims were plotted as 
separate time series (sets of regular, time-ordered observations taken at successive, 
equidistant points of time) (278). These rates were measured using different scales. 
In order to facilitate the analyses and their reporting, the core clinical indicator and 
maternity claims time series were standardised using the zero-mean standardisation 
method (279). This standardised each time series to have a mean of 0. 
 
7.2.4.3 Vector autoregression (VAR) models 
I intended to investigate the associations between the core clinical indicators and 
maternity claims. In particular, I wanted to investigate whether the current rate of 
maternity claims (output series) could be predicted by historical claim rates and past 
rates of individual core clinical indicators (input series). An alternative way of 
expressing this is investigating whether the current rates of individual core clinical 
indicators (input series) predict the future rate of maternity claims (output series). Not 
all historical core clinical indicator rates may be helpful in determining the current claim 
rate. Similarly, the current rate of an individual core clinical indicator may not be useful 
in predicting all maternity claim rates in the future – it may only be helpful in predicting 
the claim rate over a discrete time frame. We wanted to identify whether a previous 
month’s core clinical indicator rate could predict the current obstetric claim rate, or 
alternatively, how many months into the future could the current rate of a core clinical 
indicator be used to forecast future litigation. This is known as the lag in statistical 
terms and can be specified using any time unit – in this study it was measured in 
months (280).  
 
Vector autoregression (VAR) models provided a statistical modelling framework to 
realise these objectives. These models investigated dynamic relationships between 
two different time series (monthly rates of a core clinical indicator and monthly rates 
of maternity claims) across various time points. Traditional methods such as the 
Pearson or Spearman correlation coefficients were not used as these are limited to 
assessing the association between two variables at a single time point. There were 
several steps to building and checking each VAR model. Firstly, each time series was 
checked for stationarity using the augmented Dickey-Fuller test. A stationary time 
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series is a time series where the mean and variance remain constant and correlation 
between two observations is dependent on the time period between these two 
observations rather than time itself (281). Secondly, the optimal lag length (in months) 
for each model (VAR (p)) was determined by the Bayesian Information Criterion. A lag 
length of 1 (VAR (1)) indicated the previous month’s rate of core clinical indicator, 
whereas a lag length of 4 (VAR (4)) indicated the core clinical indicator rate measured 
4 months ago. Once stationarity was assessed and the optimal lag length identified, 












The Granger causality test was used to assess the lag coefficient of each VAR model 
to see whether a core clinical indicator Granger causes maternity claims (282). This 
test checks for ‘statistical causation’ (i.e. statistical evidence that one variable 
precedes another variable), rather than actual cause and effect, and is frequently used 
in economics (283-285). If both time series were stationary, then the Granger causality 
test did not need to be modified. However, if a VAR model contained a non-stationary 
time series, Granger causality testing could lead to spurious results (286). In these 
cases, Toda and Yamamoto suggested adding one more lag (or month) to the model 
before continuing with the Granger causality test (287). P-values around 0.05 were 
assumed to represent weak evidence against the null hypothesis of the Granger 
causality test (i.e. that a core clinical indicator did not Granger cause maternity claims) 
and p-values <0.001 as strong evidence (171). Any core clinical indicator with a p-
value ≤0.05 meant that past values (as specified by the lag coefficient – e.g. values 
measured x months ago for a lag of x) of this particular indicator (along with past 
VAR model assumptions 
Stability of model 
Structural stability in time series 
Absence of autoregressive conditional heteroscedastic 
effects 
Absence of any residual autocorrelation 
Multivariate normality of error 
Table 7-2 VAR model assumptions 
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figures for maternity claims i.e. knowledge of previous trends in claims) were helpful 
in predicting current litigation. Alternatively, any core clinical indicator with a p-value 
≤0.05 also meant that current values of this particular indicator (along with knowledge 
of previous trends in claims) were helpful in predicting future litigation (as specified by 
the lag coefficient – e.g. litigation x months into the future for a lag of x).  
 
As the model assumptions were not fully satisfied – there were mildly skewed residuals 
– the standard error of the coefficient may be biased. To overcome this issue, the 
Granger causality test was conducted with bootstrap standard errors, and then with 
robust standard errors as a crude sensitivity analysis. This was to ensure the validity 
of the results. All statistical analyses were performed in R statistical software.  
 
7.3 Results 
Clinical data from 273,766 births and data from 144 maternity claims (from May 2011 
to May 2017) were used to derive monthly rates of the core clinical indicators and 
maternity claims. Unfortunately, and surprisingly, 3rd and 4th degree tears were poorly 
recorded and had 60% missing data. This core clinical indicator could not be 
meaningfully investigated and was excluded from the analysis.  
 
Figure 7-4 Standardised rates of term babies with 5-minute Apgar score <7 and 
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Figure 7-4 illustrates the time series of the monthly rate of 5-minute Apgar scores <7 
and the monthly rate of maternity claims. The continuous pink line represents the 
maternity claim rate over the evaluation period and the continuous blue line represents 
the rate of term babies with 5-minute Apgar scores <7. There are no obvious trends 
to these rates. However, the dotted lines demonstrate possible trends for maternity 
claims and the rate of term babies with low 5-minute Apgar scores. The time series 
graphs of the other core clinical indicators and the maternity claims are located in the 
7.6 Chapter appendix.   
 
There was evidence to suggest that there was a relationship between the rate of term 
babies with 5-minute Apgar scores <7 and the maternity claim rate (Table 7-3). This 
model had a VAR (1) structure and a Granger causality test <0.05, suggesting that the 
previous month’s rate of low 5-minute Apgar scores in term babies Granger caused 
the current maternity claim rate. By extension, the current rate of term babies with 5-
minute Apgar scores <7 would be predictive of the following month’s maternity claim 
rate. The same result was drawn when using the Granger causality test with robust 
standard errors. There was no evidence of relationships between the rates of the 
remaining core clinical indicators and the maternity claim rate (Table 7-3). The other 
core clinical indicators were therefore not deemed to be useful in predicting the 
maternity claim rate in this dataset.  
 
7.4 Discussion 
This is the first study to employ recognised econometric methods to investigate 
whether core maternity and neonatal clinical indicators could be used to forecast future 
maternity-related litigation. Other studies have demonstrated associations between 
health-related indicators and litigation claims (137,138,276). Greenberg et al. 
estimated that an increase in 10 adverse events in a given year would correspond to 
an average increase of 3.7 malpractice claims (137). Black et al. concluded that a one 
standard deviation reduction in the rate of adverse clinical outcomes could lead to a 
16.2% fall in paid litigation claims (138). However, neither of these studies explored 
whether core clinical indicators or adverse events could be used to robustly predict 
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Table 7-3 Granger causality test results 
Model 
Two time series in fitted 
VAR model 










Maternity claim rate Yes 
VAR (5) 0.90 0.84 
Induction of labour rate Yes 
2 
Maternity claim rate Yes 
VAR (1) 0.25 0.21 
Preterm birth rate Yes 
3 
Maternity claim rate Yes 
VAR (1) 0.61 0.58 
Multiple birth rate Yes 
4 
Maternity claim rate Yes 




Maternity claim rate Yes 
VAR (3) 0.14 0.22 
Caesarean section rate Yes 
6 
Maternity claim rate Yes 




Maternity claim rate Yes 
VAR (1) 0.041 0.046 Rate of term babies with 5-
minute Apgar scores <7 
Yes 
8 
Maternity claim rate Yes 




Maternity claim rate Yes 
VAR (1) 0.98 0.98 
Term NICU admission rate Yes 
10 
Maternity claim rate Yes 
VAR (7) 0.12 0.36 
Stillbirth rate Yes 
11 
Maternity claim rate Yes 
VAR (4+1) 0.20 (Toda-Yamamoto method)* 
Shoulder dystocia rate No 
12 
Maternity claim rate Yes 
VAR (4) 0.47 0.32 
Brachial plexus injury rate Yes 
* VAR model contained a non-stationary time series, therefore one more lag (or month) added to the model before continuing 
with the Granger causality test (Toda-Yamamoto method) 
 
The rate of term babies with 5-minute Apgar scores <7 was the only potentially useful 
litigation indicator identified in this dataset. None of the other core maternity and 
neonatal clinical indicators under investigation had any useful predictive ability for 
future maternity claims. To date, only one other study has attempted to explore 
whether there are correlations between core clinical indicators and maternity claims. 
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This local feasibility study of one English maternity unit (see Thesis appendix) 
investigated possible correlations between maternity claims and a range of core 
clinical indicators, including multiple births, caesarean sections, postpartum 
haemorrhage and term babies with low Apgar scores at 5 minutes. Despite 10 years 
of data, the number of claims (n=19) was insufficient to be able to demonstrate any 
strong correlations. The findings in this chapter are the first to demonstrate an 
association between a core clinical indicator and maternity claims. In addition, this link 
may also be helpful in forecasting future maternity-related litigation.  
 
In this analysis, the current monthly rate of low 5-minute Apgar scores was predictive 
of the following month’s maternity claim rate. Although the connection between low 5-
minute Apgar scores and maternity claims is clinically plausible, the time frame of one 
month for this effect to take place is less realistic. A longer time period is probably 
needed for the potential clinical consequences of low 5-minute Apgar scores to 
manifest and affect the claim rate. Nevertheless, this statistical link between low Apgar 
scores at 5 minutes and the maternity claim rate may still be of use to policymakers 
(137).  
 
The Apgar score has a couple of key attributes that make it a promising litigation 
indicator. Firstly, it is routinely collected worldwide and is the most frequently used 
measure of newborn well-being at the time of birth (288). This means that it could 
potentially be introduced as a litigation indicator in multiple healthcare settings. A good 
indicator should measure something important (289). As the risks of developing 
cerebral palsy and epilepsy increase with decreasing 5-minute and 10-minute Apgar 
scores (290), the Apgar score is a critical quality indicator and can serve as a proxy 
for long term morbidity. Lastly, the rate of low Apgar scores at 5 minutes can be 
modifiable with training. Multi-professional obstetric simulation training was associated 
with a 49% fall in the number of babies born with low 5-minute Apgar scores in an 
English maternity unit (93). These features make the rate of 5-minute Apgar scores 
<7 a useful indicator for incentivising safer intrapartum care. Medical indemnifiers 
(MIs) could provide premium discounts for hospitals and health services with low rates 
of 5-minute Apgar scores <7. This might encourage maternity units to improve their 
care and rates of low 5-minute Apgar scores in order to take advantage of the premium 
discounts available. Money saved from avoidable litigation could also be used to 
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support units to improve patient safety. For example, MIs could support the poorest 
performing maternity units by funding evidence-based interventions designed to 
improve clinical outcomes. In practice, the incentivisation process may not be so 
simplistic; nevertheless, this represents a possible incentive model that may work in 
certain health systems.  
 
There are a number of potential barriers to using the Apgar score as a form of 
incentivisation. The Apgar score is based on the assessment of five signs: heart rate, 
respiratory effort, reflex irritability, muscle tone and colour (109). Some of these signs 
are susceptible to a degree of subjectivity and as such, the Apgar score is at risk of 
observer bias, particularly if the medical professional assigning the Apgar score is 
aware of the link with a financial reward or penalty. For example, doctors and midwives 
may consciously (or subconsciously) round up (‘game’) Apgar scores to increase the 
likelihood of their hospital receiving a premium discount. However, as there is no 
personal financial benefit, there may be less motivation to ‘game’ the process.  
 
One population-based case-control study from Sweden identified substandard care in 
62% babies born with Apgar scores <7 at 5 minutes. The authors of this study also 
estimated that up to 42% of low 5-minute Apgar scores could be prevented by avoiding 
substandard care in labour, assuming a causal association between the two (291). 
Whilst there is a possible relationship between low 5-minute Apgar scores and poor 
maternity care, there are other factors that may also influence the Apgar score. A large 
population-based registry study (also from Sweden) identified several obstetric factors 
that were significantly associated with an Apgar score of <7 at 5 minutes (292). 
Primiparity, maternal age, smoking, increasing gestational age post due date, use of 
epidural analgesia, having a male infant and delivering at night were all significant risk 
factors for an Apgar score <7 at 5 minutes (292). Socioeconomic factors may also 
have an impact on the Apgar score. Studies have demonstrated that mothers working 
in non-manual occupations or with higher educational status were less likely to have 
babies with an Apgar score <7 at 5 minutes (288,293). The Apgar score may therefore 
require some element of adjustment for intrapartum and demographic factors before 




Maternity and neonatal litigation indicators: can core clinical indicators predict litigation? 
 239 
The data available for analysis restricted the statistical methods that were used. 
Demographic factors may affect the capability of certain core maternity or neonatal 
clinical indicators in predicting future litigation. Furthermore, some core clinical 
indicators may only be useful in predicting malpractice claims in specific cohorts of 
patients. In order to robustly assess the effects of different demographics on potential 
litigation indicators, patient-level data would have been needed. This data would have 
enabled generalised linear models (such as logistic regression models) to be 
developed to adjust for different covariates. Unfortunately, we did not have ethical 
approval to analyse individual clinical and claims data. It might have been possible to 
identify patients in high-profile cases, even if the data were anonymised. The lack of 
individualised patient and claims data is a limitation of this study but it did ensure 
patient confidentiality. There are no established procedures for covariate adjustment 
in VAR models. Important and logical next steps for this research would be to develop 
relevant VAR models that allow adjusted analyses and to investigate whether 
controlling for specific demographic and clinical factors has an impact on the predictive 
capability of the different core clinical indicators studied in this chapter. In particular, it 
would be interesting to see if the rate of Apgar scores <7 at 5 minutes is still helpful in 
predicting the rate of future maternity-related litigation after adjustment. 
 
Another limitation of this study is the use of aggregated claims data. Different health 
services/hospitals may have different infrastructures, safety cultures or clinical 
practices. In other words, the aggregation of claims and clinical data is likely to have 
introduced a degree of ecological bias in the analyses. Health service/hospital specific 
time series analyses would have accounted for these factors and would also have 
enabled additional checks to see whether the rate of term babies with 5-minute Apgar 
scores <7 was predictive of future litigation in smaller subsets of data. However, some 
health services/hospitals had very few claims overall so meaningful and statistically 
powered sub-analyses would have been impossible.   
 
The predictive ability of low 5-minute Apgar scores has only been confirmed in this 
Australian dataset. Further research with datasets from other geographical areas is 
needed to validate this finding before this litigation indicator can be widely employed 
for incentivisation. It would be useful to conduct a similar analysis with data from 
England and to determine whether the results are comparable. I decided to focus 
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mainly on indicators that were recommended by an expert panel and that provided 
broad coverage of intrapartum outcomes (277). It is possible that clinical indicators not 
included in this study may be helpful in predicting the maternity claim rate.  
 
Authors have suggested that ordinal composite measures may be useful for MIs (294). 
Ordinal composite measures are combinations of different variables or outcomes that 
are subject to ordering (e.g. mild, moderate and severe). It could be possible that 
composite indicators may be useful in predicting future litigation but this was not 
investigated in this study. Given that only one clinical indicator predicted claims in this 
dataset, combining clinical indicators in this study is unlikely to reveal a potential 
composite litigation indicator. However, this may not be the case in larger and/or 
different datasets. Encouragingly, it seems feasible to derive a composite neonatal 
adverse outcome indicator with good predictive ability for overnight readmission or 
death in the first year of life from routinely collected English hospital administrative 
data (295). Future work on litigation indicators should combine core clinical indicators 
into either maternity or neonatal composite outcomes to explore whether these have 
any predictive potential for malpractice claims.  
 
Data from a total of 64,904 births (17%) were excluded from the analyses as there 
was uncertainty surrounding the completeness of the clinical data from January 2009 
up to and including April 2011. Maternity claims originating from the corresponding 
time period (n=307, 26%) were also excluded. This was a significant loss of data but 
these exclusions were enforced to ensure valid comparisons between the rates of the 
core clinical indicators and the maternity claim rate. Had this data been complete and 
accurate, incorporating the 17% of clinical data and 26% of claims data into the 
analyses may have affected the final findings.  
 
Although statistical links between clinical indicators and malpractice claims may be 
useful, it is worth remembering that there will be other factors influencing whether a 
claim is made, such as communication around the time of the clinical incident (273). 
Parental expectations may also determine whether the litigation process is pursued or 
not. For example, parents of a premature baby may expect a poorer prognosis 
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This study presents a novel approach that could potentially be applied to other clinical 
and litigation datasets to search for litigation indicators in other medical specialties. 
The use of litigation indicators may provide a basis for future pay-for-performance 
(sometimes abbreviated to P4P) programmes i.e. financial incentives to improve 
quality of care and patient outcomes (296). Current P4P programmes appear to have 
limited impact on improving patient outcomes in general. A meta-analysis of 31 studies 
did demonstrate that P4P had a positive effect on process measures (effect size 0.18, 
95% confidence interval (CI) 0.06, 0.31) but it failed to show that P4P had any effect 
on patient outcomes (effect size 0.00 95% CI -0.01, 0.01) (297). In terms of the impact 
of hospital-based P4P, a review conducted in 2007 stated that the evidence base in 
this area was too limited to draw any definitive conclusions (296). More recently, a 
systematic review from 2017 found low-strength evidence of P4P having little or no 
effect on patient outcomes in hospitals (298). Finally, a US observational study 
published in 2018 found that the clinical process scores and mortality rates in hospitals 
under a P4P scheme for over a decade were no better than those from hospitals where 
incentives had been running for a much shorter time period (2 years) (299). New P4P 
schemes should carefully consider the size and structure of their financial incentives, 
and the clinical relevance of their quality targets (300). Litigation indicators could be 
new incentive tools with a ‘double-edged’ effect of both improving patient care and 
also reducing malpractice claims. Litigation indicators are therefore likely to be of 
interest to macro level organisations (such as MIs) hoping to influence these two 
domains in healthcare.  
 
7.5 Conclusions 
This scoping analysis is the first to explore whether core maternity or neonatal 
clinical indicators can be used to predict and quantify future maternity claims. The 
rate of Apgar scores <7 at 5 minutes in term babies was the only potentially useful 
litigation indicator identified in the Victorian dataset where the current monthly rate of 
low 5-minute Apgar scores was predictive of the following month’s maternity claim 
rate. Robust litigation indicators could be part of future pay-for-performance 
programmes that could affect both patient safety and the rate of litigation. However, 
further research is needed before litigation indicators can be widely adopted for 
direct clinical incentivisation schemes. 
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7.6 Chapter appendix 
 




Figure 7-5 Standardised rates of induction of labour and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time. 
Figure 7-6 Standardised rates of preterm births and maternity claims. Restricted 
cubic splines (dotted lines) indicate the trend over time. 
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Figure 7-7 Standardised rates of multiple births and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time.  
Figure 7-8 Standardised rates of instrumental vaginal deliveries and maternity 

























Figure 7-10 Standardised rates of maternal ICU admissions and maternity 
claims. Restricted cubic splines (dotted lines) indicate the trend over time. 
 
Figure 7-9 Standardised rates of caesarean sections and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time. 
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Figure 7-11 Standardised rates of PPH and maternity claims. Restricted cubic 
splines (dotted lines) indicate the trend over time. 
Figure 7-12 Standardised rates of term NICU admissions and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time. 
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Figure 7-13 Standardised rates of stillbirths and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time. 
Figure 7-14 Standardised rates of shoulder dystocia and maternity claims. 
Restricted cubic splines (dotted lines) indicate the trend over time. 
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Figure 7-15 Standardised rates of brachial plexus injuries and maternity 
claims. Restricted cubic splines (dotted lines) indicate the trend over time. 
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8.1 Overview 
This concluding chapter summarises the findings from all the studies in this thesis, as 
well as outlining the main strengths, weaknesses and challenges of each study. The 
potential impact of this thesis is also explored, and I have identified potentially useful 
areas for future research. Finally, the key messages and recommendations from this 
thesis are presented for both clinical staff and policymakers.  
 
This thesis is in two main parts to reflect the current health system and landscape. 
Chapters 2, 3 and 4 represent the first part of the thesis where I employed a ‘bottom-
up’ approach to engaging with all three levels of a health system. Chapters 5, 6 and 7 
form the second part of the thesis and represent a ‘top-down’ approach to interacting 
with the macro, meso and micro levels of a health system.  
 
8.2 Part 1 of the thesis 
 
8.2.1 The quality of life associated with permanent OBPIs 
Chapter 2 investigated the impact of permanent obstetric brachial plexus injuries 
(OBPIs) on the quality of life of affected adults and caregivers of children with OBPIs. 
I employed a preference-based instrument (EQ-5D-5L) (157) to calculate formal 
quality of life utility scores in these populations. Both adults with OBPIs and caregivers 
of children with permanent OBPIs reported a worse quality of life compared to the 
general population; the mean utility score for adults with OBPIs was 0.56 and for 
caregivers it was 0.80 (p<0.001 and p=0.007 respectively). I also used multivariable 
regression models to identify particular characteristics that might influence the utility 
score. For adults with OBPIs, previous OBPI surgery, non-manual employment, 
partner status and receiving disability benefits related to OBPI were associated with 
quality of life. For caregivers, employment status and the presence of one or more 
caregiver medical condition appeared to impact most on quality of life.  
 
This work was the first to directly measure the quality of life of adults with OBPIs as 
well as that of caregivers of children with OBPIs using a recognised preference-based 
quality of life instrument. The utility scores I have derived in Chapter 2 are a substantial 
improvement on the estimated utility scores that currently exist in the literature (150). 
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However, one important limitation was the small sample sizes for both adults with 
OBPIs and caregivers of children with the injury. Despite multiple strategies to improve 
response rates, only 50 adults with OBPIs and 78 caregivers were recruited. Careful 
data management also lead to the exclusion of some participants, thereby further 
reducing the samples. This limited statistical power in my regression analyses, which 
meant that I may not have been able to detect some true associations with the utility 
score for some characteristics. Alternatively, some of the associations that I did identify 
may no longer be applicable in larger datasets, as demonstrated by some of my 
sensitivity analyses. The study may also have been subject to selection biases due to 
its cross-sectional design and recall biases as questionnaires were used.  
 
Overall, the work in Chapter 2 represents the best available evidence quantifying the 
impact of an important birth-related injury on the quality of life of affected adults and 
caregivers of children with the injury. These quality of life utility scores were derived 
from a widely used health status instrument that is preferred by NICE. This offers the 
additional advantage that any quality adjusted life years (QALYs) calculated from 
these utility scores would be comparable with QALYs in other NICE health technology 
assessments used by policymakers.  
 
8.2.2 The cost of simulation training for obstetric emergencies 
Despite regular recommendations for maternity training, there has been little 
information regarding the likely cost of their implementation. The study presented in 
Chapter 3 is the first to calculate the cost of multi-professional simulation training for 
obstetric emergencies. These cost data would be useful in helping international, 
national and local decision-makers decide how best to allocate healthcare resources.  
 
I performed a retrospective micro-costing analysis to calculate the cost of 
implementing and sustaining multi-professional simulation training for obstetric 
emergencies (PROMPT), or standalone shoulder dystocia training, for one year at 
Southmead Hospital, Bristol. The start-up costs were £4,336 and the variable costs 
for one year were £111,773, resulting in a total cost of £116,109 to establish and run 
PROMPT at Southmead for one year. The cost of running training in subsequent years 
could be modelled on the variable costs. Releasing staff to attend and facilitate training 
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accounted for 89% of the total first year costs and 92% of the variable costs. For 
standalone shoulder dystocia training, the start-up costs were £2,577 and the variable 
costs for one year were £10,256. Using the annual birth rate at Southmead hospital in 
2015 (6,517 births), I estimated that it would cost around £18,000 per 1,000 births for 
the first year of training and roughly £17,000 per 1,000 births for training in subsequent 
years. It would cost around £2,000 per 1,000 births to run standalone shoulder 
dystocia for the first year and approximately £1,600 per 1,000 births for subsequent 
years. 
 
This was a single-centre study so the results may not be generalisable outside the 
immediate context of the study. It was also performed based on a number of 
assumptions including fixed working patterns within professional groups, backfilling of 
positions, and fixed training programmes and faculty teams throughout the year. There 
is therefore an element of uncertainty in these reported costs.  
 
Nevertheless, Chapter 3 defined the unit level costs for multi-professional simulation 
training for obstetric emergencies. It is definitely not free as can be assumed by some 
macro level agencies making recommendations for training. As not all obstetric 
training is clinically effective (103,105), maternity units and policymakers should 
carefully review the evidence of effect for training programmes before investing in 
them.  
 
8.2.3 Cost-utility of simulation training for obstetric emergencies 
Chapter 4 was a model-based cost-utility analysis of multi-professional simulation 
training for obstetric emergencies (PROMPT), with a particular focus on the training 
programme’s impact on reducing permanent OBPIs.  
 
I estimated the cost-utility of all maternity units in England adopting annual PROMPT 
(scenario 1a) or just the shoulder dystocia component of PROMPT (scenario 1b) 
compared with current practice, where only a proportion of English units use the 
training programme (scenario 2). The utility scores I derived in Chapter 2 were 
employed to generate quality adjusted life years (QALYs) for this study. The cost data 
from Chapter 3 were also included in this analysis. Over the 30-year duration of the 
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economic model, 1,753 permanent OBPIs would be avoided with national PROMPT 
or shoulder dystocia training compared with current practice. National PROMPT or 
shoulder dystocia training also resulted in increases in adult, caregiver and dyadic 
(combination of adult and caregiver QALYs with equal weighting) QALYs. Both 
national PROMPT and just shoulder dystocia training conferred significant savings (in 
excess of £1 billion) over current practice. This led to cost-savings of at least £1 million 
per QALY gained, irrespective of the QALY measure used. Similar results were 
demonstrated in the probabilistic sensitivity analysis. The probabilistic sensitivity 
analysis also provided strong evidence that opting for either nationwide PROMPT or 
standalone shoulder dystocia training instead of current practice could result in cost-
savings of over £1 billion and savings of over £2 million per adult QALY gained over 
30 years. 
 
The economic model was subject to assumptions that may have influenced the final 
results. For example, assumptions were made about the national birth rate, the training 
programme’s initial coverage and the cost of an OBPI. Extensive sensitivity analyses 
were conducted to account for uncertainties in the model inputs and produced similar 
findings. The effectiveness of training was also modelled on a single observational 
study, albeit with robust findings over 12 years (113).  
 
This study was the first cost-utility analysis of obstetric training and the first to use 
QALYs to demonstrate the impact of a maternity training programme. The clinical 
benefits of multi-professional simulation training for obstetric emergencies can now be 
expressed using language familiar to policymakers. The findings from Chapter 4 
should therefore help policymakers decide how to use their limited healthcare funds 
and should encourage more investment in effective obstetric training programmes. 
The findings in Chapter 4 could be compared with other health technology 
assessments reviewed by NICE.   
 
 
8.2.4 Summary – Part 1 of the thesis 
Chapters 2, 3, and 4 represent the first part of the thesis where I employed a ‘bottom-
up’ approach to engaging with all three levels of a health system. Chapter 2 
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investigated the quality of life associated with OBPIs by involving the affected 
individuals and caregivers of affected children. This is therefore an excellent example 
of engagement with the micro level of a health system. Chapter 3 focused on the cost 
of multi-professional simulation training for obstetric emergencies. This information is 
important to managers with financial responsibilities for their department or maternity 
unit. Chapter 3 offers a means to engage with the meso level of a health system. The 
data from Chapters 2 and 3 were used for the economic evaluation in Chapter 4. Cost-
utility analyses, like the one conducted in Chapter 4, are often reviewed by macro 
organisations like NICE. Expressions of costs and effectiveness of healthcare 
interventions, such as costs per QALY, will be more familiar to national commissioners 
and other macro sector organisations than hospital managers or clinicians at the 
frontline of care. Chapter 4 therefore attempts to open a dialogue with the macro level 
of a health system through the use of an economic evaluation. Together, these 
chapters convey the clinical benefits and value of multi-professional simulation training 
for obstetric emergencies in a more understandable format for policymakers.  
 
8.3 Part 2 of the thesis 
 
8.3.1 Models of clinical-medical indemnifier engagement  
In Chapter 5, I conducted interviews or focus groups with state-based medical 
indemnifiers (MIs) from England, Wales, Scotland, Republic of Ireland, Sweden and 
Victoria, Australia to explore the different ways MIs engage with clinical staff. The 
engagement activities identified from these interviews/focus groups could be divided 
into general engagement, clinical engagement and research/collaborative 
engagement. Examples of general engagement included feedback from claims audits, 
hosting conferences, and presentations to executive boards. Direct clinical 
engagement included site visits, training clinical staff, running incentive schemes and 
providing financial or administrative support for patient safety initiatives. Some state-
based MIs also engaged with research, with many MIs wanting to learn more from 
their claims data. For example, some MIs permitted researchers to use their claims 
databases and some MIs have also been co-applicants on research grants.  
 
Although many examples of clinical-MI engagement were reported, there was a sense 
that this relationship could be developed further. Through analysing the participants’ 
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responses, several themes were identified that might be crucial for ongoing, effective 
clinical-MI engagement. Key themes included MI identity and scale, use of data and 
commitment to research, and how MIs attempt to incentivise improvement and 
integrate the health system. The mindset of a MI will dictate their approach to 
engagement with clinical staff. For example, is there a role for a MI in harm prevention? 
Or is its sole purpose to compensate patients who have experienced negligent care? 
The size of the health system may also impact on the scope of any engagement 
activities. Claims data could complement clinical data and improve learning when 
preventable harm has occurred. MIs, clinicians and researchers should collaborate 
more to develop a system that would enable both claims and clinical data to be 
analysed together. MIs are not equipped to undertake clinical research in isolation and 
should aim to develop partnerships with researchers and clinicians. Embracing 
research would be an easy way of maintaining clinical-MI engagement.  
 
Incentives can have an important role in encouraging improvement in patient care; 
however, there was universal agreement that an ideal incentive model is yet to be 
determined. MIs have the financial resources and administrative capacity to develop 
and support incentive schemes. For incentive schemes to be successful they will need 
to be relevant to frontline staff. They should also be aligned with the main objectives 
of a health system. In order to achieve this, MIs, clinical staff and other important 
agencies in a health system should all be involved in the co-design of future incentive 
models. MIs may also be ideally placed to facilitate health system integration through 
their multi-level contacts and financial influence. 
 
Limitations of this work include a one-sided perspective (MIs’ viewpoints) on clinical-
MI engagement, selection biases and being unable to achieve data saturation through 
interviewing only 17 participants from six state-based MIs. Despite these limitations, 
there has been little empirical research in this area, so this study offers preliminary 
insights into how state-based MIs currently engage with clinical staff and how clinical-
MI engagement could be more effective.  
 
8.3.2 Using data from Australia and changing perspective 
This thesis has been written primarily in the context of healthcare decision-making in 
the UK/England. Although Part 1 of the thesis (Chapters 2, 3, and 4) and Chapter 5 
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used data from England or the UK, this was not possible for Chapters 6 and 7. After 
exploring different models of clinical-medical indemnifier (MI) interaction in Chapter 5, 
I wanted to evaluate one form of clinical-MI engagement. The evaluation of the Sign 
up to Safety Incentivisation Scheme in England was already out for tender around the 
start of my studies – I was part of the evaluation team for the Sign up to Safety 
Incentivisation Scheme and the report has been included in the Thesis Appendix. At 
that time, there were no other clinical-MI engagement activities related to maternity 
care to evaluate in England. However, the Victorian Managed Insurance Authority 
(VMIA) had supported the implementation of multi-professional simulation training for 
obstetric emergencies (PROMPT) in maternity units in Victoria and there was an 
opportunity to evaluate the state-wide impact of this training programme. I was 
particularly interested in whether this form of clinical-MI engagement was associated 
with any improvements in the costs and rates of maternity litigation in Victoria. This 
work formed the basis of Chapter 6.  
 
Chapter 7 was inspired by a local, feasibility study investigating possible maternity and 
neonatal litigation indicators for the UK Department of Health. Again, I was part of the 
team involved in this project and the report has been included in the Thesis Appendix. 
The aim of this feasibility study was to identify clinical indicators that correlated with, 
and were therefore predictive of, claims. If any litigation indicators exist, then these 
could be included into medical indemnifiers’ premium modelling and be used as ways 
to incentivise better care. However, as it was a single-centre study, the number of 
claims was insufficient even over 10 years. We estimated that at least 12 years of data 
from 15-20 maternity units would be needed to detect any correlations between clinical 
indicators and claims. This would have required a multi-regional study in England. 
Whilst it would have been possible to retrieve the claims data from NHS Resolution, it 
would have been more challenging to obtain the necessary clinical data for a number 
of reasons. Firstly, the two national maternity datasets in England (Maternity Services 
Data Set and the National Maternity and Perinatal Audit) are relatively new. The 
Maternity Services Data Set comprises of antenatal, intrapartum and postpartum care 
data but was only started in 2014 (301,302). The National Maternity and Perinatal 
Audit collects similar information but only commenced in 2016 (303,304). These 
datasets would not have provided adequate clinical data and potential maternity units 
for the multi-regional study would have needed to be approached independently for 
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data. This in itself would have posed some problems, such as local data quality issues 
and differences in the clinical information collected between units. Secondly, whilst 
both national maternity datasets collect a wide range of information, only some of the 
data were available to the public. For example, in the National Maternity and Perinatal 
Audit, only data that passed the quality checks were available to the public. Worryingly, 
the majority of hospitals failed the data quality checks for at least one measure (304).  
 
In contrast, as part of the PROMPT evaluation project in Victoria, clinical data were 
available for 22 health services/hospitals and claims data were available for these 
units from 2003-2017. There was significantly more data here compared to the data 
for the initial feasibility study. It therefore made sense to interrogate the available 
Victorian data and begin investigating possible maternity or neonatal litigation 
indicators using this larger dataset. This was presented in Chapter 7.  
 
8.3.3 The impact of obstetric simulation training on litigation 
Chapter 6 investigated the impact of a clinical-MI engagement activity – supporting 
multi-professional simulation training for obstetric emergencies (PROMPT) – on the 
frequency and cost of maternity-related litigation in Victoria, Australia. This study 
demonstrated that the introduction of PROMPT was associated with improvements in 
both maternity claims frequency and litigation costs.  
 
There was evidence of a 53% reduction in the overall rate of maternity claims after 
PROMPT was implemented (95% CI 18%, 73%, p=0.008). Similarly, there appeared 
to be an overall 49% reduction in the mean cost per claim post-PROMPT 
implementation (95% CI 2%, 74%, p=0.045) and borderline evidence suggesting that 
monthly spending on maternity litigation had reduced by 57% (95% CI 0%, 82%, p= 
0.05). There was also a 70% reduction in maternity claims (95% CI 29%, 88%, 
p=0.007) and an 81% decrease in the mean monthly litigation cost (95% CI 20%, 96%, 
p=0.02) for the first group of trained health services/hospitals (Group I) after PROMPT 
was introduced. Previous studies have also observed decreases in the maternity claim 
rate (33,231,262) and obstetric litigation costs (106,229,231) following the introduction 
of maternity safety programmes. However, a major strength of Chapter 6 was the use 
of robust statistical modelling to demonstrate these reductions.  
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Health systems by their very nature are complex entities (9). It would therefore be 
unwise to suggest that the decreases in litigation frequency and costs were solely due 
to a single intervention. There are likely to have been a multitude of factors contributing 
to these findings. For example, The Australian tort law reforms in 2002-2006 
introduced statutory limits such as thresholds and caps on damages (268,269) and 
would have affected the cost of claims. However, as these reforms predate PROMPT, 
any effects of these reforms on the cost of claims are likely to have been equally 
applicable to both the pre-PROMPT and post-PROMPT implementation data. As a 
result, these reforms are less likely to be responsible for the differences noted between 
the evaluation periods.  
 
High-risk incidents that were more likely to become formal claims were included in the 
analyses. Two sensitivity analyses were conducted to address the possible bias 
towards cost-savings due to the higher proportion of high-risk incidents in the post-
PROMPT implementation period. In these additional analyses, however, there was 
only evidence supporting a reduction in the mean monthly maternity litigation cost for 
the group of health services/hospitals that had been trained the longest (Group I) 
following the introduction of PROMPT. These sensitivity analyses provided a crude 
estimate of the potential costs of these high-risk incidents. In reality, as claims are 
settled case-by-case, it would be very difficult to predict the potential impact of these 
high-risk incidents.  
 
The findings from Chapter 6 have wider policy implications as any patient safety 
initiative that is associated with reductions in the rate and cost of litigation is more 
likely to be supported by medical indemnifiers. Such improvement initiatives will be 
critical in attempts to curb the unsustainable rise in malpractice damages and costs, 
particularly within the field of obstetrics. 
 
8.3.4 Maternity and neonatal litigation indicators 
In Chapter 7, I explored whether core maternity and neonatal clinical indicators were 
associated with litigation and whether they could be used to predict future claims. I 
investigated 13 core clinical indicators using clinical and claims data from Victoria, 
Australia. Eleven of these core indicators have been recommended by an expert panel 
as suitable measures for care in labour (277). Of all the core clinical indicators, only 
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one was identified as a potential litigation indicator. The rate of term babies with 5-
minute Apgar scores <7 was the only core clinical indicator that appeared to be related 
to the overall maternity claim rate and that was robust enough to be useful for future 
work. The previous month’s rate of low 5-minute Apgar scores in term babies was 
predictive of the current maternity claim rate (p=0.046); in other words, the current rate 
of term babies with 5-minute Apgar scores <7 would be predictive of the following 
month’s maternity claim rate. 
 
These findings could form the basis for new pay-for-performance models. Litigation 
indicators could be used to incentivise better patient care and also help to reduce 
malpractice claims. As such, litigation indicators would be of interest to macro level 
agencies, particularly medical indemnifiers. The Apgar score is subjectively derived, 
at risk of observer bias and likely to require population adjustment. However, it is also 
an important metric, is routinely collected and modifiable with regular, multi-
professional training (93). These features make it an exciting prospect as a potential 
incentive tool.  
 
The predictive capability of low 5-minute Apgar scores has only been identified in one 
dataset. Before the low 5-minute Apgar score can be widely used as an incentivisation 
tool, the results from Chapter 7 must be replicated and validated in other datasets. 
The lack of patient-level data meant that the effects of different demographics on 
potential litigation indicators could not be assessed. Another limitation was the use of 
aggregated data, which meant that any hospital effects were disregarded. The use of 
composite indicators was not investigated either. Despite these limitations, the study 
was performed with robust statistical techniques and provides a new methodological 
platform for analysing claims and clinical data together. These methods could be 
applied to data from other medical specialties where it would be useful to forecast 
litigation from clinical events.    
 
8.3.5  Summary – Part 2 of the thesis 
Chapters 5, 6 and 7 form the second part of the thesis and represent the ‘top-down’ 
approach to interacting with the macro, meso and micro levels of a health system. 
Chapter 5 featured empirical research of different strategies that medical indemnifiers 
(MIs) use to engage with hospitals and clinical staff. Chapter 6 evaluated the impact 
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of a clinical-MI engagement activity – supporting hospitals in implementing a patient 
safety initiative – on the rate and cost of maternity-related litigation. Finally, Chapter 7 
investigated possible maternity or neonatal litigation indicators that have the potential 
to be used for incentivisation and therefore influence hospital safety and the care 
provided by clinical staff. All three of these chapters have their main perspective 
situated at the macro level of a health system (from the viewpoint of a MI) and explore 
how macro levers can affect organisational (meso level) and individual or clinical 
(micro level) practice.  
 
8.4 Rationale behind approach to thesis  
The overarching aims of this thesis were to explore whether a system-based approach 
to improving maternity care and reducing obstetric litigation was feasible and what this 
type of approach could entail. Health systems are complex and it would not have been 
possible to study every component. I decided to focus my approach on cost as I felt 
that this was a universally understood concept that might help align the different levels 
of a health system. Two vehicles for investigation were identified to enable me to study 
both ‘bottom-up’ and ‘top-down’ approaches to improving maternity safety. Exploring 
both approaches provides a more balanced overview of how a health system functions 
compared to examining a single approach in isolation. 
 
Firstly, I chose multi-professional simulation training for obstetric emergencies 
(PROMPT) as a vehicle for investigating a ‘bottom-up’ approach to improving 
maternity care and reducing litigation. Other interventions could also have been 
studied but PROMPT has been recognised as a leading example of obstetric training 
in the recent National Maternity Review in England (8) and was familiar to me, having 
participated in the training as both an attendee and facilitator. PROMPT has also been 
associated with preventing permanent OBPIs (113) which are important sources of 
litigation. Moreover, OBPIs are less complex than other intrapartum complications, 
such as cerebral palsy. All these features facilitated the creation of a pathway 
connecting the micro level (investigating the quality of life of adults with OBPIs and 
caregivers of children with permanent OBPIs), the meso level (calculating the cost of 
the training) and the macro level (economic evaluation of the training) of a health 
system. NICE make important recommendations regarding care in the NHS and 
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economic evaluations appear to have a prominent role in their decision-making 
process (64). I wanted to present multi-professional simulation training for obstetric 
emergencies in the same way as other interventions in NICE’s technology appraisal 
programme. It was therefore logical to conduct the economic evaluation in NICE’s 
preferred format (cost-utility analysis).  
 
Secondly, I chose the state-based medical indemnifier (MI) as my vehicle for 
examining a ‘top-down’ approach to improving maternity care and reducing obstetric-
related litigation. Other macro organisations would also have been worth studying. For 
example, professional bodies such as the Royal College of Obstetricians and 
Gynaecologists (RCOG) would have different ways of influencing patient care 
compared to what has been identified in the second part of this thesis. However, as 
my focus was on cost and reducing the maternity litigation burden, it made sense to 
directly investigate the institutions that deal with medical indemnity and explore how 
they can contribute to making maternity care safer and decrease litigation.    
 
8.5  Impacts of this thesis 
As health systems are complex entities, there have been increasing calls for more 
system-based approaches to patient safety (9,11,13,14). This thesis has 
demonstrated that it is possible to adopt a system-based approach to improve 
maternity care and tackle the escalating cost of litigation in obstetrics. My work has 
examined how costs and finances can have a central role linking the different levels 
of a health system and help align priorities within maternity services. Other medical 
specialties may benefit from a similar approach and find costs a useful starting point.  
 
Work from Chapter 3 was published around the time the Secretary of State for Health 
in England announced the Maternity Safety Training Fund as part of a new Safer 
Maternity Care plan. This made £8 million available for maternity training and enabled 
each NHS Trust in England to apply for at least £40,000 to help support their training 
of staff (196,197). 
 
Chapter 4 has improved the evidence base for multi-professional simulation training 
for obstetric emergencies and has strengthened the argument for more investment in 
this area. In order to disseminate the key findings to policymakers, I developed a short 
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animation to summarise the results of Chapter 2 and Chapter 4 (Figure 8-1) (305). 
This animation has been circulated on numerous social media platforms.   
 
Economic evaluation in patient safety is a ‘neglected necessity’ (p.444) (201). Full 
cost-utility analyses of patient safety initiatives are rarely performed as the data 
required are often unavailable (306). Part 1 of this thesis provides a framework for 
generating utility scores for important clinical outcomes, costing an intervention and 
developing a decision model to estimate the cost-utility of a training programme. These 
methods could be used for economic evaluations of other training interventions.  
 
 
Figure 8-1 Screenshot from animation 
 
The one-day workshop with the medical indemnifiers (MIs) participating in the study 
in Chapter 5 was very informative. This was the first time that MIs met together to 
discuss issues surrounding clinical risk and malpractice litigation. The workshop, and 
the lack of any formal meetings between international MIs, inspired the VMIA to host 
the inaugural Global Medical Indemnity Forum in Melbourne in December 2018. This 
was attended by state and private MIs from Australia, USA, England and New 
Zealand. The Minister for Finance for Victoria was also in attendance. I was invited to 
be a plenary speaker and shared my research findings from Chapter 6 and Chapter 7. 
The forum itself was a resounding success and has already resulted in some global 
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collaborations. There are also plans to establish an online community for MIs to share 
ideas and keep in touch. NHS Resolution will be hosting the next meeting in London 
in 2020.  
 
The maternity and neonatal litigation indicators work has generated interest from a 
number of MIs, particularly NHS Resolution. If the results from Chapter 7 can be 
replicated and validated in other datasets, it may be possible that NHS Resolution 
would consider using litigation indicators, such as low 5-minute Apgar scores in term 
babies, as part of their maternity incentive scheme in future.  
 
8.6  Proposed further work 
There are a number of ways that the work in this thesis could be developed further. 
Chapter 2 demonstrated poorer quality of life in adults with OBPIs and caregivers of 
children with OBPIs when compared to the general population. I was also able to 
identify some participant characteristics that influenced the utility score. However, as 
the sample sizes for the studies in Chapter 2 were small, I may not have been able to 
detect any true associations between certain demographic factors and the utility score. 
Performing similar analyses on larger datasets might reveal different characteristics 
affecting the utility score in these cohorts. Identifying these influential variables will 
allow population adjustment of these utility scores in future research. 
 
The work from Chapter 5 presented some empirical insight into different models of 
clinical-MI engagement from the perspective of the MI. In the spirit of the system-
based approach of this thesis, it would be equally useful to explore clinical-MI 
engagement from the clinical viewpoint. A better understanding of both perspectives 
might result in more effective engagement. The focus of Chapter 5 was also on state-
based MIs. However, there will be opportunities to learn from, and work with, private 
MIs too and future research could explore models of engagement in the private sector.  
Chapter 7 identified low 5-minute Apgar scores in term babies as a core clinical 
indicator that could be used to predict and quantify prospective maternity claims. 
Litigation indicators could potentially be used as new incentive tools. More research is 
clearly required before this can happen. The study in Chapter 7 only detected one 
litigation indicator. This finding needs to be replicated and validated in other datasets 
before it can be reliably used as a means for incentivisation.  
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I have secured funding to support similar analyses using Swedish data. There will be 
around 2 million birth episodes to analyse (using data dating back from 1997). It is 
harder to estimate how many claims will be available for the corresponding period, but 
since 2014 there have been around 250 settled claims each year regarding maternal 
or neonatal injuries in Sweden according to Landstingens Ömsesidiga 
Försäkringsbolag (LÖF) (the national MI of Sweden). These will be much larger clinical 
and claims datasets than those used in Chapter 7. The core maternal and neonatal 
clinical indicators from Chapter 7 should all be re-investigated, as well as other clinical 
indicators. There is a well-established registry for neonatal care in Sweden so this will 
enable the inclusion of additional indicators such as neonatal mortality rates and 
asphyxia-related brain injuries. The merit of combining core clinical indicators into 
composite outcomes should also be examined. In addition, there may be an 
opportunity to perform similar analyses using national data from England. There are a 
number of national datasets in England, such as the Maternity Services Data Set 
(301,302) and the National Maternity and Perinatal Audit (304), that could be usefully 
combined for research into litigation indicators. NHS Resolution has a high volume of 
English claims data available for analysis and would be an excellent potential 
collaborator in any research into litigation indicators in England.  
 
The practical implications of using a litigation indicator for incentivisation will need 
further investigation. For example, there needs to be work investigating whether 
controlling for specific intrapartum or demographic factors has any impact on the 
predictive capability of core clinical indicators. It may be possible to begin exploring 
this using the Swedish data. If adjustment is required, will this data be available in 
other health systems, and if not, how will this data be collected? Should litigation 
indicators be used as standalone incentive tools, or should they be incorporated into 
existing schemes? How much incentive should be given and at what stage should this 
be activated? There may also be scope for some qualitative work with frontline staff 
(micro level) and hospitals (meso level) to research how potential litigation indicators 
could affect them and how they operate. As illustrated, there are many questions to 
be answered before litigation indicators can be used for incentivisation. The work from 
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Thinking further ahead, any new incentive scheme in the future should also have a 
careful evaluation plan. This may be in the form of a difference-in-difference analysis 
of predetermined patient outcomes.  
 
8.7  Key messages and recommendations 
Finally, the key messages and recommendations from this thesis for both clinical staff 
and policymakers are summarised.  
 
8.7.1 Key messages and recommendations for clinical staff 
• Adopting a system-based approach to patient safety is possible  
• A greater appreciation of the health system, the levels within it and their 
different interactions will help quality improvement efforts 
• Adults with OBPIs and caregivers of children with OBPIs have worse quality of 
life than the general population 
• Medical indemnifiers can be important collaborators in the pursuit for safer care 
– they have the financial resources and administrative capacity to support 
clinical staff  
• Clinical results may not be immediately accessible to policymakers – consider 
translating clinical results into language that policymakers can understand more 
easily (such as economic evaluations)  
 
8.7.2 Key messages and recommendations for policymakers 
• Multi-professional simulation training for obstetric emergencies is not free but 
can be cost-effective, and cost-saving in the long term 
• More investment is needed to support maternity units in training their staff 
• Collaboration with patients, clinical staff/researchers and hospitals will help 
harness the potential of the health system from ‘women to Whitehall’, and back 
again 
• A system-based approach to policymaking may help to streamline and link the 
health system 
• Work with clinical staff and researchers to use data to drive improvement
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Feasibility study of maternity litigation indicators 
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The tender required investigation of any potential correlation of clinical indicators and claims 
that could provide a reliable and robust predication of a Trust’s future maternity claims for 
clinical negligence.  
The identification of relevant clinical indicators has been conducted by assessing the 
correlations between 10 years of maternity information and claims data (2000-2009) from the 
North Bristol Trust maternity unit. 
It is feasible to use local maternity information systems to provide robust and reliable clinical 
indicators.  
Prior to the assessment of those correlations, time series analyses were conducted to identify 
whether the original data could be used, or if they required a transformation (i.e. detrending or 
first difference). This approach was employed to avoid spurious association and correlation 
between the claims and indicators data.  
The proportion of missing data was less than 1% for the variables used to construct the 
indicators.  
55,000 births with 19 claims were insufficient numbers to demonstrate any strong correlations 
between clinical indicators and claims.  
Clinical outcomes that form the basis of claims e.g. 3rd/4th degree tears & neonatal brachial 
plexus injuries and proxies for neonatal outcome i.e. low Apgar score for asphyxia, may be 
useful subjects for future investigation.  
A larger study of between 15-20 units followed for at least 12 years, of a similar size to Bristol 
and using claims data reported quarterly, is required to accurately identify any 
correlations(r>0.4) between clinical indicators and claims data.  
It would also be useful to explore the feasibility of including data from neonatal databases 
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1. Introduction 
UK maternity care could and should be safer (1). Adverse events in maternity care are frequently 
avoidable and the cost of litigation for maternity care is rising for many health services across 
the world (2-4); a tragedy for families for whom the injury was preventable, an enormous loss of 
resource to healthcare in general and possibly even a perverse incentive against best care (5). 
Quality schemes using self-certification based on process measures alone should no longer be 
considered satisfactory (6). We need to know when we are not doing well (7), and certification 
based solely on process measures can mask poor clinical care (6). However, the current Hospital 
Episode Statistics (HES) data cannot be used to undertake this kind of analysis until the data 
quality greatly improves (7). Moreover, the neonatal data in the HES maternity tail are very 
limited.  
Unit based maternity databases are amongst the most accurate data sets in the NHS  (8,9) and 
since 2015, maternity units have started to submit standardized extracts from these to form a 
national maternity dataset that includes much of the perinatal information that is not currently 
available from routine HES data. Therefore, there is an excellent opportunity to develop a set of 
clinical indicators that could be used with the forthcoming national data.  
Insurers could use these outcome indicators to model insurance premiums based on each 
individual maternity unit’s current clinical performance, as well as their historical claims made, 
or paid.  




North Bristol NHS Trust (NBT) has one of the largest maternity units in the UK, with around 
6,500 births per annum. It also has an alongside midwifery-led unit and a freestanding 
midwifery-led unit. It serves a population consisting of approximately 900,000 people across 
Bristol, South Gloucestershire and North Somerset. In the period of this research: the Bristol 
Local Authority average Index of Multiple Deprivation score was in the second-most deprived 
quintile, South Gloucestershire in the least deprived quintile and North Somerset in the second-
least deprived quintile (10). Black and minority ethnicity makes up 16.1%, 5.1% and 2.8% of the 
populations of Bristol, South Gloucestershire and North Somerset respectively (11).  
Therefore the NBT catchment population is broadly representative of England, although it is 
recognised there is less ethnic diversity than some areas.  
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 2. Objective 
The tender specified the following requirements: 
The key outcome required is a dataset of a small number of individual indicators (no more than 
five) that: 
• when aggregated together, can provide a reliable and robust predication of a Trust’s 
future maternity claims for clinical negligence;  
• are precisely defined and able to be collected accurately and uniformly from existing 
data sources or, if new, could be easily and cheaply collected and reported centrally; 
• can be used by the NHS Litigation Authority (NHS LA) to set benchmarks for 
organisations on an annual basis in order to determine the size of the Clinical Negligence 
Scheme for Trusts (CNST) contributions; 
• enable NHS LA to adjust Trust’s maternity CNST contributions based on their current 
systems and performance; 
• incentivise Trusts to deliver safe maternity care and reduce their CNST contributions; 
• did not result in an unintended adverse impact on existing good practice; and 
• ultimately, enable may more funding to be spent on front line health services. 
 
We investigated 10 years of local claims data (2000-2009 inclusive) and a selection of potential 
clinical indicators, based on a previously published Delphi process – section 3.3, to perform a 
series of correlations between the indicators and litigation costs. Our aim was to identify any 
clinical indicators that best correlated with litigation claims.  
We also selected three clinical indicators to analyse and investigate whether these correlated 
with individual maternal characteristics. A clinical indicator that is independent of maternal 
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3. Method 
We investigated a decade of both clinical & claims data from the period 2000 – 2009 to align 
with the NHSLA publication: Ten years of maternity claims (4).  
3.1 Clinical data  
An anonymised extract of the STORK electronic maternity records system including all births at 
North Bristol NHS Trust from 1/1/2000 to 31/12/2009 was obtained. STORK maternity record 
data are entered by midwives at the point of care or very shortly after, thereby facilitating 
accurate recording of data.  Unit based maternity databases are amongst the most accurate 
data sets in the NHS (8,9) and more complete than the current Health Episode Statistics (HES) 
data.  
Clinical data relating to the selected indicators were examined for completeness and plausibility, 
and validated using additional fields where necessary.   
Where the proportion of missing data exceeded 0.5%, missing patterns were examined and 
sensitivity analyses were performed to assess the effect of any imputations.  
 
3.2 Claims data 
The NHS LA provided all available obstetrics and gynaecology related claims data for NBT as of 
31st March 2016. These data were anonymised and included claims from the Existing Liabilities 
Scheme (pre 1995), which predated the NHS LA. Successful, unsuccessful and open cases were 
provided. 
The NHSLA recognise that their claims database is primarily designed for claims and financial 
management rather than clinical detail (4) but the incident summaries have allowed broad 
categorisation of claims. All incident summaries were reviewed and all gynaecology related 
claims were excluded. Incidents that could be attributed to either maternity or neonatal care 
were included but further information was requested to aid further categorisation. Unsuccessful 
claims were excluded from the analysis. We focussed the analysis on successful or open 
obstetric claims with an incident date from 2000-2009 (inclusive); the same time period 
investigated in the NHSLA’s Ten Years of Maternity Claims report (1). 
Nineteen cases met the inclusion criteria and were analysed. We concentrated on total damages 
per claim as this gave an indication of the monetary burden of each incident. For a claim settled 
with periodical payments, the final cost cannot be calculated until the death of the claimant. In 
such cases, the total damages are therefore important as they can be used as estimates of 
capitalised figures for total damages had these claims been settled on a lump sum only basis. 
The sum of the total damages is derived for each year, using the year of the incident. 
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3.3 Indicators 
Recent years have seen unprecedented efforts to measure healthcare quality and the 
methodological and pragmatic complexities of these efforts have led to major debates: which 
‘dimensions’ of quality to measure; whether to focus on processes or outcomes; which 
outcomes to prioritise; traditional clinical outcomes or more patient-centred ones; and, perhaps 
most important, how to link measurement to action through policy, professional and 
management levers (12). 
Although many quality indicators (QI) have been proposed and are in use in maternity care, 
there are no standardised, uniformly agreed sets of indicators. Many calls have been made for a 
standard set of QIs both internationally (13-16) and in the UK (6,17). However, the current lack 
of structure and rigor has resulted in an enormous variation in the quality indicators monitored 
and definitions used: 290 clinical indicators were identified within 96 clinical categories with up 
to 18 different definitions in 4 sets of nationally recommended intrapartum QIs from UK, 
Australia, USA and Canada (17). Moreover, in one UK region comprising 10 maternity units there 
were 352 different quality indicator (QI) definitions, covering 37 different QIs with up to 39 
different definitions for each indicator (18)! This is clearly unnecessary variation and should be 
streamlined.  
The NHS Good Indicators Guide (19) recommends that quality indicators should be routinely 
measured, important to women and the service, and alterable by best care.  
Suites of indicators have been developed using robust methodologies: systematic review (16) 
and Delphi panels (15, 17). 
The focus for this report was on intrapartum indicators. Some high-cost claims relate to 
antenatal care, in particular to antenatal screening, and further work could include antenatal 
indicators if routinely collected data are readily available from the majority of maternity units.  
We used the previously published series of 12 QIs developed by a UK based research team 
employing a Delphi process (17). We have further developed the headline indicators to include 
important sub-classifications.  
All of these indicators fit with the requirements defined in the tender: they are precisely defined 
and routinely collected.  
Given their likely clinical relevance to more than 60% of the highest claims cost categories in the 
recent NHSLA report (4), we also selected three indicators to investigate their association with a 
range of demographic risk factors: 
• Stillbirths 
• 3rd/4th degree tears 
• Apgar score <75mins in term babies 
In table 1 below we have provided the Clinical Indicators investigated and their definitions: 
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Table 1: Definition of Clinical Indicators 
 Indicator Definition in this report Rationale for inclusion 
1 Number of birth 
episodes 
Number of women who gave birth  This is currently used by the 
NHS LA as one of the 
measures to determine 
insurance premiums  
2a Preterm birth rate 
(all) 
Proportion of all babies born who were 
born before 37 completed weeks of 
gestation 
A substantial number of 
claims concern s preterm 
babies 
2b Preterm birth rate 
before 34 weeks 
Proportion of all babies born who were 
born before 34 completed weeks of 
gestation 
3 Multiple birth rate Proportion of all birth episodes which 
involved a multiple pregnancy 
A substantial number of 
claims concerns multiple 
births 
4 Induction of 
labour rate 
Proportion of all women who gave birth 
who had an induced labour onset 
(including where labour is started off in 
case of pre-labour prolonged rupture of 
membranes) 
A potential proxy for the 
complexity of the women 
cared for but also associated 
with risks to mother and 
baby 
5 Normal birth rate Proportion of all women who gave birth 
who had a spontaneous vaginal birth (i.e. 
not operative vaginal birth or caesarean) 
This may be a candidate for 
a ‘balancing indicator’ to 
avoid incentivising operative 
births 
6 Operative Vaginal 
Birth (OVB) rate 
Proportion of all women who gave birth 
who had a vaginal birth assisted by 
instruments (vacuum or forceps) 
Operative vaginal births 
carry an increased risk of 
injury to mother and baby 
and a substantial number of 
claims concern OVBs 
7a Caesarean birth 
rate (all) 
Proportion of all women who gave birth 
who had a caesarean birth (either elective 
or emergency) 
Caesarean births carry 
increased risks for the 
mother and are implicated 
in a substantial number of 
claims 
 
The caesarean birth rate is 
also a potential candidate 
for a ‘balancing indicator’ to 
avoid incentivising operative 
births  
 
The WHO have recently 
recommended the use of 
Robson Groups for 
classification of Caesarean 
births.  
 
Robson groups 1, 2 and 5 
are the largest contributors 
to caesarean birth numbers 
7b Elective caesarean 
birth rate 
Proportion of all women who gave birth 
who had an elective caesarean birth, i.e. 




Proportion of all women who gave birth 
who had an emergency caesarean birth, 
i.e. caesarean birth categories 1, 2 & 3 
7d Robson Group 1 
rate 
Proportion of all women who gave birth, 
who had a caesarean birth and fell within 
Robson Group 1 criteria: 
• primips  
• singleton  
• cephalic 
• ≥37 weeks 
• spontaneous labour 
7e Robson Group 2 
rate 
Proportion of all women who gave birth, 
who had a caesarean birth and fell within 
Robson Group 2 criteria: 
• primips,  
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• singleton,  
• cephalic,  
• ≥37 weeks,  
• induced labour or pre-labour 
caesarean section  
 
7f Robson Group 5 
rate 
Proportion of all women who gave birth, 
who had a caesarean birth and fell within 




• ≥37 weeks 
• one or more previous caesarean 
section(s) 
8a 3rd & 4th degree 
tear rate (all) 
Proportion of all women who had a 
vaginal birth (normal or OVB) and who 
sustained a 3rd or 4th degree perineal 
tear 
A substantial number of 
claims concerns obstetric 
anal sphincter injury and 
related maternal morbidity 
8b 3rd & 4th degree 
tear rate in 
unassisted 
(normal) births 
Proportion of all women who had an 
unassisted (normal) vaginal birth and who 
sustained a 3rd or 4th degree perineal 
tear 
8c 3rd & 4th degree 




Proportion of all women who had an OVB 






Proportion of all women who gave birth 
who had a recorded blood loss of 1500ml 
or more, after the birth of their baby 
Postpartum haemorrhage is 
associated with maternal 
morbidity and mortality 
10  Stillbirth rate Proportion of all babies born who were 
born at 24 weeks gestation or more 
without signs of life 
A substantial number of 
claims concerns intra-
uterine deaths 
11 Low Apgar rate at 
5 minutes in term 
babies 
Proportion of all babies live-born at 37 
weeks gestation or more who had an 
Apgar score of less than 7 at 5 minutes 
A low Apgar score at 5 
minutes is associated with 
an increased risk of short 
and long term 
complications, including 
cerebral palsy, which 
accounts for 40% of the total 
value of claims nationally 
12 Admission to 
neonatal intensive 
care unit (NICU) 
rate in term 
babies 
Proportion of all babies live-born at 37 
weeks of gestation or more who were 
admitted to the neonatal unit 
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3.4  Statistical analysis 
The investigation of the indicators most likely to provide a reliable and robust predication of a 
Trust’s future maternity claims for clinical negligence was performed by assessing the 
correlation between each indicator described in table 1 and the claims data.  
The correlation (r) was derived from the coefficient of determination (r2) provided by the linear 
regression modelling the time-series of the claims and indicator of interest. Indicators showing 
the highest correlation with claims would be good candidates for use as proxy measures for 
maternity claims. Correlation ranges from -1 (maximum negative correlation, i.e. the higher the 
indicator the lower the claims) to 1(maximum positive correlation, i.e. the higher the indicator 
the higher the claims). A correlation close to 0 is an indication of independence between the 
two variables investigated. 
Prior to deriving the correlation, the data structure of claims and indicator time-series were 
investigated with time-series analyses - reported in the appendices.  
The internal structure of time-series data, in particular their stationarity and autocorrelation, 
were explored to determine whether the original data could be directly correlated or whether a 
transformation of those data was required before computing the correlation. A stationary 
process has the property that its mean, variance and autocorrelation structure do not change 
over time. Stationarity can be defined as a “flat looking series, without trend, constant variance 
over time, a constant autocorrelation structure over time and no periodic fluctuations”. In the 
absence of stationarity, the mean and variance of the series will change over time and its 
correlation with another variable will be wrongly defined. This can lead to spurious association 
and correlation between two variables. The autocorrelation of the time-series refers to the 
“lagged correlation” within the data, i.e. the degree of similarity between a measurement of an 
indicator at a specific time point and another measurement of the same indicator performed at 
another time-point. When measurements of the same indicator are correlated over time, non-
randomness in the series is identified; and the estimation of the correlation (r) involving this 
variable becomes inflated.  
Original data can be directly used when the series is stationary. However, if the data are not 
stationary, then the series can be "stationarised" by transforming the original data prior to 
investigating any correlations. 
 
Data management 
The claims and various indicators data were aggregated by year to obtain a time-series 
(sequence of data points made over a continuous time interval, out of successive measurements 
across that interval, using equal spacing between every two consecutive measurements and 
with each time unit within the time interval having at most one data point). 
The number of birth episodes (women who gave birth) and the total damages were aggregated 
by year using their sum. All the other indicators were aggregated as rates. For example, the 
rates of low Apgar score were derived as the number of babies born with a low Apgar score over 
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Data stationarity and trends of the time-series 
Stationarity was checked by investigating whether the time series contained a time trend. A 
linear model regressing the indicator on time was conducted to assess the significance of this 
time-trend (The null hypothesis is that the series followed a “random walk” and the alternative 
was that the series had a trend).  
Stationarity was also checked using the augmented Dickey-Fuller test. Specifically, this tested 
whether the time-series followed a unit-root process (The null hypothesis was that the series 
contained a unit root, and the alternative was that the series was generated by a stationary 
process(20, 21)). Any evidence of unit root and trend suggested that the time-series was not 
stationary and would require a transformation. If this was evident, detrending (by removing the 
trend from the original time-series data) and/or first-, second-differing (rather than using zt as a 
dependent variable, the dependent variable becomes zt-zt-1 or (zt-zt-1)- (zt-1-zt-2)) was used to 
transform the series from non-stationary to stationary.  
If there was no unit root and no trend identified then the original time-series was used to derive 
the correlation. 
 
Autocorrelation within a time-series 
Evidence of serial correlation was then investigated using an autocorrelation 
(correlation between values of the time-series at different times) plot and formally tested using 
the Ljung–Box test (The null hypothesis was that the data of the time-series was independently 
distributed and the alternative was that the data was not independently distributed and 
exhibited serial correlation(20,21)). Whitening transformation (using ARIMA model) was applied 
to the time-series if there was evidence of serial correlation, otherwise the original time-series 
was used for the following analyses (21). 
 
Association and correlation between the claims and indicator time-series 
Evidence of association between the claims damages time-series and each indicator was 
investigated using univariate linear regression with the claims damages used as the dependent 
(endogenous) variable and the indicator used as the explanatory (exogenous) variable. Evidence 
of an association between the indicator and claims damages times-series was assessed with a t-
test, using a p-value<0.05. The strength of their association was derived using the coefficient of 
determination (r2) assessed by the linear mode: R2 equals the squared Pearson correlation 
coefficient of the dependent and explanatory variable.  
Details of analyses are provided in the appendix section and a summary table is provided in the 
results section. 
 
Requirement for population risk adjustment 
An ideal indicator would be routinely, reliably and accurately collected; have evidence of 
association with claims damages, and there would be minimum requirement for population risk 
adjustment. For a selected group of indicators we therefore also investigated whether the 
indicators were related to maternal and child characteristics.  
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Clinical outcome measures are appealing, but there can be issues with appropriate case-mix or 
population risk adjustment. Caesarean birth rates in the UK vary with different population 
demographics (22) and maternity risk managers recently highlighted lack of accurate population 
risk adjustment as a significant obstacle to their measurement of clinical quality (23). 
Given their likely clinical relevance to more than 60% of the highest claims cost categories in the 
recent NHSLA report (4), we selected three indicators to investigate their association with a 
range of demographic risk factors: 
• Stillbirths 
• 3rd/4th degree tears 
• Apgar score <75mins in term babies 
These three indicators are dichotomous (Stillbirth vs Livebirth; Tears or not; Score<7 vs Score≥7). 
Univariate log-binomial regressions were used to investigate the association between these 
three indicators (as dependent outcome) and the maternal and child characteristics 
(independent variable (24)). Wald test was used to estimate these associations, a p-value<0.05 
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4. Results 
There were 52296 birth episodes between 1/1/2000 and 31/12/2009. Characteristics of the 
sample are described in Table 2 below.  
 
 
Table 2: Sample description 








Maternal age All 52296  29.7 5.8 21 37 
Age group <20 2788 5.3%     
20-24 7656 14.6%     
25-29 13496 25.8%     
30-34 17238 33.0%     
35-39 9302 17.8%     
≥40 1816 3.5%     
Ethnicity White 44921 85.9%     
Asian 2023 3.9%     
Afro-Caribbean 1550 3.0%     
Other 1276 2.4%     
Unknown 2526 4.8%     
Index of Multiple 
Deprivation (IMD) 
2010 rank quintile 
1 (most deprived) 5831 11.2%     
2 8887 17.0%     
3 8057 15.4%     
4 9551 18.3%     
5 (least deprived) 17307 33.1%     
Missing  5.1%     
BMI All 48950  25.2 5.2 19.9 32.2 
BMI category 18.5-24 27274 52.2%     
<18.5 1343 2.6%     
25-29 12667 24.2%     
≥30 7666 14.7%     
Missing 3346 6.4%     
Parity All 52296  0.9 1.1 0 2 
Nulliparous 23719 45.4%     
Multiparous 28577 54.6%     
Gestation All 51992  39.3 2.0 37 41 
Gestation category 
(weeks) 
<37 3373 6.45     
37,38,39 18856 36.06     
40,41 27718 53     





34 0.07     
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Birthweight All 52172  3378 601 2700 4060 
Birthweight category ≤2500g 3,157 6.0%     
2500g-4000 42,696 81.6%     
>4000g 6,319 12.1%     
Multiple pregnancy  847 1.6%     
Smoking   7,374 14.1%     
Pre-existing 
hypertension 
 3274 6.3%     
Pre-existing diabetes  337 0.6%     
Gestational diabetes  408 0.8%      
Pre-
eclampsia/eclampsia  
 1288 2.5%      
Placenta 
praevia/abruption 
 286 0.6%     
Pregnancy-induced 
hypertension 
 787 1.5%     
Antepartum 
haemorrhage 
 2,373 4.5%      
(Suspected) sepsis in 
labour 
 660 1.3%     
Cord prolapse  77 0.2%     
Shoulder dystocia  1,125 2.2%     
Episiotomy  6,647 12.7%     
 
Missing data 
Table 3 in appendix 7.23 describes the number and percentage of missing data related to each 
maternal or neonatal characteristic or indicator; if the percentage missing exceeded 0.5% we 
evaluated whether there were any relevant discernible patterns to the missing data using t, chi 
squared or Fisher's exact tests dependent on the nature of the data.  
There was generally a high level of data completeness and few discernable missing patterns of 
clinical relevance.  
Mean gestation and birthweight were lower, and stillbirth and low Apgar rates higher in the 
0.1% with missing mode of birth, as was the stillbirth rate in the 0.6% of babies with missing 
gestation. 
There was a higher proportion of non-hospital births, preterm births and NICU admissions in the 
0.7% with missing Apgar score at 5 minutes but when restricted to term babies (as in the 
indicator), only the difference in the proportion of non-hospital births remained. Since low 
Apgar scores in term babies are relatively rare we performed a sensitivity analysis to examine 
the impact of the missing data – see 7.21.5. 
 
A description of the annual prevalence of the clinical indicators and total damage claims are 
presented in Table 4. Nine (47%) out of nineteen cases were still classified as open.  
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The breakdown of claims by categories include: cerebral palsy/brain injury, antenatal screening, 
retained swab, 3rd or 4th degree tear/fistula, maternal harm, management of labour, 
intrauterine/neonatal death and assessment/treatment of the newborn.   
The total damages per claim ranged from £5,000 to £8 million. The annual total damages ranged 
from £0 to £12.5 million, with a mean annual cost of £4.47 million. 
 
Table 4: Clinical Indicators and Claims over investigation period 










year) 12500 0 9.3 217.5 5780 8050 6000 5750 6400 25 44731.8 
1 Birth 
episodes 
number 4694 4487 4642 4923 5108 5180 5346 5673 6104 6139 52296 
2a Preterm 
births 
number 292 265 291 326 345 354 379 374 386 395 3407 




number 73 87 68 84 89 70 87 69 89 64 780 
rate 1.6% 1.9% 1.5% 1.7% 1.7% 1.4% 1.6% 1.2% 1.5% 1.0% 1.5% 
3 Multiple 
births 
number 76 66 72 74 90 75 80 82 93 139 847 
rate 1.6% 1.5% 1.6% 1.5% 1.8% 1.5% 1.5% 1.5% 1.5% 2.3% 1.6% 
4 Inductions of 
labour 
number 946 905 1001 1035 1031 1043 1018 1123 1121 1211 10434 
rate 20.2% 20.2% 21.6% 21.0% 20.2% 20.1% 19.0% 19.8% 18.4% 19.7% 20.0% 
5 Normal 
births 
number 3154 2945 3068 3203 3244 3245 3342 3535 3739 3731 33206 




number 593 529 532 600 545 615 696 642 784 798 6334 
rate 12.6% 11.8% 11.5% 12.2% 10.7% 11.9% 13.0% 11.3% 12.8% 13.0% 12.1% 
7a Caesarean 
births (all) 
number 909 998 1031 1097 1280 1289 1292 1480 1554 1594 12524 
rate 19.4% 22.2% 22.2% 22.3% 25.1% 24.9% 24.2% 26.1% 25.5% 26.0% 24.0% 
7b  Elective 
caesarean 
births  
number 415 466 502 538 577 592 577 640 774 724 5805 




number 494 532 529 559 703 697 715 840 780 870 6719 




number 118 124 135 144 205 196 200 263 201 243 1829 
rate (as % of 
all births) 2.5% 2.8% 2.9% 2.9% 4.0% 3.8% 3.7% 4.6% 3.3% 4.0% 3.5% 
rate (as % of 





number 113 128 143 148 160 168 162 202 214 193 1631 
rate (as % of 
all births) 2.4% 2.9% 3.1% 3.0% 3.1% 3.2% 3.0% 3.6% 3.5% 3.1% 3.1% 
rate (as % of 
all CS) 12.4% 12.8% 13.9% 13.5% 12.5% 13.0% 12.5% 13.7% 13.8% 12.1% 13.0% 
 












number 221 261 281 287 316 338 343 389 435 427 3298 
rate (as % of 
all births) 4.7% 5.8% 6.1% 5.8% 6.2% 6.5% 6.4% 6.9% 7.1% 7.0% 6.3% 
rate (as % of 
all CS) 24.3% 26.2% 27.3% 26.2% 24.7% 26.2% 26.6% 26.3% 28.0% 26.8% 26.3% 
8a 3rd & 4th 
degree tears 
(all) 
number 100 82 97 117 108 165 181 224 269 299 1642 
rate 2.6% 2.4% 2.7% 3.1% 2.8% 4.2% 4.5% 5.3% 5.9% 6.6% 4.1% 





number 48 46 55 67 63 100 89 129 169 194 960 
rate 1.5% 1.6% 1.8% 2.1% 1.9% 3.1% 2.7% 3.6% 4.5% 5.2% 2.9% 






number 51 36 42 50 44 65 92 95 100 105 680 
rate 8.6% 6.8% 7.9% 8.3% 8.1% 10.6% 13.2% 14.8% 12.8% 13.2% 10.7% 




number 37 29 39 60 51 49 41 61 86 113 566 
rate 0.8% 0.7% 0.8% 1.2% 1.0% 1.0% 0.8% 1.1% 1.4% 1.8% 1.1% 
10 
Stillbirths 
number 16 14 20 21 12 17 24 23 24 27 198 
rate 0.3% 0.3% 0.4% 0.4% 0.2% 0.3% 0.5% 0.4% 0.4% 0.4% 0.4% 
11 Low Apgar at 
5 minutes in 
term babies 
number 28 19 20 17 15 28 25 27 18 34 231 
rate 0.6% 0.5% 0.5% 0.4% 0.3% 0.6% 0.5% 0.5% 0.3% 0.6% 0.5% 






number 222 224 225 220 159 168 194 263 219 207 2101 
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Correlation of claims and clinical Indicators 
Table 5: correlation of clinical indicators with claims 





Total damages Yes None No Not applicable Not applicable 
Birth episodes No None Yes P=0.198 R=0.44 
Preterm births No None Yes P=0.187 R=-0.52 
Preterm births <34 
weeks No Yes Yes P=0.975 R=0.01 
Multiple births No None Yes P=0.258 R=-0.45 
Induction of labour No None Yes P=0.136 R=-0.54 
Normal births No None Yes P=0.793 R=-0.10 
Operative vaginal  
births (OVB) Yes None No P=0.767 R=0.11 
Caesarean births (all) No None Yes P=0.629 R=-0.17 
Elective caesarean 
births  No None Yes P=0.223 R=-0.42 
Emergency caesarean 
births No None Yes P=0.802 R=0.09 
Robson Group 1 No None Yes P=0.616 R=0.18 
Robson Group 2  No None Yes P=0.588 R=-0.20 
Robson Group 5 No None Yes P=0.153 R=-0.49 
3rd & 4th degree tears 
(all) No None Yes P=0.261 R=0.42 
3rd & 4th degree tears 
in unassisted (normal) 
births 
No None Yes P=0.493 R=0.26 
3rd & 4th degree tears 
in assisted (operative 
vaginal) births 
No None Yes P=0.383 R=-0.36 
Postpartum 
haemorrhage ≥1500ml No None Yes P=0.499 R=-0.28 
Stillbirths (all) Yes None No P=0.335 R=-0.34 
Low Apgar at 5 minutes 
in term babies Yes None No P=0.387 R=0.31 
Admission to neonatal 
intensive care unit in 
term babies 
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Investigation of 3 Clinical Indicators with maternal and child demographics 
Three clinical indicators were selected a priori because they were clinically likely to be relevant 
to the some of the highest cost claims  
 
3rd/4th degree perineal tears  
In the NBT population the rate of 3rd/4th degree tears in unassisted (normal) births was 
associated with: 
• Nulliparity (no previous birth at 24 weeks or more)  
• Increasing maternal age 
• Asian ethnicity  
• Shoulder dystocia 
• Birthweight >4000 grams 
• Episiotomy 
• Index of Multiple Deprivation rank quintile (most deprived) 
 
The risk was reduced for smoking at the time of birth and birthweight ≤2500grams. 
No evidence of association between 3rd/4th degree tears in unassisted births and the following 
factors was found: 
• Maternal BMI at booking 
• Pre-existing diabetes 
• Gestational diabetes 
We found evidence of association and lack of association for the same factors in assisted 
(operative vaginal) births as in unassisted births. However, for 3rd/4th degree tears after assisted 
births there was no association with IMD rank. 
 
Stillbirths 
In the NBT population the rate of stillbirth was positively associated with:  
• Maternal age (≥40) 
• Asian ethnicity 
• Index of Multiple Deprivation rank quintile (most deprived) 
• Pre-existing diabetes 
• Maternal BMI (≥30) 
• Nulliparity 
• Birthweight (≤2500grams) 
 
However, in this population, there was no evidence of association with: 
• Maternal smoking status at time of birth 
• Pre-existing hypertension 
• Gestational diabetes 
The association of stillbirths with maternal demographics is well recognised, and the 
associations in the NBT data set appear to be mostly similar those reported previously in the UK.  
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This suggests that our data are likely to be reasonably representative of other English units  
 
Apgar <75mins in term babies 
Nulliparity was associated with a higher risk of giving birth to a term live-born baby with an 
Apgar score of less than 7 at 5 minutes.  
There was also an increased risk with birthweight ≤2500 grams or >4000 grams. 
There were associations with some pregnancy and intrapartum complications, but these were 
not specifically population based and therefore have not been included in our report.  
However, there was no evidence of association with other population demographics: 
• Maternal age 
• Maternal ethnic group 
• Index of Multiple Deprivation rank quintile (IMD 2010) 
• Maternal BMI at booking 
• Maternal smoking status at time of birth 
• Pre-existing hypertension 
• Pre-existing diabetes 
In these data the Apgar score is independent of almost all maternal population demographics.  
However, our unit serves a less ethnically diverse population than the English average, and 
therefore further investigation with data from other units is required to determine whether risk-
adjustment is required for this indicator.  
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5. Conclusions  
This is a feasibility study performed over a very short period of 1 calendar month and we aimed 
to investigate the questions raised in the tender. Given the short time period of the study it was 
possible only to investigate a decade of data for a single maternity unit.  
A total of 19 successful claims related to maternity care were identified for analysis between 
2000 -2009. The annual total damages ranged from £0 to £12.5m, with a mean annual pay-out 
of £4.47m. 
Over the same time period there were 52,296 birth episodes for analysis.  
 
Clinical Indicators 
The 12 indicators that we selected were based on a previous Delphi process and also 
recommendations from the NHS Good Clinical Indicators guide. They comprised a pragmatic 
selection of both maternal and neonatal outcomes, as well as process measures and 
denominator data.  
These 12 indicators, including those with sub-classifications (CS and 3rd/4th degree perineal tear):  
could be precisely defined, were routinely collected on a standard UK maternity database and 
there were very few missing values.  
 
Most of the clinical indicators did not demonstrate evidence of stationarity and therefore 
required some degree of transformation. This is likely to be the same with other data sets and 
therefore similar statistical methods and analysis should be included in future research to 
determine whether the original data could be directly used to compute the correlation. The 
strategy used to transform are well documented and straightforward. 
Finally, we demonstrated a number of associations for 3rd/4th degree perineal tears and 
stillbirths with maternal demographics. These associations are similar to previous research and 
demonstrate that the NBT data are likely to be representative of English maternity units.  
However, an Apgar score <75mins was independent of most maternal demographics, indeed all 
except nulliparity in these data. This is similar to data sets from other European countries, 
although an association with socio-economic class has been reported in Sweden (25). Therefore 
population risk adjustment does not appear to be necessary prior to any comparison of 
maternity units for an Apgar score <75mins. However, with the caveat that our unit serves a less 
ethnically diverse population than the English average, and therefore further investigation with 
data from other units is required to determine whether risk-adjustment is required for this 
indicator 
 
Correlation – clinical indicators and claims 
There were no strong correlations (r2>0.7) for any of the clinical indicators with claims data in 
the decade investigated.  
The strongest correlations between claims and the clinical indicators were found with rate of 
induction of labour, rate of preterm births and rate of Robson Group 5. While the quantitative 
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analysis identifies those three outcomes, their clinical relevance as a proxy for total damages 
claims is debatable and outcome such as the rate of Apgar score <75mins could be more 
relevant.    
The analyses would need to be replicated on a larger sample with more claims and units to 
obtain more accurate estimates of all the indicators investigated. The small sample size, ten 
years of data, could explain the absence of significant association between all the investigated 
indicators and the total damage claims. However, the correlations observed in our sample 
should be considered as preliminary evidence of the indicators likely to have the largest strength 
of association with claims.   
Much larger numbers of both claims and births are required to validated our preliminary results 
and demonstrate robust correlations.  
Even where there were correlations r >0.5, these did not seem to be biologically plausibly 
related to claims i.e. induction of labour, however it would be interesting to investigate these in 
a larger data set.  
This investigation has provided important feasibility data about the identification and collection 
of clinical indicators.  
Furthermore, this study also provides some useful information to accurately determine the 
sample size required to robustly investigate correlations between clinical indicators and claims. 
The highest correlations of the indicators investigated in this study range between |0.40| and 
|0.50|. Around 48 time periods, i.e. 12 years of data with 48 quarters, would be required to 
obtain a coefficient of correlation of at least r≥0.4, significantly different from zero. Assuming a 
similar annual number of claims as NBT, 12 years of data from 15 to 20 maternity units of similar 
size would therefore be required to obtain a reasonable number of claims per quarter (~7 and 
10 per quarter). This should be feasible from routine maternity data sets, although the data may 
require cleaning, and would be possible from a limited number of regions. However, a broader 
sample might be useful to more accurately capture the diversity of maternity care in England.  
We have not aggregated any of the clinical indicators because the correlations were low. A 
larger sample would be required to fit the statistical model required to determine the weight to 
apply to each selected indicator in order to derive a final composite indicator. However, this 
would be potentially useful in future, larger data sets.  
 
Strengths and limitations 
The main limitation for this project was the short timeline, which restricted the investigation to 
a single maternity unit over a 10 year study period. There was insufficient time to recruit other 
units with the appropriate research permissions, and there was also insufficient time for the IT 
department at NBT to provide patient level data from before 2000. Although there were more 
than 50,000 births investigated, the smaller number of claims than anticipated from previous 
data, means that the study was underpowered and a larger data set will be required to identify 
potentially useful correlations between claims and clinical indicators. In addition, subsequent 
information from the NHS LA revealed that three of the claims included in our analysis were 
actually related to neonatal care. Excluding these three claims would underpower the study 
further. 
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Moreover, we only investigated intrapartum (labour related) clinical indicators because care in 
labour and these outcomes were most likely to correlate with claims.  
 
However, there were a number of strengths for this study: the data were prospectively and 
robustly collected; the data were cleaned and have been validated in a number of previous 
studies.  
Furthermore, the analysis was performed by an experienced research team with an established 
research interest, including peer-reviewed publications, for the development of quality 
indicators in maternity care.  
Finally, the data from this feasibility study will inform the size of future studies, as well as 
prioritise and direct future investigation.  
 
Use of Apgar scores as a measure of maternity care 
Fetal asphyxia is the most common reason for compensation in the UK (4), Norway (26) and 
Sweden (27).  
Apgar scores have been criticised for their subjectivity, but an Apgar score <75mins is a 
reasonable predictor for perinatal brain damage related to asphyxia in labour with a negative 
predictive value of 96% (28) Moreover, a recent study from Scotland has confirmed that infants 
with low Apgar scores have a substantially increased risk of death within the first year of life, 
particularly for term infants, and the strongest associations were noted for deaths attributed to 
anoxia (29). 
In Norway it has been recognised that an Apgar score <45mins was a better prediction of 
compensation than an Apgar score <75mins (30) and it is noteworthy that the definitions of 
intrapartum cerebral palsy also use an Apgar score <45mins (31, 32) 
Apgar scores are routinely collected in maternity information systems almost ubiquitously 
across the world where maternity data is recorded (15, 33). The value of an Apgar score <75mins 
as a clinical indicator has been recognised in France (15), the UK (17) and Europe (34)  
In our feasibility study there were only 0.7% missing values and a sensitivity analysis 
demonstrated that imputed values did not change the associations, therefore a ‘first slice’ of the 
data is accurate and further cleaning is likely to be unnecessary.  
Prematurity has a significant effect on Apgar scores and therefore we recommend that this 
indicator should be reserved for births >37 weeks gestation.  
Data from this study and Scotland (29) indicate that the Apgar scores were not associated with 
maternal demographics, except nulliparity in Bristol, and therefore population risk adjustment 
may not be required to directly compare units.  
Apgar scores <75mins can be improved with better intrapartum care (35,36), but there is a 
significant variation from 0.4% - 2.8% in 2 UK regions that is unexplained by population 
demographics.  
Therefore Apgar scores provide a potentially useful avenue for future research in this area, as a 
proxy for neonatal asphyxia claims.  
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Future 
A larger study of between 15-20 units, of a similar size to Bristol and using claims data reported 
quarterly, is required to accurately identify any correlations between clinical indicators and 
claims data. We have demonstrated that it is feasible to collect robust data from local maternity 
information systems over a long period of time  
Clearly, outcome measures alone do not fully capture the quality of maternity care and it would 
be useful in the future to investigate maternal feedback and compare maternal awarded scores 
with claims.  
We were not able to investigate potential new indicators that were not included in standard 
maternity databases, but we have identified some potentially useful indicators that are routinely 
collected by most Trusts and could be usefully investigated in future work.  
For example, it would be useful to investigate the correlation between an Apgar score <45mins 
and claims as this may improve the specificity of the indicator.  
It would also be beneficial to explore any correlation between neonatal encephalopathy rates 
and claims using the national neonatal Badger Network. However, these data are not routinely 
collected on maternity databases.  
Another potentially useful indicator might be brachial plexus injury (BPI) after shoulder dystocia. 
Shoulder dystocia is a complication of birth and is routinely collected on maternity data sets 
whereas BPI is only available from neonatal databases. Shoulder dystocia is also recognised to 
be unpreventable (37) whereas permanent brachial plexus injury after shoulder dystocia may be 
almost completely preventable (38). Claims related to shoulder dystocia account for >3% of NHS 
LA claims (4) and 72% of successful obstetric claims in Saudi Arabia (39).  
Finally, it may be helpful in the future to publish these data for benchmarking, as recently 
recommended in the Maternity Services review to facilitate improvement.  
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7.1 Claims 




7.1.2 Stationarity investigation 
No evidence of trend in the total damages time-series was found (p=0.821) and the null 
hypothesis of a unit root was rejected (Z(T)=-3.11, p=0.026). The series was therefore assumed 
to be stationary and no transformation was required. 
7.1.3  Serial correlations investigation 
The autocorrelation plot showed no evidence of serial correlation in the total damages time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 2.98, 
p=0.394).  
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7.2 Claims and birth episodes 
7.2.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the number of birth episodes was found (p<0.0001). The series was 
detrended (by subtracting the predicted values from the original values; the predicted values 
being assessed from the model regressing the number of babies born in year of birth). 
The null hypothesis of a unit root was rejected (Z(T)=-3.10, p=0.027). The detrended series was 
assumed to be stationary. 
7.2.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the number of babies born 
time-series, suggesting an independently distributed time-series (Ljung Box Q statistics= 1.46, 
p=0.692).  
There was therefore no need to apply a whitening transformation to the time-series. 
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There was no evidence of association between the total damages time-series and the number of 
babies born time-series (p=0.198). The residuals of the model were normally distributed, 
homoscedastic and had no evidence of autocorrelation. 
 
7.2.4 Correlation between claims and the indicator 
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7.3 Claims and preterm births 
 
7.3.1 Stationarity investigation of the indicator times-series 
The null hypothesis of a unit root was not rejected (Z(T)=-1.42, p=0.573). The second difference 
of the series was derived to obtain a series with no unit root (Z(T)=-3.21, p=0.019). No evidence 
of trend in the transformed time-series was found (p=0.265). The second difference transformed 
time-series was assumed to be stationary. 
7.3.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the preterm births  time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 1.269, 
p=0.530).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
7.3.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series  and the preterm 
births time-series (p=0.187). The residuals of the model were normally distributed, 
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7.3.4 Correlation between claims and the indicator 
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7.4  Claims and preterm births <34 weeks 
7.4.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the rate of severe preterm births was found (p=0.001). The series was 
detrended (by subtracting the predicted values from the original values; the predicted values 
being assessed from the model regressing the rate of severe preterm babies on year of delivery). 
The null hypothesis of a unit root was rejected (Z(T)=-8.56, p<0.0001). The detrended series was 
assumed to be stationary. 
 
7.4.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed some evidence of serial correlation in the preterm births < 34 
weeks time-series (Ljung Box Q statistics= 8.80, p=0.032).  
 
 
An AR(1) transformation was applied to obtain a “white-noise” time-series. No more evidence of 
autocorrelation was found on the transformed series (Ljung Box Q statistics= 0.41, p=0.939). The 
same filter (AR(1))  was applied to the claim time-series.  
7.4.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the preterm 
births <34 weeks-series (p=0.975). The residuals of the model were normally distributed, 
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7.4.4 Correlation between claims and the indicator 
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7.5  Claims and multiple births 
7.5.1 Stationarity investigation of the indicator times-series 
The null hypothesis of a unit root was not rejected (Z(T)=-1.46, p=0.554). The second difference 
of the series was derived to obtain a series with no unit root (Z(T)=-3.66, p=0.005). No evidence 
of trend in the transformed time-series was found (p=0.265). The second difference transformed 
time-series was assumed to be stationary. 
7.5.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the multiple births time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 3.11, 
p=0.211).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
7.5.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the multiple 
births time-series (p=0.258). The residuals of the model were normally distributed, 
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7.5.4 Correlation between claims and the indicator 
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7.6 Claims and Induction of labour 
7.6.1 Stationarity investigation of the indicator times-series 
The null hypothesis of a unit root was not rejected (Z(T)=-1.70, p=0.430). The first difference of 
the series was derived to obtain a series with no unit root (Z(T)=-4.20, p<0.0001). No evidence of 
trend in the transformed time-series was found (p=0.429). The first difference transformed 
time-series was assumed to be stationary. 
7.6.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the induction of labour 
time-series, suggesting an independently distributed time-series (Ljung Box Q statistics= 3.80, 
p=0.150).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 























1 1.2 1.4 1.6 1.8 2
Lag
Bartlett's formula for MA(q) 95% confidence bands
 Induction of labour time-series correlogram
 







40 | P a g e  
 
 
There was no evidence of association between the total damages time-series and the induction 
of labour time-series (p=0.136). The residuals of the model were normally distributed, 
homoscedastic and had no evidence of autocorrelation. 
 
7.6.4 Correlation between claims and the indicator 
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7.7  Claims and Normal birth 
7.7.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the normal birth time-series was found (p<0.0001). The series was 
detrended. The null hypothesis of a unit root was rejected (Z(T)=-3.67, p=0.005). The detrended 
series was assumed to be stationary. 
 
7.7.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the normal birth time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 2.74, 
p=0.255).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 
7.7.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the normal 
birth time-series (p=0.793). The residuals of the model were normally distributed, 
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7.7.4 Correlation between claims and the indicator 




































2000 2002 2004 2006 2008 2010
Year
Normal births rate Total damages
Normal births and total damages 
 







43 | P a g e  
 
7.8  Claims and Operative vaginal births 
7.8.1 Stationarity investigation of the indicator times-series 
No evidence of trend in the operative vaginal births time-series was found (p=0.376). The null 
hypothesis of a unit root was rejected (Z(T)=-3.47, p=0.042). The series was assumed to be 
stationary. 
7.8.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 3.64, p=0.303).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 
7.8.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the operative 
vaginal birth time-series (p=0.767). The residuals of the model were normally distributed, 
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7.8.4 Correlation between claims and the indicator 
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7.9  Claims and caesarean births (all) rate 
7.9.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the caesarean birth rate was found (p=0.043). The series was detrended (by 
subtracting the predicted values from the original values; the predicted values being assessed 
from the model regressing the caesarean birth rate on year of delivery). 
The null hypothesis of a unit root was rejected (Z(T)=-3.88, p=0.002). The detrended series was 
assumed to be stationary. 
 
7.9.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the caesarean births (all) 
time-series, suggesting an independently distributed time-series (Ljung Box Q statistics= 4.01, 
p=0.260).  




7.9.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the caesarean 
births (all) time-series (p=0.629). The residuals of the model were normally distributed, 
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7.9.4 Correlation between claims and the indicator 
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7.10 Claims and elective caesarean births  
7.10.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the Elective caesarean birth time-series was found (p=0.003). The series 
was detrended. The null hypothesis of a unit root was rejected (Z(T)=-3.00, p=0.035). The 
detrended series was assumed to be stationary. 
 
7.10.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the elective caesarean 
births time-series, suggesting an independently distributed time-series (Ljung Box Q statistics= 
1.08, p=0.781).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 
7.10.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the elective 
caesarean birth time-series (p=0.223). The residuals of the model were normally distributed, 
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7.10.4 Correlation between claims and the indicator 
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7.11 Claims and emergency caesarean births  
7.11.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the emergency caesarean birth time-series was found (p=0.003). The series 
was detrended. The null hypothesis of a unit root was rejected (Z(T)=-3.46, p=0.009). The 
detrended series was assumed to be stationary. 
 
7.11.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the emergency caesarean 
births time-series, suggesting an independently distributed time-series (Ljung Box Q statistics= 
1.86, p=0.602).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
  
7.11.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the 
transformed emergency caesarean birth time-series (p=0.802). The residuals of the model were 
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7.11.4 Correlation between claims and the indicator 
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7.12 Claims and Robson Group 1 
7.12.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the Robson Group 1 time-series was found (p=0.013). The series was 
detrended. The null hypothesis of a unit root was rejected (Z(T)=-3.13, p=0.025). The detrended 
series was assumed to be stationary. 
7.12.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the Robson Group 1 time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 0.71, 
p=0.870).  




7.12.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and this time-
series (p=0.616). The residuals of the model were normally distributed, homoscedastic and had 
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7.12.4 Correlation between claims and the indicator 
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7.13 Claims and Robson Group 2 
7.13.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the Robson Group 2 time-series is found (p=0.008). The series was 
detrended. The null hypothesis of a unit root was rejected (Z(T)=-3.51, p=0.008). The detrended 
series was assumed to be stationary. 
 
7.13.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in this time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 3.50, p=0.321).  





7.13.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the Robson 
Group 2 time-series (p=0.588). The residuals of the model were normally distributed, 
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7.13.4 Correlation between claims and the indicator 
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7.14 Claims and Robson Group 5 
7.14.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the Robson Group 5 time-series was found (p<0.0001). The series was 
detrended. The null hypothesis of a unit root was rejected (Z(T)=-5.03, p=0.002). The detrended 
series was assumed to be stationary. 
 
7.14.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 4.288, p=0.232).  





7.14.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and the Robson 
Group 5 time-series (p=0.153). The residuals of the model were normally distributed, 
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7.14.4 Correlation between claims and the indicator 
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7.15 Claims and 3rd/4th degree tears (all) 
7.15.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the 3rd/4th degree tears group time-series was found (p<0.0001) and the 
null hypothesis of a unit root was not rejected (Z(T)=0.736, p=0.991).  The first difference of the 
time-series was derived. The transformed series had no significant time trend (p=0.157) and no 
evidence of unit root (Z(T)=-4.048, p=0.001).  It was assumed to be stationary. 
7.15.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 2.693, p=0.260).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 
7.15.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and 3rd/4th degree 
tear (all) time-series (p=0.261). The residuals of the model were normally distributed, 
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7.15.4 Correlation between claims and the indicator 
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7.16 Claims and 3rd & 4th degree tears in unassisted (normal) births 
7.16.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the 3rd/4th degree tears in unassisted (normal) births group time-series was 
found (p<0.0001) and the null hypothesis of a unit root was not rejected (Z(T)=0.703, p=0.990).  
The first difference of the time-series was derived. The transformed series had no significant 
time trend (p=0.196) and no evidence of unit root (Z(T)=-3.885, p=0.002).  It was assumed to be 
stationary. 
7.16.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 3.51, p=0.173).  




7.16.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and 3rd/4th degree 
tears in unassisted (normal) births time-series (p=0.493). The residuals of the model were 
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7.16.4 Correlation between claims and the indicator 
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7.17  Claims and 3rd & 4th degree tears in assisted (operative vaginal) births 
7.17.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the 3rd/4th degree tears in assisted (operative vaginal) births group time-
series was found (p=0.01) and the null hypothesis of a unit root was not rejected (Z(T)=-0.638, 
p=0.862).  The second difference of the time-series was derived. The transformed series had no 
significant time trend (p=0.507) and no evidence of unit root (Z(T)=-3.05, p=0.031).  It was 
assumed to be stationary. 
7.17.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 1.56, p=0.458).  




7.17.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and 3rd/4th degree 
tears in assisted (operative vaginal) births time-series (p=0.383). The residuals of the model 
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7.17.4 Correlation between claims and the indicator 


































2000 2002 2004 2006 2008 2010
Year
3rd/4th degree tears rate Total damages
 3rd/4th degree tears in assisted (operative vaginal) births and total damages 
 







64 | P a g e  
 
7.18 Claims and postpartum haemorrhage (PPH) ≥1500ml 
7.18.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the postpartum haemorrhage (PPH) ≥1500m time-series was found 
(p=0.01) and the null hypothesis of a unit root was not rejected (Z(T)=0.150, p=0.969). The 
second difference of the time-series was derived. The transformed series had no significant time 
trend (p=0.916) and no evidence of unit root (Z(T)=-3.27, p=0.016).  It was assumed to be 
stationary. 
7.18.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics= 1.10, p=0.578).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
 
7.18.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and PPH≥1500 ml 
time-series (p=0.499). The residuals of the model were normally distributed, homoscedastic and 
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7.18.4 Correlation between claims and the indicator 
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7.19 Claims and Stillbirths 
7.19.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the stillbirths time-series was not found (p=0.261) and the null hypothesis 
of a unit root was rejected (Z(T)=-3.253, p=0.017). The time-series was assumed to be stationary. 
7.19.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed no major evidence of serial correlation in the still birth rate 





7.19.3 Association between claims and the indicator 
There was no evidence of association between the claims and stillbirth time-series (p=0.335). 
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7.19.4 Correlation between claims and the indicator 
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7.20  Claims and intrapartum stillbirths at term 
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7.21  Claims and Apgar score less than 7 at 5 minutes in term babies 
7.21.1 Stationarity investigation of the indicator times-series 
No evidence of trend in the Low Apgar time-series was found (p=0.849) and the null hypothesis 
of a unit root was rejected (Z(T)=-3.70, p=0.004) . The series was therefore assumed to be 
stationary and no transformation was required. 
 
7.21.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the low Apgar time-
series, suggesting an independently distributed time-series (Ljung Box Q statistics= 2.38, 
p=0.499).  
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There was no evidence of association between the total damages time-series and the low Apgar 
time-series (p=0.387). The residuals of the model were normally distributed, homoscedastic and 
had no evidence of autocorrelation. 
 
7.21.4 Correlation between claims and the indicator 
The correlation between the two time-series was r=0.31. 
7.21.5 Sensitivity analysis 
To account for the 0.5% of the 48,824 eligible births without Apgar score at 5 minutes 
information, we imputed their score as follows:  
Where the Apgar scores at 1 minute and at 10 minutes were available and normal (i.e. 7 or 
more), the Apgar score at 5 minutes was assumed to be normal. Where the Apgar score at 1 
minute was available and normal (i.e. 7 or more) and the Apgar score at 10 minutes was missing 
and the baby did not receive resuscitation, the Apgar score at 5 minutes was assumed to be 
normal.  
The remaining missing Apgar scores at 5 minutes were assumed to be low if the Apgar score at 1 
minute was available and low, or normal if the Apgar score at 1 minute was available and 
normal. Following this 0.2% of Apgar scores at 5 minutes remained missing. 
The previous findings were unchanged with no association between the total damages time-
series time-series and the “imputed” Low Apgar rates (p=0.367). The correlation between the 
two time-series was r=0.32 
The analysis was also performed by using the rates of low Apgar at 5 minutes published by 
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used above to obtain the rates for the 1996 to 2009 period. We applied the same selection 
criteria as those described in the published article: Liveborn, term, cephalic, singleton, without 
abnormalities, born at the North Bristol Trust hospital and excluding elective caesarean birth.  
No evidence of trend in the extended (1996-2009) total damages time-series was found and the 
null hypothesis of a unit root was rejected. The series was also independently distributed 
Evidence of trend in the extended Low Apgar rates at 5 minutes time-series was found (p=0.013) 
and the hypothesis of a unit root was not rejected (p=0.290). The first difference of the time-
series was derived which had no time trend and the hypothesis of a unit root was rejected 
(p=0.009). The transformed series was also independently distributed (p=0.775) 
No association was found between the Low Apgar rate at 5 minutes and the total damages 
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7.22 Claims and admission to neonatal intensive care unit (NICU) in term babies 
7.22.1 Stationarity investigation of the indicator times-series 
Evidence of trend in the admission to neonatal intensive care unit (NICU) in term babies rate 
time-series was found (p=0.05) and the null hypothesis of a unit root was not rejected (Z(T)=-
1.485, p=0.541). The second difference of the time-series was derived. The transformed series 
had no significant time trend (p=0.853) and no evidence of unit root (Z(T)=-3.44, p=0.010). It was 
assumed to be stationary. 
7.22.2 Serial correlations investigation of the indicator times-series 
The autocorrelation plot showed little evidence of serial correlation in the time-series, 
suggesting an independently distributed time-series (Ljung Box Q statistics=2.03, p=0.363).  
There was therefore no need to apply a whitening transformation to the time-series. 
 
7.22.3 Association between claims and the indicator 
There was no evidence of association between the total damages time-series and NICU 
admission time-series (p=0.997). The residuals of the model were normally distributed, 
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7.22.4 Correlation between claims and the indicator 
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7.23 Missing data 
 
Table 3: Missing data analysis 
Variable Missing 
number 
Missing % Missing pattern/ comments 
Maternal age 0 0.0% N/A 
Ethnicity 2526 4.8% No difference in PPH, stillbirth or low Apgar rates 
where ethnicity was missing but ethnicity missing 
group less deprived, higher mean gestation and 
lower 3rd/4th degree tear rate 
Index of Multiple Deprivation 
(IMD) 2010 rank 
2663 5.1% Lower mean gestation, fewer women of non-white 
ethnicity and more caesarean births in IMD missing 
group but no difference in stillbirths, PPH, 3rd/4th 
degree tears and low Apgar rate in term babies 
BMI 3346 6.4% Mean gestation lower and fewer 3rd/4th degree 
tears in BMI missing group but no difference by 
index of multiple deprivation rank or ethnicity, 
stillbirth rate, operative vaginal birth, caesarean 
birth, induction or PPH rates 
Parity 0 0.0% N/A 
Gestation 304 0.6% No difference in mean birthweight and low Apgar 
rates but higher stillbirth rate in those with missing 
gestation 
Gestation category 34 0.1% The preterm category was based on corrected 
gestation where gestation was missing (taking into 
account estimated delivery date by scan and 
birthweight (after checking distribution of 
birthweight by week of gestation)). This allowed 
broad categorisation into likely term and preterm 
babies but not precise gestation (although this could 
be imputed too using mean weight) 
Birthweight 124 0.2% Not investigated as proportion missing <0.5% and 
plausible values and distribution 
Multiple pregnancy 0 0% N/A 
Smoking   0% N/A; where smoking status at birth was unknown, 
but smoking during pregnancy was known, this was 
used 
Pre-existing hypertension   n/a  It was assumed that the condition was not present if 
it was not explicitly recorded Pre-existing diabetes   n/a  
Gestational diabetes   n/a  
Pre-eclampsia/eclampsia    n/a  
Placenta praevia/abruption   n/a  
Pregnancy-induced hypertension   n/a  
Antepartum haemorrhage   n/a  
(Suspected) sepsis in labour   n/a  
Cord prolapse   n/a  
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Shoulder dystocia   n/a  Shoulder dystocia is not itself preventable, but 
brachial plexus injury (BPI) may be. BPI rates are not 
currently collected in maternity datasets 
Episiotomy   0.1% Only those recorded as episiotomy were assumed to 
have had episiotomy; very small proportion missing 
so not investigated further 
Mode of birth 51 0.1% Mean gestation and birthweight were lower, and 
stillbirth and low Apgar rates higher in those with an 
unknown mode of birth 
Apgar score at 5 minutes in 
liveborn babies 
352 0.7% No difference in non-white ethnicity or IMD if Apgar 
score at 5 min is missing, but considerably more 
missing if preterm or homebirth or NICU admission 
(the latter not if preterm babies are excluded) 
Admission to neonatal unit 0 0% N/A 
Baby outcome (live/stillborn) 0 0% N/A 
Labour onset 75 0.1% Not investigated as proportion missing <0.5% 
Estimated blood loss at birth 183 0.4% Not investigated as proportion missing <0.5% 
Perineal trauma 132 0.3% Not investigated as proportion missing <0.5% 
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Evaluation of the Sign Up to Safety incentive scheme 
I was a contributor to the maternity component of this evaluation of the Sign Up to 
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This document constitutes the final report for the project P i i  f Da a A a i  a d Ec ic 
Evaluation of the Incentivisation Scheme (IS) in support of Sign up to Safety (SU2S) on behalf of the 
NHS Li iga i  A h i  The NHS Litigation Authority (NHS LA) is supporting Sign up to Safety, a 
campaign launched in June 2014 aiming to improve and strengthen the safety of patients in the 
NHS. As part of the scheme over £18 million has been awarded to Trusts across the country as 
financial incentives to implement interventions aimed at reducing harms leading to clinical claims.  
In January 2015, the NHS LA received 249 bids from 114 member Trusts to the Sign up to Safety 
incentive funding scheme across a wide geographical reach. Sixty-seven bids were approved from a 
range of safety improvement areas, of which around £8.6 million was allocated to maternity units 
and £0.8 million to A&E units.  The payment of the awarded funds was made between May and 
September 2015. Despite there being no official end date for the Sign up to Safety scheme, the 
initiative aimed to see impacts within 3 years. 
 
The NHS LA subsequently commissioned a study to evaluate the cost-effectiveness of the 
incentivisation scheme and to explore the feasibility of developing a dataset to improve safety and 
avoid claims.  
 
An economic evaluation was conducted to assess the impact of the incentivisation scheme and the 
funded interventions on incidents, health and claims. Impacts on health and on claims may not 
materialise until sometime after the incidents occur, perhaps several years afterwards. Therefore it 
was difficult to measure the difference in benefits and costs directly. For this reason we adopted a 
modelling approach, whereby longer-term costs and benefits were modelled from short-term 
impacts on incidents. 
  
We also conducted a qualitative analysis to understand what Trusts thought of the scheme. Overall 
Trusts had a positive perception of the scheme. The main benefit they reported was the provision of 
financial resources for reducing harms, which given the current economic climate were viewed as 
extremely important; without the resources from the scheme the interventions would not have 
been implemented. One Trust reported:  being able to demonstrate quick wins and timely 
improvements/evaluations when presenting business cases can be challenging when there are so 
many demands on resources from all disciplines and whilst it is anticipated the improvements will 
achie e he de i ed effec  he e i  no immedia e ea ance ha  can demon a e i  cce    
Another perceived benefit was that the scheme was supported by the Department of Health, which 
helped Trust staff understand the investment and commitment to improvements a d the fact that 
the staff can see, touch, benefit from the investment in the additional resources provides a direct link 
f om hem o he Depa men  of Heal h   i  i  eall  al able fo  he staff delivering the care to 
have that recognition and understanding . 
 
Trusts also reported that the scheme raised awareness of errors, reporting and claims, improved the 
morale of teams, and had initiated a culture change. For example, one Trust reported: For 
organisations and NHS staff to truly learn from patient harm and medical errors it is important to 
create a safe environment which is less performance based and more values based, to allow staff 
and patients to work more collectively towards creating an open learning service and provide better 
ca e and ea men  a  a e l    
 
The main limitation of the scheme was seen by Trusts to be the short-term and non-recurrent 
nature of the funding and that without future funding impacts were unlikely to be seen in the long 
term. Trusts also recognised that their IT systems could be improved, to assist with routine 
collection of data and evaluate interventions in a more appropriate and timely way.  
 


















































The main aim of the evaluation was to undertake 3 pieces of work:  
 
(1) Collec ing rob  ca e of harm  da a  
This aim was to explore the feasibility of developing a dataset for a range of clinical areas, 
including maternity and A&E, that could be used by a range of stakeholders to improve safety 
and help avoid claims.  
 
(2) Reducing missed fractures in A&E 
Funds were given to a number of Trusts to fund o t of ho rs  senior radiographers and other 
interventions. The aim was to evaluate the impact of the incentivisation scheme on reducing 
the number of missed fractures and subsequent claims for missed fractures.  
 
(3) Reducing intrapartum harm 
Funds were provided for 28 maternity units to implement a range of self-selected interventions 
including: additional cardiotocography (CTG) machines, additional supervisory staff and staff 
training. The aim was to evaluate the impact of the incentivisation scheme on reducing the 
number of adverse outcomes, including stillbirth, hypoxia, and brain injury at birth and 
downstream, the number of litigation claims for maternity services. 
 
Here we summarise what we did and the results of the 3 pieces of work. 
 
(1) Collec ing rob  ca e of harm  da a  
In the first part of the study we explored the feasibility of developing a potential learning dataset. 
The main aim of the dataset would be to assemble data at Trust level on incidents and claims for a 
range of clinical areas that could be used by a range of stakeholders to learn from and help avoid 
claims. There are several datasets already available and we reviewed the following: the National 
Reporting and Learning System (NRLS), the Perinatal and maternity patient management data from 
BadgerNet, the National Neonatal Research Database (NNRD), the National Neonatal Audit 
Programme (NNAP), the risk management software, the NHS maternity statistics and the Hospital 
Episodes Statistics Admitted Patient Dataset, the Friends and Family Test Data for maternity 
services, MBRRACE-UK, the Maternity dashboard, the Each Baby Counts national improvement 
programme and data from the Getting it Right First Time  project on orthopaedic errors.  
 
We explored the availability of a broad range of datasets at national and local levels but most of 
these sources were not sufficient to provide complete data. To be useful, a database should collect 
data on the number and type of incidents and their association with health and claims, but should 
also provide extra information useful in reducing incidents and claims such as adverse events and 
near miss reporting, risk assessment, safety alerts, patient experience and feedback, complaints and 
concerns (e.g., as in risk management software tools and local incident reporting systems, 
MBRRACE-UK or the maternity dashboard).  
 
Given the number and type of datasets currently available, the benefits of collecting new data 
should be clearly identified before embarking on new data collection activities. Any new data that 
are collected should be related to claims, and should be collected in a way that can minimise or 
avoid under-reporting. Finally, costs should be taken into account, not only to set up and maintain a 
database, but also in terms of resources and time spent to collect data at Trust level, extract them, 
clean them and analyse them. There appears to be a considerable amount of data available, but 
little effort to co-ordinate databases or improve their reliability. Therefore we recommend that 
more investment should be made to improve existing datasets (e.g., in terms of data linkage 
between them and improving reporting) rather than creating new ones.  
 
 


















































(2) Reducing missed fractures in A&E 
To evaluate the impact of the incentivisation scheme on reducing harm and claims in A&E units, we 
collected data at Trust level (from both Trusts that received funding from the scheme and those that 
did not)1 on number of X-rays, number of missed fractures in A&E and claims due to missed 
fractures. However, the data were not consistent or complete mainly due to the difficulty in 
measuring missed fractures. 
 
As it was not possible to quantify missed fractures from participating Trusts, we used evidence from 
published studies to assess the effectiveness and cost-effectiveness of the interventions 
implemented by the Trusts as part of the SU2S incentivisation scheme. 
 
A decision model was built to assess the cost-effectiveness of 2 main interventions adopted in 
successful Trusts: continuous quality improvement (CQI) strategies; and, hot reporting of radiology 
imaging. Costs were measured in terms of the funding received by Trusts and the impact of the 
interventions on treatment costs and litigation costs. Outcomes were measured in terms of quality 
adjusted life years (QALYs) using published evidence. The results show that both interventions 
reduce overall costs and improve the health outcomes of patients. Annual cost savings across the 4 
successful Trusts were estimated to be £250,000 and £678,000 with CQI and hot reporting 
interventions, respectively. These values are equivalent to a mean cost saving per patient of £2.50 
and £6.70.  
 
 
(3) Reducing intrapartum harm 
To evaluate the impact of the Sign up to Safety (SU2S) financial incentive scheme in reducing 
intrapartum harm we collected data at Trust level (from both Trusts that received funding from the 
scheme and those that did not) on a broad range of clinical and process measures (stillbirths, low 5 
minute Apgar score <7, therapeutic hypothermia (cooling), unexpected neonatal intensive care unit 
(NICU) admissions, 3rd and 4th degree tears, rates of instrumental delivery and Caesarean sections) 
that could be used to assess the impact of the interventions in reducing harm and future claims. We 
used these to undertake a cost-consequences analysis of the SU2S financial incentivisation scheme 
in maternity units. 
 
A difference-in-differences (DiD) analysis was used to see how these measures changed before and 
after the introduction of the scheme in Trusts who received funding compared with the changes 
over the same time period seen in Trusts that were not part of the scheme. 
 
From the quantitative analysis we found no evidence for any improvements in clinical outcomes in 
either the Trusts who received funding or those who did not. In Trusts who received funding, there 
was no statistically significant difference in any of the outcomes measured, except for a significant 
increase in the number of reported tears, which is likely to be related to increased identification 
with the scheme. These findings were confirmed using a series of sensitivity analyses.  
 
Given these results, it was not possible to calculate cost savings associated with the interventions, 
reduced claims, or improvements in health-related quality of life and mortality.  
 
Further analysis at a later date may be beneficial, after a longer period has elapsed since Trusts 
implemented the interventions. It is difficult to specify what this period might be. We speculate that 
interventions might take a year to implement fully from the start date and then at least a year to 
                                                     
1 In he repor  e se he erm s ccessf l  and ns ccessf l  Trust to refer only to whether or not the Trust 
was successful in being awarded funding as part of the scheme (e.g., we do not refer to the ability of the Trust 
in improving outcome measures).  
 


















































have an effect on incidents. For maternity care, in our data, the average time gap between the date 
of incident and the date a claim is made was 3.5 years, and so if future research was to measure the 
impact on claims directly in maternity services a substantial period from the date at which 
interventions were implemented needs to have elapsed. This time period might vary by the type of 
intervention and the clinical specialty. Further research on the appropriate time period for 
measurement would be useful.   
 
In analysing data from the NHS LA Claims Database we calculated the minimum number of claims 
that would need to be avoided for the SU2S financial incentivisation scheme to be considered good 
value for money. Using the average cost for a successful cerebral palsy (CP) claim to the NHS LA of 
£4,745,295, and that in total just over £8 million pounds were invested in maternity interventions 
for the scheme, then it would be cost saving if there were two fewer CP claims across the 28 Trusts 
who received funding over the duration of the project.  Based on published data, in order to achieve 
this it would be necessary to avoid: 18 cases of babies cooled, or alternatively 70 babies born with 
an Apgar score <75 minutes or 24 babies born with an Apgar score <45 minutes across these Trusts.  
This is likely to be possible as the mean Apgar score <75 minutes was 1.3% and there are reported 
rates in the UK of <0.5% that have been sustained for more than a decade2.  
 
An indirect benefit of the scheme reported by NHS LA was that the NHS LA partnered with NHS 
Supply Chain to assist the maternity units in collectively procuring their equipment, and a saving of 
£36k was achieved from sales of £227k.  
 
We identified several reasons why the scheme might not have had an impact on reducing 
intrapartum harm: 
- Choice of interventions. Taking the results of the statistical analysis at face value, the 
interventions implemented by Trusts within the evaluation timeframe, may not have been 
effective in reducing harms. The maternity units invested their funding in a broad range of 
interventions, and evidence of effectiveness for the interventions they implemented is limited. 
Also, the Trusts all implemented different interventions, so the overall result could reflect a 
mixture of effective (although not demonstrably so due to the short timeframe) and ineffective 
interventions. 
- Implementation problems. At the time of the analysis (conducted 12-14 months after the Trusts 
had received funding from the scheme) not all Trusts had implemented all of the interventions 
they had originally proposed. 
- Short duration of follow up. There is likely to be a delay before the benefits of the interventions 
are seen, so even if interventions are fully implemented then it may take longer than the time 
horizon of our evaluation (one year) to see a tangible benefit. In at least one unit level 
intervention with positive outcomes, a year was required to train all of the unit, and outcomes 
changed in the following year.  
- Data quality. The results of our analysis may be limited by the quality of data provided. 
Maternity datasets are recognised to be some of the most accurate in the NHS, however many 
Trusts found it difficult to provide data from their IT department for this evaluation, and some 
used paper records to source data for us, which might have negatively impacted on the accuracy, 
reliability and completeness of the data. In addition, the small sample size (we only had 
aggregate data for 44 Trusts, and this was not always complete) and the lack of patient level data 
may also have affected the results.  
 
                                                     
2 Draycott T, Sibanda T, Owen L, Akande V, Winter C, Reding S et al. (2006) Does training in obstetric 






















































Summary and recommendations 
 
The evaluation has provided two different results, both of which are limited by the availability of 
data. On one hand providing funding to reduce missed fractures in A&E has shown a reduction of 
the overall costs (including litigation costs) and an improvement in patients’ health and health care, 
but it was not based on actual data from participating Trusts.  On the other hand providing funding 
in maternity units did use data from participating Trusts but did not demonstrate any statistically 
significant impacts of the interventions on clinical outcomes. 
 
On the basis of the evidence generated for this report it appears that the interventions regarding 
missed fractures in A&E may be cost-effective, but those to reduce intrapartum harms in maternity 
units may not be or it may be too early to tell; however, it is difficult to draw conclusions given the 
available data in both areas.  
  
Recommendations 
   
1. Given the timelines involved, further evaluation of the scheme in the future may be beneficial. 
This is likely to vary by the type of intervention and the clinical speciality, but is likely to be 
several years.  
 
2. A balance needs to be made between making top-down recommendations about the 
interventions Trusts ought to implement, and giving Trusts autonomy to which interventions to 
implement in response to local needs. However, interventions in this and similar schemes 
should be based on good evidence of effectiveness and cost-effectiveness. We concur with the 
2016 NHS England National Maternity review recommendation: Most importantly, any training 
undertaken must have been proven to be effective in improving outcomes or other aspects of 
qualit  and its impact monitored locall .  
 
3. Future schemes could include establishing evidence on the main causes of errors, and 
signposting effective interventions with support for local measurement and regional 
benchmarking of clinical outcomes (A&E, maternal and neonatal outcomes), process measures 
(interventions), and implementation (e.g., proportion of staff trained).  
 
4. Recognition needs to be given to the timescale between allocation of funding and 
implementation time (e.g., implementation of intervention can be delayed by procurement 
time). Efforts should be made to ensure that Trusts awarded funding from this and similar 
schemes can act on that funding in a timely manner, so the interventions can be of maximum 
benefit to patients as soon as possible.  
 
5. At present there is a considerable amount of data available on errors and claims but more effort 
is required to coordinate these data, improve their reliability and reduce under-reporting.  
 
6. To assist with reporting, investment in providing integrated, flexible, efficient and user-friendly 
IT systems is needed to bring all Trusts up to a minimum standard. This will allow data to be 
collected in a timely, accurate, complete and reliable way.  
 
7. The NHS LA could usefully partner with recognised academic, Improvement Science and clinical 
groups to improve the selection, implementation and evaluation of improvement initiatives in 
the future.  
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1. Background and aims  
 
The NHS Litigation Authority (NHS LA) has supported Sign up to Safety (SU2S)
3
, a campaign launched 
in June 2014 by the Secretary of State for Health aiming to improve and strengthen the safety of 
patient care in the NHS. The initiative aimed to save 6,000 lives, halve avoidable harm and halve the 
costs of harm in the NHS over the following three years. All health organisations have been asked to 
develop safety improvement plans to reduce harm and save lives by working to reduce the causes 
of harm and take a preventative approach.  
 
The NHS LA provided support to the campaign offering financial incentives to those organisations 
that provided evidence that their Safety Improvement Plans would reduce harm and claims. A 
description of the SU2S incentivisation process is available in Appendix 1. In January 2015, the NHS 
LA received 249 bids from 114 member Trusts to the Sign up to Safety incentive funding scheme 
across a wide geographical reach. Sixty-seven bids were approved from a range of safety 
improvement areas; the top five focus areas were:  
 
1. Maternity - purchase of cardiotocography (CTG) electronic monitors, STAN (ST analysis - 
fetal ECG m ni  ec i men  f  ec nd ai  f e e  cen al CTG m ni ing and ale  
systems, remote access to tracings, training. 
2. Safety Culture - a range of human factors and teamwork interventions. 
3. Surgical - includes training and equipment, human factors training in a number of surgical 
specialties particularly orthopaedics and neurological surgery. 
4. A&E - improving missed and delayed diagnosis, especially fractures, diagnostics, h  
radiography reporting in 24 hours, performance feedback on missed diagnoses. 
5. Deteriorating patient - early and improved recognition, electronic flags, improved 
management pathways. 
 
The 67 bids received total funding of £18.7 million, of which around £8.6 million was allocated to 
maternity and £0.8 million to A&E.  
 
The payment of the awarded funds was made in 2015, but at different points in time: 32 Trusts 
were given funding in May, 8 Trusts in June, 2 in July, 4 in August and 2 in September. Only 
Foundation Trusts were allowed to carry forward funding allocated, whereas others were required 
to implement plans of their bid within 2015. A detailed description of all the interventions is 
provided in the relevant chapters below. Despite there being no official end date for the Sign up to 
Safety scheme, the initiative aimed to see impacts within 3 years. Trusts were required to provide 
reports at six months and one year to monitor their progress.  
 
The NHS LA subsequently commissioned a study to evaluate the cost-effectiveness of the 
incentivisation scheme and to explore the feasibility of developing a dataset to improve safety and 
avoid claims. 
 
The main aim of the evaluation was to undertake 3 pieces of work:  
 
(1) Collec ing rob  ca e of harm  da a  
This aim was to explore the feasibility of developing a dataset for a range of clinical areas, 
including maternity and A&E, that could be used by a range of stakeholders to improve safety 
and help avoid claims.  






















































(2)Reducing missed fractures in A&E 
Funds were given to a number of Trusts to fund ‘out of hours  senior radiographers and other 
interventions. The aim was to evaluate the impact of the incentivisation scheme on reducing 
the number of missed fractures and subsequent claims for missed fractures.  
 
(3) Reducing intrapartum harm 
Funds were provided for 28 maternity units to implement a range of self-selected interventions 
including: additional cardiotocography (CTG) machines, additional supervisory staff and staff 
training. The aim was to evaluate the impact of the incentivisation scheme on reducing the 
number of adverse outcomes, including stillbirth, hypoxia, and brain injury at birth and 
downstream, the number of litigation claims for maternity services.  
 
We also conducted a qualitative analysis to understand what Trusts thought of the scheme.  
 
The report is structured in seven sections: we first report the results of the qualitative analysis 
performed to capture the views of the Trusts about the scheme. In section 3 we provide an 
overview of the dataset already available and the feasibility of developing a new learning dataset to 
avoid harm. In this section we will highlight some of the problems encountered in collecting the 
data for the main analysis. After describing the overall methodology of the economic evaluation in 
section 4, we then present the results of the evaluation in A&E and maternity units in sections 5 and 
6 respectively. We conclude the report in section 7 by discussing the results of the study and 
providing some recommendations.  
 
2. What do Trusts think of the Sign up to Safety Bid Incentivisation Scheme?  
 
Before exploring the cost-effectiveness of the financial incentive scheme, it is useful to understand 
the impressions of the Trusts regarding the scheme.  
 
To this end, on 1st December 2016 we contacted by email both Trusts that received funding and 
those who applied for funding but were unsuccessful and asked them to complete and return a 
questionnaire aimed at capturing their impressions of the scheme (Appendix 2). The questionnaires 
were directed to the contact person referred by NHS Litigation Authority, most of whom occupied a 
senior management position, for example Director of Quality, Head of Corporate Risk or 
Governance Lead. 
We asked the Trusts to tell us what they thought were the main positive aspects of the scheme, 
what were the main limitations and what could be done differently. A reminder was sent in the 
following weeks. Overall 15 of the 55 Trusts contacted responded (27%) by 20th December and two 
of these were unsuccessful Trusts.  
 
Here we summarise what, according to these Trusts, are the positive aspects of the scheme, the 
limits and challenges, what could be changed or improved upon and some key messages to the 
Department of Health. A full list of comments is reported in Appendix 3.  
 
Positive aspects of the Sign up to Safety Incentivisation Scheme  
Overall the Trusts provided very constructive comments about the SU2S financial incentives 
scheme. When asked, Trusts identified five main positive aspects of the scheme:  
- Availability of resources and funding: the scheme financially supported the organisations in 
taking forward some safety projects that would have otherwise not been possible without 
the funding. In the current economic climate Trusts find it extremely difficult to obtain 
 

















































additional resources, therefore the scheme was essential to implement intervention that 
otherwise would have been difficult to achieve.  
- Improved safety and outcomes: the scheme has allowed Trusts to get organised around 
safety and to focus on reducing avoidable harm. As a large majority of incidents and claims 
are due to human factors, being given the opportunity to understand how and why medical 
errors occur, and tackle these issues has been valued as extremely important. 
- Support from NHS LA and communication: the Trusts appreciated the support received from 
NHS LA and the communication provided via webinars and weekly emails. Being part of the 
SU2S scheme has been extremely important for Trusts to increase their awareness of safety. 
Being connected with other organisations has allowed networking and exchange of ideas.  
- Learning and sharing with other organisations: the scheme has allowed organisations to 
learn from each other, share good practice and improvements nationally.  
- Impact on staff: the scheme has increased awareness among staff, increasing their 
confidence through training, but also promoting multidisciplinary working, bringing together 
staff at all levels across the NHS all facing similar challenges. During the NHS LA workstream 
events, staff have been given the chance to speak up and be listened to. The SU2S financial 
incentive scheme might have made a bigger impact than the one that can be quantified, in 
terms of team work, enthusiasm and change in culture. The scheme has sent a strong 
message to staff that the Department of Health recognises and cares about the work they 
do and that, despite the current cuts in the NHS, the SU2S financial incentives scheme has 
provided a tangible help in terms of investment.  
 
Limits and challenges of the Sign up to Safety Incentivisation Scheme  
Trusts raised the following limitations of the scheme:  
- Funding process and monetary aspects: funding was limited and some Trusts could not get 
the necessary resources to implement new interventions at all or at least in some areas. 
Moreover the funding was only made available for a short time, limiting the potential to 
observe substantial long-term benefits.  
- Sustainability of the scheme: related to the funding is the sustainability of the scheme and 
embedding it into everyday care. For example, Trusts that have used the funds to recruit 
new staff are now facing the risk of not being able to retain those posts without additional 
resources.  
- Organisational priorities: organisations have to ensure that the scheme fits in with their 
strategic objectives, otherwise it will not get the Trust Board support and fail. Also, in many 
cases the need to bid for funding before the work began meant that the original project 
scope did not necessarily match what was actually needed, because needs can change 
overtime.  
- Data collection: several Trusts found it difficult to collect the data necessary to evaluate 
whether or not the interventions implemented were effective at reducing harms. 
- Many Trusts noted the time required to see improvement may be long: many interventions 
will show their impact in the long term, therefore the scheme length may not be sufficient 
to show significant change. 
 
Proposed changes 
Trusts provided the following suggestions to improve different aspects of the scheme if it were to 
be run again in the future: 
- Bidding process: the bidding process was perceived as very onerous, therefore more time 
and support should be provided with the bid and project planning.  
- Support and collaboration: almost all Trusts have requested additional support from the 
NHS LA but also from academics to plan the interventions and to evaluate the impact made. 
This could be achieved by the NHS LA collaborating with established groups of academics 
 


















































who could work with both the NHS LA and the locally funded teams. Additional support is 
also required from an IT perspective, to make sure that the data required for the evaluation 
of the interventions are collected in an appropriate, timely and complete way.  
- Funding and sustainability: the Trusts suggest that funds should be given for long term 
investment of at least 3 years, to enable embedding and sustainability of change. This might 
mean funding fewer Trusts, each for a long period of time.  
- Selection of the interventions: according to some Trusts it would have been useful to focus 
on key aspects of patient safety that need improving according to evidence and select 
interventions which have shown to be effective.  
- Evaluation of he cheme  im ac  while some Trusts suggest that they should be free to 
provide their individual measures of success, others think that an evaluation strategy with 






















































3. Development of a learning dataset 
 
In this section we explore the feasibility of developing a potential learning dataset. The main aim of 
the dataset would be to collect data at Trust level on incidents and claims for a range of clinical 
areas, including maternity and A&E that could be used by a range of stakeholders to learn from and 
help avoid claims.  
 
To be useful a dataset should have the following components:  
 
1. Data on the number and type of incidents and their association with health and claims. 
A detailed dataset containing these data would be able to provide background epidemiological data 
on the causes of incidents and how they relate to claims. To be useful, the type of incidents being 
collected should have a proven relationship with health and/or claims, and should be collected in a 
routine way to minimise under-reporting. 
 
2. Data on interventions to reduce incidents and claims.  
Another useful component would be a database of interventions that have been shown to be 
beneficial in reducing incidents or claims. This could also include interventions that have been 
proven to be not effective so these could be avoided.  
 
3. Data to routinely evaluate the impact of interventions when they are implemented. 
Such a dataset would facilitate evaluation of similar schemes in the future and more precisely 
analyses of the reduction in incidents and extra costs of interventions, plus supplementary data that 
could be used for modelling improvements in health, reduction in claims, a reduction in the cost of 
treating incidents and reduction in spending on claims.  
 
3.1. Methods  
 
We first describe what data are available in the NHS LA claim dataset, then we explored the content 
of the dataset available at national and local levels with specific reference to maternity and A&E.  
3.1.1. NHS LA claims dataset 
The NHS LA dataset contains data on claims at a national level from 1995 on a broad range of 
specialties. The data include the ID code of the claim, the name of the Trust or setting, the specialty 
(e.g., obstetrics or A&E), the main type of injury (e.g., cerebral palsy or missed fracture), the second 
and third injury if present, any concatenated injury (e.g., deafness, brain damage, unnecessary pain), 
the main cause of error (e.g., fail to monitor 1st stage labour, fail to diagnose fracture), the 
description of incident, including the date of incident, date of case creation (claim to NHS LA), the 
payout/outcome of case, including indication of the total cost paid, that includes costs for damage, 
defence and claimant costs. Recently a new field has been included in the dataset reporting whether 
the claim was preceded by a formal complaint. 
 
The analysis of the NHS LA claim dataset could provide useful information on the main type of 
injuries and most importantly on the main causes of incident. 
 
A detailed analysis of the maternity and A&E claim data is in sections 5 and 6.  
 
 


















































3.1.2. Other available databases at national and local level 
We checked the feasibility of linking the data available from NHS LA and from the Trusts with other 
databases at national and local level. In particular we looked at databases that could provide 
information on safety, harm and incidents, or that could be linked to errors with specific reference 
to maternity and A&E. These include: 
- National Reporting and Learning System (NRLS); 
- Perinatal and maternity patient management data from BadgerNet; 
- Neonatal data as derived from the National Neonatal Research Database, maintained by the 
Neonatal Data Analysis Unit (NDAU); 
- National Neonatal Audit Programme (NNAP); 
- Risk management software tool; 
- NHS maternity statistics; 
- Hospital Episodes Statistics Admitted Patient Dataset; 
- Friends and Family Test Data for maternity services; 
- MBRRACE-UK: Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries 
across the UK; 
- Maternity dashboard; 
- The Each Baby Counts national improvement programme; 
- Da a f m he Ge ing i  Righ  Fi  Time  f  h aedic  e  
 
A detailed description of each database is provided below.  
 
The National Reporting and Learning System (NRLS)  
The National Reporting and Learning System (NRLS)4 is a central database of patient safety incident 
reports. Since the NRLS was set up in 2003, over four million incident reports have been submitted. 
All information submitted is analysed to identify hazards, risks and opportunities to continuously 
improve the safety of patient care. 
The database includes data on incidents by: 
- type of incident: this includes accident, implementation of care and ongoing monitoring or 
review, medication, treatment and procedure, access, admission, transfer or discharge (or 
missing patients), documentation (including electronic and paper records, identification and 
drug charts), infrastructure, clinical assessment (diagnosis, scans, tests, assessments), self-
harming behaviour, consent, communication, confidentiality, disruptive, aggressive 
behaviour (including patient to patient), medical device or equipment, infection control 
incident or other incidents; 
- setting: acute and general hospital, ambulance, mental health service, community nursing, 
medical and therapy service, learning disability service, ambulance service, community 
pharmacy, general practice, community and general dental service and community 
optometry service;  
- degree of harm: no harm, low, moderate, severe, death;  by care setting and type of 
incident. 
Despite being very informative, the quality of the data still needs improvement in terms of both 
completeness and accuracy (there are still many gaps in data, spelling errors and inconsistencies)5 
and the current dataset is not necessarily reflective of other measures of hospital quality and 
safety6.    
                                                     
4 http://www.nrls.npsa.nhs.uk/; https://report.nrls.nhs.uk/nrlsreporting/  
5 NIHR Imperial Patient safety translational research centre (2016). NRLS Research and Development. 
www.imperial.ac.uk/media/...of.../IMPJ4219-NRLS-report_010316-INTS-WEB.pdf   
6 Howell AM, Burns EM, Bouras G, Donaldson LJ, Athanasiou T, Darzi A. (2015). Can Patient Safety Incident 
Reports Be Used to Compare Hospital Safety? Results from a Quantitative Analysis of the English National 
Reporting and Learning System Data. PLoS One;10(12):e0144107. 
 


















































Perinatal and maternity patient management data from BadgerNet 
BadgerNet Maternity7 is a full end-to-end, paperless maternity system with an easy to use interface 
that allows real-time recording of all events wherever they occur: in the hospital, community or 
home. This includes both high risk and low risk pregnancy pathways. The BadgerNet system is 
managed by Clevermed Ltd, an authorised NHS hosting company.  
The system includes: 
- BadgerNet Maternity, with data on maternity events and pregnancy pathways occurring in 
hospital, community or home;  
- BadgerNet Neonatal, with records of care for all babies within neonatal services and it is in 
use in over 250 hospitals in the UK; 
- BadgerNet Paediatric Intensive Care (PICU), that records all events within a paediatric 
intensive care or high dependency unit.  
Despite the system having been improved in the last few years, BadgerNet needs to be 
complemented with data from the Trusts as some are not complete. This is done by the National 
Neonatal Research Database.  
 
The National Neonatal Research Database 
The National Neonatal Research Database (NNRD)8 has been created through the collaborative 
efforts of neonatal services across the country to be a national resource. The NNRD is maintained 
and managed at the Neonatal Data Analysis Unit (NDAU) at Imperial College London and Chelsea 
and Westminster NHS Foundation Trust. The NNRD contains a defined set of data items (the 
Neonatal Dataset) that have been extracted from the BadgerNet neonatal electronic health record 
of all admissions to NHS neonatal units. Contributing neonatal units are known as the UK Neonatal 
Collaborative. The NNRD is updated each quarter and approximately 80,000 new patient records are 
incorporated each year. Data are currently available from 2010 when 96% of neonatal units in 
England contributed; from 2012 there has been 100% contribution from English neonatal units. The 
main advantage of using NNRD is that it contains data from BadgerNet and data from the Trusts that 
are cleaned and linked, so that the proportion of missing data is reduced.  
 
National Neonatal Audit Programme 
The National Neonatal Audit Programme (NNAP)9 was established in 2006 to support professionals, 
families and commissioners in improving the provision of care provided by neonatal services which 
specialise in looking after babies who are born too early, with a low birth weight or who have a 
medical condition requiring specialist treatment. The NNAP Annual Report highlights the key 
findings and recommendations from the analysis of the data provided by neonatal units on the 
admissions of babies for neonatal care in England, Scotland and Wales each year. Data in the NNAP 
include data on: body temperature, antenatal steroids, retinopathy of prematurity, feeding, 
consultation with parents, disability follow-up, bronchopulmonary dysplasia, cultures and infections.  
 
Risk management software tool (vendor system)  
To electronically submit patient safety incident reports to NRLS, all Trusts use a risk management 
software tool, such as Datix10, Prism, Sentinel, Ulysses11 or other locally designed systems. These are 
web-based patient safety software for healthcare risk management applications. Using a variety of 
integrated software modules these software deliver a broad range of elements related to safety, 
risk and governance (e.g., incident, adverse event and near miss reporting, patient relations, 
                                                     
7 http://www.clevermed.com/badgernet/badgernet-maternity/ 
























































malpractice claim management, risk assessment, safety alerts, patient experience and feedback, 
accreditation self-assessment, complaints, compliments, comments and concerns).  
 
NHS maternity statistics 
NHS maternity statistics12 contains a wide range of maternity information with details of all births 
taking place in NHS hospitals (in England) excluding home births and those taking place in 
independent sector hospitals. This includes a wide range of information such as details of how the 
baby was born (method of delivery, onset), mother age, level of deprivation, ethnicity, delivery and 
birth complications, birth weight and gestation.  
 
Hospital Episodes Statistics Admitted Patient Dataset  
Hospital Episodes Statistics (HES)13 is a data warehouse containing records of all patients admitted 
to NHS hospitals in England. It contains details of every hospital stay in English NHS hospitals and 
English NHS commissioned activity in the independent sector. Each record in HES includes a wide 
range of information including details of the patient (age, gender, geographic details), when they 
were treated and what they were treated for. This is the most complete database on admissions 
data in England.  
 
Friends and Family Test Data for maternity services 
The Staff FFT14 was introduced in April 2014 to allow staff to give feedback on NHS services based on 
recent experience. Staff are asked to respond to 2 questions: a) the care question asks how likely 
staff are to recommend the NHS services they work in to friends and relatives needing care; b) the 
work question asks how likely staff would be to recommend the NHS service to friends and family as 
a place to work. The survey is conducted on a quarterly basis. The data are not classified as Official 
Statistics.  
 
MBRRACE-UK: Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries 
across the UK; 
MBRRACE-UK15 is a national collaborative programme of work involving the surveillance and 
investigation of maternal deaths, stillbirths and infant death, including the Confidential Enquiry into 
Maternal Deaths (CEMD). MMBRRACE-UK collects information about all mothers in the UK who die 
during pregnancy or within 12 months after giving birth and some mothers who experience a 
serious illness in pregnancy or soon after giving birth, all mothers of babies who are stillborn or 
whose baby dies in the first few weeks after being born or have serious illnesses, and all births and 
stillbirths across UK (data cover England, Wales and Scotland but arrangements are still ongoing for 
Northern Ireland).   
 
Maternity dashboard  
The maternity dashboard16 is a tool used to monitor the care given by maternity service against 
what is considered to be good practice in relation to safety and quality. It was first developed in 
2008/09 for use across Kent, Surrey and Sussex and it was reviewed in 2014 by the South East 
Maternity, Children and Young People’s Strategic Clinical Network (SE MCYP SCN . The dashboard 
includes a range of metrics that look at process and outcomes from several sources: HES, the 
national Friends and Family Test, and locally supplied data. Metrics include data on care, type of 
delivery (vaginal birth, caesarean sections, instrumental births, epidural, and episiotomy), serious 


























































incidents, complaints, 3rd and 4th degree tears, emergency readmissions within 30 days of delivery 
and NICU admissions. It provides information about the quality and safety of maternity services 
across the South East and is designed as a quality improvement tool for hospital providers of 
maternity care and commissioners of maternity services. Dr Matthew Jolly, National Clinical Director 
for the National Maternit  Re ie  and Women s Health  is currently leading the innovative 
development of a national interactive maternity dashboard. This could in the future have potential 
links with NHS LA claims data.  
 
The Each Baby Counts national quality improvement programme 
Each Baby Counts17 is the RCOG s national qualit  impro ement programme to reduce the number 
of babies who die or are left severely disabled as a result of incidents occurring during term labour. 
The aim of the programme is to reduce unnecessary loss of life by 50% by 2020. 
Since 2015 data on still birth, death of a new-born baby and the birth of a baby with brain injuries 
have been collected and analysed from all UK units to identify lessons learned to improve future 
care. This will allow making recommendations to be made on how to improve practice at a national 
level.  
 
Da a f  he Ge i g i  Righ  Fi  Ti e  f  h aedic  e  a  a  f he R al Na i al 
Orthopaedic Hospital NHS Trust) 
The Getting it right first time  GIRFT 18 report published by Professor Briggs in late 2012, 
considered the current state of England s orthopaedic surger  pro ision and suggested that changes 
can be made to improve pathways of care, patient experience, and outcomes with significant cost 
savings. The report takes the view that this approach has the potential to deliver a timely and cost 
effective improvement in the standard of orthopaedic care across England.  Part of the project 
looked at claims in orthopaedics, but data were gathered from the NHS LA claim database. A new 
pilot will undertake a national review of baseline data and collect new data on clinical outcomes, 
processes, patients experience and pathways, network arrangements, financial impacts and waiting 
times. 
 
3.2. Experience of data correspondence from this study    
As part of the study we have tried to correlate data on incidents provided to us by the Trusts with 
data on claims from the NHS LA. However this proved to be extremely difficult as the Trusts are not 
currently provided with a computerised system to record this information.  
 
Positive aspects of the data gathering to evaluate the scheme  
Having to collect data to evaluate the scheme meant that some Trusts discovered anomalies across 
different systems they used, or glitches where data moves from one system to another. Based on 
the sanity checks that we ran on their data, Trusts had to look into discrepancies and are now able 
to look into fixing this and were grateful for the queries. 
 
Main challenges  
The main difficulties in obtaining sufficient data to analyse the potential harm and to be used to 
avoid incidents have been identified as the following:  
- Lack of dedicated staff to register the data; 
- Lack of time for current staff (in same cases people had to work during days off to collect 
the data); 





















































- Lack of expertise in accessing the data already available and consequent requirement to 
involvement of more people (especially if data held with more than one department); 
- Information is stored across different systems and in different departments (e.g., data on 
perinatal harm is stored in maternity units and neonatal units in different systems); 
- Limitations of access to IT systems regarding what has been recorded; 
- Lack of access to IT system altogether (this is rare, but it was reported in one Trust), 
meaning that people had to search through paper records for some information;  
- Changing IT systems, meaning that figures are recorded differently between old and new 
systems and separate searches have to be done for different time periods.  
 
Potential changes and improvements 
According to Trusts some things could perhaps help change the current system and make data 
collection easier:  
- Knowing ahead of time that they would be required to submit this information as part of 
the evaluation of the SU2S scheme would have meant that they could have tried to record 
it, at least for the last 2-3 years, in the right format, to make access simpler and faster; 
- Providing funding for proper IT systems in some Trusts. It seems there is little point in trying 
to improve things if there is no way of measuring whether or not it has worked.  
- Providing funding for extra or dedicated staff to collect and record data. 
 
3.3. Discussion  
A detailed dataset containing data on the type and number of incidents and their association with 
health and claim would provide background epidemiological data on the causes of incidents and 
help in designing strategies for reducing claims.  Data to routinely evaluate the impact of 
interventions when they are implemented would facilitate the analyses of the reduction in incidents 
and extra costs of interventions.   
 
Various software systems are being used in maternity units to collect and store electronic data, 
which can be easily retrieved and linked to other databases. However, each unit should have a 
designated person responsible to ensure accurate recording and maintenance of maternity data. 
The CNST clinical governance standards require maternity units to have a risk management midwife 
or a manager in place.  
 
It is important to crosscheck the data to ensure accuracy; for example, the operation book in the 
operating theatre could be checked to verify the number of caesarean performed each month or 
week. Information about patient complaints could be obtained from the complaints manager of the 
Trust. 
 
As mentioned, to be useful a dataset should have the following components:  
 
1. Data on the number and type of incidents and their association with health and claims. 
A detailed dataset containing these data would be able to provide background epidemiological data 
on the causes of incidents and how they relate to claims, which would be useful for designing 
strategies for reducing claims, plus evaluating them (see number 3, below). To be useful, the type of 
incidents being collected should have a proven relationship with health and/or claims, and should 
be collected in such a way so as to ensure reliable reporting (i.e., minimising under-reporting by 
making data collection routine). The costs of collecting, analysing and disseminating the data should 






















































2. Data on interventions to reduce incidents and claims.  
While having epidemiological data of the kind described above is useful it is unlikely to directly 
inform strategies to reduce claims. Therefore, another useful component would be a database of 
interventions that have could be beneficial in reducing incidents or claims. This could also include 
interventions that have been proven to be not effective so these could be avoided. Data would also 
ideally be recorded on the incremental cost-effectiveness of interventions, where these data exist, 
as well as their impact on incidents and claims, along with the available evidence. This is likely to 
consist of systematic reviews that are routinely updated and disseminated.  
 
3. Data to routinely evaluate the impact of interventions when they are implemented. 
Such a dataset would facilitate evaluation of similar schemes in the future and more precisely 
analyses of the reduction in incidents and extra costs of interventions, plus supplementary data that 
could be used for modelling improvements in health, reduction in claims, a reduction in the cost of 
treating incidents and reduction in spending on claims. As noted, this dataset should be able to 
accommodate a study design that can evaluate the impact of interventions that is not affected by 
confounding factors, and therefore data need to be collected across Trusts and over time.  
 
Several datasets are currently available on incidents, health outcomes and claims. Given the number 
and type of datasets that are currently available, careful thought needs to be given to the costs and 
benefits of collecting new data and before doing so confidence is needed that it will provide 
additional new information that could be used to learn from and help avoid claims. Important 
questions to consider before embarking on a new data collection exercise might include: 
 
1. What are the benefits of collecting new data? 
1.1. Is there evidence the data on incidents being collected are related to claims? 
1.2. Can the data be collected in such a way so as to minimise or avoid under-reporting? 
1.3. How, precisely, will the data being collected be useful to learn from and help avoid claims? 
2. What are the costs of collecting the data? These are likely to include costs incurred to: 
2.1. Collect and record the data in Trusts.  
2.2. Extract the data from Trusts and assemble it into a central database for analysis, including 
dealing with data security and information governance issues. 
2.3. Analyse the data. 
2.4. Disseminate the data and analyses.  
 
An alternative approach that should also be considered is to build on existing datasets, focusing on 
better linkage between them and improving data quality by encouraging accurate and timely 
reporting. We suggest that the way forward may be to invest more in coordinating and improving 
the reliability of what already exist, instead of starting to collect new data.  
 
Information Governance issues need to be resolved so data can be easily interrogated and shared 
with researchers and Trusts, with appropriate data handling and security restrictions. These data 
could also be routinely disseminated, though impact on participation should be explored if data are 
not anonymised (see the Sentinel Stroke National Audit Programme19 and the National Chronic 
Obstructive Pulmonary Disease (COPD) Audit Programme20 for examples of widely disseminated 
routinely collected data).  
 





















































4. Economic evaluation of the Incentivisation Sign up to Safety Scheme  
In this section we describe the overall methodology we planned to adopt for the evaluation of the 
Sign up to Safety financial incentives scheme in maternity and A&E units.  
More specifically we describe the: 
- overall approach adopted  
- identification of interventions and measures  
- iden ifica ion and assessmen  of he in er en ions  cos s 
- identification of comparators 
- identification and assessment of the impact of the interventions in terms of errors  
- Difference-in-Difference approach 
- identification and estimation of the reduction in costs due to avoided errors/incidents and 
future claims 
- estimation of the improvement in health due to a reduction of errors and incidents 
- assessment of the difference in benefits and costs  
- measurement of cost-effectiveness 
- sensitivity analysis 
- data collection 
- final analysis  
 
A more detailed description of the methods is provided in sections 5 and 6 where the A&E and the 
maternity interventions are specifically analysed. 
 
4.1. Economic Evaluation Approach  
 
The approach 
Our proposed conceptual framework to evaluate the cost-effectiveness of the incentive funding 
scheme is summarised in Figure 1. The aim is to calculate the incremental cost-effectiveness of the 
scheme  The anal sis is incremen al  in he sense ha  cos -effectiveness is evaluated with respect 
to a comparator, the counterfactual (i.e. not participating in the scheme). The incremental cost-
effectiveness of the scheme depends on the difference in benefits or outcomes associated with 
participating in the scheme compared with not participating in it, and the differences in costs. 
 
Interventions and measures 
The first phase of the evaluation consisted of the identification of the single interventions /actions 
proposed by each Trust to reduce harm and incidents in the maternity and A&E units.  
 
We contacted the successful21 Trusts to provide us with a report summarising the specific areas  
they were addressing as part of the scheme, which interventions they were proposing, how the 
funds were allocated and spent across different interventions, what outcome measures they were 
planning to use and the type of information available on the impact of the scheme (number and 
types of incident and claims). The form used to collect these information is in Appendix 4.  
 
Due to the heterogeneity of the interventions implemented in each Trust we grouped the 
interventions in 9 groups according to aim and similarity (e.g., computer hardware/software, fetal 
monitoring equipment, patient monitoring equipment, Q&S improvement administrator or 
staff/nurse/midwife, specialised obstetric equipment, training and development and neonatal 
                                                     
21 No e ha  he erms s ccessf l  and unsuccessful  in the context of this report refer only to whether or not 
the Trust was successful in being awarded funding for improvements via the Sign up to Safety Scheme. We do 
not refer to the ability of the Trust in reducing errors or claims.  
 


















































transport equipment). A more detailed description of the interventions will be provided in the 
specific sections 5 and 6 and in Appendices 4-6. 
 






Assessment of the cost of activities/interventions 
We assessed the extra costs of activities/interventions introduced by Trusts as part of the incentive 
funding scheme by looking at the data available in the applications they submitted to get the funds.  
However, we also contacted individual Trusts to determine if the actual expenditure on 
interventions reflected the costs included in the original application. This allowed us to get further 
detail on exactly what the intervention entailed (e.g., staff training, monitoring) for those activities 
and interventions whose cost is not that straightforward to value.  
 
Identification of comparators 
To assess whether the Sign up to Safety scheme has had an impact in reducing harms and errors we 
needed to identify a comparator. We used both the time period before the introd ction of the 
scheme  and the sit ation in absence of scheme  as comparators. This allowed us to compare the 
costs and benefits of participating in the scheme with those of not participating in it. Specifically we 
looked at the extra costs of interventions and the reduction in incidents, as all the other benefits 
and costs can be estimated indirectly from the latter. The extra cost of interventions and the 
reduction in incidents were collected directly by the Trusts or derived using the measures they 
identified, and equivalent data were available for the comparator. We used Trusts that were not 
awarded funding in the Sign up to Safety scheme and collected data before and after the 
introduction of the scheme. This allowed us to apply a difference-in-differences (DiD) approach and 
take into account confounding factors that might have occurred during the implementation of the 
scheme. A more detailed description of the approach is provided in the methodology section 6.  
 
Assessment of the impact of the interventions in terms of errors and incidents 
Because of the wide range of interventions implemented, their effects on incidents are not the 
same and do not have the same intensity. Therefore, we tried to disaggregate incidents as much as 
possible by the degree of harm they cause (e.g., no harm, low harm, moderate harm, severe harm, 
death) and/or by type of incident.  
 


















































In order to adopt a DiD approach, similar data had to be collected before the implementation of the 
scheme and in other Trusts not participating (the control group), therefore we selected specific 
outcome measures that could be collected from  all Trusts  ro ine da a.   
 
The Difference-in-Differences approach  
We used a Difference-in-Differences (DiD) approach for the analysis of the difference in incidents 
before and after the introduction of the Sign up to Safety scheme in maternity units.  
This is a statistical technique that attempts to mimic an experimental research design using 
observational study data. It calculates the effect of a treatment (e.g., participating in the incentive 
funding scheme) on an outcome (e.g., the number of unexpected admissions of term babies to 
neonatal intensive care unit or the number of term babies born with a low Apgar score) by 
comparing the average change over time in the outcome for the treatment group (e.g., successful 
(funded) Trusts) to the average change over time for the control group (unsuccessful (non-funded) 
Trusts). This method may eliminate possible confounding effects as it measures the difference-in-
differences between the treatment and control group over time. DiD requires data measured at two 
(or more) different time periods for the two options being compared. In Fig. 2, the intervention 
group is represented by the solid blue line (IB IA) and the comparator group is represented by the 
solid red line (CB CA). Both groups are measured on the outcome (number of incidents) over time, 
before the intervention group has implemented the intervention (shown by IB and CB in Fig. 2). The 
intervention group then participates in the intervention and both groups are again measured after 
this point (IA and CA). Not all the change in outcomes over time for the intervention group (IA minus 
IB) is an effect of the intervention, because some benefits were achieved by the comparator group 
over time due to other factors (e.g., other interventions that were introduced at around the same 
time), and these would also have been achieved by the intervention group. DiD therefore calculates 
the change in the outcome variable over time for the intervention group, subtracting from this the 
change over time that was achieved by the comparator group due to other factors, shown by the 
dashed blue line (note that the slope of the line connecting IB and IN is the same as the slope 
connecting CB to CA). Hence the treatment effect of the incentive funding scheme is ((IA minus IB) 
minus (IN minus IB)), which is equal to (IA minus IN). This method is more demanding in terms of data 
because it requires data on incidents for Trusts participating in the scheme before and after 
implementing the interventions; it also requires equivalent data over the same time period for 
Trusts not participating in the scheme. However, given the probability of generating more accurate 
estimates of the impact of participating in the scheme we decided to adopt this approach. 
 
Figure 2. Difference-in-differences approach 
 
 


















































Identification and estimation of the reduction in costs due to avoided errors/incidents 
Once we estimated the reduction in number of incidents and errors (by type and degree) we 
measured the monetary value of treating those incidents using payment by results data and, where 
not available, evidence from the literature and cost-of-illness studies. This focused on the short-run 
costs of dealing with incidents, rather than the long-term financial impacts, which are captured 
below.  
 
Assessment of the reduction in claims 
The relationship between incidents and claims was based on data disaggregated by clinical area 
(e.g., maternity, A&E) and by type of incident, as the number of claims as a percentage of incidents 
is unlikely to be constant across types of incident.  
 
We decided to use specific data at Trust level instead of using the NRLS as the latter contains data 
on reported safety incidents, which may underestimate the actual number of incidents for several 
reasons:22 
x Persistence of the "blame culture"23; 
x Fear of litigation or prosecution23; 
x Lack of response to previous reports24; 
x Lack of appropriate reporting systems25; 
x Lack of contractual incentives22; 
x Poor understanding of what to report as an incident25; 
x Lack of knowledge about how to report an incident 24; and, 
x Lengthy and complicated reporting processes26. 
For example, in a survey undertaken by the National Audit Office it was found that on average 
around 22 per cent of incidents went unreported and 39 per cent of near misses  We acknowledge 
there may also be some degree of under-reporting in the data we collected directly from Trusts, but 
we preferred to use local data. 
 
Given the specified time frame of the evaluation we could not measure any direct effect of the 
scheme on improving health outcomes and, in particular, in reducing claims. This is because there is 
a time lag from the time of perceived harm or incident, to settlement of a claim. We evaluated this 
time frame as part of the analysis of claims contained in specific sections 5 and 6.  
 
Estimation of the reduction in costs due to avoided claims 
The reduction in spending on claims has been measured focusing on the value of claims rather than 
the number, i.e., applying a mean value per claim. The mean value is specific to the type of incident 
(e.g., cerebral palsy, tears, missed fracture etc.) and reported degree of harm, since the value of the 
claim will vary by these factors. In addition, as the mean value of claims is not constant over time, it 
has been valued using the most recent data.  
 
Estimation of the improvement in health due to a reduction of errors and incidents 
Reduction in errors and incidents should translate into improvements in health. Generally the most 
common outcome measure in economic analyses is the Quality Adjusted Life Year, a measure that 
combines the length of life and the quality of that life. The use of this measure is recommended as it 
allows to comparison of interventions in different clinical areas. As Trusts are not capturing such 
                                                     
22 http://www.publications.parliament.uk/pa/cm200809/cmselect/cmhealth/151/15108.htm 
23 Committee of Public Accounts, A safer place for patients, p 5 
24 Centre for Patient Safety and Service Quality, Imperial College, commissioned research 
25 National Patient Safety Agency, Seven Steps to Patient Safety-Step 4: Promote reporting, August 2004, p 97 
26 National Audit Office, commissioned research 
 


















































information, improvements in health have been modelled, being predicted from reductions in 
incidents. To illustrate, suppose we have a patient population of 100 people. If patients experience 
an adverse incident then their health outcomes are 1 quality adjusted life year (QALY) each; if they 
do not experience an incident their outcomes are 10 QALYs each. In the absence of treatment via 
the Sign up to Safety incentive funding scheme 10 patients experienced an adverse incident and 90 
do not. Therefore, the total QALYs available in the absence of the SU2S scheme across all patient 
are 10 patients*1 QALY + 90 patients*10 QALYs = 910 QALYs and the mean QALYs per patient are 
910 QALYs/100 patients = 9.1.  
Suppose now that the SU2S scheme pays for an intervention to improve safety, and this reduces the 
number of patients experiencing incidents from 10 to 5, the total QALYs across all patients are now 
5*1 + 95*10 = 955 and the mean QALYs per patient are now 9.55. Hence, the intervention produces 
a mean improvement in health per patient of 9.55-9.1 = 0.45 QALYs. 
 
Calculations of this kind required an estimate of the impact of the intervention on the reduction in 
the number of incidents, as above. They also required mapping the number of incidents to some 
measure of health, e.g., QALYs. To do this in the A&E setting, we used data from published sources 
on the health consequences of adverse incidents.  
 
Assessment of the difference in benefits and costs to calculate the incremental cost effectiveness 
As mentioned above, the proposed conceptual framework to evaluate the cost-effectiveness of the 
incentive funding scheme is summarised in Fig. 1. The aim is to calculate the incremental cost-
effectiveness of he cheme  The anal i  i  inc emen al  in the sense that cost-effectiveness is 
evaluated with respect to a comparator, the counterfactual (e.g., Trusts not participating in the 
scheme). The incremental cost-effectiveness of the scheme depends on the difference in benefits or 
outcomes associated with participating in the scheme compared with not participating in it, and the 
differences in costs. 
 
Measuring cost-effectiveness   
The framework described in the previous section is designed to measure the incremental cost-
effectiveness of the Sign up to Safety incentive funding scheme. For two or more interventions or 
strategies (e.g., participating in the scheme versus not participating in it), an incremental cost-
effectiveness analysis compares the resources used by each alternative (the costs) with the number 
of incidents, health, claims or other outcomes achieved (the effectiveness). Costs may be higher or 
lower with the scheme, and outcomes may be better or worse; the combinations of these 
differences are shown in Fig. 3. If the scheme has lower costs and better outcomes than the 
alternative (falling into the bottom right hand quadrant of Fig. 3), then it represents good value for 
money and will look attractive to decisions makers. Or, if the scheme incurs higher costs and worse 
outcomes than the alternative (top left hand quadrant of Fig. 3) then it does not represent good 
value for money. If the scheme is more effective than the alternative but only at a higher cost (top 
right hand quadrant of Fig. 3), then to decide whether or not the scheme represents good value for 
money requires a judgement as to whether the improved outcomes are worth the extra costs. If it is 
judged that the extra benefits are worth the extra costs then the scheme represents good value for 
money. Note that an intervention does not necessarily need to save money to be cost-effective. 
Ho e e  i  doe  need o gene a e o come  ha  a e o h  pa ing fo    
One way to weigh up the relative differences in outcomes and costs and make the trade-off is to 
measure outcomes using a generic health outcome measure, such as QALYs as discussed above.  
Since most interventions designed to improve health affect quality of life or length of life or both 
then this measure can be used across all clinical areas, allowing broad resource allocation decisions 
to be made. The National Institute for Health and Care Excellence (NICE) recommends a cost-
 


















































effectiveness threshold value for QALYs: an intervention that costs more than £30,000 per QALY is 
nlikel  to be considered to be orth it  beca se it is belie ed that the mone  co ld be better 
spent elsewhere in the NHS.  
 
As noted in the previous sections, improvements in health associated with the scheme can 
theoretically be measured in terms of QALYs; in this case it is possible to judge whether the 
improvements in health associated with the scheme are good value for money  are cost-effective  
by applying the NICE threshold. Alternatively, it is possible to use the cost-effectiveness threshold to 
convert QALY gains associated with the Sign up to Safety incentive funding scheme into monetary 
terms, meaning that it is possible to compare the different in costs and the improvement in health 
associated with the scheme directly. If improvements in health are quantified using some measure 
other that QALYs then a cost-effectiveness threshold value is unlikely to exist for that measure, 
meaning that it will be difficult to judge if the scheme is cost-effective if it falls into the top right 
hand quadrant of Fig. 3. Empirically, measuring the impact of the scheme on health outcomes 
(QALYs or otherwise) is quite difficult. Nonetheless, we tried to measure possible improvements in 
health associated with the scheme in terms of QALYs using published sources. 
 
 












Due to the uncertainty in each component of the modelling process we used univariate and 
probabilistic sensitivity analysis to explore and quantify uncertainty. Univariate sensitivity analysis 
has been performed varying all model inputs one at a time within plausible ranges to investigate the 
impact on incremental cost-effectiveness. Probabilistic sensitivity analysis (PSA) applies appropriate 
distributions to reflect the uncertainty with each parameter value in the model. The PSA can be 
used to present confidence intervals around the point estimates of cost-effectiveness, and be used 
to create a cost-effectiveness acceptability curve. 
 
Data collection 
We asked the Trusts to produce a report containing relevant information about the interventions. 
The report included information on the type of intervention, the date funds were awarded and the 
amount spent to implement each intervention (Appendix 4).  
 


















































We also asked Trusts to provide some outcome measures that could help evaluating the effect of 
the interventions in reducing incidents and therefore the number of future claims (Appendix 4-7). 
We asked Trusts to provide these data for the period before the implementation of the 
interventions and afterwards (up to the most recent date). Different questionnaires were 
administered for the maternity and A&E analyses (Appendix 8-9).  
 
Data on claims before and after the implementation of interventions have been collected at Trust 
level by accessing the NHS LA claims database. 
 
Applying the methodology 
As noted, impacts on health and on claims may not materialise until sometime after the impact on 
incidents, perhaps several years afterwards. Therefore it is difficult to measure the difference in 
benefits and costs directly.  
 
We therefore measured the reduction in incidents and extra costs of interventions directly, and use 
the reduction in incidents plus data from other sources to model improvements in health, reduction 
in claims, cost of treating incidents and reduction in spending on claims. We are aware that this 
approach is much more speculative and uncertain and does not measure impacts on health and 
claims directly.  
 
Following the results of the DiD approach we planned to undertake an incremental cost-
effectiveness analysis to compare the resources used by each intervention (the costs) with the 
number of incidents, health, claims or other outcomes achieved.  
A sensitivity analysis has been performed to take into account of uncertainty in the input data and 
test the robustness of the results.  
 
In the following sections we provide a more detailed analysis of the evaluation of the scheme in 























































5.  Evaluation of the Incentivisation Scheme in A&E: missed fractures  
5.1. Overview of funding and claims  
In total, 13 Trusts from across a wide geographical locations applied to the Sign up to Safety 
incentive funding scheme for interventions to reduce missed fractures in A&E. Out of these, 5 Trusts 
were successful in obtaining the funds, while for 8 Trusts funds were not awarded. Funds were given 
to Trusts that proposed to impro e o t of ho rs  ser ices  to aid rapid diagnosis and to red ce the 
number of missed fractures and subsequent claims for missed fractures. 
 
Between 2011 and 2016, the NHS LA received 146 claims related to missed fractures in A&E for the 
13 Trusts that applied to the Incentive Scheme (68 claims were successful, 26 were unsuccessful and 
51 are still open, most of which refer to claims made from 2014 onwards). Figure 4 shows the 
trends in total, successful, unsuccessful and open claims referring to incidents that occurred 
between 2011 and 2015. Over time we notice an increased trend until 2014, when there is a sudden 
decrease. Despite the funding that occurred in 2015 we cannot attribute a reduction to the financial 
incentive scheme mainly because the decline shown is probably due to the fact that many incidents 
from 2014/15 may not have been registered as claims yet. As the average time gap between the 
incident and claim is approximately 2 years, we can infer that the number of claims referred to 
incidents occurred in 2014 is still not complete and therefore we are unable to predict the trend in 
the following years. 
 























Source: our analysis based on NHS LA claim data 
 
The number of claims due to missed fractures or related incidents in the Trusts that received the 
funds is 67, which corresponds to 45.9%. Figure 5 shows the total number of claims and claims in 
successful Trusts by year. The trend presented should be considered cautiously, particularly for 
2016, for two reasons: (1) considering the average time for a claim to be made of two years, it is 
possible that not all claims from 2015 and 2016 have been opened yet and (2) given that the data 
provided only refers to claims made up until August 2016. Nonetheless, from the Figure, we observe 
that after 2014, the successful Trusts are increasing their relative proportion of claims, narrowing 
 


















































the gap between the solid and dotted lines. The funds for the Sign Up to Safety financial incentives 
Scheme were granted in 2015, when a sudden drop in trends is observed. However, as mentioned 
previously this may be partly attributable to the fact that some claims for the last two years are yet 
to be opened, so this drop cannot be attributed to the scheme. 
 
Figure 5. Number of claims by year: Total and Successful Trusts 
 
Source: our analysis based on NHS LA claim data 
 
 
The main causes of incident are: failure or delay in diagnosis (52% of all cases), failure to interpret X-
Ray (15% of all cases) or failure to X-Ray (13% of all cases).  
 
On average the total cost of a claim for missed fracture is £51,456, including the unsuccessful cases.  
The average cost of a successful case is £41,969, but it can vary from a minimum of £1,200 up to 
£270,870. The cost of the total damage, on average £17,677, is very low compared to a maternity 
claim and can reach maximum £150,000. The defence costs are generally very low, £3,000, whereas 
the claimant costs are higher – on average £21,000 but could reach £127,000.   
 
5.2. Descriptive analysis of interventions 
We asked the 5 successful Trusts to complete a standardised report (Appendix 4) to understand 
what was the main problem they wished to address (e.g., missed fractures) and how they were 
planning to address it through the scheme. In the same report we also asked Trusts to list some 
outcome measures that could help evaluate the effect of the interventions.  
 
All five have completed the report, but a preliminary analysis showed that one successful Trust had 
been granted funds to improve alternative outcomes, including Sepsis and Pressure Ulcers. 
Therefore, the information from this particular Trust was not used to define the interventions put in 
place to reduce the number of missed fractures on A&E, and the consequent modelling performed 
in the next sections. 
 
The four remaining Trusts had each chosen a very different approach to reducing missed fractures. 
One Trust invested in radiology imaging equipment for rapid interpretation and analysis of x-ray 
images, also known as hot reporting in out-of-hours A&E services; two invested in employing a 
nurse to focus on quality improvement, analysis of incidents and data recording, and one invested in 
 


















































support training for staff in the interpretation of x-rays. Finally, one of the Trusts that chose to 
employ a nurse was also awarded funds to employ a radiographer allowing for hot reporting 7 days 
a week. Thus, in the 4 Trusts, five different types of interventions were introduced. 
 
In total, for improvements on A&E focusing on missed fractures £388,208 were granted by NHS LA27. 
The most expensive intervention was the purchase of radiology imaging equipment, which received 
£257,194 in funding, whilst the cheapest intervention was the employment of one WTE 
radiographer for one year, which received £18,304. The relatively large sum invested in the 
radiology imaging equipment can be understood due to its capital nature and considering that the 
expected life use of the equipment is between 5 and 10 years. 
 
Overall 19 of the 25 planned interventions have been implemented from 2014 and the majority of 
them were fully implemented within 2015 (74%), or by July 2016 (26%). It is worth noticing that 
some interventions (12%) were partially implemented or not implemented (20%) at the time the 
evaluation started.  
5.3. Data collection 
In order to measure the impact of the adopted interventions in reducing the number of missed 
fractures using the DiD approach described in the previous section we requested data from 
successful and unsuccessful Trusts before and after the introduction of the scheme. To do so we 
sought expert advice from The Society and College of Radiographers, to define the necessary 
information to be collected from the Trusts in order to perform this evaluation.  
 
All five successful Trusts and eight non-successful Trusts were contacted by phone and email, and a 
questionnaire on the number and severity of missed fractures and claims as well as on the number 
of x-rays taken at their A&E departments was sent to all Trusts (Appendix 8). The questionnaires 
were directed to the contact person referred by NHS LA, and most occupied a senior management 
position, including Director of Quality, Head of Corporate Risk and Governance Lead. The data 
gathering process took several months, and the research team had to engage with Trusts due to 
difficulties in data gathering. The leads in each Trust involved other members of staff, including 
clinical leads in an attempt to fill in the data to the best of their capacity. Having consulted many of 
the responsible staff in each Trust, it became clear that most (both participating and non-
participating) do not consistently collect data on missed fractures. Some consider this data 
collection not feasible, given that if a fracture was missed it is unlikely that the patient will return to 
the same A&E where an error has occurred, and thus missed fractures will not be identified in their 
Trust unless a claim was presented.   
 
In the end, we received three incomplete datasets from participating Trusts, with one Trust stating 
that none of the requested data could be collected. Similarly, only one Trust that was not awarded 
funding provided (incomplete) data.  
 
5.4. Methods 
We undertook an analysis of the effectiveness and cost-effectiveness of the interventions put in 
place to reduce the number of missed fractures in the participating Trusts funded by the Sign up to 
Safety incentive funding scheme. The effectiveness of the interventions could not be measured from 
the data provided by the Trusts, as most Trusts did not respond, and those which did provided 
incomplete reports, as explained above. Therefore, we were unable to adopt the methodological 
approach described in section 7. Instead, the effectiveness of the interventions aimed at reducing 
                                                     
27 In total £0.8 milion was awarded to A&E Trusts, but only £388,208 was for interventions to reduce missed 
fractures and the remaining £400,000 was for interventions to avoid sepsis, ulcers, infections etc.   
 


















































the number of missed fractures in A&E departments was based on the effect measured in previous 
studies identified by a means of a systematic literature review undertaken by the research team. 
This review is presented in the next section. 
 
Based on this information, a cost-effectiveness analysis was conducted to estimate the costs and 
health consequences of implementing the interventions to reduce the number of missed fractures 
at A&E compared with standard practice. In this analysis we simulated and compared the costs and 
health outcomes of a cohort of patients attending A&E due to a suspected fracture at each of the 4 
funded Trusts with and without the interventions in place. The analysis took the perspective of the 
National Health Service (NHS). Effectiveness was measured using quality-adjusted life years (QALYs). 
The analysis followed the standard assumptions of the National Institute for Health and Care 
Excellence (NICE) reference case including applying a discount rate to future costs and benefits of 
3.5%. A lifetime horizon was used, but no costs were modelled beyond the first year and therefore 
discounting was only applicable to health effects. As described in section 4, cost-effectiveness was 
summarized by the incremental cost-effectiveness ratio (ICER), defined as the incremental cost 
divided by the incremental effectiveness of two competing alternatives. The ICER represents the 
additional cost required to achieve one additional unit of effectiveness. The ICER is then compared 
with the decision makers’ willingness to pay threshold in order to draw conclusions about the cost-
effectiveness of the intervention. NICE recommends a cost-effectiveness threshold value for QALYs: 
an intervention that costs less than £20,000-£30,000 per QALY gained is considered to be cost-
effective.  
 
In the following sections we describe the literature review undertaken to measure the effectiveness 
of the interventions, and the cost-effectiveness model developed to estimate the cost and health 
outcomes of such interventions compared to standard care. This allows us to provide a 
comprehensive evaluation of the potential impact of Sign up to Safety Scheme in A&E missed 
fractures.  
 
5.5. Literature review 
5.5.1. Search aim 
A systematic review of international literature was undertaken with the aim of identifying the effect 
of the interventions adopted in participating Trusts aimed at reducing missed fractures in A&E 
departments.  
5.5.2. Search methods 
Study identification 
We used the following search terms: missed fractures  AND A E  OR emergency department  
OR accident and emergency  in the full text. The literature search was carried out using the 
electronic databases Scopus, the Cochrane Library and the NHS Economic Evaluation Database held 
by the Centre for Reviews and Dissemination (http://www.crd.york.ac.uk/CRDWeb/). We also 
searched the database of NICE Guidelines. The search covered the literature back to the beginning 
of each database forward until October 2016. Titles and abstracts of all the articles identified were 
reviewed and relevant studies were obtained.  
After removing duplicates, the search yielded 180 results. The reference lists of articles were 
searched to identify additional relevant citations.  
Study selection 
Papers that contained data on the impact of the interventions adopted by participating Trusts (i.e., 
related with hot reporting of radiology imagining and/or with continuous quality improvement 
strategies (CQI)) to reduce missed fractures in patients attending A&E departments were considered 
 


















































for this review. CQI is a term used in the literature to describe interventions that seeks to improve 
the provision of services by establishing a system to identify improvement needs, to set new 
processes to reduce failures and means to measure them, as well as educational and results 
measurement protocols. We included systematic reviews, randomised and non-randomised 
controlled trials, before-and-after studies and economic evaluations. Papers written in languages 
other rather than English or Spanish were excluded. These inclusion/exclusion criteria led to the 
selection of 3 papers (Preston et al, 1998 28; Espinosa and Nolan, 2000 29; Hardy et al, 2013 30)  17 
were selected based on title/abstract, of which 15 were rejected after reviewing full papers, and 1 
additional article was included based on cited references of identified studies.  
 
5.5.3. Search results 
We present the characteristics and outcomes of interest reported in the selected papers in Table 1. 
We identified 2 studies that provided information on the effect of CQI strategies at A&E using a 
before-and-after design, and one paper that evaluated the effect of hot reporting based on a 
randomised control trial (RCT).  
 
The interventions evaluated in the identified studies are similar to the interventions adopted by 
participating Trusts, however, there are might be differences as the specific characteristics of the 
CQI interventions and the measures to achieve hot reporting of radiology imaging may vary. 
Therefore, we acknowledge that the effect of the interventions identified in the literature might not 
necessarily correspond to the effect of the interventions put in place in the participating Trusts. In 
order to alleviate this limitation we have excluded from the literature review studies focusing on 
interventions not related to those applied in the participating Trusts, according to the description 
provided in the standardised reports (Appendix 4 and 5) of the interventions and actions that were 
implemented with the funds granted by the scheme. Also, we do not include the impact of one 
intervention evaluated in one of the identified studies (see intervention 2 in Espinosa, 2000 in Table 
1) as we did not find an equivalent approach in the participating Trusts. It is also worth noting that 
some of the studies evaluated the impact among all interpretive errors of radiographs, not only 
missed fractures. While we are able to identify the effect corresponding to missed fractures only in 
some of the studies, others did not provide sufficient evidence to calculate the effect on missed 
fractures alone. Nevertheless, these studies stated that the most common errors were related to 
missed fractures.  
 
The evidence from the identified studies indicates that both types of interventions (i.e., CQI and hot 
reporting) have a significant impact in reducing the number of missed fractures (i.e. reducing false 
negative cases). The effect is larger for interventions related with hot reporting. In Hardy et al, 2013 
the number of false positive cases (i.e., patients diagnosed with a fracture when they did not have 
one) is also reported and evaluated, finding also a significant reduction in this outcome as well. We 
also point out that most of these findings were obtained under research conditions rather than real-
world conditions, and that in only one study were the data from the UK. Hence, the generalisability 
of the findings to the present context should be treated with caution. We investigate this 
uncertainty more in sensitivity analyses.  The effects estimated in these papers are used to populate 
a cost-effectiveness analysis of the interventions aimed at reducing the number of missed fractures 
in the participating Trusts, as we present next.  
                                                     
28 Preston CA, Marr JJ, Amaraneni KK, Suthar BS. (1998). Red c ion of callback  o he ED d e o 
discrepancies in plain radiograph interpretation. Am J Emerg Med. 16(2):160-162. 
29 Espinosa JA, Nolan TW. (2000). Reducing errors made by emergency physicians in interpreting radiographs: 
longitudinal study. Bmj.;320(7237):737-740.  
30 Hardy M, Hutton J, Snaith B. (2013). Is a radiographer led immediate reporting service for emergency 
department referrals a cost effective initiative? Radiography. 2013;19(1):23-27.  
 


















































Table 1. Characteristics of selected publications and main results 
Author, 




(1) Review and discussion of clinically 
significant film discrepancies by ED 
physicians and radiologists within 24 
hours, (2) periodic joint retrospective 
review by both departments of all 
interpretive discrepancies regarding 
frequency and type, (3) 
encouragement of ED physicians to 
have a lower threshold for consulting 
the radiologist for any questionable 
findings while the patient is in the 
ED, and (4) agreement by the 
radiologist to be more available to 
review films even after hours. 
Patients undergoing 
radiographic 
studies in the ED 
who required 
further follow-up as 






30/13,200 = 0.22% 
After CQI: 
37/31,680 = 0.12% 
 
RR = 0.514 
95% CI = 0.318  
to 0.832  
This study included 
other final 
diagnoses, such as 
chest mass and 
pneumonia, but 
only the values 
related to fractures 
were used to 
calculate the effect 
of the intervention 
Espinosa, 
2000 USA 
Intervention 1 - CQI 
(1) Creation of a file of clinically 
significant errors. 
(2) Mandatory study of the entire file 
becomes part of the orientation of all 
new staff. 
(3) Overall departmental patterns of 
error are identified from this file, and 
a focused review of these patterns 
take place at staff meetings 
Intervention 2 - Rearrangement of 
X-ray interpretation by ED 
physicians & radiographers 
All standard radiographs were to be 
brought directly to the ED for 
immediate interpretation. A 
radiologist would provide an 
interpretation within 12 hours as a 
quality control measure. When a 
clinically significant misinterpretation 
was found by the radiologist, staff 
from the ED would contact patients 
and ask them to return 
The rate of clinically 
significant 
misinterpretation 
A false negative 
interpretation that 
would have 
resulted in a change 










RR = 0.400 









Errors might include 
fractures, foreign 
bodies, and other 
misinterpretations 
of radiographs. The 
most common (but 




The effect of 
intervention 2 was 
not considered as 
this intervention 
was not 
implemented in any 




Intervention - Hot reporting  
Immediate reporting arm: Patients 
wait in the radiology department 
following radiographic examination 
while the report is generated. The X-
ray report returned to the ED at the 
same time as the patient for the ED 
clinician to review alongside the 
images.  
Delayed reporting arm: 
Patients return to the ED following 
radiographic examination to await 
review of the images by the referring 
ED clinician. X-ray report are issued 
by the radiology department at a 
later time and returned to the ED as 
was standard practice at each site. 





False negative cases 
based on ED 
interpretive errors. 
False positive cases 




1/752 = 0.13% 
Control arm: 
12/750 = 1.6% 
 
RR = 0.083 





14/752 = 1.86% 
Control arm: 
36/750 = 4.6% 
 
RR= 0.388 




not only fractures 
Note: ED = Emergency department; CQI = Continuous Quality Improvement; RR = Relative Risk;  
 


















































5.6. Cost-effectiveness analysis  
5.6.1. Model structure 
The cost-effectiveness analysis was based on a decision analytical model. The model took the form 
of a decision tree shown in Figure 5. The structure of the tree is similar to that used in the cost-
effectiveness analysis of imaging alternatives for suspected scaphoid fractures, undertaken in the 
ecen  NICE G ideline  n F ac e  n n-c m le  a e men  and managemen 31 (NICE, 2016).  
 
Figure 5. Structure of the decision tree 
Note: Decision node represented by squares and chance node by circles. A&E Accident and Emergency 
 
Under both the intervention and non-intervention arms, patients presenting at the A&E department 
with a suspected fracture might follow one of the following pathways: patients having a true 
fracture might be incorrectly diagnosed leading to a false negative case (missed fracture). Among 
these patients, some will require a change in management, and some cases will result in a litigation 
case. Patients with a fracture who are correctly identified and diagnosed will be treated accordingly 
to the severity of the fracture; with main treatment options consisting in immobilisation and fixation 
surgery. Among patients who do not truly have a fracture, some might be incorrectly diagnosed (i.e. 
false positive) and unnecessarily treated for a fracture. Patients that are correctly identified as not 
having a fracture (i.e., a true negative) will have no further consequences.  
                                                     
31 National Institute for Health and Care Excellence. Fractures (non-complex): assessment and management 
Fractures: diagnosis, management and follow-up of fractures. NICE Guideline NG38. February 2016 
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The possible pathways and the probabilities of each of the outcomes in the tree would be the same 
for patients under the intervention and non-intervention arm, with the exception of the probability 
of a false negative and a false positive case in the intervention arm, to which we applied the relative 
risks estimated by the studies identified in the literature review (see section 5.5).  
5.6.2. Data 
In order to populate the model the following set of parameters are required: 1) probabilities and 
relative risks; 2) health care resource use and unit costs associated to the diagnosis and treatment 
of suspected fractures; and 3) utilities associated with fracture-related outcomes and life 
expectancy values.  
 
Probabilities and relative risks 
Data on the probabilities and relative risks used in the model are summarised in Table 2. The 
probability of having a fracture among patients presenting at A&E departments with a suspected 
fracture was estimated using information on the number of x-rays plain films taken at A&E 
attendances during 2014-15, according to the data collected by Hospital Episode Statistics (HES)32; 
and the number of diagnosis of fractures recorded at Accident and Emergency Statistics33 in the 
same year. We also considered the number of missed fractures based on the estimated rate of 
missed fractures at A&E departments.  
 
Table 2. Probabilities and relative risks 
Probabilities Value SE Source 
Prevalence of fractures among suspected cases 0.19693 0.00312 HES/Baker, 2016 
False negative  0.01028 0.00079 Thomas, 1992 
False positive 0.00443 0.00052 Thomas, 1992 
Sensitivity 0.94780 0.00393 Thomas, 1992 
Specificity 0.99448 0.00065 Thomas, 1992 
Missed fractures requiring change in management 0.53293 0.03849 Thomas, 1992 
Missed fractures leading to litigation case 0.02159 0.00534 Guly, 2001 
Fractures treated with fixation surgery 0.20000 0.02821 NICE, 2016 
Relative risks (RR) Value Var 
ln(RR) 
Source 
RR of false negative with CQI 0.40807 0.00480 Preston, 1998 
Espinosa, 2000 
RR of false negative with Hot Reporting 0.08311 1.08067 Hardy, 2013 
RR of false positive with Hot Reporting 0.38785 0.09654 Hardy, 2013 
Note: SE= Standard error; RR= Relative risks; HES= Hospital Episode Statistics 
 




                                                     
32 The Health and Social Care Information Centre, Hospital Episode Statistics for England, Accident and 
Emergency (A&E) statistics, 2014-15 
33 Baker C. Accident and Emergency Statistics: Demand, Performance and Pressure. Briefing paper umber 6964. 
November 2016. House of Commons Library.   
𝑃 𝑒 𝑎𝑙𝑒𝑛𝑐𝑒 𝑎𝑚 𝑛𝑔 𝑒𝑐 𝑒𝑑 𝑐𝑎 𝑒 =  𝐷𝑖𝑎𝑔𝑛 𝑒𝑑 + 𝑚𝑖 𝑒𝑑 𝑓 𝑎𝑐 𝑒  𝑎  𝐴&𝐸
𝑁 𝑚𝑏𝑒  𝑓 𝑎  𝑙𝑎𝑖𝑛 𝑓𝑖𝑙𝑚  𝑎  𝐴&𝐸  
 


















































This formula assumes that x-rays taken at A&E departments are primarily for the diagnosis of 
potential fractures; however, some patients might have an x-ray for a different reason, e.g., a 
potential chest infection. On the other hand, some patients with a fracture or a potential fracture 
might never have an x-ray undertaken during the A&E attendance. Nevertheless, this formula 
provides an approximation of the number of fractures among suspected cases, and a similar 
approach have been used in previous studies to estimate number of missed fractures at A&E 
departments (Lee and Bleetman, 2004)34.  
 
The literature review conducted to identify studies on the impact of the evaluated interventions 
also allowed us to identify studies that provided information of UK estimates on the underlying 
rates of false positive and false negative fractures at English A&E departments, as well as missed 
fractures requiring a change in management and the proportion of missed fractures that lead to a 
litigation case (Thomas et al., 1992 35; Guly, 2001 36). With respect to the proportion of fractures 
treated by a means of fixation surgery versus immobilisation, we applied the same assumption used 
in the aforementioned cost-effectiveness analysis conducted in the NICE guidelines on fractures37. 
These values are reported in Table 2.  
 
The relative risks estimated from the literature review were used to evaluate interventions related 
with CQI and interventions related with hot reporting separately. Therefore, we provide two 
separate sets of results; 1) using the effect of the interventions among the two studies that 
evaluated CQI interventions which were combined by a means of a meta-analysis, and 2) using the 
effect estimated in the study that evaluated hot reporting. Note that while the former studies only 
estimated the effect on false negative cases, the latter also estimated the impact on false positive 
fractures.  
  
Resource use and unit costs 
The funds allocated by each of the participating Trusts to the interventions aimed at reducing 
missed fractures are presented in Table 3. In order to compute the cost on a per patient basis we 
considered the number of A&E attendances in each of these participating Trusts that are due to 
suspected fractures. This was computed considering the total number of attendances and the total 
number of x-rays taken at A&E departments, according to HES data38. Based on this information we 
compute that the cohort of patients attending A&E departments at the four participating Trusts 
with a suspected fracture in a given year is 100,957 patients. Considering this cohort and the total 
cost of the implemented interventions, the cost per patient is estimated in under £4 when we 
considered all the Trusts combined; the cost per patient varied from £1.5 to £9.6 among the four 
funded Trusts.  
 
                                                     
34 Lee C, Bleetman A. (2004). Commonly missed injuries in the accident and emergency department. 
Trauma;6(1):41-51.  
35 Thomas HG, Mason AC, Smith RM, Fergusson CM. (1992). Value of radiograph audit in an accident service 
department. Injury;23(1):47-50. 
36 Guly HR. (2001). Diagnostic errors in an accident and emergency department. Emerg Med J.;18(4):263-269.  
37 National Institute for Health and Care Excellence. Fractures (non-complex): assessment and management.  
Fractures: diagnosis, management and follow-up of fractures.  NICE Guideline NG38. February 2016 
38 The Health and Social Care Information Centre, Hospital Episode Statistics for England, Accident and 
Emergency (A&E) statistics, 2014-15 
 


















































Table 3. Cost per patient of interventions implemented by Trusts 
Cost of interventions implemented by Trusts Value Source 
Trust 9 £45,704 Trust report 
Trust 4 £257,194 Trust report 
Trust 10 £20,310 Trust report 
Trust 28 £65,000 Trust report 
Total cost (all Trusts combined) £388,208 Trust reports 
Patients attending A&E in each Trust a year   
Trust 9 124,007 HES 
Trust 4 131,209 HES 
Trust 10 68,129 HES 
Trust 28 171,455 HES 
Proportion of A&E attendances that are due to suspected fractures 0.204 HES 
Patients attending A&E due to  suspected fracture (all Trusts combined) 100,957 HES 
Cost per patient attending A&E due to suspected fracture   
Trust 9 £1.81 Own calculation 
Trust 4 £9.61 Own calculation 
Trust 10 £1.46 Own calculation 
Trust 28 £1.86 Own calculation 
Cost per patient (all Trusts combined) £3.85  
Note: HES = Hospital Episode Statistics. Trusts have been anonymised and numbered using the coding for the analysis  
 
 
The unit costs of the health care items required for the management of patients are included in 
Table 4. We considered that every patient receives an x-ray and therefore, this cost is not included 
in the model. We assumed that missed fracture cases will have an additional ED visit, and if the 
patient requires a change in management this will include a fracture clinic visit and salvage surgery 
in the cases that lead to a litigation case, and immobilisation in the cases that do not lead to a 
litigation case. We applied the same unit costs as the ones used in the NICE guidelines cost-
effectiveness model (NICE, 2016), most of which are based on NHS Reference Cost data. The cost of 
a litigation case was estimated as the mean total cost of claims notified between 2011 and 2016 for 
Sign up to Safety successful and unsuccessful Trusts where one of the injuries was 'Fracture' or 'Poor 
Outcome - Fractures etc' or where the incident details mention 'missed fracture' or 'misdiagnosis of 
fracture'. 
 
Table 4. Unit costs of health care services and litigation costs 
Unit costs Value Source 
Cost of immobilisation £10  NICE, 2016 – assumption 
Cost of fixation surgery £1,373  
NICE, 2016 
HRG: HA54Z (Day case), NHS Reference Costs 
 
Cost of salvage surgery £1,549  NICE, 2016 
HRG: HA52Z (Day case), NHS Reference Costs 
 
Cost of fracture clinic visit £128  NICE, 2016 
HRG: WF01B (Trauma and Orthopaedics) 
Cost of ED visit £120  NICE, 2016 
HRG: WF01B (Accident and Emergency) 
Cost of litigation case   £51,456  NHS LA 
 





















































Effectiveness was measured using QALYs. We used the same Quality of Life (QoL) values and similar 
assumptions regarding the duration of the reduced QoL effect on patient with identified and missed 
fractures than those applied in the cost-effectiveness analysis conducted by NICE (NICE, 2016). 
These values are presented in Table 5.  
  
Table 5. Quality of life and life expectancy values  
QoL weights  Value (SE) Source 




Mapped from PRWE scores 
from MacDermid,199839 
EQ-5D general population for 30 years old 0.930 
(0.009) 
NICE, 2016 – Kind, 199940 
 
 Duration of effects Value Source 
Duration of fracture-related QoL for identified 
fractures and missed fractures that do not lead to 
litigation case 
1 year NICE, 2016 - assumption 
Dur of fracture-related QoL for missed fractures 
that lead to a litigation case 
Lifetime NICE, 2016 - assumption 
Mean age at time of injury 30 years NICE, 2016 - assumption 
Mean age at death 80 years NICE, 2016 - Interim life tables 
 Note: QoL= Quality of Life; SE= Standard error; PRWE= Patient Rated Wrist Evaluation 
 
5.6.3. Sensitivity analysis 
We conducted a one-way sensitivity analysis where we varied the following parameters: 
intervention cost per patient (we used the lowest and the highest costs estimated in each Trusts); 
the probability of a missed fractures (we used information provided by one participating Trust that 
allowed us to compute this parameter instead of the value identified in the literature); probability 
that a missed fracture leads to a litigation case (similarly, using data from the same participating 
Trusts); and the time horizon (assuming shorter time horizons of 5, 10 and 15 years, respectively). 
The remaining probabilities (i.e. prevalence of fracture, missed fractures requiring change in 
management; and proportion of fractures treated with fixation surgery) as well as the value of the 
relative risks in reducing false positive and false negative cases were also varied one at the time by 
applying a value equivalent to half and to double that used on the base case. We used the same 
approach to vary each of the treatment unit costs and the QoL values.  
 
We also undertook a probabilistic sensitivity analysis using 1000 simulations in a Monte Carlo 
analysis to compute cost-effectiveness acceptability curves (CEACs). CEACs indicate the probability 
that an intervention is cost-effective for different values of the willingness to pay for an extra unit of 
outcome taking into account the overall uncertainty in the model parameters. For this we need to 
apply probability distributions to each of the parameters that depend on the nature of the 
parameter. Probabilities were characterized by a beta distribution. Resource use data inputs were 
characterized using a gamma distribution, while uniform distributions were applied to unit costs 
                                                     
39MacDermid JC, Turgeon T, Richards RS, Beadle M, Roth JH. (1998). Patient rating of wrist pain and disability: a 
reliable and valid measurement tool. J Orthop Trauma;12(8):577-86 
40 Kind P, Hardman G, and Macran S. UK population norms for EQ-5D. York. Centre for Health Economics, 1999. 
Available from: http://www.york.ac.uk/che/pdf/DP172.pdf 
 


















































parameters; in both cases, we used upper and lower limits of 20% around the mean values. We 
used beta distributions to characterise the uncertainty around the utility values. 
 
5.7. Results  
 
Base case 
The results of the analysis are presented in Table 6, showing the costs and QALYs for a cohort of 
100,957 patients attending the A&E with a suspected fracture at the four participating Trusts in a 
given year. We present two separate sets of results; 1) using the effect of the interventions among 
the two studies that evaluated CQI interventions, and 2) using the effect estimated in the study that 
evaluated hot reporting. 
 
Both interventions are found to reduce overall costs and to improve the health outcomes of 
patients; yielding in both cases to the conclusion that the intervention strategies dominate standard 
practice, i.e. the interventions are less costly and more effective compared to standard care. Cost 
savings in this annual cohort are estimated at £250,000 and £678,000 with CQI and hot reporting 
interventions, respectively. These values are equivalent to a mean cost saving per patient of £2.5 
and £6.7. The number of total QALY gained are estimated in 18.2 and 34.2 for each type of 
intervention; equivalent to a QALY gain per patient of 0.0002 and 0.0003, respectively.  
 
 
Table 6. Base case estimates of costs and QALYs for a cohort of 100,957 patients attending A&E with 





vs. No Intervention) 
CQI Intervention    
Costs £6,573,333 £6,823,815 -£ 250,482 
QALYs 2,276,154.5 2,276,136.4 18.2 
Cost per QALY (Base case for CQI intervention) Intervention dominates 
Hot reporting intervention    
Costs £6,145,311 £6,823,815 -£ 678,504 
QALYs 2,276,170.6 2,276,136.4 34.2 
Cost per QALY (Base case for hot reporting intervention) Intervention dominates  
Note: CQI= Continuous Quality Improvement; QALY= Quality-Adjusted Life Year. 
 
 
Sensitivity analysis  
Our extensive one-way sensitivity analysis found very robust results in the case of the hot reporting 
intervention; in each of the analyses conducted the result indicated that the intervention was both 
more effective and less costly than standard care (results not shown). This was also the case in most 
of the analyses of the CQI interventions. However, in this case we found three instances where the 
intervention, while still leading to a better health outcome, was more costly than the standard case: 
1) when the mean cost of a litigation claim was assumed to be half of that used in the base case 
(ICER estimated to be £4,997 per QALY gained); 2) when the relative risk for reducing missed 
fractures was half of that estimated in the identified papers (£33,638 per QALY gained); and when 
the cost of the intervention was assumed to be equal to the cost of the Trust found to have the 
largest cost (£18,232 per QALY gained).  
 


















































Figure 6 shows the CEACs computed based on the probabilistic analysis. At a threshold value of 
£20,000-£30,000 per QALY, the probability that the interventions are cost-effective compared with 
no intervention reaches over 99%. 
 
 































































5.7.1. Concluding remarks 
In this evaluation of the Sign up to Safety financial incentives Scheme in A&E missed fractures we 
first identified the implemented interventions and developed a data collection questionnaire to 
gather information to estimate the impact of such interventions in reducing missed fractures in 
A&E. However, most Trusts were not capable of providing the required information, arguing in some 
cases that this data is not feasible to collect, as by definition the fractures of concern are missed. 
Therefore, Trust are required to enhance efforts to identify and record missed fractures at A&E 
departments in order to allow a proper evaluation of the impact of the interventions that are 
funded with the aim of reducing such incidents.  
 
Given the difficulties in using the data from the Trusts to estimate the effect of the interventions 
funded by the Sign up to Safety scheme, we decided to review the scientific literature in order to 
estimate the effectiveness of these interventions based on the impact found in previous studies. We 
identified three relevant studies that evaluated interventions similar to the ones applied in the 
successful Trusts. However, there are might be differences between the interventions evaluated in 
these studies and those applied in the Trusts. Therefore, we acknowledge that the effect of the 
interventions identified in the literature might not necessarily correspond to the effect of the 
interventions put in place and funded by the scheme. This evaluation provides thus a tentative 
analysis of the potential effectiveness and cost-effectiveness of the interventions implemented in 
the Trusts, and the results should be treated with caution.  
 
We found evidence of the effectiveness of these interventions in reducing the number of missed 
fractures, especially for intervention related to hot reporting, rather than those concerned with CQI. 
We then developed a decision analytical model to synthesise all available information into a cost-
effectiveness analysis.  We estimated that the intervention are not only more effective, but also less 
costly than standard care, yielding the conclusion that funding these types of interventions are a 
potential good value for money.  
 


















































6. Evaluation of the Incentivisation scheme in maternity units 
6.1. Overview of funding and claims 
In total 56 Trusts from across a wide geographical area applied to the Sign up to Safety Incentive 
scheme for funding to reduce harms in maternity services. Out of these, 28 Trusts were successful in 
obtaining funds, while 28 were not. In brief, funds were given preferably to Trusts that proposed to 
improve intrapartum monitoring, staff improvement, training and to buy equipment (see below for 
further details).  
 
In total, for improvements in maternity and intrapartum harm around £8 million was awarded by 
the NHS LA. The most expensive intervention was the purchase of K2 central monitoring equipment, 
which received £735,000 in funding, whilst the cheapest intervention was £340 for teaching 
materials.  The large figure invested in the monitoring equipment can be understood due to its 
capital nature and considering that the expected life use of the equipment is between 5 and 10 
years. 
 
An indirect benefit of the scheme reported by the NHS LA was that NHS LA partnered with NHS 
Supply Chain to assist the maternity units in collectively procuring their equipment, and a saving of 
£36k was achieved from sales of £227k.  
 
In Figure 7 we show the trend of claims for cerebral palsy registered between 1996-2016 related to 
incidents occurring between 1995-2015. The graph shows that in 15 years the number of claims has 
decreased over time, halving from 236 claims in 1996 to 104 in 2009, with a higher proportion of 
unsuccessful cases compared to the successful ones over time.  
 
The time gap between the date of incident and the date of claim is on average 3.5 years and it has 
remained constant over time (at least until 2011). This means that the data in the last 4 years could 
still be incomplete, as there is still time for a claim to be made on incidents occurred in the past.  
 
Looking more precisely at the trend of successful claims between 1995 and 2011 (when the time 
gap would suggest that no further claims should be registered for incidents occurring in that years), 
it seems they are decreasing from 2006. This could have been a disincentive factor for future claims 
and explain why the trend in claims is overall decreasing. 
 
In addition to cerebral palsy other registered injuries are brain damage (49), blindness (4 cases) 
amputation  case  Erb s pals   case  and uterine rupture (1 case).  
 
Among the main reported causes of incident, 30% were due to failure to respond to an abnormal 
fetal heart rate (FHR) (767 cases out of 2512), 28% were due to failure to monitor 2nd stage labour 
(416 cases) and 1st stage labour (297 cases), 8% were due to a delay or failure in performing an 
operation (116 and 103 respectively), 7% were due to failure/delay in treatment (198 cases), and 
6% were due to failure to recognise a complication (145). Other less common causes of claims 
include birth defects (65), failure of antenatal screening (51), failure to monitor dose of syntocinon 
(39), inappropriate use of forceps/failure to correctly apply forceps (32), failure to act on abnormal 
tests (27), failure to diagnose pre-eclampsia (22), failure/delay admitting to hospital (18) or failure 























































Figure 7. Trend of claims for cerebral palsy due to incidents occurred in 1995-2016 
 
 
Source: analysis of NHS LA claims data 
 
The average total cost of claims since 1995 is £2,716,684, including the unsuccessful claims (for 
which the costs have been paid by the claimants). A successful claim costs on average £4 million, but 
the cost can vary between £22,655 and £18million. The main part of the cost is represented by the 
cost of damage, estimated to be on average £3.6 million (but it can vary between £1,000 and £15.5 
million), whereas the claimant cost is on average £258,000 (but can vary between £3,200 and £1.8 
million) and the defence cost is on average £103,000 (with a maximum value of £778,750).  
We also looked at the trend in claims for perineal tears but the numbers are very small: overall 41 
claims have been registered between 1995 and 2014 with an average total cost of £89,229 for 
successful cases. 
6.2. Descriptive analysis of interventions  
First we asked the successful and unsuccessful Trusts to produce a report (Appendix 4) to 
understand what was the main problem they wished to address and how they were planning to 
address it through the scheme. In the same report we asked the Trusts to include some outcome 
measures that could help evaluate the effect of the interventions.  
 
Eighty-three interventions were identified which can be grouped into the following categories: 
- Cardiotocography (CTG)/intrapartum monitoring (fetal monitoring equipment)  
- Staff  
- Ultrasound equipment/software 
- IT infrastructure 
- Equipment (specialised obstetric equipment (episiotomy scissors), neonatal transport 
equipment) 
- Training and development (mostly related to CTG interpretation)  
 
































































As maternity units often chose interventions in more than one of the above categories, and 
sometimes multiple interventions within categories, we have used the total number of 
interventions as the denominator, rather than total number of maternity units in the following 
descriptive analysis of the range of interventions proposed. 
 
Between March 2015 and September 2016, 54% of the planned interventions were completely 
implemented and 25% only partially. However, 21% of the interventions were not implemented at 




Seventy-five percent of the interventions were focused on training, intrapartum monitoring and 
staff (Figure 8).  
 
 





CTG and intrapartum monitoring represent the 27% of all interventions. In particular, central 
monitoring (37% over all CTG monitoring systems) was the most popular intervention within the 
CTG/intrapartum monitoring category (Figure 9). This figure is likely to be even higher, as the K2 
Portal system can also be used as a form of central monitoring.  
 
New staff  
The 27% of all interventions in maternity units were related to recruitment of new staff. Midwives 
made up almost 60% of the staff that were funded. There was a variation in the job titles submitted 
by the units that decided to use the money for staffing.  Only 27% of the roles reported had detailed 
job specifications and remits.  
 
 


















































Figure 9. CTG Intrapartum monitoring interventions 
 Source: our data analysis  
 
Figure 10. New staff 
Source: our data analysis  
 
 
Table 6. Job titles as described in the Trusts report 
 
Different job titles 
Clinical Improvement Facilitator Consultant 
Intrapartum clinical practice educator Fetal well-being midwife 
Midwife Project manager 
Midwife lead Admin support 
Project lead Sign up to safety campaign lead 
Clinical champion Human factors midwife 
Management consultant Specialist midwife for safer and active birth 











































































Of the interventions aimed at purchasing ultrasound equipment or software, more than half (57%) 
were on ultrasound scan (USS) capacity, machine and equipment, 29% on hand held USS and 
Doppler and 14% on growth chart software.  
 
Figure 11. Ultrasound equipment 
 




Interventions on IT structure included electronic observations, ANC/postnatal IT system, electronic 
triage or pregnancy phone app or touchscreen on CDS.  
 
 
Figure 12. IT infrastructure 






























































8% of all interventions were aimed at purchasing new equipment. The most popular equipment 
were the episiotomy scissors and the PROMPT mannequin.  Other types of equipment include fetal 
pillows, neonatal transport equipment, teaching materials and carbon monoxide monitoring.  
 
Figure 13. Equipment 
 
Source: our data analysis  
 
Training  
CTG interpretation was the most commonly chosen form of training, representing 62% of this 
category. Whilst established CTG training packages such as STAN, K2, and the CTG master class, 
make up around 50% of the CTG training, 38% was not clearly defined.  
 



























































































Commentary on the interventions selected 
The aim of the Sign up to Safety incentive funding scheme was to reduce harm and therefore 
litigation. Issues with CTG interpretation represent 15% of the total value of a decade of maternity 
claims in England (Anderson, 2013)41 and there is a national ambition to reduce stillbirth and 
intrapartum asphyxia (National Maternity Service Review, 2016)42.  It therefore makes sense that 
almost 25% of the interventions were focused on intrapartum monitoring, and 62% of the training 
on CTG interpretation.  
 
However, the successful maternity units have invested their money in a broad range of 
interventions. Such diversity could suggest that there are no clear-cut solutions or obvious choices. 
Alternatively, this could be due to maternity units identifying different areas for improvement.  
 
Four different forms of CTG training have been defined but 38% of CTG training was not clearly 
defined. Training is not always effective and can sometimes be harmful (Draycott et al, 2015).43 
Evidence of clinical benefit therefore has an important role in guiding and signposting towards the 
most effective interventions. There is currently a lack of evidence base for the CTG training 
programmes ha  ha e been adop ed and his co ld e plain he sca erg n  approach    
 
With regards to funding for new staff, both the range of job titles described and the lack of clarity in 
their responsibilities illustrate the lack of detail about roles and responsibilities.    
 
Another important finding was that 46% of the units (13/28) had not yet fully implemented or 
started introducing their interventions at the time of the final reports. This may mean that the 
impact of the scheme may be underestimated, however, even if all the maternity units 
implemented all of their interventions by the time of the reports, it is unlikely that there will be 
much change after only one year.  One training programme allowed one year for training and then 
observed improvements over two years after the training was introduced (Draycott et al., 2006)44. 
The Victorian Managed Insurance Authority (VMIA) mandated the same training programme in 
Victoria, Australia and provided financial support to maternity units for implementation.  In contrast 
to before, an initial evaluation demonstrated a significant reduction in one outcome (Apgar <7 at 1 
minute) during the year of intervention (Shoushtarian et al., 2014)45. Finally, there were 
improvements in outcomes reported after shoulder dystocia in 4 years (Draycott et al., 2008)46, but 
outcomes continued to improve for up to a decade after the introduction of training (Crofts et al., 
2015)47.  
                                                     
41 Anderson A. (2013). Ten years of maternity claims: an analysis of the NHS Litigation Authority data  key 
findings. Clinical Risk;19(1):24-31.  
42 National Maternity Services Review. Better Births. Improving outcomes of maternity services in England. 
London; 2016. 
43 Draycott TJ , Collins K J, Crofts JF, Siassakos D, Winter C, Weiner CP, et al. (2015). Myths and realities of 
training in obstetric emergencies. Best Pract Research Clin Obstet Gynaecol;29(8):1067-76 
44 Draycott T, Sibanda T, Owen L, Akande V, Winter C, Reading S et al. (2006). Does training in obstetric 
emergencies improve neonatal outcome? BJOG: An International Journal of Obstetrics &Gynaecology. 
113(2):177-82.  
45 Shoushtarian M, Barnett M, McMahon F, Ferris J. (2014). Impact of introducing Practical Obstetric Multi-
Professional Training (PROMPT) into maternity units in Victoria, Australia. BJOG: An International Journal of 
Obstetrics & Gynaecology121(3):1710-8.  
46 Draycott T, Crofts J, Ash JP, Wilson LV, Yard E, Sibanda T, et al. (2008). Improving neonatal outcome through 
practical shoulder dystocia training. Obstet Gynecol.;112(1):14 20. 
47 Crofts J, Lenguerrand E, Bentham GL, Tawfik S, Claireaux HA, Odd D, et al. (2015).Prevention of brachial 
plexus injury-12 years of shoulder dystocia training: an interrupted time-series study. BJOG: An International 
Journal of Obstetrics & Gynaecology;123(1):111 8.  
 
 


















































These 46  could also be considered as slo er starters  and ma  ha e benefited from additional 
support.  
 
There have recently been a number of reports from well designed, robust evaluations of national 
safety interventions abroad, none of which have been associated with improved clinical outcomes.  
 
TOSTI Study (Netherlands) 
A multicentre, cluster randomised controlled trial investigated whether simulation-based obstetric 
team training in a simulation centre improves patient outcomes (Fransen et al, 2016) 48. The study 
was based on MOET (Managing Obstetric Emergencies and Trauma) course (Howell et al, 2007) 49. 
24 units were randomised to interventions and control combining a total of 28,657 women. In total 
471 medical professionals received the training. The results show no improvements in clinical 
outcomes and the training did not reduce obstetric complications.  
 
National Perinatal Safety programme (Sweden) 
The programme involved all 46 obstetric units in Sweden. The programme, based on peer review 
process and local implementation of guidelines was initiated in 2008 and included a web-based fetal 
monitoring programme. A study conducted to evaluate the impact and effects of the national 
programme to improve safety for the new-borns show no significant improvement in outcomes, no 
change in Apgar score lower than 7 at 5 minutes and a doubled risk of incautious management of 
oxytocin (Luthander et al., 2016) 50.  
 
CTG education programme (Denmark) 
A national study conducted in Denmark with historical controls over 331,282 births tested new 
national CTG programme. Overall 53 courses were developed and 97% of maternity carers trained. 
The analysis of the impact of the training programmes found no significant effect, with no change in 
Apgar score lower than 7 at 5 minutes and reduced operative vaginal birth rates by 14% (Tellesen, 
2016).51  
 
The Sign up to Safety (SU2S) incentivisation scheme devolved the identification and choice of 
interventions down to unit level to local Trust clinical leaders, instead of making top-down 
recommendations, e.g., at the national level.    
 
 
Review of the evidence base for the selected interventions 
The recent NHS England National Maternity Services review52 observed: any training 
undertaken must have been proven to be effective in improving outcomes or other aspects of quality, 
and its impact monitored locally . In particular, we should endeavour to put women and their 
families at the centre of these programmes to ensure that staff are trained in a way that improves 
outcomes, and uses finite resources in a useful way. 
 
                                                     
48 Fransen AF, van de Ven J, Schuit E, van Tetering A, Mol BW, Oei SG. (2016). Simulation-based team training 
for multi-professional obstetric care teams to improve patient outcome: a multicentre, cluster randomised 
controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology; 123(11):1753-60.  
49 Howell C, Grady K, Cox C. (2007). Managing Obstetric Emergencies and Trauma. The NMOET Course Manual. 
2nd edition. Cambridge University Press 
50 Luthander CM. (2016). The national perinatal patient safety programme: the challenges of implementation 
and evaluation. BMC Health Serv Res.;12(1):274. 
51  Tellesen L, 2016. PhD thesis. Submitted to University of Copenhagen  
52 National Maternity Services Review. Better Births. Improving outcomes of maternity services in England. 
London; 2016.  
 
 


















































Cardiotocography (CTG)/ Intrapartum monitoring 
Cardiotocography (CTG), or electronic recording of the fetal heart rate, is a way of assessing fetal 
wellbeing during labour and despite the limited evidence of clinical benefit, CTG monitoring is 
widely used as a screening tool for fetal distress/hypoxia in labour. Failures related to fetal 
monitoring are reported in all countries who routinely use it and there have been many attempts to 
reduce the error rate to improve outcomes.  
 
CTG monitoring is known to have a low sensitivity for predicting intrapartum fetal hypoxia, meaning 
that an abnormal CTG trace does not always indicate that fetal hypoxia is present (NICE, 2007)53.  
 
ST analysis (STAN) can be used in combination with CTG monitoring to help improve the sensitivity 
and detect fetal heart ischemia. STAN software can analyse changes to the ST or T waves of the fetal 
electrocardiogram (ECG) that may suggest fetal heart hypoxia/ischemia. A recent Cochrane review 
concluded that when compared to electronic fetal monitoring alone, the use of adjunctive STAN 
demonstrated no improvements in numbers of babies with severe metabolic acidosis at birth or 
babies with neonatal encephalopathy (Neilson, 2006)54. There was also no improvement in the 
numbers of babies with low Apgar scores at 5 minutes (Olofsson et al., 2014)55.  
 
Staff 
A number of Trusts opted to recruit more midwives or consultant obstetricians. There are some 
data that have demonstrated that higher numbers of midwives per births and a higher ratio of 
consultant obstetricians to midwives were associated with a lower probability of postnatal 
readmissions to hospital (Gerova et al., 2010)56. We did not investigate this outcome but it might be 
a useful measure in future evaluations. However, it is unlikely that funding would have significantly 
improved the staff/birth ratio and moreover increasing consultant presence alone does not appear 
to improve perinatal outcomes (Knight et al., 2016)57.  
 
Many Trusts employed personnel in a quality improvement capacity. Both the range of job titles 
described and the lack of clarity in their responsibilities illustrate the problems of work-as-imagined 
versus work-as-done  These non-specific roles represent a slightly aspirational work-as-imagined , 
or work that should happen according to those completing the applications compared to what 
actually needs to happen or the work-as-done  on the front line to promote improvement 
(Braithwaite et al., 2015)58.  
 
Finally, there is also a risk that those assigned to quality improvement roles may not have the 
appropriate skills, influence and resources to initiate the necessary changes for improvement. As a 
result, they may miss the problems that need addressing and instead focus on temporary solutions 
(Dixon-Woods and Martin, 2016)59. 
                                                     
53 Intrapartum Care. NICE Clinical Guideline. 2007;55(1):1 65. 
54 Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. The Cochrane Library. 2006. 
55 Olofsson P, Ayres-de-Campos D, Kessler J, Tendal B, Yli BM, Devoe L. (2014). A critical appraisal of the 
evidence for using cardiotocography plus ECG ST interval analysis for fetal surveillance in labor. Part II: the 
meta-analyses. Acta Obstet Gynecol Scand.;93(6):571 86.  
56 Gerova V, Griffiths P, Jones S, Bick D. (2010). The association between midwifery staffing and outcomes in 
maternity services in England: observational study using routinely collected data.  Preliminary Report and 
Feasibility. 
57 Knight HE, van der Meulen JH, Gurol-Urganci I, Smith GC, Kiran A, Thornton S, et al. (2016). Birth Out-of-
Hours : An Evaluation of Obstetric Practice and Outcome According to the Presence of Senior Obstetricians on 
the Labour Ward. Myers JE, editor. PLoS Med.;13(4):e1002000 15. 
58 Braithwaite J, Wears RL, Hollnagel E. From Safety-I to Safety-II: A White Paper. University of Southern 
Denmark, University of Florida, USA, and Macquarie University, Australia; 2015 Aug pp. 1 43. 
59 Dixon-Woods M, Martin GP. (2016). Does quality improvement improve quality? Future Hosp J. Royal College 
 



















































Two Trusts purchased specialised episiotomy scissors that are designed to help achieve an 
episiotomy at 60 degrees from the perineal midline, thereby reducing the incidence of severe 
perineal tears. However, there are very few data supporting their use. The current RCOG guideline60 
recognises that these scissors may improve the angle of episiotomy, but that there are conflicting 
data about the protective effect of episiotomy and there are no data supporting the use of these 
scissors in current practice to reduce severe perineal tears.  
 
Training 
Four different forms of CTG training were chosen but 38% (5/13) of CTG training was not clearly 
defined. Training is not always effective and can even sometimes be harmful (Draycott et al, 2015)61.  
 
There is currently almost no evidence for the CTG training programmes that have been adopted. 
One study evaluating the K2 interactive computer-based training package demonstrated that the 
programme improved participant knowledge, but there was no assessment of outcomes (Beckley et 
al., 2000)62. The recent national Danish study (Tellesen, 2016) 63 did not demonstrate any 
improvement in outcomes after CTG education after training 97% of maternity staff.  
 
There is a plethora of other data, including some large randomised trials, related to different 
elements of CTG use published recently: standardisation of CTG assessment (FIGO guidelines), the 
Infant study, the use of the Sis-Porto system and also the Swedish national perinatal safety 
programme. None of these studies demonstrated any clinically significant improvements in 
perinatal outcome despite the different approaches taken: standardisation of assessment (FIGO), 
computerised decision support (Infant & Sis-Porto  and a unit level human  intervention in Sweden  
 
Improving outcomes is likely to be more complex than CTG interpretation alone, and certainly more 
complex than some form of knowledge transfer. Other programmes with positive outcomes have 
employed cognitive aids (stickers), learning in communities of practice and normalisation process 
theory, all of which is likely to be required for improvement (National Maternity Service Review, 
2016)64.    
 
This is reinforced in a recent editorial on the negative results of a skills and drills  intervention in 
India that proposed some possible explanations, particularly the need to recognise behavioural or 
organizational barriers related to hierarchical structures, roles, and team formation (Ricca, 2016)65.  
The current lack of signposting to the evidence base for CTG training could explain the Trusts  
scattergun  approach and their valorising overl  simplistic solutions   
 
                                                                                                                                                                     
of Physicians;3(3):191 4.  
60 Royal College of Obstetricians & Gynaecologists. Green-top Guideline No.29. The Management of Third- and 
Fourth- Degree Perineal Tears. London: RCOG; 2015. 
61 Draycott T, Collins KJ, Crofts J, Siassakos D, Winter C, Weiner CP, et al.(2015). Myths and realities of training 
in obstetric emergencies. Best Practice & Research Clinical Obstetrics and Gynaecology. 
62 Beckley S, Stenhouse E, Greene K. (2000). The development and evaluation of a computer-assisted teaching 
programme for intrapartum fetal monitoring. BJOG.;107(9):1138 44.  
63 Tellesen L, 2016 PhD thesis. Submitted to University of Copenhagen 
64 National Maternity Services Review. Better Births. Improving outcomes of maternity services in England. 
London; 2016. 
65 Ricca J. (2016). Limits of Skills And Drills  Interventions to Improving Obstetric and Newborn Emergenc  
Response: What More Do We Need to Learn? Global Health: Science and Practice; 4(4):518-521. 
 
 


















































Training is a complex intervention, for an even more complex system, but at its simplest: 
accoucheurs should ensure they use evidence-based training programmes to help them provide the 




Most of the programmes were based on training, or training was a significant part of the 
interventions chosen. More and better training has been an almost ubiquitous recommendation for 
almost two decades. Robust evaluation using scientifically rigorous study designs is essential 
because training for obstetric emergencies, however well intentioned, is not cheap (Yau et al., 
2016)66 and nor is it always associated with improvements in clinical outcomes (Draycott et al, 
2015)67  as we have demonstrated.  
 
In particular, isolated staff training for fetal monitoring was not successful in any of these national 
programmes.  
 
In 2016 a review of all the 23 obstetric emergencies training programmes that investigated clinical 
outcomes ere more positive still in their conclusion that  training  can impro e qualit  of life 
and save lives  (Bergh, 2015)68. However, the authors recognised that not all training was associated 
with improvements in outcome and training should be locally based in the maternity unit.  
 
Most recently, a commentary on the Netherlands trial observed: Currently, the evidence supports 
local, multi-professional training, with integrated clinical and teamwork/human factors elements, for 
all staff annually  (Draycott, 2016)69. 
 
This model of training has been very successful in Australia where a project supported by the 
Victorian Managed Insurance Authority (VMIA) has been associated with improvements in clinical 
outcome (Shoushtarian et al., 2014)70 as well as a parallel reduction in claims, sufficient for the 






                                                     
66 Yau CWH, Pizzo E, Morris S, Odd DE, Winter C, Draycott TJ. (2016).The cost of local, multi-professional 
obstetric emergencies training. Acta Obstet Gynecol Scand.; 95(10):111-9.  
67 Draycott T, Collins KJ, Crofts J, Siassakos D, Winter C, Weiner CP, et al. (2015). Myths and realities of training 
in obstetric emergencies. Best Practice & Research Clinical Obstetrics and Gynaecology; 29(8):1067-76. 
68 Bergh A-M, Baloyi S, Pattinson RC. (2015). What is the impact of multi-professional emergency obstetric and 
neonatal care training? Best Practice & Research Clinical Obstetrics and Gynaecology; 29(8):1028-43. 
69 Draycott T. (2016). Not all training for obstetric emergencies is equal, or effective. BJOG: An International 
Journal of Obstetrics & G. (in press). 
70 Shoushtarian M, Barnett M, McMahon F, Ferris J. (2014). Impact of introducing Practical Obstetric Multi-
Professional Training (PROMPT) into maternity units in Victoria, Australia. BJOG: An International Journal of 
Obstetrics & Gynaecology;121(13):1710-8. 
 


















































6.3. Methods  
In this section we describe the methods adopted for the evaluation of the Sign up to safety scheme 
in maternity units. More specifically we will clarify which approach has been adopted, how costs and 
outcomes have been assessed, and we will explain why we ended up running a cost-consequence 
evaluation instead of a cost-effectiveness analysis as described in section 4.   
 
Overview 
In order to carry out an economic analysis of the scheme, we calculated the incremental costs and 
effects in successful Trusts who were awarded funding via the scheme, compared to the control 
group of Trusts who were not awarded funding via the scheme, using the DiD approach mentioned 
in section 4 . 
Further details of the evaluation and the literature review are provided in Appendix 10.  
 
6.4. Model 
Difference-in- differences analysis  
The difference-in-differences (DiD) analysis requires data from the intervention group (i.e. 
successful (funded) Trusts, abbreviated to Y  in this section  and the control group unsuccessful 
(unfunded) Trusts, abbreviated to N  in this section  in order to test whether the intervention i e  
implementing any specific interventions, or receiving funds for the SU2S incentive funding scheme) 
has had an effect (Figure 15). We also need data from each group from time periods before and 
after the boundary date  when the intervention is deemed to have come into effect in order to 
control for any underlying differences between the two groups, or for any effects of external 
influences that might take place at certain dates. This allows us to clarify whether any effect seen is 
in fact due to underlying changes with time that would have taken place regardless, or whether it is 
really due to receiving money from the NHS LA as part of the SU2S scheme.  
 
Figure 15. Schematic of the Difference in Difference analysis design.  
Point estimates of the numbers of incidents in the before and after periods are compared, with an adjustment for the 
difference between control and intervention/treatment groups. 
 
 
A boundary date must therefore be chosen which separates the before  and after  time periods  
We have two possible dates: the date on which the first of the specific interventions was 
implemented in each Trust (information taken from the reports sent to us by the Trusts  intvn 
date , and the date on which monies were received by the Trust from the NHS LA (information 
given to us by NHS LA, i e   working days after the money left the NHS LA account  BACS date  
 


















































These two dates are different for each of the successful Trusts, meaning that the plots in our results 
are not as neat as the example above, as the before and after periods for each Trust do not 
necessarily correspond to the same calendar periods. We examined the results obtained using each 
of the two dates to check if the overall results are robust to the choice of boundary date. 
 
We received Trust-level aggregated data, by calendar month, from 44 Trusts. This imposes some 
limitations on the conclusions that we can draw as it is not patient-level data, meaning that for 
example it is not possible to know what proportion of the mothers suffering perineal tears did in 
fact have instrumental assistance during birth and what proportion did not. Also, we do not know 
the proportion of babies admitted unexpectedly to NICU that were also cooled, or who also had a 
low Apgar score at 5 minutes. We only have the overall proportions for each Trust by month, and no 
further associations between variables. In order to account for the natural variation between Trusts, 
we have considered this dataset to be a panel dataset, meaning that each Trust is seen as an 
individual, which produces outcome values per month. We note also that a sample size of 44 is fairly 
small, so this is likely to limit the power of the analysis. 
 
The variables which are thought might vary as a result of the interventions implemented are given in 
Table 7 below, along with the expression by which they are calculated.  
 
Table 7. Outcome variables that might be affected by the specific maternity interventions 
implemented (and/or by signing up to the scheme itself), and expressions used to calculate them. 
 
Variable Expression 
Proportion of term  singleton stillbirths 
No. term singleton stillbirths 
÷ 
No. term singleton births 
Proportion of term singleton newborns with 
Apgar score<7 at 5 minutes 
No. term singleton newborns with Apgar<7 at 5 mins 
÷ 
(No. term singleton births - No. term singleton 
stillbirths – No. term singleton babies whose Apgar not 
known/not recorded at 5 mins) 
Proportion of term singleton babies 
therapeutically cooled after birth 
No. term singleton babies therapeutically cooled 
÷ 
(No. term singleton births - No. term singleton 
stillbirths) 
Proportion of term singleton newborns 
admitted unexpectedly to NICU 
No. term singleton babies unexpectedly admitted to 
NICU 
÷ 
(No. term singleton births - No. term singleton 
stillbirths) 
Proportion of mothers with 3rd degree 
perineal tears (excluding Trusts that only 
reported combined figures) 
No. 3rd degree tears 
÷ 
(No. mothers delivered – No. mothers delivered via 
Caesarean section) 
Proportion of mothers with 4th degree 
perineal tears (excluding Trusts that only 
reported combined figures) 
No. 4th degree tears 
÷ 
(No. mothers delivered – No. mothers delivered via 
Caesarean section) 
Proportion of mothers with 3rd or 4th degree 
perineal tears (including all Trusts) 
No. 3rd or 4th degree tears 
÷ 






















































Therefore, the variables for which we have collected data, by Trust and by month, are (note that 
e m  indica e  ge a ion  eek  
x Total number of all births (i.e. all babies)  
x Total number of mothers delivered of any birth 
x Number of instrumental vaginal births 
x Number of Caesarean sections  
x Number of mothers with 3rd degree perineal tears  
x Number of mothers with 4th degree perineal tears  
o Note that for three Trusts this information was given as a combined number of 3rd and 4th 





 degree tears were combined into a single variable for all Trusts, allowing 
inclusion of those three Trusts  da a 
x Number of singleton births (live and stillbirth) 
x Number of term singleton births (live and stillbirth) 
x Number of singleton stillbirths 
x Number of term singleton stillbirths 
x Number of term singleton newborns with Apgar score<7 at 5 minutes 
x Number of term singleton newborns with Apgar score not known at 5 minutes 
x Note that this variable was requested as if babies do not have their Apgar score recorded 
we cannot assume that the unknown Apga  co e i   o he n mbe  of nkno n co e  
was subtracted from the denominator when calculating the proportion of babies with a low 
Apgar score (<7) at 5 minutes 
x Number of term singleton babies therapeutically cooled after birth 
x Number of term singleton newborns admitted unexpectedly to NICU (not for e.g., congenital 
malformations or social reasons) 
 
Data collected for certain other variables around the outcomes required for analysis (e.g., total all 
births) were used to perform sanity checks to test the data and ensure that each dataset was 
coherent and contained the information that we had requested. Different Trusts  epo ing em  
filtered the data in different ways with different assumptions, so it was important to test this. Not 
all Trusts could provide data for all the variables, or for all months, particularly before around 2013.  
 
The rate of Caesarean sections is not expected to change as a result of the interventions, but these 
figures are required to calculate the correct denominator for the proportion of mothers with tears, 
who have had vaginal births. We assume that mothers who have had Caesarean deliveries are not at 
risk of tears. Similarly, the rate of instrumental births is not expected to change with the 
interventions, but we investigated controlling for this variable when considering rates of tears.  
 
We combined all the Trusts  da a in o a ingle panel da a e  he e each Trust was considered to 
be an individual, which reported various outcomes every month. We performed a multi-level 
analysis looking at the difference in differences between successful and unsuccessful Trusts in the 
period after the boundary date compared to before. The numbers calculated as part of this analysis 
were the following: 
 


















































x Raw proportions: Average differences in proportions of each outcome separately before and 
after the intervention, in each of the successful and unsuccessful groups (i.e. four groups). 
o We calculated the point estimate and the 95% confidence intervals71 for these values. 
x Difference (Y): The difference in average differences in proportions of each outcome in the 
successful (Y) group, before and after the boundary date (after minus before)  
o We calculated the point estimate, and estimated the 95% confidence intervals for these 
values using the 95%CIs of the four separate results above 
x Difference (N): The difference in average differences in proportions of each outcome in the 
unsuccessful (N) group, before and after the boundary date (after minus before)  
o We calculated the point estimate, and estimated the 95% confidence intervals for these 
values using the 95%CIs of the four separate results above 
x Difference in differences: The difference in these two differences. This is the main DiD result. 
o We calculated the point estimate, and estimated the 95% confidence intervals for this 
value using the various 95%CIs of the results above 
In order to provide meaningful numbers, these proportions were then converted into rates per 
100,000 patients (i.e. per 100,000 mothers or per 100,000 babies), and we report the point estimate 
and 95% confidence intervals for these figures. 
 
Using these rates or outcomes per 100,000 patients, we were able to calculate the consequences of 
the money given to Trusts as part of the Sign up to Safety scheme, in terms of the costs of extra 
outcomes arising, i.e. extra costs for procedures done or health care resource used, and differences 
in consequences in terms of health-related quality of life at a point in time around the birth, or 
mortality outcomes (for stillbirths). The results are in Appendix 10.  
 
 
What is the intervention and what are the boundary dates? 
The intervention  can be thought of in either one of two ways: as granular specific interventions, or 
as the overall SU2S scheme. Challenges with the first approach are that all the Trusts implemented 
different interventions, at different times, including some implemented at different times within the 
same Trust. All of this means that for each specific intervention, there is insufficient data to perform 
an analysis looking at its effect in this context. For this approach, the cost of the intervention would 
correspond to how much has been spent on purchasing the specific interventions that the Trusts 
planned to buy using the NHS LA funding, and the date at which it took place is taken as the date of 
the first specific intervention implemented in each Trust. The abbreviation used in the Results 
ec ion o indica e hi  cena io i  In n  
 
In the second case, this presumes an argument that the act of giving money, control and 
responsibility to a Trust to implement quality-related measures, with the aim of improving 
outcomes and reducing claims made, might be an effective intervention in itself, at a higher level. 
The cost of the intervention in this case would be the funds provided by the NHS LA to Trusts, 
                                                     
71
 The results throughout this section of the report are reported as point estimate with its 95% confidence 
in e al  Thi  mean  ha  he poin  e ima e i  an e ima e of he e  answer, and there is a 95% chance that 
the true answer lies somewhere within that 95% confidence interval. We can never state the point estimate 
without also stating its confidence interval, as that would be misleading.  
When the confidence interval also contains zero (i.e. the lower bound is negative and the upper bound is 
positive), then the result that we have obtained from our data is not statistically significant. This means that it is 
po ible ha  he e  an e  o  he e diffe ence in o come  before and after the scheme, is actually 
zero. One way to reduce the size of the confidence interval and obtain a more precise answer (reduce 
uncertainty) is to use a larger sample size (more Trusts), and so the small sample size is an important limitation 
of this analysis. On the other hand, if the true effect on using the scheme is in fact very large, then the 
difference in outcomes can be significant even with a small sample size.  
 


















































regardless of whether or not they had been spent, and the date of the intervention would be the 
date on which the monies transferred from the NHS LA arrived in the Trust’s bank account. The 
abbreviation used in the Results section to indicate this scenario is BACS . 
 
We have therefore carried out two parallel analyses, looking at the impact of each of these types of 
intervention, i.e. the specific interventions purchased Intvn , and the overall scheme as an 
intervention BACS . The unsuccessful control  Trusts did not receive funds from the NHS LA so do 
not have their own intervention dates, but a date is needed for the DiD analysis. Therefore, the 
control group, i.e. the unsuccessful Trusts, were assigned an intervention date  corresponding to 
the median intervention date reported by the successful Trusts. The second case considers the date 
on which funds were received by each Trust via BACS from NHS LA, which is assumed to be three 
working days after the money was sent
72
. Again, the control Trusts were assigned the median date 
of the successful Trusts for this payment date. 
 
We have assumed that in the case where the intervention is taking part in the SU2S scheme in 
general, rather than the implementation of specific interventions listed by the Trusts, the same 
short-term proxy outcomes for the number of claims made as discussed in the overview above 
might be influenced. For further details on the reasons behind the choice of these outcomes as 
proxy outcomes for litigation claims, please see Appendix 10. 
 
Outcome data collection 
We prepared and sent a data entry sheet (see Appendix 9) to 28 successful and 23 unsuccessful 
Trusts requesting information on these outcomes from June 2011 to July 2016, inclusive. Not all 
Trusts sent complete data, and there was large variation in the source data that Trusts used to 
collate responses to our questions. Most used an in-house or externally provided electronic 
database or dashboard, and some Trusts sourced data from more than one system across different 
hospital departments. One Trust retrieved the data from paper copies of the monthly report. This 
has previously been discussed in the previous section, and it should be noted that a future funding 
priority should aim to provide integrated, flexible, efficient and user-friendly IT systems to bring all 
Trusts up to a minimum standard as a high priority, in order to both improve data quality and save 
time, which might then be spent with patients. We performed basic checks on all datasets received 
to test their face validity, corresponding with Trusts to ensure that the data received were as 
accurate as possible within the constraints of Trusts’ IT systems, and time and staffing limitations. 
We then put the data received into a single dataset with Trusts identified only by code numbers so 
that their individual responses are not identifiable, and only aggregated data are reported. 
 
Intervention dates 
We have carried out two parallel analyses, firstly looking at the impact of the specific interventions 
purchased, using the implementation dates provided by each Trust regarding when the first of their 
interventions was implemented. The control group, i.e. the unsuccessful Trusts, were assigned an 
intervention date  corresponding to the median intervention date of the successful Trusts (8 May 
2015). The second analysis considers the date on which funds were received by each Trust via BACS 
from NHS LA. Again, the unsuccessful Trusts were assigned the median date of the successful Trusts 
for this payment date (29 Sep 2015). The Sign up to Safety dates of implementation of specific 
interventions in the successful Trusts fall between March 2015 and September 2016 (the latest date 
was an anticipated date stated in a report that we received in the spring of 2016). The BACS 
payment dates for the successful Trusts fall between May and September 2015. 
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 Information provided by NHS LA 
 




















































Of the 28 successful Trusts (Y), we received information from all 28 Trusts and were able to include 
data from 26 Trusts in our final dataset. The remaining 2 contained inconsistencies that had not 
been resolved before the data analysis was finalised. 
 
Of the 23 unsuccessful Trusts (N), we received data from 21, and were able to include data from 18 
in our final dataset. The remaining 3 contained inconsistences that had not been resolved before 
the data analysis was finalised.  
 
The results are reported separately for babies and mothers. We firstly show histograms to illustrate 
how common each outcome is in each group (successful and unsuccessful). 
 
The results are reported in tables, where we give the proportion of events of each outcome type, 
averaged over the Trusts. Then we calculate the before and after difference in each group, 
Difference (Y) and Difference (N), and then we use these values to calculate the difference in 
differences, which is the right-most column in Tables 8, 9, 12 and 13) 
 
These proportions are then multiplied up to give the number of events per 100,000 term singleton 
babies for the outcomes relating to babies, and per 100,000 mothers for the outcomes relating to 
mothers (Tables 10, 11, 14 and 15). The uncertainty in all the results is very large, partly due to the 
small sample size, and also due to the low incidence of some of the outcomes, especially cooling, 
stillbirth, and 4th degree tears. 
 
The raw proportions, split into the four groups (Before N; After N; Before Y; After Y), are shown in 
plots of the proportions against time, along with their linear regression lines, to illustrate more 
clearly the large amount of uncertainty in this dataset and the wide variation of results over time. 
 
Finally, using the unit costs and the unit reductions in HRQOL from the NHS Reference Costs and the 
literature, we present the total differences in costs and HRQOL per outcome per 100,000 babies or 
mothers, and relate this to the amount spent by the NHS LA. 
 
We requested data from June 2011 to July 2016, and we received the full dataset in some cases but 
not all. In particular, some Trusts could not extract data for the early part of that period for all 
outcomes, meaning that the level of missing data was higher in the earlier years. To mitigate any 
selection or other bias arising from this missing information, we considered only the data reported 
in the 12 months before and after the boundary dates, and the base case analysis is presented using 
only this one-year data. An added advantage to this is that we do not need to control for annual 
























































Babie  c me  
 
Histograms (N=unsuccessful Trusts, Y=successful Trusts) 
These graphs show  
x pc APGAR  the average proportions of low Apgar scores at  minutes with reported numbers 
of unknown Apgar scores subtracted from the denominators as detailed in Table 7 above), split 
by successful/unsuccessful Trusts (Graph 1);  
x pc stillborn  the average proportions of stillbirths per month  in successful and unsuccessful 
Trusts (Graph 2); 
x pc cooled  the average proportions of babies therapeuticall  cooled per month, in successful 
and unsuccessful Trusts (Graph 3); 
x pc NICU  the average proportions of babies unexpectedl  admitted to NICU per month  in 
successful and unsuccessful Trusts (Graph 4). 
 
The x-axis in each plot represents the proportion of the specified outcome (i.e. 0.01 = 1%), and the 
y-axis  called Densit  represents the frequenc  of each value on the x-axis; for example, in both 
the N Trusts and the Y Trusts, the most frequent (highest column) monthly rate of low Apgar score 
recorded is about 1%, and the most frequent rate of stillbirth or cooling is close to zero. 
 











































































































































































































































Diffe ence  in o o ion  of babie  o come  in o  am le 
These results are shown in Table 8 (using the date of implementation of the first specific 
intervention, or the median of that date) and Table 9 (using the date on which the BACS payment 
arrived at the Trust, or the median of that date). The data are described using the next set of tables 
(Table 10 and Table 11) as it is easier to discuss when considering numbers of events per 100,000 
babies than when considering the proportions which are given here. The proportions are reported 
however as they relate to Graphs 1-4. 
 
Table 8. P o o ion  of o come  he diffe ence  Diff  col mn  acco ding o he he  o  no  he 
Trust received SU2S funding or not (using the specific intervention implementation date as the 
boundary date), and the difference in tho e diffe ence  DiD  col mn  o gi e he o e all effec  of 
the scheme. Values are given as point estimates and 95% confidence intervals. 
 
 
Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Proportions Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 0.00133 0.00118 -0.00016 0.00141 0.00160 0.00019 -0.00035 
lower 95%CI 0.00102 0.00083 -0.00050 0.00103 0.00122 -0.00019 -0.00073 
upper 95%CI 0.00164 0.00152 0.00019 0.00179 0.00199 0.00058 0.00004 
Low Apgar score 0.01240 0.01389 0.00149 0.01234 0.01301 0.00068 0.00081 
lower 95%CI 0.00988 0.01130 -0.00110 0.00928 0.00995 -0.00239 -0.00225 
upper 95%CI 0.01492 0.01648 0.00408 0.01539 0.01608 0.00374 0.00387 
Cooled 0.00154 0.00135 -0.00018 0.00190 0.00221 0.00031 -0.00049 
lower 95%CI 0.00113 0.00090 -0.00063 0.00139 0.00169 -0.00021 -0.00101 
upper 95%CI 0.00194 0.00181 0.00027 0.00241 0.00273 0.00083 0.00003 
Unexpected NICU 0.04177 0.04357 0.00180 0.04336 0.04286 -0.00050 0.00230 
lower 95%CI 0.03276 0.03449 -0.00728 0.03249 0.03198 -0.01138 -0.00859 
upper 95%CI 0.05077 0.05265 0.01088 0.05423 0.05375 0.01039 0.01318 
 
Table 9. P o o ion  of o come  he diffe ence  Diff  col mn  acco ding o he he  o  no  he 
Trust received SU2S funding or not (using the BACS payment arrival date as the boundary date), and 
he diffe ence in ho e diffe ence  DiD  col mn  o gi e he overall effect of the scheme. Values 
are given as point estimates and 95% confidence intervals. 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Proportions Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 0.00142 0.00130 -0.00013 0.00157 0.00153 -0.00004 -0.00009 
lower 95%CI 0.00112 0.00101 -0.00043 0.00118 0.00116 -0.00043 -0.00048 
upper 95%CI 0.00172 0.00158 0.00017 0.00196 0.00190 0.00035 0.00031 
Low Apgar score 0.01192 0.01366 0.00175 0.01134 0.01278 0.00144 0.00031 
lower 95%CI 0.00960 0.01137 -0.00057 0.00835 0.00982 -0.00155 -0.00268 
upper 95%CI 0.01423 0.01596 0.00406 0.01433 0.01574 0.00443 0.00330 
Cooled 0.00174 0.00156 -0.00018 0.00206 0.00213 0.00007 -0.00025 
lower 95%CI 0.00129 0.00112 -0.00064 0.00145 0.00154 -0.00054 -0.00086 
upper 95%CI 0.00219 0.00199 0.00027 0.00266 0.00271 0.00068 0.00035 
Unexpected NICU 0.04195 0.04488 0.00294 0.04372 0.04263 -0.00108 0.00402 
lower 95%CI 0.02951 0.03247 -0.00950 0.02755 0.02648 -0.01725 -0.01215 
























































Differences in numbers of events per 100,000 babies 
These results are shown in Table 10 (using the date of implementation of the first specific 
intervention, or the median of that date) and Table 11 (using the date on which the BACS payment 
arrived at the Trust, or the median of that date).  
 
When using the Invtn date, the stillbirth and cooling rates seem to both reduce slightly in the Y 
group (Diff (Y) is negative), and increase slightly in the N group (Diff (N) is positive). These changes 
are not however statistically significant. The rate of low Apgar score increases slightly (and not 
significantly) in both groups, leading to an overall insignificant increase. The rate of unexpected 
NICU admission seems to increase (insignificantly) in the Y group, decrease (insignificantly) in the N 
group, with an overall insignificant increase. As these changes are not significant, we cannot 
conclude that there is any change at all.  
 
When using the BACS date, the results are virtually identical, and there is no alteration in the 
conclusion drawn, which is that we can detect no change. This does not mean that there definitively 
is no change, instead it means that with the data we have, and the small sample size, there is no 
detectable change, so either it is small, or it is non-existent. 
 
 
Table 10  N mbe  of e en  pe   babie  he diffe ence  Diff  col mn  according to 
whether or not the Trust received SU2S funding or not (using the specific intervention 
implemen a ion da e a  he bo nda  da e  and he diffe ence in ho e diffe ence  DiD  col mn  




Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD Events per 100,000 
babies 
Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 133 118 -16 141 160 19 -35 
lower 95%CI 102 83 -50 103 122 -19 -73 
upper 95%CI 164 152 19 179 199 58 4 
Low Apgar score 1240 1389 149 1234 1301 68 81 
lower 95%CI 988 1130 -110 928 995 -239 -225 
upper 95%CI 1492 1648 408 1539 1608 374 387 
Cooled 154 135 -18 190 221 31 -49 
lower 95%CI 113 90 -63 139 169 -21 -101 
upper 95%CI 194 181 27 241 273 83 3 
Unexpected NICU 4177 4357 180 4336 4286 -50 230 
lower 95%CI 3276 3449 -728 3249 3198 -1138 -859 
























































Table 11. Numbers of events per ,  babies, the differences Diff  columns  according to 
whether or not the Trust received SU2S funding or not (using the BACS payment arrival date as the 
boundary date), and the difference in those differences DiD  column  to give the overall effect of 
the scheme. Values are given as point estimates and 95% confidence intervals. 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD Events per 100,000 
babies 
Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 142 130 -13 157 153 -4 -9 
lower 95%CI 112 101 -43 118 116 -43 -48 
upper 95%CI 172 158 17 196 190 35 31 
Low Apgar score 1192 1366 175 1134 1278 144 31 
lower 95%CI 960 1137 -57 835 982 -155 -268 
upper 95%CI 1423 1596 406 1433 1574 443 330 
Cooled 174 156 -18 206 213 7 -25 
lower 95%CI 129 112 -64 145 154 -54 -86 
upper 95%CI 219 199 27 266 271 68 35 
Unexpected NICU 4195 4488 294 4372 4263 -108 402 
lower 95%CI 2951 3247 -950 2755 2648 -1725 -1215 
upper 95%CI 5439 5730 1538 5989 5878 1509 2019 
 
 
Plots of mean differences in proportions against calendar month, separated by before vs. after and 
successful vs. unsuccessful Trusts 
 
Note that the DiD results in Table 10-11 above have calculated the mean proportion in the after 
period, i.e. with the average taken over the 12 months after the boundary date (or for as many 
months as there is data available), and the mean proportion for the before period (average over 12 
months before the boundary date), and subtracted one from the other. The plots shown in Figures 
16, 17, 18, 19 below show trends with time, and thus they might be able to convey some more 
meaning or direction in the data. However, the trend lines show that there are no clear trends in the 
outcomes measured for this sample. 
 
The average proportion in each of the four groups (Before N; After N; Before Y; After Y) corresponds 
to the values in the first pair of results tables (Tables 10 and 11). Each point in the scatter plots that 
are shown here (Figures 16-19) is the average proportion of all Trusts in that group over that 
calendar month. For example, the green triangle point in the left-hand plot of Figure 16 here below, 
at month 50 and lying just below 0.006 along the y-axis, tells us that, of the Y Trusts, in the before 
period (BACS boundary date), the average proportion of low Apgars in July 2015 was just under 
0.6%. 
 
Low Apgar scores 
These graphs show the progression of the rates of low Apgar scores (<7 at 5 minutes) as a function 
of time months  for each of the four groups: before and unsuccessful Before, N ; after and 
unsuccessful After, N ; before and successful Before, Y ; after and successful After, Y . No 
adjustment can be made to shift the time points such that all Trusts implement at a false ‘zero’, as 
this would mean that information regarding external influences on the low Apgar rates, e.g. 
seasonal variations, or changes in policy or funding that happened in a specific month, would be 
lost. The linear trend lines are the regression lines that fit each of the four groups. A negative 
gradient implies that the outcome became less frequent over time, and a positive gradient the 
reverse, although it is important to note that the R2 value, denoting the goodness of fit, is close to 
zero for all outcomes, indicating that there is no real trend and in fact the values are scattered 
 


















































almost randomly. This uncertainty is also reflected in the results tables in this section (see Table 10 
and Table 11 above). 
 
Note: The y-axis in each plot in Figures 16-19 indicates the proportion of events (i.e. 0.01 means 
1%), and the x-axis indicates the number of months after the start of data collection, i.e. 1 = June 
2011, 30 = November 2013, and 60 = May 2016. 
 
Figure 16. Plots for the proportions of babies with low Apgar scores as a function of time, with the 
numbers of unknown Apgar scores removed from the denominator. 
 
The four sets of points in each plot correspond to (i) unsuccessful Trusts  da a N  before he bo ndar  mon h  
(ii) successful Trusts  da a Y  before he bo ndar  mon h  iii  n cce f l Trusts  da a N  af er he bo ndar  
month, (ii) successful Trusts  da a Y  af er he bo ndar  mon h  The four linear regression lines correspond to 
each set of points. The left-hand plot used the BACS dates as the boundary dates, and the right-hand plot used 
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These plots, along with the values in Table 10-11, also show no significant changes. The lack of 
significance is given in the wide 95%CI, straddling zero (see Table 10-11 above), and in the low 
values for goodness of fit shown by the linear regression lines in Figure 17 below. 
 
Figure 17. Plots for the proportions of babies that are therapeutically cooled. The top plot used the 
BACS dates as the boundary dates, and the bottom plot used the first specific intervention dates as 








Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
months after the start of data collection, i.e. 1 = June 2011, 30 = November 2013, and 60 = May 2016. 
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Unexpected admissions in NICU 
These plots, along with the values in Table 10-11, also show no significant changes. The lack of 
significance is given in the wide 95%CI, straddling zero (see Table 10-11 above), and in the low 
values for goodness of fit shown by the linear regression lines in Figure 18 below. 
 
Figure 18. Plots for the proportions of term babies that are unexpectedly admitted to NICU. The top 
plot used the BACS dates as the boundary dates, and the bottom plot used the first specific 







Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
months after the start of data collection, i.e. 1 = June 2011, 30 = November 2013, and 60 = May 2016. 
 
 
y = -0.0001x + 0.0488
R² = 0.0135
y = 0.0002x + 0.0295
R² = 0.0758
y = -0.0003x + 0.0545
R² = 0.0272










30 35 40 45 50 55 60 65
Unexpected NICU, using BACS dates as boundary
Before, N After, N
Before, Y After, Y
Linear (Before, N) Linear (After, N)
Linear (Before, Y) Linear (After, Y)
y = -0.0004x + 0.0612
R² = 0.1289
y = 0.0001x + 0.0344
R² = 0.029
y = -0.0002x + 0.0528
R² = 0.0534










30 35 40 45 50 55 60 65
Unexpected NICU, using intvn dates as boundary
Before, N After, N
Before, Y After, Y
Linear (Before, N) Linear (After, N)
Linear (Before, Y) Linear (After, Y)
 




















































These plots, along with the figures in Table 10-11, show no significant change with time. The lack of 
significance is given in the wide 95%CI, straddling zero (see Table 10-11 above), and in the low 
values for goodness of fit shown by the linear regression lines in Figure 19 below. Possibly a slight 
increase from numbers in Table 10-11, but the trends in the graph suggest a decrease through each 
time period. This disagreement simply adds to the lack of certainty over any meaningful trend or 
conclusion. 
 
Figure 19. Plots for the proportions of babies that are stillborn. The top plot used the BACS dates as 





Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
months after the start of data collection, i.e. 1 = June 2011, 30 = November 2013, and 60 = May 2016. 
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Mo her  o come  
 
Histograms (N=unsuccessful Trusts, Y=successful Trusts) 
 
These graphs show the average proportions of: 
x 3rd degree tears (not including data from the three Trusts that only reported mixed 3rd and 4th 
degree tears) (Graph 5) 
x 4th degree tears (not including data from the three Trusts that only reported mixed 3rd and 4th 
degree tears) (Graph 6) 
x Mixed 3rd and 4th degree tears (including data from all 44 Trusts, i.e. also including the three 
Trusts that only reported mixed 3rd and 4th degree tears) (Graph 7) 
Each pair of histograms shows the unsuccessful Trusts’ (“N”) values on the left, and those of the 
successful Trusts (“Y”) on the right. The y-axis, called “Density”, represents the frequency of each 
value on the x-axis; for example, in both the N Trusts and the Y Trusts, the most frequent rate of 4th 
degree tears is close to zero, and the most frequent rate of 3rd degree or mixed 3rd/4th degree tears 
is around 3% to 4%. 
 






























































































































































Differences in proportions of mothers’ outcomes in our sample 
 
These results are shown in Table 12 (using the date of implementation of the first specific 
intervention, or the median of that date) and Table 13 (using the date on which the BACS payment 
arrived at the Trust, or the median of that date). The data are described using the next set of tables 
(Table 14 and Table 15) as it is easier to discuss when considering numbers of events per 100,000 
mothers than when considering the proportions which are given here. The proportions are reported 
however as they relate to Figures 20 and 21 below. 
 
Table 12. Proportions of outcomes, the differences (“Diff” columns) according to whether or not the 
Trust received SU2S funding or not (using the specific intervention implementation date as the 
boundary date), and the difference in those differences (“DiD” column) to give the overall effect of 
the scheme. Values are given as point estimates and 95% confidence intervals. 
 
 
Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Proportions Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 0.03253 0.03256 0.00003 0.03376 0.03013 -0.00363 0.00366 
lower 95%CI 0.02943 0.02932 -0.00321 0.03027 0.02661 -0.00715 0.00013 
upper 95%CI 0.03563 0.03579 0.00326 0.03725 0.03365 -0.00011 0.00718 
4th degree tears 0.00160 0.00141 -0.00019 0.00219 0.00186 -0.00033 0.00014 
lower 95%CI 0.00110 0.00087 -0.00073 0.00163 0.00129 -0.00090 -0.00043 
upper 95%CI 0.00210 0.00194 0.00035 0.00275 0.00243 0.00024 0.00071 
Mixed 3rd or 4th 
degree tears 
0.03347 0.03392 0.00045 0.03595 0.03199 -0.00396 0.00441 
lower 95%CI 0.03041 0.03071 -0.00276 0.03238 0.02839 -0.00756 0.00082 




Table 13. Proportions of outcomes, the differences (“Diff” columns) according to whether or not the 
Trust received SU2S funding or not (using the BACS payment arrival date as the boundary date), and 
the difference in those differences (“DiD” column) to give the overall effect of the scheme. Values 
are given as point estimates and 95% confidence intervals. 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Proportions Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 0.03246 0.03276 0.00030 0.03377 0.03158 -0.00219 0.00249 
lower 95%CI 0.02955 0.02992 -0.00261 0.03029 0.02814 -0.00568 -0.00100 
upper 95%CI 0.03537 0.03560 0.00321 0.03726 0.03502 0.00130 0.00598 
4th degree tears 0.00145 0.00153 0.00008 0.00253 0.00193 -0.00059 0.00067 
lower 95%CI 0.00096 0.00106 -0.00042 0.00194 0.00136 -0.00118 0.00008 
upper 95%CI 0.00195 0.00200 0.00057 0.00311 0.00250 -0.00001 0.00126 
Mixed 3rd or 4th 
degree tears 
0.03317 0.03417 0.00100 0.03630 0.03351 -0.00279 0.00379 
lower 95%CI 0.03030 0.03132 -0.00187 0.03274 0.03000 -0.00635 0.00023 

























































Differences in numbers of events per 100,000 mothers 
These results are shown in Table 14 (using the date of implementation of the first specific 
intervention, or the median of that date) and Table 15 (using the date on which the BACS payment 
arrived at the Trust, or the median of that date).  
When considering the Intvn date, the numbers of tears in the Y Trusts undergo small changes, and 
the numbers of tears in the N Trusts decrease dramatically, at least in the cases of the 3rd degree 
tears, and the mixed 3rd/4th degree tears. This means that the difference in differences indicates a 
significant relative increase in the numbers of tears on taking part in SU2S. 
It has been suggested that, when the scheme began, Trusts might have begun to recognise and 
record 3rd and 4th degree tears more than they previously had done, and this could cause an 
increase in the numbers of tears reported, even if the numbers of tears do not change per se. 
 
The results when using the BACS dates are similar, with significantly higher numbers of mixed 3rd/4th 
degree tears, and of 4th degree tears (but not now 3rd degree tears) reported. 
 
Table 14. Numbers of e en  pe   mo he  he diffe ence  Diff  col mn  acco ding o 
whether or not the Trust received SU2S funding or not (using the specific intervention 
implemen a ion da e a  he bo nda  da e  and he diffe ence in ho e diffe ence  DiD  col mn) 
to give the overall effect of the scheme. Values are given as point estimates and 95% confidence 
intervals. 
 
Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD Events per 100,000 
mothers 
Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 3253 3256 3 3376 3013 -363 366 
lower 95%CI 2943 2932 -321 3027 2661 -715 13 
upper 95%CI 3563 3579 326 3725 3365 -11 718 
4th degree tears 160 141 -19 219 186 -33 14 
lower 95%CI 110 87 -73 163 129 -90 -43 
upper 95%CI 210 194 35 275 243 24 71 
Mixed 3rd or 4th 
degree tears 
3347 3392 45 3595 3199 -396 441 
lower 95%CI 3041 3071 -276 3238 2839 -756 82 
upper 95%CI 3653 3714 367 3951 3558 -37 801 
 
Table 15. Numbers of e en  pe   mo he  he diffe ence  Diff  col mn  acco ding o 
whether or not the Trust received SU2S funding or not (using the BACS payment arrival date as the 
bo nda  da e  and he diffe ence in ho e diffe ence  DiD  col mn  o gi e he o e all effec  of 
the scheme. Values are given as point estimates and 95% confidence intervals. 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD Events per 100,000 
mothers 
Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 3246 3276 30 3377 3158 -219 249 
lower 95%CI 2955 2992 -261 3029 2814 -568 -100 
upper 95%CI 3537 3560 321 3726 3502 130 598 
4th degree tears 145 153 8 253 193 -59 67 
lower 95%CI 96 106 -42 194 136 -118 8 
upper 95%CI 195 200 57 311 250 -1 126 
Mixed 3rd or 4th 
degree tears 
3317 3417 100 3630 3351 -279 379 
lower 95%CI 3030 3132 -187 3274 3000 -635 23 
upper 95%CI 3603 3701 387 3986 3703 77 735 
 


















































Plots of mean differences in proportions against calendar month, separated by before vs. after and 
successful vs. unsuccessful Trusts 
 
The same plots have been drawn here for the tears data, and they all also suggest that there is a 
downward (insignificant) trend over time, apart from the 4th degree tears. The numbers of 4th 
degree tears reported made up approximately 5% of all tears (3rd or 4th degree). 
 
Figure 20. Plots for the 3rd degree tears. The top plot used the BACS dates as the boundary dates, 









Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
months after the start of data collection, i.e. 1 = June 2011, 30 = November 2013, and 60 = May 2016. 
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Figure 21. Plots for the 4th and 3rd/4th degree tears.  The top plot used the BACS dates as the 







Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
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Note: The y-axis indicates the proportion of events (i.e. 0.01 means 1%), and the x-axis indicates the number of 
months after the start of data collection, i.e. 1 = June 2011, 30 = November 2013, and 60 = May 2016. 
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6.6. Sensitivity analysis  
 
We conducted several sensitivity analyses where we: i) varied the boundary data of implementation 
of interventions; ii) included the whole data period instead of just only one year before and one 
year after the implementation of interventions; iii) ignored the numbers of “unknown  low Apgar 
scores rather than removing them from the denominator; iv) included only mothers with 
instrumental delivery in the analysis of tears; v) ran the analysis for sub-groups of interventions. 
 
Which boundary date? 
As discussed briefly above, we have carried out two parallel analyses, firstly looking at the impact of 
the specific interventions purchased, using the implementation dates. The second analysis considers 
the date on which funds were received by each Trust via BACS from NHS LA. The results show no 
difference when using one boundary date instead of the other, so this does not matter. 
 
Over what time period (whole time or 1 year)? 
The main analysis compares the average proportion of, for example, low Apgar scores (<7 at 5 
minutes  in the ‘after’ time period i.e. averaging across all months after the intervention or BACS 
payment date , with the average proportions with low Apgar scores across the whole ‘before’ time 
period. This approach was considered to possibly lead to some bias, as the successful Trusts 
managed to provide more data in early time periods (i.e. in 2011 and 2012) than unsuccessful 
Trusts, meaning that there was more missing data for the unsuccessful (control) group in early time 
periods. A similar issue arose when we considered that the intervention(s) had been implemented 
less than a year after July , so there was even less information available in the ‘after’ period 
compared to the ‘before’ period, for both sets of Trusts. 
 
To account for this and to minimise any possible bias, we carried out an analysis which only included 
12 months before the intervention date, and 12 months after the intervention date as this was felt 
to be the more appropriate. 
 
The results using the whole time period were also calculated, and the results obtained in each case 
were similar, and gave the same conclusions for all outcomes, i.e. any changes were not significant, 
and the broad trends in each outcome were the same regardless of whether 4 (or 3 or 2 depending 
on missing data) or only one year before the boundary date were included.  
 
Should the proportion of Apgar scores not known at 5 minutes be included? 
The results are similar regardless of whether the numbers of unknown Apgar scores are subtracted 
from the denominator or not. It does not affect the conclusions. The figures given in the tables 
above are for the analyses where numbers of babies for whom their Apgar score at 5 minutes was 
not known were excluded from the denominator, i.e. we made no assumptions regarding the 
unknown Apgar scores. The reason why there was a question over this is that some Trusts reported 
that there were zero unknown Apgar scores, or they did not have records of this data that were 
easily accessible without going through all the records by hand, so we did not insist on receiving 
this. 
 
What denominator should be used for tears? 
We tested the results found if only mothers with instrumental deliveries were included as the 
denominator, and this gave the same conclusions as above  there was a significant increase in tears 
recorded across both boundary date scenarios, for 3rd degree, 4th degree, and mixed tears (except 
for 4th degree tears measured with the specific Intvn boundary date  this gave a non-significant 
increase). 
 


















































Sub-group analysis of different interventions? 
We attempted some sub-group analysis to see if the effects of different interventions could be 
analysed alone.  
 
We looked at those Trusts that implemented Fetal Monitoring Equipment (intervention B), and at 
those that implemented Q&S improvement lead / nurse (staff) and/or Training and development 
(interventions E or H), for stillbirth and for low Apgar rates. The other Y Trusts that had 
implemented other interventions were omitted from this analysis. Consideration of only these 
specific intervention types did not lead to any significant results, so the conclusions were the same 
as the base case analysis. 
 
6.7. How many incidents should be avoided to cover the investment?  
 
Cooling, Apgar scores and cerebral palsy claims 
As part of the evaluation, and given the lack of significant effects found in the DiD analysis described 
above, we have sought evidence from previous studies establishing a relationship between the 
outcomes collected from the Trusts and cerebral palsy cases and claims. The idea was to determine 
the minimum number of claims avoided necessary for the Sign Up to Safety Scheme to be good 
value for money. 
 
The first relationship investigated was between the number of babies cooled and the cerebral palsy 
cases and claims. After obtaining expert advice and conducting a brief literature review, we have 
identified one UK-based study that explored the relationship between cooling and poor long-term 
outcomes in babies (Azzopardi et al., 2009)73.  According to the authors, 25.71% of the babies 
cooled will end up being diagnosed with a severe disability, most of which due to cerebral palsy. 
Although the exact proportion of cerebral palsy cases is not given in the study, one could 
understand the above-mentioned proportion as the upper limit of cerebral palsy cases.  
 
National level data from the NNRD shows that in the years of 2010 and 2011, there were 1,343 
babies cooled in England. We have chosen to focus on those years, given that normally cerebral 
palsy takes at least 2 years to be diagnosed. Furthermore, the average time gap between the date of 
incident and the date of claim is on average 3.5 years, therefore we expect most cases referring to 
incidents that took place in 2010 and 2011 to have been opened already, allowing for a relationship 
between babies cooled and number of claims to be established. 
 
Using the number of babies cooled in 2010 and 2011 and the proportion calculated by Azzopardi et 
al, we estimate that 346 infants would end up with some form of severe disability, most of which 
with cerebral palsy. 
 
Following clinical expert advice, we have also sought to establish a relationship between low Apgar 
scores and cerebral palsy. The 5-minute Apgar<7 (Apgar <75) rate in term infants is an important 
measure of intrapartum care as it is associated with a considerably higher rate of cerebral palsy in 
later life (OR 62, 95% CI 52-74) as well as lower levels of cognition, lower levels of education and 
lower incomes (Graham, 2008; Hogan et al., 2007; Thorngren-Jerneck et al., 2001)74. There is also 
                                                     
73 Azzopardi DV et al (2009). Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 
361(1):1349-58 
74 Graham (2008). A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal 
encephalopathy AmJObsGyn; Hogan L, Ingemarsson I et al. (2007) How often is a low 5min Apgar score in term 
newborns due to asphyxia ? EurJObsGyn 130(2):169-75. Thorngren-Jerneck K, Herbst A. Low 5-minute Apgar 
score: a population-based register study of 1 million term births. Obstet Gynecol. 2001;98(1):65–70  
 


















































evidence of long-term impact of poor birth condition on social and economic outcomes in early 
adulthood.  
 
Crucially, Apgar scores can be improved by training. Moreover, some pilot work has shown that 
Apgar scores are reliably collected, with missing data not affecting the robustness of the score as 
outcome measure. 
 
Finally, a significant majority of claims and also the successful applications are related to reducing 
asphyxial damage, for which Apgar <7 5 is a very sensitive marker.  
Unfortunately, no UK-based studies were found exploring this relationship. However, a robust 
population-based cohort study carried in Norway and published in the British Medical Journal (BMJ) 
has been identified (Lie et al., 2010)75. This study has the strength of estimating the relationship 
between Apgar scores and cerebral palsy using direct observation of the total population born over 
a long period of time, avoiding important biases due to time lags and sampling.  
 
We have relied on national data (NNRD) to gather information on number of babies born with an 
Apgar score less than 7 at 5 minutes (Apgar <75) in England between 2010-2011 and applied a rate 
from the Norway study to estimate the number of babies having cerebral palsy. In 2010 and 2011, 
there were 5187 born with Apgar scores lower than 7 at 5 minutes. Using the proportion of babies 
developing cerebral palsy obtained by Lie and other, we would have that 232 babies would be later 
diagnosed with cerebral palsy, having been born in England between January 2010 and December 
2011. The discrepancy between the previous estimate using cooling and the one using Apgar scores 
may be explained by the fact that the previous did not focus on cerebral palsy cases only, but in any 
form of severe disability. 
 
Finally, we tried to determine the relationship between cases and claims. According to the NHS 
Litigation Authority data, 147 cerebral palsy claims were opened referring to incidents occurring in 
2010 and 2011. This implies that not all cerebral palsy cases are directly translated into claims, 
although the majority does become a legal action. Table 16 displays the relationship between 
cooling and low Apgar and cerebral palsy claims. 
 
Table 16. Cooling, Apgar Scores and Cerebral Palsy Claims  
 
Outcomes Cases (2010/11) Proportion that becomes a claim 
Babies cooled 1343 10.95% 
Babies with Apgar lower 
than 7 at 5 minutes 5187 2.83% 
Babies with Apgar equal to 
or lower than 4 at 5 minutes 1783 8.20% 
  
  
The relationship between cooling, Apgar scores and cerebral palsy claims can be used to estimate 
the necessary decrease in numbers of babies cooled and with low Apgar necessary for the Sign Up 
to Safety Scheme to be good value for money. 
 
Considering that on average, a successful cerebral palsy claim has a total cost to the NHS Litigation 
Authority of £4,745,295 (NHS claims database), and that in total just over £8 million pounds were 
invested in maternity interventions in the Sign Up to Safety financial incentives Scheme to decrease 
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both cerebral palsy claims and claims in tears, the scheme could be considered good value for 
money had it decreased two claims in terms of cerebral palsy. Table 17 displays the necessary 
reduction in each outcome to reduce the number of cerebral palsy claims by one. 
 
Table 17. Necessary decrease in outcomes 
Outcomes Necessary decrease 
Babies cooled 18 
Babies with Apgar lower 
than 7 at 5 minutes 70 
Babies with Apgar equal to 
or lower than 4 at 5 minutes 24 
 
Thus, had the Sign up to Safety scheme produced an overall reduction in the number of babies 
cooled and with low Apgar scores in the amount displayed in Table 17 in the participating Trusts, the 
scheme could be considered good value for money. This is likely to be possible as the mean Apgar 
score <75 minutes was 1.3% and there are reported rates in the UK of <0.5% that have been 
sustained for more than a decade (Draycott et al., 2006)76.  
 
Similarly, if we think that an admission in NICU cost on average £3,440 (Table A1- Appendix 10) in 
order to cover the £8 million investment in maternity units would be sufficient to avoid the 
admission of 2,325 babies.  
 
6.8. Discussion  
 
The res l s of he anal sis don  sho  a s a is icall  significan  effec  of he scheme in red cing 
stillbirth, babies born with a low Apgar score at 5 minutes or receiving cooling, unexpected NICU 
admissions, or 4th degree tears or instrumental delivery or CSs.  The only significant effect is 
represented by an increase in 3rd degree tears, thought to be due to improved reporting. Hence it 
was not possible to calculate cost savings associated with the interventions or improvement in 
health related quality of life and mortality. These results have been confirmed by the sensitivity 
analysis.  
   
We identified several reasons why the scheme might not have had an impact on reducing 
intrapartum harm based on our results: 
- Choice of interventions. Taking the results of the statistical analysis at face value, the 
interventions implemented by Trusts may not have been effective in reducing harms. The 
maternity units invested their funding in a broad range of interventions, and evidence of 
effectiveness for the interventions they implemented is limited.  
- Implementation problems. At the time of the analysis (conducted 12-14 months after the 
Trusts had received funding from the scheme) not all Trusts had implemented the 
interventions they had originally proposed to: almost half of the participating maternity 
units (46% of those awarded funding) had not implemented some or all of their 
interventions at the time we completed the evaluation.  
- Short duration of follow up. There is likely to be a delay before the benefits of the 
interventions are seen, so even if interventions are fully implemented then it may take 
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longer than the time horizon of our evaluation (one year) to see a tangible benefit. In at 
least one unit level intervention with positive outcomes, a year was required to train all of 
the unit, and outcomes changed in the following year.  
- Data quality. The results of our analysis may be limited by the quality of data provided. 
Maternity datasets are recognised to be some of the most accurate in the NHS, however 
many Trusts found it difficult to provide data from their IT department for evaluation. 
Despite the enormous efforts by Trusts, we are aware that the retrospective collection 
might have negatively impacted on the accuracy, reliability and completeness of the data. In 
addition, the small sample size (we only had aggregate data for 44 Trusts) and the lack of 
patient level data may also have affected the results.  
 
Future recommendations 
There have been a number of successful maternity improvement programmes and some that have 
been less successful and it is imperative that we use the learning from both.  
 
Firstly, as recommended by the Trusts, it would be useful in future for the NHS LA to work with 
experienced academic and clinical collaborators to provide further clinical oversight, help signpost 
units to potentially effective interventions and also help units with local evaluation. 
 
Secondly, local measurement of care is very important to both prioritise interventions and also 
measure effect (Macrae, 2016)77. We should make measurement of care easier, timely and more 
understandable to all the actors in the system, from Government to patients themselves. Quality is 
multi-faceted and we must ensure that measurement is broad enough to include what is important 
to all stakeholders, not merely what can easily be measured (Draycott et al., 2010)78.  
 
High quality healthcare systems are those that produce the best outcomes with the fewest 
interventions, to the satisfaction of their patients, within a cost-effective framework. 
Measuring a combination of outcomes and processes is required, with perception of care if possible. 
There is probably a sweet spot of best care: the best outcomes, with the least intervention and the 
best experience. 
We should collect and produce a standard, relevant set of quality indicators, ideally from routinely 
collected data, and present these in a manner that facilitates on-going quality improvement, just as 
recommended in the recent Better Births report (National Maternity Service Review, 2016)79. 
Ideally, these data could then be employed to focus regulatory visits from bodies like the Care 
Quality Commission as well as being used for local prioritisation of improvement initiatives and 
energy.  
 
Thirdly, the evidence base for policy makers is lacking and this should be addressed to help national 
level bodies in the system to use finite resources most effectively. It is important that we identify 
which national level levers can be used to incentivise bo om p impro emen  a  a local le el   
 
NHS LA is perfectly placed o align and n angle he priori  hicke  of national, regional and local 
actors in the current policy landscape (Dixon-Woods et al., 2013) 80.  
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Going forward, we propose that a useful framework for insurers and other actors in the Quality 
Improvement space may be divided into national, regional and local elements: 
National 
 Establish a network of active academics and clinicians to work with the NHS LA  
 Set evidence based standards (proportion staff trained etc.) 
 Signpost evidence based Interventions  
 Monitoring and Evaluation  
± Alignment: Care Quality Commission, NHS England, Professional bodies 
 Incentivise good outcomes  Premium modelling 
Regional 
 Incentivise support networks including buddying 
 Support benchmarking 
Local 
 Consider funding some Implementation research (including General Medical Council 
and  Nursing and Midwifery Council revalidation) 
 Prioritisation based on local outcomes/benchmarking 
 
Sustainable improvement in intrapartum outcomes is likely to require an integrated approach of: 
incentivising best care, local multi-professional training with tools for staff to provide best care and 
also the measurement of best care. Insurers are very well placed to identify, fund and promote 
successful models of care.  
 
Finally, he e i  a Heal h Fo nda ion f nded ojec  in e iga ing a elec ion of S a e in e  
approaches to clinician engagement. It is currently at the analysis stage, but there is clearly 
significant interest in this area from all the participants. Some preliminary observations suggest that 
Insurers with better clinical insight and partnership can potentially have a more positive influence 
on patient safety. Whilst there are important learning points from each of the insurers, the single 
over-arching finding is an aspiration for positive partnerships: embracing and directing research as 
well as developing collaborations between Insurers, academics and clinical teams, to improve care 
and thereby reduce both harm and litigation. 
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The aims of this project were threefold: 
(1) To examine the feasibility of collecting robust ‘cause of harm’ data to inform strategies to 
improve safety, reduce harm and reduce litigation claims. 
(2) To evaluate the impact of the SU2S financial incentive scheme on reducing missed fractures in 
A&E 
(3) To evaluate the impact of the SU2S financial incentive scheme on reducing intrapartum harm. 
 
To meet aim 1 we suggested that to be useful a dataset should contain data on the number and 
type of incidents and their association with health and claims, data on interventions to reduce 
incidents and claims, and data to routinely evaluate the impact of interventions when they are 
implemented. We identified several datasets already in existence that could meet these 
requirements, and rather than collect new data, and incur the associated time and money costs of 
this, further work would be beneficial to coordinate these data and improve their reliability and 
reduce under-reporting. 
 
To meet aim 2 we undertook a cost-utility analysis of the interventions put in place to reduce the 
number of missed fractures in A&E in participating Trusts funded by the Sign up to Safety financial 
incentives scheme. The interventions were based around hot reporting of imaging results and 
continuous quality improvement strategies. We approached participating Trusts for data on the 
effectiveness of these interventions but it was not possible for them to provide it, mainly due to 
difficulties in identifying and recording missed fractures. We therefore based our analysis on 
published estimates of the effectiveness of these interventions from published studies, noting the 
limitations of this approach. Accounting for the costs of the interventions, and their impact on 
missed fractures, health-related quality of life, health care costs and litigation costs, both 
interventions were found to reduce overall costs and improve the health outcomes of patients.  
 
To meet aim 3 we undertook a difference-in-differences analysis of the range of interventions put in 
place to reduce the intrapartum harms in maternity units funded by the Sign up to Safety financial 
incentive scheme. Our analysis was based on data from units on a range of measures, collected 
before and after the interventions were implemented, for Trusts who were successful in obtaining 
funds, and for those who did not receive funds from the scheme. Our detailed analysis showed that 
the intervention did not have a significant effect on any of the outcomes (other than the number of 
reported tears, which were higher as a result of the scheme, possibly because with the introduction 
of the scheme more tears were recognised and reported). Given these results it was not possible to 
identify cost savings associated with the interventions, or improvements in health-related quality of 
life and mortality, or a reduction in claims. We discussed a range of possible reasons for our 
findings, including that the interventions were not effective, that that it was too early to undertake 
the evaluation, and that the quality of the data precluded a definitive analysis.  
 
We calculated that for the Sign up to Safety financial incentive scheme to be cost saving across the 
28 Trusts, then it would need to reduce the number of claims for cerebral palsy by two, which based 
on published data, would require on average 18 fewer babies to be cooled, 70 fewer babies born 
with an Apgar score lower than 7 at 5 minutes, or 24 babies born with an Apgar score equal or lower 






















































Another feature of the evaluation was that at the time of the analysis (12-14 months after the 
Trusts had received funding from the scheme) not all Trusts had implemented the interventions 
they had originally proposed due to a range of reasons: almost half the participating maternity units 
(46% of those awarded funding) had not implemented some or all of their interventions at the time 
we completed the evaluation.  
 
Moving forward more work should be done to make sure that similar schemes are supplemented by 
an initial evaluation of what are the most critical areas to be improved, what are the main causes of 
errors and what interventions could potentially be the most effective in reducing errors according to 
available evidence.  
 
Further analysis at a later date may be beneficial, after a longer period has elapsed since Trusts 
implemented the interventions. It is difficult to specify what this period might be. We speculate that 
interventions might take a year to implement fully from the start date and then at least a year to 
have an effect on incidents. For maternity care, in our data, the average time gap between the date 
of incident and the date a claim is made was 3.5 years, and so if future research was to measure the 
impact on claims directly in maternity services a substantial period from the date at which 
interventions were implemented needs to have elapsed. This time period might vary by the type of 
intervention and the clinical specialty. Further research on the appropriate time period for 
measurement would be useful.   
 
At present there is a considerable amount of data available on errors and claims but more effort is 
required to coordinate and improve its reliability. This could be achieved by improving existing 
databases so that data are routinely collected, in a standardised way and analysed. For example, the 
maternity dashboard, now limited to South East could be potentially very useful for building a more 
comprehensive database to be linked with NHS LA data on claims. This should be accompanied by 
investments and efforts in improving the IT systems of Trusts so that all the necessary data are 
collected in a timely, accurate, complete and reliable way.   
 
Further consideration should be given to the trade-off between top-down recommendations on the 
most cost-effective interventions and interventions that are more responsive to local needs.  
If on the one hand decisions on what interventions to invest in should follow clear considerations of 





1. Given the timelines involved, further evaluation of the scheme in the future may be beneficial. 
This is likely to vary by the type of intervention and the clinical speciality, but is likely to be 
several years.  
 
2. A balance needs to be made between making top-down recommendations about the 
interventions Trusts ought to implement, and giving Trusts autonomy regarding which 
interventions to implement in response to local needs. However, interventions in this and 
similar schemes should be based on good evidence of effectiveness and cost-effectiveness. We 
concur with the 2016 NHS England National Maternity review recommendation: Most 
importantly, any training undertaken must have been proven to be effective in improving 
o comes or o her aspec s of q ali  and i s impac  moni ored locall   
 
3. Future schemes could include establishing evidence on the main causes of errors, and 
signposting effective interventions with support for local measurement and regional 
 


















































benchmarking of clinical outcomes (A&E, maternal and neonatal outcomes), process measures 
(interventions), and implementation (e.g., proportion of staff trained).  
 
4. Recognition need to be given to the timescale between allocation of funding and 
implementation time (e.g., implementation of intervention can be delayed by procurement 
time). Efforts should be made to ensure that Trusts awarded funding from this and similar 
schemes can act on that funding in a timely manner, so the interventions can be of maximum 
benefit to patients as soon as possible.  
 
5. At present there is a considerable amount of data available on errors and claims but more effort 
is required to coordinate these data, improve their reliability and reduce under-reporting.  
 
6. To assist with reporting, investment in providing integrated, flexible, efficient and user-friendly 
IT systems is needed to bring all Trusts up to a minimum standard. This will allow data to be 
collected in a timely, accurate, complete and reliable way.   
 
7. The NHS LA could usefully partner with recognised academic, Improvement Science and clinical 
groups to improve the selection, implementation and evaluation of improvement initiatives in 
the future.  
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1. Description of the SU2S incentivisation scheme process. 
2. Questionnaire to capture Trusts impression of the SU2S scheme. 
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10. Details of the evaluation of the incentivisation scheme in maternity units. 
 
 


















































Appendix 1. Description of the SU2S incentivisation scheme process 
 
NHS LA Bid Incentivisation Process in Support of Sign up to Safety 
  
The following outlines the different steps and timing of these involved in the roll out the Scheme 
 
1. Date of invitation to apply  
 
The Sign up to Safety Campaign was launched on 24 June 2014. The NHS LA advised its members 
that it was delivering a bid incentivisation scheme on behalf of the Department of Health to support 
the Sign up to Safety initiative. The deadline for receipt of the bids to be forwarded from the Sign up 
to Safety Campaign team was 16 January 2015  
 
2. Application process and Time scales  
 
The first 12 Trusts o ign p o Sign p o Safe  kno n b  he campaign a  ailbla e  e e 
informed about the bid scheme in July 2014.   The second tranche roll out to the rest of the country 
took place in September 2014.  Members could only apply to the scheme if they had signed up to 
safety through the campaign.   The claims incident scorecards were produced to support the 
analysis of claims profile for the Trusts and the criteria for the scheme was provided to Trusts to 
complete (see last page). 
 
3. Judging process 
 
Bids against set criteria were assessed via processes set up by the NHS LA using a cross directorate 
approach (Safety and Learning, Claims and Finance): 
 
They established the following committees for this process:  
 
x Steering Group for Review of Safety Improvement Plans with bids (SIPs) from Sign up to 
Safety (cross directorate)    
x Approvals Committee  (Executive) 
 
4. NHS LA internal governance systems  
 
x All bids were submitted to the Sign up to Safety Campaign office.  The NHS LA requested all 
bids which had been received by 16 January 2015  to be forwarded on to the NHS LA  these 
were all received by the NHS LA the week beginning 19 Jan 2015 
x All bids were  reviewed by the Safety and Learning team, supported by the Claims and 
Finance sections of the NHS LA 
x The combined teams reported into a Sign up to Safety steering group   
x Outcome of these review scores were presented to the NHS LA Approvals Committee and 
allocation of the funding to the successful organisations was agreed.   
 
5. Number of bids received and awarded funds 
 
The NHS LA received 249 bids from 114 member Trusts across a wide geographical reach by the 
time of the closing date on 16 January 2015. The bids covered a range of specialties. The process of 
assessing bids was undertaken from 16 January- mid March 2015. Compliance with the NHS LA bid 
criteria was scored (met, partially or fully met) recorded for individual questions as well as 
additional qualitative information added to determine a threshold of scoring agreed by the Steering 
 


















































Group. 67 bids were approved for funding from a total of 47 Trusts (some Trusts submitted multiple 
bids). 
 
The top five focus areas for successful bids were: 
 
1. Maternity- purchase of CTG electronic monitors, recruitment for econd pair of eyes , 
central CTG monitoring and alert systems, remote access to tracings, training. 
2. Safety Culture  a range of human factors and cross cutting areas. 
3. Surgical  includes training and equipment, human factors training in a number of surgical 
specialties particularly orthopaedics and neurological surgery. 
4. A&E  improving missed and delayed diagnosis, diagnostics, ho  radiography reporting in 
24 hours, performance feedback on missed diagnoses. 




6. Details of verification/review process proposed by NHS LA 
 
The awarding of funding was subject to a number of conditions from the submitting Trusts  CEO  a  
stated below.  The monitoring of the plans was the responsibility for the submitting Trusts, who 
were required to share learning with the NHS LA Safety and Learning team. 
 
1. Confirmation to be provided that the funds allocated to be used only in relation to the 
submitted bid; 
2. The Trust is asked to publish a summary of their successful bid, including details of the 
anticipated outcomes, on their public website;  
3. The Trust will provide details of their successful bid(s) to their Trust Board and their local 
commissioners and provide regular updates on the monitoring of their progress; 
4. The Trust will provide feedback and share safety and learning themes with external partners 
and directly with the Safety and Learning team at the NHS LA; 
5. The Trust will agree to collaborate with the NHS LA and Royal Colleges in the progress of 
implementation of the bid and in particular for all maternity bids with relevant Royal 
Colleges as regards maternity claims and outcomes from the bid.  More details will follow.     
6. The Trust ill agree o b dd  i h an n ccessful bidder in terms of sharing best practice 
to support quality improvements to those requiring additional support; 
7. The Trust will agree to coordinate with Trusts requesting the same specific equipment or 
training to ensure procurement benefits from economies of scale and value for money  
NHS LA will be in contact to provide details of those Trusts with shared purposes, 
equipment and training.  
 
 
7. Dates Trusts received funding   
 
Payments of bid funding were made to successful Trusts during the period May-September. The 
different dates of these separate transfers related to when commitments were received from CEOs 
to the conditions set for receiving the funds as above.  Trusts were then responsible for allocating 
the funds to budget holders for expenditure.  
 


















































Table 1. Criteria scoring sheet 
CRITERIA SCORING SHEET ʹ INCLUDED ON SHAREPOINT FOR CROSS-DIRECORATE SCORING  
Criteria for 





(January 2015)  
Appendix 1 
        
  Information for Informatics on Sharepoint areas to include        
  Summary Page Text boxes  Scoring    
  Full Name of Organisation and T number        
  Date of  Bid Submission       
  Summary of Bid to NHS LA       
  Specialties related to the Bid       
  Sum requested and is this within 10%       
  Was External review required       
  Sign up to Safety Steering Group Recommendations to the 
Approvals Committee 
    
  
  Recommend Yes/No     Y/N 
  Date Agreed        
          
  SLT Section to Complete       
1 Provide a summary of comments from Sign up to Safety        
2 Is the Bid signed off by the Executive Sponsor     Y/N 
3 Area of Focus: 
Does the bid adequately describe why the member has 
selected this area to focus on in relation to claims  
  out of 5 
  
4 Goal: 
Does the Bid articulate how claims could be reduced 
  out of 5 
  
5 Timing: 
Are implementation timelines sufficiently detailed within the 
bid  
  out of 5 
  
6 Actions: 
Are actions sufficiently detailed in the bid 




Do expected outcomes represent a reduction of the 
identified harm being addressed by this bid 
  out of 5 
  
8 measurement: 
Does the plan state: 
what will be measured 
When it will be measured 
By whom 
How these measures will be monitored and reported 
  out of 5 
  
  Quality and Safety (input by SLT)       
9 Evidence of clinical involvement in the development of the 
plan  
Free text   
  
10 Cross cutting themes across several specialties  Free text     
11 Impact on patient safety culture for the member Free text     
12  Evidence of patient engagement in either informing or 
supporting the plan  
Free text   
  
13 Reference to published evidence base or guidance  Free text     
14 Innovative/reflects an approach from which other members 
would benefit 
Free text   
  
15 Reference to alignment with other stakeholders and 
professional bodies e.g. AHSNs 
Free text   
  
  Completion by Claims        
16 Quality: 
Does the plan describe how it aligns with the member's 
claims profile  
    
  
17 Quality: 
From your knowledge of this member, does this plan address 
claims in the way you would expect  
  0 
 18 Number/value 
Has the member articulated the numbers and values of 
claims associated with this focus 
  out of 5 
  
  For Completion by Finance        
19 How much money has been requested  Figure to be inserted 0   
20 Contribution: is the requested amount within 10% of the 





Table 1. Criteria scoring sheet (continued) 
 


















































21 Do the figures add up? Free text 
 
Y/N 




Any other type of investment  
  Out of 5 
  
23 Financial data/timings: 
Has the member detailed how it would spend the money in 
the fiscal year 2015/2016 with financial milestones  




   
 
Scoring rationale  
   
 
0=not met 
   
 
1=partially met by weak 
   
 
2=partially met and adequate 
   
 
3=completely met and adequate 
   
 
4=completely met and good 
   
 
5=completely met and exceptional/innovative  
   
     
 
Did the team have to have to go to member for further 
information  Date 
  
 
Date requested information received    
  
     
 
Date of Review by Approvals Committee  
  
 
Agreement with SUTS Steering Group Recommendations and 
Rationale for Decision   
  
 
Non Agreement with SUTs Recommendations and Rationale    
  
 
Other Qualifying Comments   
  
 
Award Agreed  Y/N 
  
 
Amount of Award agreed   
  
 
Rationale for level of funding/(formula)   
  
 
Outcome letter to Member    
   
Table 1. Criteria scoring sheet (continued) 
 










































 Appendix 2. Questionnaire to capture Trusts impression of the SU2S incentivisation scheme 
 
Thank you for taking part in the evaluation of the Sign up to Safety Scheme. We think that your views 
of the scheme are really important and should be taken into account for the future.   
Could you please answer the following questions so that we can include a paragraph in the final report 
with a summary of the Trusts  i e i ?  ( he a e  ided he e i  e ai  a  a d 
we will ensure that your identity will not be recognised). Thank you.   
 
 
1) Overall, what do you think are the main positive aspects of the Sign up to Safety scheme? 
 
 
2) What do you see as the main limitations of the scheme?  
 
3) What would you like to change (either from the NHS LA end, or from your end) if the 




4) What are the key messages you would like to send to the DoH regarding the Sign up to 
Safety scheme? 





































































Appendix 3. What Trusts think of the SU2S incentivisation scheme?  
 
Positive aspects of the Sign up to Safety Scheme  
 
Funding and monetary aspects 
- The scheme financially supported the organisation in taking forward three focussed safety 
projects. It would not have been possible to take forward the schemes without the 
additional funding allocated.  
- The NHS LA funding has allowed for investment to go directly to front line services to 
improve patient safety 
- Being able to have NHS LA money and thereby resource to make the changes that will make 
a real difference to patient outcome without having to wrangle with commissioners to make 
the work a funded CQUIN. Has enabled us to find the amount of money that we would 
never be able to find within the Trust to do this work. 
- Providing cash to enable implementation of steps that can improve safety. 
- Funding  receiving external funding was essential in implementation of SU2S. In the current 
economic climate finding additional resource is extremely difficult. In relation to reducing 
intrapartum harms in Obstetrics demonstrating a reduction in neonatal brain injury will take 
years to evaluate as claims come into the Trust years after the birth and the main milestone 
for longer term predictors of outcome and degree of damage cannot be assessed until 2 
years of age in the child. Not being able to demonstrate quick wins and timely 
improvements/evaluations when presenting business cases to the Trust can be challenging 
when there are so many demands on resources from all disciplines and whilst it is 
anticipated the improvements will achieve the desired effect there is no immediate 
reassurance that can demonstrate its success. 
 
Safety aspects and outcomes 
- This scheme has enabled us to get organised around safety, to engage better with staff and 
to focus the Board to some safety improvement work  
- I think having the themes for action clearly identified helps engender a consistent approach 
and gives organisations a clear direction. In the current financial situation, having safety so 
clearly at the top of the agenda focuses resources.   
- National focus on improving outcomes in conjunction with the ability for Trusts to focus on 
projects that are specific to their service users thus increasing the potential for improved 
o come  
- The campaign has supported us to focus on a key area of concern for which improvements 
will have a significant impact on identifying patient harm in a high flow patient area. 
- Having only purchased the software this year we are still waiting for some of the evidence 
to come in, but the overall impression is that it has been very supportive of changes that 
were required by our teams to support patient safety. The immediate impact is raising the 
monitoring and reporting of the initiative to reporting Committees within the Trust on a 
quarterly basis. 
- Raising awareness and focusing teams on steps that can improve safety 
- Safe  become  he no m  embedding hi  in e e one  p ac i e and in everything we do, 
ensuring the patient (quality and safety) remain the focus 
- The focus is on patient safety and staff wellbeing and the emphasis on creating a positive 
learning culture to reduce avoidable harm and focus on organisational culture 
- It recognises that changes and improvements are necessary to reduce avoidable harm and 
a e pa ien  li e  and i  ha  a ed he deba e of he e i emen  locall  and na ionall  
needed to allow this to happen. 
 


















































- It is creating an environment where learning and reflection on what could be done 
differently or better can take place safely to reduce avoidable harm which will benefit both 
patients and staff  
- A large majority of incidents and claims are due to human factors  specifically the actions 
and behaviours of those looking after patients. Being given the opportunity to understand 
how and why medical errors occur and the contributions made by poor 
communication/behaviours and having the funding to take targeted focussed action is a 
step to reinforcing patient and staff experiences and outcomes. 
 
Communication and support 
- Webinars good 
- Good communications from the central team via webinars and weekly emails 
- Overarching support and help with the spread of the campaign via social media (e.g., 
Twitter). 
- Opportunities for publicity and reaching a wider audience. 
- The link with the NHS LA was what made it different  and it will be interesting to see 
whether there is any evidence of impact on claims.  
- In addition to supporting the local focus, we have used the signage and branding of the Sign 
up to Safety campaign as part of our Patient Safety Conference held last month and locally 
the Patient Safety Lead circulates any relevant Sign up to Safety campaign details to our 
clinical leads and subject specialists. 
- Profile  having the SU2S campaign recognised as a national scheme and the fact that it is 
supported by the DoH has really helped the staff at ground level understand the investment 
and commitment to improvements. The fact that they can see, touch, benefit from the 
investment in the additional resources provides a direct link from them to the DoH. I think it 
is really valuable for the staff delivering the care to have that recognition and 
understanding. The midwives and obstetrician providing intrapartum care are passionate 
about delivering high quality care, they care about their patients and at that time become a 
part of their birth experience and bring new life into that family. So, when there is a poor 
outcome for a baby it is devastating for all and knowing that the DoH want to directly help 
us in reducing that provides a direct connection for them. I think at times the front line staff 
e cei e he D H  be e n ible f  c  in he NHS and hi  cheme ha  defini el  
provided a positive message.  
- As a Manager m elf i  ha  al  all ed me  ell he b and  f SU2S and discuss with staff 
how the campaign is being implemented across the country and also link in with the other 
SU2S streams in my own Trust and other Trusts, networking ideas and challenges. 
- It allows Trusts to develop their own local ideas and plans to support the Scheme goals and 
aims 
- It can give staff and patients the opportunity to have a voice and share their personal 
experiences in a safe environment 
 
Learning and sharing with other organisations 
- Encouraging sharing between organisations is really important 
- Being able to learn from and share good practice and improvements nationally via Sign up 
to Safety updates, webinars etc. 
- The scheme also helps promote multi-disciplinary working and shared learning which is 
always positive. 
- The focus is on patient safety and staff wellbeing and the emphasis on creating a positive 
learning culture to reduce avoidable harm and focus on organisational culture 
- It brings together staff at all levels across the NHS all facing similar challenges, issues and 
concerns 
 


















































- It enables Trusts to share their ideas and approaches to tackle and make safety 
improvements 
- It brings together people all who want to make a difference to patient and staff safety in a 
safe manner 
 
Impact on staff  
- The NHS LA finding for a Sign up to Safety Matron allowed for ring fenced staff and time to 
do work that is important (safety culture, Trust wide changes to handover practice) rather 
than getting tied up doing work that is urgent (fire fighting/quick fixes). It also allowed for a 
dedicated member of staff rather than the work being an add-on o ano her per on  
workload.  
- Improved confidence in CTG assessment as shown by Survey Monkey questionnaire. 
- Improved knowledge in CTG assessment by an intense program of learning through CTG 
master classes, weekly CTG meetings and daily bedside teaching.   
- Improved multidisciplinary team work between midwives, obstetricians and neonatologists 
(HIE report, posters presented at the RCOG congress with multidisciplinary contributions) 
- The focus is on patient safety and staff wellbeing and the emphasis on creating a positive 
learning culture to reduce avoidable harm and focus on organisational culture 
- It brings together staff at all levels across the NHS all facing similar challenges, issues and 
concerns 
- It can give staff and patients the opportunity to have a voice and share their personal 
experiences in a safe environment 
- Running NHS LA events where staff  have been given the chance to speak up and be listened 
to  
- It has served as a reminder to show compassion and care for all those responsible for either 
delivering or receiving care 
 
Limitations of the scheme  
 
Funding and monetary aspects 
- Financial support: the Trust was successful in receiving funds to support developments in 
three of our four identified areas. The fourth area was not successful in receiving funding 
and, while the initiative was taken forward, this was limited to what could be achieved 
within available resource.   
- Funding was only made available for a short-time, therefore limiting the potential to 
observe substantial benefits.  
- We were fortunate to receive NHS LA funding for our Sign up to Safety projects, but without 
this funding finding additional resources from within existing budgets would have been very 
challenging. 
- It is non-recurrent funding from NHS LA bid and there has been no further calls for bids for 
monetary support. 
- The scheme is time and cost-limited so momentum may fall away 
- Lack of resources i.e. finance  
- Generally there is a short timescale to apply for funds such as these which means that a 
case has to be pulled together at short notice.  This can mean that what at the time seems a 
good idea is, after reflection, not quite so practical. 
 
Sustainability 
- One of the limitations of any external scheme supporting a local initiative is not necessarily 
maintaining the life of the scheme itself in the early stages, but ensuring that the practice 
change that has been facilitated by such schemes is embedded into everyday care  in other 
 


















































words, it becomes ‘business as usual’. This is not necessarily a criticism of the campaign 
itself, nor is it something that the campaign can directly influence with local Trusts, but it is 
something to be aware of in local implementation of schemes. 
- I spent a large proportion of the funding we received on staffing and as the funding was a 
one of payment I am now going to put a business case into the Trust to retain those posts 
which may or may not be approved. In the event they are not approved as an increase in my 
establishment it may be difficult to sustain the improvements long term. 
 
Learning from other organisations 
- Headroom and capacity to really understand the learning from other organisations. 
 
Organisation priorities 
- Organisations have to ensure that the Sign up to Safety scheme fits in with their strategic 
objectives otherwise it will not get the Board support and fail. 
- SU2S itself as a driver for patient safety was a bit vague. We already identify quality 
priorities and work relating to improving patient safety that we then had to badge as being 
part of SU2S. Although the aspirations of the scheme are good, it was the funding from NHS 
LA that enabled us to maintain a specific focus on the aspects of safety improvement that 
were included in our safety improvement plan and selected for funding. But alongside this 
we are progressing other patient safety work streams that are just as important.    
- The need to bid for funding before work began meant that the original project scope did not 
necessary match what was actually needed 




- I don’t really see any limitations but there are challenges.  Accurate comparable data being 
one challenge.  
- Limited length for the type of project where main outcomes (HIE) are rare and need a 
minimum of 3 years to show significant change not explained by normal variation 
 
Staff resources and engagement  
- Capacity and engagement from the MDT (multidisciplinary team ….tends to be nurse led 
- The limitations are more about the service pressures on the NHS, staffing and capacity 
issues facing NHS staff and their capacity to remove themselves from the day to day 
operations and participate in the local interventions being made available to staff and to 
have the space and capacity to learn and reflect on what could have been done better when 
harm or medical errors occurs. These are not limitations of the scheme but do have an 
impact on the scheme and can affect or delay the level of involvement from frontline staff 
who in reality wants things to get better and support improvements. 
 
Proposed changes  
 
Bidding process 
- The Trust was successful in our bid for funds  however  the process felt onerous with 
detailed project plans being required in a short timeframe 
- More support with the bid and project planning 























































Support and collaboration 
- Deliver very focussed on the Trust schemes identified.  Centrally  more support with 
initiatives to support learning  such as Root Cause Analysis training and safety events.   
- Locally, running these kind of projects can be isolating, forming an effective team support 
structure is essential. 
- Would be useful to have support from national team and /or academics to evaluate the 
impact of improvements made 
- Clear links with the Regional PS collaboratives might prove helpful  i) in having local 
e e i e o d a  on and ii  o ha  he na ional eam ha  boo  on he g o nd  in all 
regions to support the scheme. 
- A national virtual safety faculty would be a valuable resource. 
- We would suggest that each Trust has a linked member of staff from your NHS LA team who 
can suggest ideas and challenge plans before they are submitted.   
- Additional support for IT/ admin/ data collection 
- Support for all organisations and consideration of a catalogue of proven safety initiatives to 
choose and embed 
- More time given to Clinicians to be given time and space to focus on preventative actions 
and less on reactive systems and processes currently in place. 
 
Funding and sustainability 
- Investment for a longer period of time of 3 year 
- Flexibility of the projects really helps to keep them responsive and effective. 
- Funding for more than one year (recurrent funding) for safety improvement work 
programmes would be beneficial to enable embedding and sustainability of change 
- I would have to say funding! There was initial funding and those initiatives which were 
successful in their bids did benefit.  
- Access to funds to enable more projects/schemes   
- The scheme to become integral to the way Trusts operate and at the heart of the way Trusts 
and various departments work more closely together to improve patient safety and staff 
wellbeing 
 
Learning and sharing with other organisations and stakeholders 
- Regarding the NHS LA incentivisation scheme funding, one Trust stated that it would have 
really helped with collaboration if the successful and unsuccessful Trusts could have been 
introduced to each other to assist with sharing lessons learnt. Seeking out a Trust  o 
b dd  i h a  perceived as extremely time consuming. 
- A further meeting of the successful organisations would have been in inspiring an 
informative. As far as I know there was only 1 national meet up 
- Better collaboration between Trusts, maybe some networking events for those involved. 
- Improved networking with other units running the same type of projects 
- More patient involvement in the scheme and events run by the NHS LA 
- More partnership working between Trusts and collaborative approach to tackling similar 
areas for improvement within Trusts based on themes identified by NHS LA scorecard data 
 
Type of interventions and their selection 
- O  e e ience ha  been ha  e  ecific clinicall  ba ed ojec  a e ea ie  o in do n  
and bring about change in the time span. Those that involve broader concepts are much 
harder to get a grip on. 
- More input from NHS LA colleagues to work with the organisations to identify claims 
themes and required focus of work and triangulate with other data sources. 
 















































- It would be useful to focus on a key aspect of patient safety that needs improving across the 
board and direct support at that  particularly if there is anything that comes out of this 
scheme that provides evidence of impact on claims. 
- If to run again central monitoring is the priority in terms of equipment to improve safety, 
documentation and as a learning/ teaching tool 
- Support for all organisations and consideration of a catalogue of proven safety initiatives to 
choose and embed 
- More identification of interventions which have so far worked, the issues and challenges 
and how they have overcome them to increase participation and engagement in the scheme 
 
Outcomes, evaluation and impact awareness 
- The outcomes of the scheme itself focussed primarily on the process outcome (e.g., the 
management of missed fractures) and the secondary outcome of litigation prevention in the 
Trust. For the future, it might be helpful to understand the health economic impact of such 
interventions which may be larger than just the locally agreed measures, and which might 
provide some evidence as to why the scheme should continue to be locally sustainable by 
both providers and commissioners. Too often patient safety initiatives rely solely on the 
individual desire not to do harm, or the negative connotation of avoiding litigation or 
prosecution. In the longer term, for work around the avoidance of adverse events to 
become commonplace, one opinion is that this needs to be linked to productivity and 
economics. 
- I might have liked to have seen the evaluation strategy at the point we put the bid in. My 
personal thoughts are that every Trust has implemented a project with the same aim but 
are trying to achieve that in so many different ways and I do not think that can be reflected 
in arbitrary figures of outcomes within the first 2 years. It will be difficult to use quantitative 
measures alone to evaluate the impact of individual Trusts success with this scheme. 
- I think each Trust should be asked to submit a report at the 3 year point with their individual 
measures of success which will include other quantitative and qualitative measures which 
they feel are pertinent in demonstrating the impact of SU2S in their particular Trust for their 
particular population. 
 
Key messages for the Department of Health regarding the scheme  
 
Positive messages 
- Overall, as a Trust that was successful in receiving funds to take forward specific projects  
the scheme has been successful 
- Great leadership and great engagement via the weekly emails, blogs, twitter feeds, 
webinars, tool kits etc. Thank you! 
- Learning from each other and sharing improvement work nationally is key for the NHS 
- Really useful scheme 
- This scheme has been very well received across the Trust, the focus on local ownership 
helps keep the front line staff engaged. It’s not about “the management said we should do 
this”, it’s about looking at what is really happening, listening to why staff feel it is the way it 
is and what they would like to do instead then helping to facilitate that change with local 
ownership and ward level leadership to ensure sustainability. 
- Having the opportunity to bid for this type of funding and receiving it boosts morale of a 
team, allows implementation of change that the team may not have been able to secure 
through their own Trust due to competing demands for financial investment, and also sends 
a strong message to frontline staff that the DoH recognise and care about the work they do 
on a daily basis and the outcomes for their patients. I don’t for one minute think that that 
DoH haven’t cared but with so much focus in the media on negative effects of ‘cuts in the 
 


















































NHS  i  i  eall  nice f  he aff  angibl  feel he in e men  SU2S has provided and the 
positive impact that has had on our particular Maternity services, staff and patients alike. 
- The scheme is definitely worthwhile as it serves as reminder to put patient and staff safety 
first and allows Trusts to tackle their local issues with local ideas and interventions  
- For organisations and NHS staff to truly learn from patient harm and medical errors it is 
important to create a safe environment which is less performance based and more values 
based to allow staff and patients to work more collectively towards creating an open 
learning service and provide better care and treatment as a result 
 
Funding and sustainability 
- Keep going with the scheme 
- For unfunded projects, arguably, the scheme was less successful with the need to balance 
delivery alongside other national safety initiatives within available resources 
- A great way of funding different approaches to deliver front line services to improve patient 
afe  i  a hame he f nding nl  la  a h  e i d f ime 
- Good support and publicity but limited effectiveness without funding 
- Need more investment to improve outcomes in maternity services as many Maternity Units 
will not have been successful in their bids for funding. 
- Think about how the scheme can influence long term sustainability of changes locally. 
- Having the opportunity to apply for external funding is vital in being able to implement 
changes like these. Every unit knows their own challenges and areas for focus and 
improvements but very few sustainable changes comes without any additional resource. It 
is extremely difficult with existing budgets to maintain the status quo and also invest in the 
future, particularly when trying to demonstrate a reduction in something that will take years 
to really be able to evaluate its impact.  
 
Challenges and suggestions 
- For real national working and avoidance f d lica i n  NHS gani a i n need a h  
- Changing culture is really hard to measure, compared to clinical projects where you can 
count numbers   
- Let organisations decide on what they need to focus on locally instead of producing a set of 
national standards for us to work to ie NHS LA standards. 
- It would be useful to focus on a key aspect of patient safety that needs improving across the 
board and direct support at that  particularly if there is anything that comes out of this 
scheme that provides evidence of impact on claims. 
- Support wider understanding within Trusts of the health economic impact of adverse events 
and the intrinsic value of a positive safety culture. 
- It would be beneficial to have more collaboration between Trust  and he NHS LA 
- Make it easy for teams to share what worked well for them without having to attend 
meetings (e.g., Webinar)  
- Sign up to safety made a bigger impact than the one we can quantify in terms of team work, 
enthusiasm and a change in culture.  We would like to thank you for this opportunity and 
encourage the scheme to continue 
- Although safety is crucial the governance structures and skills are also crucial. Would like to 
see some specific support for governance leads and some type of benchmarking/gap 
analysis 
- Simplifying the processes and constant request for information, setting targets and 
monitoring performance which in a way have become more important than the people 
(receiving & delivering care) and inhibits staff to who just want to do a good job of 
delivering good quality care and treatment.  
 


















































- The scheme should continue and be sustained to allow enough time for organisations to 
grow and become preventative learning hubs, embedding the safety improvements within 
their culture.  It should not just as another scheme but needs to become part and parcel of 





Appendix 4  


























































































































Appendix 5. List of interventions and outcome measures: reducing intrapartum harm 
 
Trust * Intervention 
Intervention 
ID Outcomes Monitored  
Trust 2 Fetal monitoring equipment 2 
N. of falls, n. of hospital acquired pressure ulcers, Summary 
Hospital-level Mortality Indicator (SHMI), formal complaints 
 
Training and development for fetal monitoring 8 
N. of falls, n. of hospital acquired pressure ulcers, Summary 
Hospital-level Mortality Indicator (SHMI), formal complaints 
Trust 3  
Q&S improvement lead / nurse (staff) Intrapartum clinical practice 
educator 5 
% babies born with an APGAR less than 7 at 1 minute, % term 
babies admitted to the NICU  
Trust 4 Computer Hardware/Software 1 NA 
 
Fetal monitoring equipment 2 NA 
Trust 5 Fetal monitoring equipment  STAN 2 
Reported incidents and associated harm, n. of falls, emergency CS 
rate,  unexpected term admissions to the NNU 
 
Q&S improvement lead / nurse (staff) 2 Midwives 5 
Reported incidents and associated harm, n. of falls, emergency CS 
rate,  unexpected term admissions to the NNU 
Trust 6 Q&S improvement lead / nurse (staff) midwife 5 % 3rd/4th degree tear 
 
Specialised obstetric equipment episiotomy scissors 7 % 3rd/4th degree tear 
Trust 7 Q&S improvement lead / nurse (staff) 5 
N. of stillbirths and early neonatal deaths, n. of babies transferred 
for active cooling 
 Fetal monitoring equipment USS capacity and equipment 2 
N. of stillbirths and early neonatal deaths, n. of babies transferred 
for active cooling 
 Training and development K2 training (fetal monitoring) 8 
N. of stillbirths and early neonatal deaths, n. of babies transferred 
for active cooling 
 Computer Hardware/Software 1 
N. of stillbirths and early neonatal deaths, n. of babies transferred 
for active cooling 
Trust 8 Computer Hardware/Software electronic obs 1 
Sepsis related incidents, % IV antibiotics for sepsis, SHMI, reported 
incidents 
 
Training and development CTG training video/human factors 8 
Sepsis related incidents, % IV antibiotics for sepsis, SHMI, reported 
incidents 
Trust 11  
Q&S improvement lead / nurse (staff) Midwives and consultant 
time 5 
NNU unexpected admissions, HIE, intrapartum interventions like 
FBS, emergency caesarean section rates 
 Q&S improvement administrator (staff) Management 4 
NNU unexpected admissions, HIE, intrapartum interventions like 
FBS, emergency caesarean section rates 
 Training and development CTG masterclass and training 8 
NNU unexpected admissions, HIE, intrapartum interventions like 
FBS, emergency caesarean section rates 
* Trusts have been anonymised and numbered using the coding for the analysis  
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Appendix 5. List of interventions and outcome measures: reducing intrapartum harm (continued) 
Trust * Intervention 
Intervention 
ID Outcomes Monitored  
Trust 12 Training and development CTG training package 8 
Stillbirths rate, perinatal morbidity, compliance with guidelines, n. 
women who stopped smoking 
 
Fetal monitoring equipment CTG equipment 2 
Stillbirths rate, perinatal morbidity, compliance with guidelines, n. 
women who stopped smoking 
 
Computer Hardware/Software IT system for ANC and postnatal 
care 1 
Stillbirths rate, perinatal morbidity, compliance with guidelines, n. 
women who stopped smoking 
 Patient monitoring equipment More USS machines 3 
Stillbirths rate, perinatal morbidity, compliance with guidelines, n. 
women who stopped smoking 
Trust 13 Q&S improvement lead / nurse (staff) Midwives and consultant 5 
N. babies diagnosed with HIE, n. babies born with a low cord gas 
of less than 7.0 (i.e. requiring admission to neonatal unit) 
 Q&S improvement administrator (staff) 4 
N. babies diagnosed with HIE, n. babies born with a low cord gas 
of less than 7.0 (i.e. requiring admission to neonatal unit) 
 
Fetal monitoring equipment handheld dopplers and central 
monitoring 2 
N. babies diagnosed with HIE, n. babies born with a low cord gas 
of less than 7.0 (i.e. requiring admission to neonatal unit) 
 Training and development fetal monitoring training 8 
N. babies diagnosed with HIE, n. babies born with a low cord gas 
of less than 7.0 (i.e. requiring admission to neonatal unit) 
Trust 14  Computer Hardware/Software K2 software and hardware 1 NA 
Trust 17 Fetal monitoring equipment central monitoring 2 
Incidence of claims due to HIE, admission temperatures of baby  
being transported between hospitals  
 Q&S improvement lead / nurse (staff) midwives 5 
Incidence of claim  d e o HIE  admi ion empe a e  of bab  
being transported between hospitals  
 Neonatal transport  equipment 9 
Incidence of claims due to HIE  admi ion empe a e  of bab  
being transported between hospitals  
Trust 18 Computer Hardware/Software IT system 1 N.of claims, n. 3rd degree tear 
 
Fetal monitoring equipment Wifi Sonicaids (CTG) 2 N.of claims, n. 3rd degree tear 
Trust 20  Fetal monitoring equipment K2 central monitoring 2 
N. intra-partum stillbirths, unexpected admissions of term infants 
to the NNU, n. of claims 
 Computer Hardware/Software K2 electronic storage of CTG 1 
N. intra-partum stillbirths, unexpected admissions of term infants 
to the NNU, n. of claims 
 Training and development K2 training 8 
N. intra-partum stillbirths, unexpected admissions of term infants 
to the NNU, n. of claims 
Trust 21 
Q&S improvement lead / nurse (staff) Midwife focus on CTG and 
sepsis 5 
Reduction in reported incidents, improved training compliance, 
adherence to sepsis CQUIN 




Appendix 5. List of interventions and outcome measures: reducing intrapartum harm (continued) 
 
Trust * Intervention 
Intervention 
ID Outcomes Monitored  
Trust 22 Fetal monitoring equipment K2 central monitoring 2 NA 
 Computer Hardware/Software Pregnancy App 1 NA 
 Patient monitoring equipment More USSscans 3 NA 
 Specialised obstetric equipment fetal pillow / episiotomy scissors 7 NA 
 
Computer Hardware/Software IT system for triaging 1 NA 
Trust 23 
Fetal monitoring equipment Central monitoring and fetal 
telemetry monitors 2 Incidents relating to HIE grade 2/3, emergency caesarean sections 
Trust 24 Fetal monitoring equipment – STAN 2 
% emergency c-section, % instrumental delivery, HIE, babies into 
NNU, n. cooling, stillbirths, neonatal deaths (<7days) 
 
Training and development Training for STAN 8 
% emergency c-section, % instrumental delivery, HIE, babies into 
NNU, n. cooling, stillbirths, neonatal deaths (<7days) 
Trust 25 Training and development Training for central monitoring 8 N. incidents, N. complaints 
 
Fetal monitoring equipment Central monitoring  2 N. incidents, N. complaints 
Trust 26 
Patient monitoring equipment Handheld USS scans to detect 
breech 3 N. women scanned, n. breech presentations, birth outcomes 
 
Training and development Training for handheld USS scans 8 N. women scanned, n. breech presentations, birth outcomes 
Trust 27 Fetal monitoring equipment - CTG telemetry 2 NA 
 
Training and development- electronic CTG and face-to-face 
training 8 NA 
Trust 29 Q&S improvement lead / nurse (staff) Midwives 5 Admissions to NICU, Grade 2/3 HIE 
Trust 31 Training and development CTG training 8 NA 
Trust32 Fetal monitoring equipment K2 central monitoring 2 NA 
 
Training and development 8 NA 
Trust 34 Q&S improvement lead / nurse (staff) Midwifes (clinical and CTG) 5 
HIE Grades 2 & 3, Babies to NNU >36+6 weeks, APGAR at 5 min <7 
at term, Stillbirths, Early Neonatal Deaths, Mat. Serious incidents 
 Training and development Scanning training 8 
 Q&S improvement administrator (staff) 4 
 Fetal monitoring equipment  K2 monitoring and  CTG console 2 
Trust 35 Q&S improvement lead / nurse (staff) Midwifes  5 
Incident rate  Training and development conference 8 
 Computer Hardware/Software Touch screen TV  1 
Trust 36 Q&S improvement lead / nurse (staff) Midwifes  5 babies into NNU 
 
Fetal monitoring equipment - CTG telemetry 2 babies into NNU 
* Trusts have been anonymised and numbered using the coding for the analysis  
 
 


















































Appendix 6. List of interventions and outcome measures: A&E missed fractures 
 
Trust * Intervention Interv. ID Outcomes Monitored  
Trust 1 Q&S improvement lead / nurse (staff) 5 Incidence reporting, hospital acquired infections, formal complaints 
Q&S improvement administrator (staff) 4 
Computer Hardware/Software 1 
Training and development 8  
Trust 2 Q&S improvement lead / nurse (staff) 
Patient monitoring equipment 
5 
3 
N. of falls, n. of hospital acquired pressure ulcers, Summary Hospital-level 
Mortality Indicator (SHMI), formal complaints  
Trust 4 Radiology equipment 6 NA 
Trust 5 Q&S improvement lead / nurse (staff) 5 Reported incidents and associated harm, n. of falls, emergency caesarean 
section rate,  unexpected term admissions to the NNU 
Trust 9 Radiology equipment 6 N. of missed fractures,  time from report to ED actions 
Q&S improvement lead / nurse (staff) 5 
Trust 10 Computer Hardware/Software 1 NA 
 Training and development 8 
Trust 15 Q&S improvement lead / nurse (staff) 5 % falls, % sepsis, % deteriorating patients, % AKI, % patients with diabetes 
management problems 
 Q&S improvement administrator (staff) 4 % falls, % sepsis, % deteriorating patients, % AKI, % patients with diabetes 
management problems 
Trust 16 Q&S improvement lead / nurse (staff) 
Q&S improvement administrator (staff) 




SHEWS, Sepsis and AKI audits, cardiac arrest rate 
 
Trust 28 Q&S improvement lead / nurse (staff) 
Q&S improvement administrator (staff) 
5 
4 
N. claims for missed fractures 
Trust 30 Training and development  8 Incidents reported by category, n. falls, % sepsis, % deteriorating patients, 
missed or delayed diagnosis Computer Hardware/Software  1 
Q&S improvement lead / nurse (staff) 5 
Trust 33 Training and development  
Q&S improvement lead / nurse (staff) 
Patient monitoring equipment  
Handheld Profile beds/pressure-relieving heel 
devices 
8 Freq. pressure ulcers grades 3/4, freq. avoidable harm, Hospital 
Standardised Mortality Ratio, mortality audits 
5 
3 
* Trusts have been anonymised and numbered using the coding for the analysis 
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Appendix 7. List of interventions and outcome measures: maternity and A&E common interventions 
 
Trust * Intervention 
Intervention 
ID Outcomes Monitored  
Trust 2 Q&S improvement administrator (staff) 4 
N. of falls, n. of hospital acquired pressure ulcers, Summary Hospital-level 
Mortality Indicator (SHMI), formal complaints 
Trust 5 Training and development 8 
Reported incidents and associated harm, n. of falls, emergency caesarean 
section rate,  unexpected term admissions to the NNU 
Trust 6 
Training and development teaching material for 
episiotmy scissors 8 Incidence reporting 
 
Q&S improvement administrator (staff) 4 Incidence reporting 
Trust 19 Q&S improvement lead / nurse (staff) 5 Incidence reporting,  formal complaints 
 Q&S improvement administrator (staff) 4 Incidence reporting,  formal complaints 
 
Training and development PROCESS 
COMMUNICATION MODEL 8 Incidence reporting,  formal complaints 



















     
1. Total numbers of x-rays taken in A&E    
2. Number of missed fractures in A&E    
2.1. Number of missed fractures in A&E resulting in no harm    
2.2. Number of missed fractures in A&E resulting in low harm    
2.3. Number of missed fractures in A&E resulting in moderate harm    
2.4. Number of missed fractures in A&E resulting in severe harm    
2.5. Alternatively - Number of missed fractures resulting in harm (versus no harm)    
3. Number of claims due to missed fractures in A&E    
3.1. Number of claims due to missed fractures classified as no harm    
3.2. Number of claims due to missed fractures classified as low harm    
3.3. Number of claims due to missed fractures classified as moderate harm    
3.4. Number of claims due to missed fractures classified as severe harm    
3.5. Alternatively - Number of claims due to missed fractures classified resulting in harm (versus no harm)    




































































Total numbers of births       
Numbers of singleton births       
Numbers of term (>=37 weeks) singleton births       
Total numbers of mothers delivered       
Numbers of instrumental vaginal births       
Numbers of caesarean sections       
3rd degree perineal tears: 
Numbers of mothers with 3rd degree perineal tears 
      
4th degree perineal tears: 
Numbers of mothers with 4th degree perineal tears 
      
APGAR 5-min scores: 
(1) Numbers of term (>=37 weeks) singleton neonates with APGAR score<7 at 5 
minutes 
      
APGAR 5-min scores: 
(2) Numbers of term (>=37 weeks) singleton neonates for whom their APGAR 
score at 5 minutes is not known 
      
Cooling: 
N mbe  of ingle on  babie  ha  e e he ape icall  cooled af e  bi h   
    
Unexpected* NICU admissions at term: 
(1) Number of term (>=37 weeks) singleton neonates admitted unexpectedly to 
NICU 
      
Stillbirths: 
Number of singleton stillbirths 
      
Stillbirths: 
Number of term (>=37 weeks) singleton stillbirths 
      
* Unexpected does not include babies who are admitted to the NICU for 
congenital malformations that require treatment, or for social reasons (e.g., using 
the NICU as a place of safety). 
      
        
        
Questions about the Trust itself - please respond Yes or No Y/N     
Are you a level 3 NICU?       
If so, do you provide neonatal surgery?       
Are you a local neonatal unit (LNU)?     
 






















































Appendix 10. Details of the evaluation of the incentivisation scheme in maternity units 
 
 Costs  
The costs include the following potential components, for successful and unsuccessful Trusts81: 
 
x Extra cost of the intervention  
x Extra cost to the NHS in terms of resources used as a result of treating harms, i.e. costs of 
providing maternity care relating to the maternity outcomes that we measured  
Change in consequences in terms of health-related quality of life (HRQOL) or mortality, 
where values for these can be attached to maternity  
x Longer-term savings in costs of claims (assuming there is a reduction)  
 
The final result here is presented as a cost-consequences analysis (CCA), which is a type of 
economic anal i  here differen  pe  of o come  ha  can be bo gh  b  in e ing in 
the intervention are listed in their own natural units. We have assigned monetary values 
where possible, to aid in making comparisons. 
We cannot directly measure the numbers of claims resulting from care in the last 5 years, as with 
maternity claims it can sometimes take a long time for claims to arise and then a further lengthy 
period until the claim is settled and any financial transfer is made. Costs of claims include not only 
settlements awarded, but also include legal fees and other costs. Due to this limitation, we are 
instead measuring short-term outcomes that are thought to possibly have an effect on claims, i.e. 
they can be used as proxy outcomes. These proxy outcomes have been discussed above according 
to Sibanda et al 201382.  
  
We assume in this analysis that the relationship between short-term outcomes (e.g., low Apgar 
score) and longer-term outcomes (e.g., cerebral palsy) and from there to numbers of claims, all 
remain the same over time, and the only thing that changes therefore is the proportion of low 
Apgar scores or other short-term outcomes, as a result of the interventions introduced. 
 
There are a number of proxy outcomes that could be used to predict numbers of future claims using 
this approach, and we have focused on those that might be influenced by the specific interventions 
chosen by the successful maternity units that have been previously discussed, as this then affords a 
causal pathway by which the interventions could potentially influence the overall outcome. The 
primary example that we use here is reduction in rates of low (<7) Apgar score at 5 minutes and the 
relationship of low Apgar scores with cases of cerebral palsy and therefore claims against the NHS 
for perceived problems with care during labour and birth.  
 
                                                     
81 As mentioned before  no e ha  he erm  cce f l  and n cce f l  in he con e  of hi  repor  refer 
only to whether or not the Trust was successful in being awarded funding for improvements in maternity care 
via the SU2S (Sign up to Safety) scheme from the NHS LA.  
82 Sibanda T, Fox R, Draycott T, Mahmod T, Richmond D, Simms RA, (2013). Intrapartum care quality indicators: 
a systematic approach of achieving consensus. European Journal of Obstetrics & Gynecology and Reproductive 
Biology 166:23-29 
 


















































Literature review on interventions, impact on claims, QALYs and costs  
 
We have conducted a literature review to obtain information on the linkages from the proxy 
outcomes to the numbers of claims. We have investigated what information is available on the 
impact of these interventions (e.g., CTG monitoring) on the claims categories that the NHS LA 
collects. There is not much evidence that the specific interventions implemented by the Trusts will 
have any direct impact on maternity indicators that might lead to reductions in claims, which is the 
overall aim of the scheme.   
 
We have also conducted a literature review to obtain supplementary input data for the model, 




Unit health care costs for the model were taken from the 2014-15 NHS Reference Costs as described 
in the Model section below, except for the cost associated with a low Apgar score (Pagano et al., 
2010) 83, and that for cooling (Table A.1). It is not clear exactly what extra health care costs are 
associated with a low Apgar score, as it is not a clinical diagnosis and does not lead to a specific test 
or admission, so this empirical study where costs of services used during a study were calculated 
and then different levels of cost associated with different brackets of Apgar scores was the best 
estimate to use, to our knowledge. 
 
Regarding cooling, a literature search of the Web of Science and the grey literature yielded a report 
published by the Swedish HTA authority84 giving a range of costs but not much detail (in English) 
regarding their provenance. There was also a UK cost-effectiveness analysis (Regier et al., 2010 85) 
which gave a cost for cooling and this lay within the range given in the Swedish report, so we felt 
that using this point estimate was justified.  
 
Regarding the unexpected NICU admissions, the weighted average cost per day from relevant unit 
costs in the NHS reference costs was calculated as described in the Model section below, and a 
literature review was performed to estimate the average length of stay in NICU. This involved 
searching the Web of Science Core Collection  for papers mentioning “length of stay , “NICU  and 
“term , which gave  hits, three of which Khazaei et al.,2015 86, Girsen et al., 2015 87, Schiariti et 
al., 2008 88) gave the data we required, and all three of these stated that the mean or median length 
of stay was 5 days. The cost per unexpected NICU admission therefore was the weighted mean day 
cost, multiplied by five. 
 
                                                     
83 Pagano E, De Rota B, Ferrando A, Petrinco M, Merletti F, Gregori D (2010). An economic evaluation of water 
birth: the cost-effectiveness of mother well-being. Journal of Evaluation in Clinical Practice 16:916 919 
84http://www.sbu.se/en/publications/sbu-assesses/therapeutic-hypothermia-in-fullterm-infants-affected-by-
birth-asphyxia/; 25th Feb 2009 
85 Regier DA, Petrou S, Henderson J, Eddama O, Patel N, Strohm B, Brocklehurst P, Edwards AD, Azzopardi D, 
(2010). Cost-Effectiveness of Therapeutic Hypothermia to Treat Neonatal Encephalopathy. Value in Health 
13:695-702 
86 Khazaei H, McGregor C, Eklund JM, El-Khatib K (2015). Real-Time and Retrospective Health-Analytics-as-a-
Service: A Novel Framework. JMIR Med Inform ;3(4):e36)  
87  Girsen AL, Greenberg MB,  El-Sayed YY, Lee H, Carvalho B and Lyell DJ (2015).Magnesium sulfate exposure 
and neonatal intensive care unit admission at term; Journal of Perinatology 35:181 185  
88 Schiariti V, Klassen AF, Hoube JS, Synnes S, Lisonkova S and Lee SK (2008). Perinatal characteristics and 
parents’ perspective of health status of NICU graduates born at term; Journal of Perinatology 28, 368 376;  
 












































No estimate of any increase or reduction in costs has been included for stillbirth as the range is 
expected to be very wide as parents of a stillborn child can request some or no tests 89. No empirical 
studies with usable values were found by our searches, and discussions with clinical colleagues 
concluded that there is no way of knowing if tests performed in the aftermath a stillbirth would be 
more costly or numerous than the work done in a similar time period with a live birth, and it is the 
difference in cost that we would need for our analysis, i.e. how much more (or less) is done 
compared to a live birth. 
 
For the cost of repairing 3rd or 4th degree tears, we calculated the weighted average cost difference 
bet een Assisted Deliver  ith Epidural or Induction  ith an  CC complications and 
comorbidities  score  and Assisted Deliver  with Epidural or Induction, and with Post-Partum 
Surgical Intervention  ith an  CC score from the NHS reference costs  We used assisted deliver  
costs only as it is more common to suffer 3rd or 4th degree tears when forceps or ventouse are 
used90, therefore it is more likely that the post-partum surgical intervention is for repairing a tear of 
this type.  
 






We cannot justify a specific difference between 
the financial cost of a stillbirth and that of a live 
birth as there is no published data on this. 




Admission to NICU  weighted average across 
relevant NHS Reference Costs for a 5-day stay. 






Cost of cooling 
Swedish report 2009 (gives range of £430-860 at 
2008 prices)93 
Regier 2010 
Swedish HTA report 
2009  
Low Apgar score £289.20 
From study looking at water birth, empirical 
summing of costs split by Apgar score range. 
 at  prices  adjusted to  prices 
using HCHS P&P index and converted to GBP using 
2014 exchange rate) 
Pagano 2010  
3rd degree tear or 
4th degree tear 
£582.90 
Post-partum surgical intervention  in NHS 
Reference Costs. Found by subtracting average 
costs excluding that factor from average costs 
including that factor. 





                                                     
89 When a baby is stillborn, parents can choose what tests they want to have carried out, if any, to determine 
or confirm the cause of death. This means that there is a wide range of things that they might want 
investigated  and a ide range of possible tests  and e don t kno  the reasons behind an  of the stillbirths in 
our data so can t make an  sensible guess  Equall  the  might not ant to have an  tests carried out at all. 
90https://www.rcog.org.uk/globalassets/documents/patients/patient-information-leaflets/pregnancy/pi-an-
assisted-vaginal-birth-ventouse-or-forceps.pdf;Vaginal tears/episiotomy: If you have a vaginal tear or 
episiotomy, this will be repaired with dissolvable stitches. A third- or fourth-degree tear (a vaginal tear which 
involves the muscle and/or the wall of the anus or rectum) affects 1 in 100 women who have a normal vaginal 
birth. It is more common following a ventouse delivery, affecting up to 4 in 100 women (4%). It is also more 
common following a forceps delivery, affecting between 8 and 12 women in every 100 (8 12%). 
Also, if we used the normal delivery figures, it turned out that repairing tears saved £500 per delivery.  
91 See various footnotes for these references 
92 NHS Reference Costs (2014-15) 
93 Should be converted to 2014 prices using HCHS; it was 5000-10000 SEK 
 



















































We searched the York CRD (NIHR Centre for Reviews and Dissemination) database for values for 
reduction in HRQOL in the event of each of the five outcomes identified above. The consequences 
for babies and mothers were included as changes in HRQOL for low Apgar, therapeutic cooling, 
unexpected NICU admission and tears, and as changes in mortality for stillbirth (Table A2). The 
consequences for babies and mothers were kept separate and independent as there was no 
published information suggesting how the overlap (e.g., reduction in HRQOL for the mother when 
her baby is admitted to NICU or is stillborn) might be quantified. It is clear that the additional 
suffering on the part of the mother will be important, but as we have no figures and cannot guess, it 
has been omitted. This is a limitation of the analysis. 
 
Some information included values for the reduction in HRQOL when in certain health states or to 
calculate quality of life and QALYs in patients with cerebral palsy, but did not say for how long the 
states were thought to last (Leigh et al, 2104 
94
; Turner et al, 2008 
95
). There were other studies 
where the classification of health states was vague although the time period was defined, for 
example operative injury  Fawsitt et al., 2013 96), which would be likely to include 3rd and 4th 
degree perineal tears, but is unlikely to be made up exclusively of these injuries.  
 
To account for this lack of data, we include only point reduction in HRQOL in the model, and over no 
specified time period. Therefore, the summing of these point reductions gives only an indication of 
the direction of travel of quality of life for a particular outcome (i.e. is it positive or negative), and 
does not reflect on how long this reduced quality of life lasts. 
 









We cannot justify a specific difference between the 
financial cost of a stillbirth and that of a live birth as 








This is also called the disutility . It is the proportion of 
the baby’s quality of life that is lost, on a scale of  no 





No change in 
HRQOL 
We found no information on the reduction of a baby’s 
HRQOL on being therapeutically cooled after birth.  
Authors’ 
assumption 
Low Apgar score 
No change in 
HRQOL 
We found no information on the reduction of a baby’s 










Mothers suffering from 3
rd
 degree tears are thought to 









Mothers suffering from 3
rd
 degree tears are thought to 
lose 41% of their HRQOL for a short (and undefined) 
time. 
Turner 2008 
                                                     
94
 Leigh S, Granby P, Turner M, Wieteska S, Haycox A, Collins B. (2014).The incidence and implications of 
cerebral palsy following potentially avoidable obstetric complications: a preliminary burden of disease study. 
BJOG: An International Journal of Obstetrics & Gynaecology;121(13):1720 8. 
95
 Turner CE, Young JM, Solomon MJ,  Ludlow J, Benness C, Phipps H. (2008). Vaginal delivery compared with 
elective caesarean section: the views of pregnant women and clinicians. BJOG 115 (12):1494-1502 
96
 Fawsitt CG, Bourke J, Greene RA, Everard CM, Murphy A., Lutomski JE (2013). At What Price? A Cost-
Effectiveness Analysis Comparing Trial of Labour after Previous Caesarean versus Elective Repeat Caesarean 
Delivery. PLoS ONE 8(3): e58577. 
97
 Jonathan M Tan, Alex Macario, Brendan Carvalho, Maurice L Druzin, Yasser Y El-Sayed (2010). Cost-
effectiveness of external cephalic version for term breech presentation; BMC Pregnancy and Childbirth 2010, 
10:3; http://www.biomedcentral.com/1471-2393/10/3 
 





















































In terms of the cost perspective taken, we are using that of NHS England (i.e. summing health care 
costs to the NHS and budgetary costs to NHS LA). This means that unit costs for the various 
outcomes were taken from NHS reference costs as far as possible then supplemented with 
information from the literature. The results are presented as differences in costs only, and the total 
co  for each gro p are no  a ailable a  e do no  ha e comple e da a on all pa h a  co  and 
consequences, only on the comparative costs and consequences for specific outcomes. The results 
of this model will feed into the longer-term pathway towards the difference in litigation and claims 
costs, specifically in the cases of low Apgar scores (which is an indicator for cerebral palsy) as this is 
an important factor in a significant number of expensive claims. 
 
Costs of the intervention(s) 
The cost of implementing the specific interventions corresponds to how much has been spent on 
purchasing the specific interventions that the Trusts planned to buy using the NHS LA funding, and 
this information, as well as information on dates regarding when interventions were implemented, 
has been made available to us by the Trusts in the overall SU2S scheme reports that were submitted 
to us (Appendix 4). 
 
The cost of the overall SU2S scheme corresponds to the funds provided by the NHS LA to Trusts, 
regardless of whether or not they had been spent immediately. This information, including the date 
on which the money was sent to Trusts via BACS, has been provided to us by NHS LA. 
 
Costs relating to the outcomes  
We have had discussions with clinicians regarding which costs will be the most appropriate ones to 
include, and how different outcomes should be classified and therefore costed and the conclusions 
of these discussion are described further below.  
 
We are using NHS reference costs as far as possible, and supplementing this with information found 
in the published literature for the cost of a low Apgar score (Pagano et al., 2010)98, unexpected NICU 
admission and cooling, as described above in the Literature Review section.  
 
 
Consequences associated with the outcomes 
We had anticipated that information on the HRQOL of different health states for newborns would 
be difficult to find and this has indeed turned out to be the case, as discussed in the Literature 
review section. We are therefore using point changes in health-related quality of life for all short-
term outcomes except stillbirth, for which we are using mortality, and we will not be able to report 
a full cost-utility analysis with total quality-adjusted life-years based on full utility analysis and 
associated time periods, as the information is not available and the uncertainty introduced were we 
to postulate possible values would be enormous. 
 
                                                     
98 Pagano E, De Rota B, Ferrando A, Petrinco M, Merletti F and Gregori D, (2010) An economic evaluation of 
water birth: the cost-effectiveness of mother well-being. Journal of Evaluation in Clinical Practice 16:916 919 
 
 


















































Differences in costs, health-related quality of life and mortality ʹ babies 
 
The two halves in Table A3 show the increase or decrease in cost based on these extra outcomes 
per 100,000 babies, along with the 95%CIs. Similarly, Table A4 shows the change in HRQOL and its 
95%CIs. Finally, Table A5 shows the mortality changes per 100,000 babies in stillbirth, as this is a 
more concrete outcome in this case than HRQOL. Note that the HRQOL of the mothers as a result of 
suffering a stillbirth are not included in the model. 
 
Table A3. Differences in costs per 100,000 babies. These costs are found by multiplying the unit 
costs by the rates in Table 10-11. The top half relates to the first specific intervention 
implementation dates being the boundary dates, and the bottom half relates to the BACS payment 
arrival dates being used as the boundary dates. 
 
 
Intvn date (using only 1 year before and after) 
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  Costs Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
lower 95%CI £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
upper 95%CI £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
Low Apgar score £358,593 £401,594 £43,001 £356,731 £376,304 £19,573 £23,428 
lower 95%CI £285,652 £326,654 -£31,938 £268,424 £287,676 -£69,053 -£65,198 
upper 95%CI £431,534 £476,531 £117,939 £445,037 £464,928 £108,199 £112,054 
Cooled £92,278 £81,399 -£10,878 £114,196 £132,683 £18,487 -£29,365 
lower 95%CI £68,003 £54,258 -£38,016 £83,815 £101,407 -£12,786 -£60,638 
upper 95%CI £116,552 £108,535 £16,260 £144,583 £163,953 £49,760 £1,908 
Unexpected NICU £14,370,939 £14,990,850 £619,911 £14,918,527 £14,747,558 -£170,968 £790,879 
lower 95%CI £11,272,177 £11,866,283 -£2,504,674 £11,178,968 £11,002,839 -£3,915,687 -£2,953,840 




BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  Costs Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
lower 95%CI £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
upper 95%CI £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 
Low Apgar score £344,584 £395,067 £50,482 £328,010 £369,658 £41,647 £8,835 
lower 95%CI £277,731 £328,716 -£16,370 £241,549 £284,047 -£44,814 -£77,626 
upper 95%CI £411,435 £461,414 £117,335 £414,472 £455,272 £128,109 £95,296 
Cooled £104,520 £93,486 -£11,034 £123,554 £127,731 £4,177 -£15,211 
lower 95%CI £77,289 £67,156 -£38,263 £87,061 £92,296 -£32,316 -£51,704 
upper 95%CI £131,745 £119,815 £16,194 £160,046 £163,165 £40,670 £21,281 
Unexpected NICU £14,432,631 £15,443,233 £1,010,602 £15,041,256 £14,669,179 -£372,077 £1,382,679 
lower 95%CI £10,152,195 £11,170,470 -£3,269,817 £9,477,680 £9,112,278 -£5,935,653 -£4,180,897 




























































Table A4. Differences in health-related quality of life per 100,000 babies. These point values are 
found by multiplying the reduction in health-related quality of life associated with a particular 
outcome by the rates in Table 10-11. 
 
 
Intvn date (using only 1 year before and after) 
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  HRQOL Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Low Apgar score 0 0 0 0 0 0 0 
lower 95%CI 0 0 0 0 0 0 0 
upper 95%CI 0 0 0 0 0 0 0 
Cooled 0 0 0 0 0 0 0 
lower 95%CI 0 0 0 0 0 0 0 
upper 95%CI 0 0 0 0 0 0 0 
Unexpected NICU 
admission 1754 1830 76 1821 1800 -21 97 
lower 95%CI 1376 1448 -306 1365 1343 -478 -361 
upper 95%CI 2132 2211 457 2278 2257 436 554 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  HRQOL Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Low Apgar score 0 0 0 0 0 0 0 
lower 95%CI 0 0 0 0 0 0 0 
upper 95%CI 0 0 0 0 0 0 0 
Cooled 0 0 0 0 0 0 0 
lower 95%CI 0 0 0 0 0 0 0 
upper 95%CI 0 0 0 0 0 0 0 
Unexpected NICU 1762 1885 123 1836 1791 -45 169 
lower 95%CI 1239 1364 -399 1157 1112 -725 -510 
upper 95%CI 2284 2407 646 2515 2469 634 848 
 
Table A5. Differences in mortality per 100,000 babies for stillbirth. 
 
 
Intvn date (using only 1 year before and after) 
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  Mortality Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 133 118 -16 141 160 19 -35 
lower 95%CI 102 83 -50 103 122 -19 -73 
upper 95%CI 164 152 19 179 199 58 4 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts)  Control (unsuccessful Trusts) DiD 
  Mortality Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (babies)               
Stillborn 142 130 -13 157 153 -4 -9 
lower 95%CI 112 101 -43 118 116 -43 -48 























































Differences in costs and health-related quality of life ʹ mothers 
 
The mothers included in this analysis are only those who had vaginal delivery. We subtracted the 
numbers of mothers delivering via Caesarean section from the total number of mothers delivered, 
and assumed that all the 3rd or 4th degree tears reported were as a proportion of this group only. 
 
The reductions in numbers of tears lead to reductions in cost, and to improvements in health-
related quality of life. 
 
We have not included any uncertainty in the costs themselves - only in the numbers of events. 
 
Table A6. Differences in costs per 100,000 mothers. These costs are found by multiplying the unit 
costs by the rates in Table 14-15. 
 
 
Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Costs Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears £1,896,186 £1,897,725 £1,539 £1,967,790 £1,756,190 -£211,600 £213,139 
lower 95%CI £1,715,422 £1,709,004 -£187,182 £1,764,275 £1,550,833 -£416,957 £7,782 
upper 95%CI £2,076,956 £2,086,446 £190,260 £2,171,305 £1,961,547 -£6,243 £418,496 
4th degree tears £93,043 £81,910 -£11,133 £127,539 £108,269 -£19,271 £8,137 
lower 95%CI £63,857 £50,503 -£42,537 £94,920 £75,084 -£52,458 -£25,050 
upper 95%CI £122,229 £113,311 £20,270 £160,164 £141,459 £13,917 £41,325 
Mixed 3rd or 4th 
degree tears 
£1,950,886 £1,977,315 £26,429 £2,095,370 £1,864,459 -£230,912 £257,340 
lower 95%CI £1,772,622 £1,789,911 -£160,972 £1,887,705 £1,654,963 -£440,407 £47,845 
upper 95%CI £2,129,149 £2,164,712 £213,830 £2,303,035 £2,073,954 -£21,416 £466,836 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
Costs Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears £1,892,187 £1,909,517 £17,330 £1,968,699 £1,840,839 -£127,860 £145,190 
lower 95%CI £1,722,696 £1,744,060 -£152,164 £1,765,353 £1,640,414 -£331,206 -£58,156 
upper 95%CI £2,061,684 £2,074,974 £186,824 £2,172,045 £2,041,265 £75,486 £348,536 
4th degree tears £84,737 £89,283 £4,547 £147,259 £112,617 -£34,642 £39,189 
lower 95%CI £55,970 £61,834 -£24,220 £113,025 £79,403 -£68,879 £4,952 
upper 95%CI £113,503 £116,738 £33,313 £181,499 £145,831 -£405 £73,425 
Mixed 3rd or 4th 
degree tears 
£1,933,235 £1,991,543 £58,308 £2,116,052 £1,953,456 -£162,595 £220,903 
lower 95%CI £1,766,210 £1,825,876 -£108,717 £1,908,398 £1,748,711 -£370,249 £13,249 

































































Table A7 Differences in level of immediate health-related quality of life per 100,000 mothers. These 
point values for the reduction in HRQOL are found by multiplying the reduction in HRQOL associated 
with a particular outcome by the numbers of events in Table 14-15. 
 
 
Intvn date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
HRQOL Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 911 912 1 945 844 -102 102 
lower 95%CI 824 821 -90 847 745 -200 4 
upper 95%CI 998 1002 91 1043 942 -3 201 
4th degree tears 65 58 -8 90 76 -14 6 
lower 95%CI 45 36 -30 67 53 -37 -18 
upper 95%CI 86 80 14 113 99 10 29 
Mixed 3rd or 4th 
degree tears 
885 897 12 950 846 -105 117 
lower 95%CI 804 812 -73 856 751 -200 22 
upper 95%CI 966 982 97 1045 941 -10 212 
 
 
BACS date (using only 1 year before and after)  
 
Intervention (successful Trusts) Control (unsuccessful Trusts) 
DiD 
HRQOL Before (Y) After (Y) Diff (Y) Before (N) After (N)  Diff (N) 
Outcome (mothers)               
3rd degree tears 909 917 8 946 884 -61 70 
lower 95%CI 828 838 -73 848 788 -159 -28 
upper 95%CI 990 997 90 1043 981 36 167 
4th degree tears 60 63 3 104 79 -24 28 
lower 95%CI 39 43 -17 79 56 -48 3 
upper 95%CI 80 82 23 128 103 0 52 
Mixed 3rd or 4th 
degree tears 
877 903 26 960 886 -74 100 
lower 95%CI 801 828 -49 866 793 -168 6 


























































Overall cost-consequences results 
Total budget given to Trusts for maternity outcomes (excluding budget that was jointly earmarked 
for maternity and other things = £8,291,996 in successful Trusts only (zero in unsuccessful Trusts, at 
least over the dates that we looked at  some reapplied at a later date and were then successful). 
 
Total amount spent so far on specific maternity-related interventions by the successful Trusts = 




(1 year before + 1 year after) 
No. mothers 
(1 year before + 1 year after) 
Intvn 297,731 357,372 
BACS 387,702 461,291 
 
 
Using Trusts  In n da e  a  bo nda  da e  
 
Therefore, the i em  b gh  for the money spent by the NHS LA in these 28 Trusts (i.e. per 
357,372 mothers or 297,731 term singleton babies) are (cost-consequences analysis): 
 
Non-significant changes, i.e. we cannot say that there is definitely a difference: 
 
x 104 fewer stillbirths  
o 95%CI from 219 fewer to 10 more 
x 241 more babies with low Apgar at 5 minutes  
o 95%CI from 671 fewer to 1,154 more 
x 145 fewer babies cooled  
o 95%CI from 300 fewer to 9 more 
x 684 more NICU admissions  
o 95%CI from 2,556 fewer to 3,925 more 
x 50 more 4th degree tears 
o 95%CI from 154 fewer to 253 more 
Significant changes, i.e. we can say that there is a statistically significant difference in the numbers 
recorded: 
 
x 1,307 more 3rd degree tears  
o 95%CI from 48 more to 2,566 more 
x 1,578 more mixed 3rd/4th degree tears 
o 95%CI from 293 more to 2,862 more 
Using Trusts  BACS pa men  a i al da e  a  bo nda  da e  
 
I ems bought  for the money spent by the NHS LA in these 28 Trusts (i.e. per 461,291 mothers or 
387,702 term singleton babies) are (cost-consequences analysis): 
 
Non-significant changes, i.e. we cannot say that there is definitely a difference: 
 
x 33 fewer stillbirths  
o 95%CI from 185 fewer to 118 more 
x 118 more babies with low Apgar at 5 minutes  
 

















































o 95%CI from 1,041 fewer to 1,278 more 
x 98 fewer babies cooled  
o 95%CI from 334 fewer to 137 more 
x 1,558 more NICU admissions  
o 95%CI from 4,711 fewer to 7,827 more 
x 1,149 more 3rd degree tears  
o 95%CI from 460 fewer to 2,758 more 
Significant changes, i.e. we can say that there is a statistically significant difference in the numbers 
recorded: 
 
x 310 more 4th degree tears 
o 95%CI from 39 more to 581 more 
x 1,748 more mixed 3rd/4th degree tears 
o 95%CI from 105 more to 3,391 more 
Overall difference in costs for the sample used  
 
TOTAL Costs  
(using the mixed 3rd/4th degree tears 





Point estimate £3,256,678 £6,354,960 
lower 95%CI -£8,998,167 -£16,649,718 
upper 95%CI £15,511,523 £29,359,637 
 
 
TOTAL Mortality  





Point estimate -104 -33 
lower 95%CI -219 -185 
upper 95%CI 10 118 
 
TOTAL Reduction in point HRQOL99  
(including NICU admissions and tears 
only; using the separate 3rd and 4th 
degree tears only, to avoid double-
counting and allow for the difference in 






Point estimate 674 1103 
lower 95%CI -1,123 -2,091 
upper 95%CI 2471 4,298 
 
 
                                                     
99 Note that these are not QALYs. 
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 483 
Carbetocin versus oxytocin for prevention of post-partum 
haemorrhage at caesarean section in the United Kingdom: an 












































Carbetocin versus oxytocin for prevention of post-partum
haemorrhage at caesarean section in the United Kingdom: An
economic impact analysis
Helen A. van der Nelsona,b,*, Tim Draycotta,b, Dimitrios Siassakosa,b,
Christopher W.H. Yaua,b, Anthony J. Hatswellc,d
aAcademic Centre for Women’s Health, North Bristol NHS Trust, Bristol, United Kingdom
b School of Clinical Sciences, University of Bristol, 69 St Michael’s Hill, Bristol, BS2 8DZ, United Kingdom
cBresMed, 84 Queen Street, Shef!eld, S1 2DW, United Kingdom
dDepartment of Statistical Science, University College London, Gower Street, London, WC1E 6BT, United Kingdom
A R T I C L E I N F O
Article history:
Received 4 August 2016
Received in revised form 16 December 2016







A B S T R A C T
Objective: To determine the economic impact of the introduction of carbetocin for the prevention of
postpartum haemorrhage (PPH) at caesarean section, compared to oxytocin.
Study design: The model is a decision tree conducted from a UK National Health Service perspective. 1500
caesarean sections (both elective and emergency) were modelled over a 12 month period. Ef!cacy data
was taken from a published Cochrane meta-analysis, and costs from NHS Reference costs, the British
National Formulary and the NHS electronic Medicines Information Tool. A combination of hospital audit
data and expert input from an advisory board of clinicians was used to inform resource use estimates. The
main outcome measures were the incidence of PPH and total cost over a one year time horizon, as a result
of using carbetocin compared to oxytocin for prevention of PPH at caesarean section.
Results: The use of carbetocin compared to oxytocin for prevention of PPH at caesarean section was
associated with a reduction of 30 (88 vs 58) PPH events (>500 ml blood loss), and a cost saving of £27,518.
In probabilistic sensitivity analysis, carbetocin had a 91.5% probability of producing better outcomes, and
a 69.4% chance of being dominant (both cheaper and more effective) compared to oxytocin.
Conclusion: At list price, the introduction of carbetocin appears to provide improved clinical outcomes
along with cost savings, though this is subject to uncertainty regarding the underlying data in ef!cacy,
resource use, and cost.
Crown Copyright © 2017 Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Primary Post Partum Haemorrhage (PPH) is most commonly
de!ned as blood loss of 500 ml or more from the genital tract
within 24 h of childbirth [1]. Uterine atony is the cause of up to 90%
of PPH and is increasing [2]. Prophylactic uterotonic drugs are part
of the active management of the third stage of labour that reduces
risk of PPH by 66% when compared with physiological manage-
ment [3], and a World Health Organisation (WHO) study concluded
that haemorrhage prevention programmes should focus on the use
of uterotonic drugs [4].
The National Institute for Health and Clinical Excellence (NICE)
in the United Kingdom currently recommend oxytocin
(Syntocinon1, Alliance) as the uterotonic drug of choice for PPH
prophylaxis: a 10IU intramuscular dose for vaginal births [5] and a
5IU slow intravenous dose for caesarean births [6]. Carbetocin
(Pabal1, Ferring) is a synthetic analogue of oxytocin, with
structural modi!cations that increase its half-life and duration
of action [7]. A Cochrane review [8] concluded that use of
carbetocin resulted in a statistically signi!cant reduction in the use
of additional uterotonic drugs at caesarean section when
compared with oxytocin and a numerical reduction in the
incidence of PPH. Although carbetocin is likely to be at least as
clinically effective as oxytocin, it is more expensive, with little
published evidence on the cost-effectiveness of its use – as
highlighted by the Cochrane review [8]. The data that does exist is
con"icting and of variable quality [9–11].* Corresponding author at: Maternity Research Of!ce, The Chilterns, Southmead
Hospital, Southmead Road, Westbury-on-Trym, Bristol, BS10 5NB, UK.
E-mail address: helenvandernelson@gmail.com (H.A. van der Nelson).
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In this paper we describe the use of a health economic model
constructed to assess the cost-effectiveness of carbetocin for PPH
prophylaxis at caesarean section from the perspective of the UK
National Health Service.
Methods
A decision tree was constructed in Microsoft Excel 20101 to
model prophylactic doses of 5 IU intravenous oxytocin, or a single
prophylactic (100 mg) dose of intravenous carbetocin at caesarean
section for PPH prevention. Oxytocin and Carbetocin were selected
for comparison as they represent current UK prophylactic
uterotonic practice and a longer lasting and potentially more
effective (but more expensive) alternative, respectively. The
evaluation was undertaken from a National Health Service
perspective, in keeping with UK National Institute for Health
and Care Excellence recommendations [12].
The primary outcome measures were the number of PPH events
prevented and the impact on total cost incurred by a large
maternity unit over a one year time horizon, as a result of using
carbetocin instead of oxytocin for PPH prevention at caesarean
section. The study population comprised all women undergoing
elective and emergency caesarean section. The number of
caesarean sections performed in the model was set to 1500, based
on a unit with approximately 6500 deliveries per annum (a
caesarean section rate of about 24%). Hospital-level audit data was
used to inform estimates of resource use.
Treatment pathway
The modelled treatment pathway is shown in Fig. 1. Patients
undergoing caesarean section receive a prophylactic uterotonic
drug after their delivery. Despite this prophylaxis, some women
experience uterine atony requiring additional uterotonic drugs
that will prevent PPH in some, but not all cases. Patients experience
varying volumes of blood loss at caesarean section – in the model
this is captured in 4 health states – ‘No PPH event’, ‘PPH 500–
999 ml’, ‘PPH 1000–1499 ml’ and “PPH > 1500 ml”. Larger volumes
of blood loss are associated with more treatment and resource use,
and as a result are more expensive. Table 1 shows the inputs to the
model by different levels of blood loss.
Patients are monitored in recovery for 2 h after their caesarean
section, as recommended by national guidelines [6]. Patients
requiring additional uterotonic drugs (e.g. 4 h oxytocin infusion)
stay in recovery, or on labour ward, for longer. In these areas staff to
patient ratios are greater, and more medical time is utilised.
Patients who experience a large PPH are more likely to require
postnatal follow up, and for their care to be discussed at a risk
management forum. A combination of published data and
hospital-level data was used in the economic model (Table 2).
Clinical effectiveness
Relative clinical ef!cacy was obtained from a published
Cochrane Collaboration meta-analysis of four randomised control
trials of carbetocin and oxytocin for PPH prophylaxis at caesarean
section [8]. Data used included the rate of PPH and the proportion
of patients requiring additional uterotonic drugs (Table 3). Point
estimates (published means) have been used in the base case, with
probabilistic estimates also presented, as the Cochrane review
concluded that although the reduction in the use of additional
uterotonic drugs was statistically signi!cant, the estimate for
differences in PPH rates was not (p = 0.086). The use of values (even
if statistically insigni!cant), with a con!dence interval around
their estimates is well established in health economics [13], as
such estimates provide a the best estimate to the real world, where
evidence is not always clear and is associated with uncertainty
regardless of the signi!cance of the !nding.
Fig. 1. Treatment pathway.
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During the review of existing literature, we noted that the
reporting of PPH categories is inconsistent: the meta-analysis data
[8] includes analyses of both “PPH > 1000ml” (two studies), and
“PPH > 500 ml or as de!ned by trialist” (all four studies). To account
for incomplete reporting, the proportion of total PPH events in
each blood loss category was interpolated from a cohort study of
1584 women in the Netherlands, which compared carbetocin and
several different dosing regimens of oxytocin for PPH prophylaxis
during caesarean section [14]. Data regarding the distribution of
PPH events across these categories was provided by the publishing
authors. The resulting data for PPH in each blood loss category for
all ef!cacy sources is shown in Table 1, with the distribution of
outcomes assumed to be the same in both arms.
Resource use
Clinical management and resource use escalates with increas-
ing blood loss. The proportion of cases requiring additional
uterotonic drugs was derived from clinical effectiveness data
shown in Table 3. The additional uterotonic drug assumed was 5 IU
oxytocin given by slow IV bolus, representing UK recommended
clinical practice [15]. This single dose was assigned to patients
Table 1
Proportionate spread of PPH events across categories of blood loss.
Proportion of all PPHs falling in each category Total
No PPH (blood loss <500ml) 500–999ml 1000–1499ml !1500ml
Holleboom 2013 Oxytocin 680 319 66 57 1122
Carbetocin 248 165 33 16 462
Raw data from published literature
Su 2012 Oxytocin 563 35 598
Carbetocin 574 23 597
Model inputs, including interpolation of missing data using data from the Holleboom et al., dataset
Su 2012 Oxytocin 94.20% 4.30% 0.90% 0.70% 100%
Carbetocin 96.20% 2.80% 0.60% 0.40% 100%
Table 2
Cost and resource use inputs for PPH events.
Resources needed for management of PPH in each category Source of resource use
estimate
PPH 500–999 ml PPH 1000–1499
ml
PPH !1500 ml
Additional uterotonic drugs given to treat PPH (cost taken from BNF volume 67)
Oxytocin 5iU (Syntocinon1, £0.80) 1 1 1 Expert opinion (see footnote)
Ergometrine 0.5IU and Oxytocin 1 ml (Syntometrine1, £1.35) 0 1 1 Expert opinion
Carboprost 250 mg (Haemobate1 £18.20) 0 1 3 Expert opinion
Intravenous replacement (cost take from sources as stated)
Hartmann’s solution 500 ml IV (£2.75 – Just Care Medical) 1 3 5 Expert opinion
Red blood cells, 1 unit








Fresh Frozen Plasma, 1 unit
(£33.81 – NHS Blood & Transfusion Services)
0 0 2 Expert opinion
Hours of staff time needed, in addition to routine uncomplicated caesarean section (costs taken from PSSRU 2013)
Anaesthetist (£94/h) 0 0 4 Expert opinion
Obstetrician (£100/h) 0 0 4 Expert opinion
Midwife (£65.44/h) 0 0 4 Expert opinion
Junior doctor (£29/h) 0 0 4 Expert opinion
Haematologist (£99/h) 0 0 1 Expert opinion
Other costs (costs taken from NHS Reference Costs 2012/2013)
Additional length of post-natal inpatient stay (days), £439.35/day 0.03 0.28 1.19 NHS Trust data
Days required in high dependency unit such as 1:1 care on Labour Ward
(£630/day)
0 1 1 Expert opinion
Additional cost for operating theatre per hour (£1139.60 – ISD Scotland) 0 1 1 Expert opinion
Case discussion at PPH meeting (£67.14) 0 0 1 Expert opinion
Post natal consultant follow up in !rst 10 post natal weeks (£129.92) 2.9% 2.6% 7.4% NHS Trust data
Total cost per event £17.28 £1782 £3507
Expert opinion provided by panel of 5 anaesthetists, 5 obstetricians and 2 midwives.
Table 3
Clinical effectiveness estimates used in the economic model.
Source PPH rate Use of additional uterotonic
drugs
Oxytocin Carbetocin Oxytocin Carbetocin
Su 2012
(systematic review and meta-analysis)
5.9% 3.9% 21.5% 13.6%
PPH de!ned as blood loss >500 ml “or as de!ned by trialist”. Meta-analysis includes 4 studies;
Borruto 2009 de!nes PPH >500 ml, Boucher 1998 and Attilakos 2010 de!ne PPH >1000 ml, and
Dansereau does not state de!nition.
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needing “additional uterotonics”, as not all patients who require
additional uterotonic drugs go on to experience a PPH.
The resources required to manage a PPH in each of the
categories used in the economic model (500–999 ml,
1000–1499 ml and !1500 ml), was estimated by a multi-profes-
sional panel of clinical experts. Resource use included the type
(and number of doses) of additional drugs needed, as well as staff
time associated with treatment of the PPH. The resulting
assumptions are shown in Table 2. These are in line with national
guidance on the management of PPH [15].
Where published estimates were not available, hospital level
data (from Southmead Hospital, Bristol, UK) was used to improve
accuracy of resource use estimates. Hospital level data included
average length of maternal inpatient stay post caesarean, propor-
tion of patients needing a blood transfusion, units of red blood cells
transfused, and provision of consultant follow-up in the !rst ten
postnatal weeks. Each item was also calculated for blood loss in the
ranges 0–499 ml (no PPH), 500–999 ml, 1000–1499 ml and
!1500 ml (see Table 3).
Unit cost estimates
Costs were calculated in Pounds Sterling, and were taken from
NHS Reference costs, the British National Formulary and the NHS
electronic Medicines Information Tool (which contains the mean
price paid for generic pharmaceuticals in the UK).
Utilities
To provide a common unit of comparison, utilities decrements
were used for the differing levels of PPH. As no direct utility values
were available, estimates for the disutility of gastrointestinal
bleeds [16] were used, such as a disutility of 0.06 for 7 days for PPH
500–1000 ml, a disutility of 0.25 for 10 days for PPH 1000–1500 ml,
and a disutility of 0.25 for 14 days for PPH > 1500 ml.
Results
Table 4 contains a breakdown of costs associated with the use of
oxytocin or carbetocin for prevention of PPH at caesarean section
in this model. In the base case, the use of carbetocin shows a
reduction of 30 PPH events (58 vs 88) and an estimated cost saving
of £27,518.41 (£2,085,989 vs £2,113,508). This difference is mainly
driven by a reduction in the number of PPH events (incremental
cost saving £35,985) and the resultant reduction in time spent in
recovery after treatment of PPH (incremental cost saving of
£12,783). These savings offset the increased drug cost of carbetocin
compared to oxytocin (unit price £17.64 v £0.80, which gives an
increase of £22,860 per year).
Probabilistic sensitivity analysis, which takes into account the
uncertainty in input values (both clinical and cost) shows
carbetocin to be more effective than oxytocin in 91.5% of scenarios,
and dominant (both cheaper and more effective) in 69.4% of
scenarios. When attaching utility values to PPH events based on
assumed disutilities, carbetocin is cost-effective at a threshold of
£20,000 per QALY in 70.5% of scenarios (Fig. 2).
Discussion
Main !ndings
The model demonstrates that carbetocin is likely to provide
superior clinical outcomes (by reducing the rate of PPH events),
along with a cost saving. However probabilistic analysis illustrates
uncertainty due to the underlying data, where carbetocin does not
provide cost savings (30.4%), and does not show cost-effectiveness
using the NICE threshold for recommendation (over £20,000 per
QALY gained, 29.5% of scenarios).
Strengths and limitations of the study
The treatment pathway used in the model is in line with
national guidelines [5,6,15]. The results should be applicable to
most maternity units in the United Kingdom, regardless of size, as
well as those internationally with similar care pathways. Whilst UK
guidelines recommend a single 5IU oxytocin dose for PPH
prophylaxis, we are aware that practice varies greatly [17,18],
and that there is some evidence suggesting that the addition of a
postoperative oxytocin infusion may further reduce risk of PPH
[19],as is common in other countries [20]. This does not affect our
conclusions however; using a 40IU infusion over 4 h for all oxytocin
patients increased the cost saving of carbetocin to £31,118 (an
increase of approximately £3600).
Our analysis is primarily in"uenced by the clinical effectiveness
data chosen for each scenario. Cochrane meta-analysis data was
used to inform the base case, which raises the question of the
methodological differences and clinical heterogeneity between
studies. An important difference was the variability in the method
of IV oxytocin administration in each individual study [21–24].
Each study referred to their method of oxytocin infusion as
“standard”, suggesting that the routine dose and administration
method for prophylactic oxytocin differs between settings, and
over time. Ultimately, a meta-analysis provides the best available
clinical evidence whilst also re"ecting some of the variability in
clinical practice. A similar limitation is that adverse events were
not included in the model; in the absence of a de!nitive head to
head trial, the variation in reporting and treatment of adverse
events in heterogeneous trials would introduce a bias of unknown
magnitude and direction. This is particularly the case as the
treatments are given alongside a complex pathway of interven-
tions; isolating the adverse events of PPH prophylaxis would be
extremely dif!cult.
Although necessary for resource use analysis, the sub-
categorisation of PPH by blood volume does place arbitrary limits
on a continuous outcome. As such, the categories have been
created based on the literature available, and resources assigned to
re"ect the mean for patients falling within each category. We are
mindful that exceedingly large PPHs may incur additional costs
such as use of Factor VII, admission to Intensive Care, and
potentially medico-legal expenses associated with litigation,
however no data exist on these rare events and as such they have
been omitted from our estimates so as not to bias the analysis. A
further assumption in the model is that the breakdown of PPH
events into the different categories is assumed to be identical
between the two treatments (as is the proportion of patients with
Table 4
Overall cost as a result of using either oxytocin or carbetocin for prevention of post
partum haemorrhage at caesarean section.
Oxytocin Carbetocin Change with Carbetocin
PPH 500–1000 ml events 65 43 "22
PPH 1000–1500 ml events 13 9 "5
PPH > 1500 ml events 10 6 "3
PPH Events 88 58 "30
Oxytocin Carbetocin Change with carbetocin
PPH Events £105,227 £69,242 "£35,985
PPH prophylaxis £3600 £26,460 £22,860
PPH re-treatment £3600 £2250 "£1350
Ante-Natal £124,312 £124,312 £0
Recovery £1,774,419 £1,761,637 "£12,783
Follow up £102,351 £102,090 "£261
Total cost £2,113,508 £2,085,990 -£27,518
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additional PPH risk factors such as obesity, prolonged labour and
placenta praevia). This is representative of clinical practice – PPH is
not treated differently based on the prophylactic treatment
received.
The lack of universally adopted categories of PPH that clinical
trials use to classify obstetric blood loss also causes uncertainty in
the clinical data, which is carried through to modelling. Although
the most commonly used de!nition of PPH is that quoted by the
WHO (loss of >500 ml blood from the genital tract within 24 h of
birth), the outcomes reported in clinical trials vary considerably,
particularly for trials involving caesarean section. As trials
commonly only report blood loss in one of these categories
(e.g. “PPH > 1000 ml”, or PPH “>500 ml”), missing category data was
accounted for by the interpolation of categorical PPH proportions
from a large published dataset [14]. These data are from a large
study population in a healthcare system comparable with that of
the UK. However, this dataset only included elective caesarean
sections, whereas PPH, particularly severe PPH, is more common
following emergency caesarean section [25–27].
Interpretation in light of existing literature
A small study [11] performed a !nancial evaluation alongside a
departmental audit in a UK hospital, after changing from routine
use of oxytocin to carbetocin at elective caesarean section. This
was an observational study which only contained 24 patients in
the oxytocin arm, and 37 patients in the carbetocin arm. It
concluded that carbetocin was associated with a £18.52 increased
cost per patient, and no signi!cant clinical bene!t. In addition to
the small sample size and lack of formal methods for adjusting for
difference in baseline patient characteristics, it is not clear how
these costs were estimated, and no formal economic modelling
was performed. Similarly a Mexican abstract [9] reported an
economic evaluation of carbetocin for the prevention of uterine
atony in patients with risk factors for PPH. This compared
carbetocin with oxytocin, and included a total of 152 patients.
Mode of delivery was not stated, nor were details of any blinding,
costs included, or treatment pathways used. It concluded that the
overall cost per patient treated with carbetocin was 529 USD less
than those treated with oxytocin (approximately £339 per
patient). However without further information about the study,
resource use, or the costs included, comparison with our results is
not meaningful.
A more useful comparison is with a cost-minimization analysis
performed from a Canadian healthcare system perspective [10]
which investigated the use of carbetocin for prevention of PPH
during elective caesarean section, with treatment pathways
modelled on guidelines from the Society of Obstetricians and
Gynecologists of Canada. This compared carbetocin with unnamed
“comparators most commonly encountered in clinical practice”.
Rather than using clinical trial data the study “assumed that the
incidence of PPH was equal between treatment strategies”, which
will have heavily in"uenced results and is inconsistent with
economic evaluation guidelines [13]. This analysis reported a per
patient cost of $31.95 for carbetocin vs $32.31 for oxytocin. While
these results are more consistent our results, it is again dif!cult to
draw comparisons due to the limited information presented, and
assumption of equal ef!cacy in prevention of PPH (contrary to
published meta-analytic data).
Conclusions
This economic evaluation combines the best available clinical
effectiveness data for the use of oxytocin versus carbetocin during
caesarean section for PPH prophylaxis, with UK hospital-level
resource use data. The model estimates that carbetocin is likely to
result in better clinical outcomes and a modest cost-saving when
compared to oxytocin, albeit with substantial uncertainty.
Whilst the results of this model will help to inform policy
makers, further work is needed. The current data indicate
carbetocin is more effective than oxytocin in reducing the use of
additional uterotonic drugs, and although existing data indicates a
numerical advantage for carbetocin in reducing the rate of PPH,
this does not reach statistical signi!cance. There exists therefore
uncertainty in the relative clinical effectiveness of carbetocin,
which we hope will be provided by an ongoing randomised control
trial (“The IMox Study”, Clinicaltrials.gov NCT02216383).
Although carbetocin appears to have a number of advantages in
our study (potentially including cost), a large randomised trial of
the use of these drugs at caesarean section with parallel health
economic evaluation, is required to conclusively inform practice.
Until this has been conducted, the evaluation presented here uses
the most robust information available and demonstrates that the
introduction of carbetocin is likely to result in better clinical
outcomes and potentially a modest per patient cost-saving, albeit
with uncertainty. At the very least, it appears that carbetocin use
Fig. 2. Scatterplot of Monte-Carlo estimates (1000 simulations).
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would be cost-neutral, meaning decisions regarding its introduc-
tion should be based on clinical effectiveness.
Disclosure and contribution of authorship
The project was led by HvdN, the model was developed by AJH,
clinical input was provided by HvdN, TD and DS. HvdN is the lead
investigator on a clinical study that has received start up funding
from Ferring (the manufacturers of carbetocin), TD has attended
advisory board meetings sponsored by Ferring. DS has attended
expert meetings organised by Ferring and has organised events
sponsored by them. AJH is an employee of BresMed, who have
received funding from both Ferring and P!zer (the manufacturers
of carboprost). All authors read and approved the !nal manuscript.
Funding
No funding was received for this project.
Detail of ethical approval
Ethical approval was not required for this project.
Acknowledgements:
The authors would like to acknowledge the help of Ash
Bullement, Dawn Lee and Thea Henry in constructing the economic
model, Eva Creutzberg for provision of PPH data, advisory board
participants for clinical input on the management of PPH, and
Helen Fenn for the collection of resource use data from Southmead
hospital, Bristol.
References
[1] WHO recommendations for the prevention and treatment of post partum
haemorrhage. World Health Organisation. 2012. [Internet – last accessed 16/
12/2016] Available from http://www.who.int/reproductivehealth/publica-
tions/maternal_perinatal_health/9789241548502/en/.
[2] Knight MCW, Berg C, Alexander S, Bouvier-Colle M-H, Ford JB, et al. Trends in
postpartum hemorrhage in high resource countries: a review and recom-
mendations from the International Postpartum Hemorrhage Collaborative
Group. BMC Pregnancy Childbirth 2009;9(1):55.
[3] Begley CM, Gyte GM, Devane D, McGuire W, Weeks A. Active versus expectant
management for women in the third stage of labour. Cochrane Database Syst
Rev 20153: Art. No. 007412.
[4] Gulmezoglu AM, Lumbiganon P, Landoulsi S, Widmer M, Abdel-Aleem H,
Festin M, et al. Active management of the third stage of labour with and
without controlled cord traction: a randomised, controlled, non-inferiority
trial. Lancet 2012;379(May (9827)):1721–7.
[5] Intrapartum Care for Healthy Women and Babies National Institute for Health
and Care Excellence. Clinical Guideline CG 190. 2014. [Internet – last accessed
16/12/2016] Available from https://www.nice.org.uk/guidance/cg190.
[6] Caesarean Section. National Institute for Health and Care Excellence. Clinical
Guideline CG 132. 2011. [Internet – last accessed 16/12/2016] Available from
https://www.nice.org.uk/guidance/cg132.
[7] Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue
carbetocin. Eur J Obstet Gynecol Reprod Biol 2009;147(November (1)):15–20.
[8] Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum
haemorrhage. Cochrane Database Syst Rev 20124: Art. No.: 005457.
[9] Del-Angel-Garcia G, Garcia-Contratres F, Nevarez-Sida A, Constantino-Casas P.
A cost effectiveness study of Carbetocine compared to oxytocin for the
prevention of uterine atony in patients with risk factors. Value Health 2006;9
(3):A50.
[10] Millsa FCC. A cost-minimization analysis of Carbetocin for the prevention of
post partum hemorrhage in Canada. Value Health 2014;17(3):A161.
[11] Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of
postpartum haemorrhage at caesarean section provide clinical or !nancial
bene!t compared with oxytocin? J Obstet Gynaecol 2011;31(8):732–9.
[12] Guide to the methods of technology appraisal. National Institute for Health
and Care Excellence. Process and Methods PMG9. 2013. [Internet – last
accessed 16/12/2016]. Available from https://www.nice.org.uk/process/pmg9.
[13] Claxton K. The irrelevance of inference: a decision-making approach to the
stochastic evaluation of health care technologies. J Health Econ 1999;18
(3):341–64.
[14] Holleboom CA, van Eyck J, Koenen SV, Kreuwel IA, Bergwerff F, Creutzberg EC,
et al. Carbetocin in comparison with oxytocin in several dosing regimens for
the prevention of uterine atony after elective caesarean section in the
Netherlands. Arch Gynecol Obstet 2013;287(6):1111–7.
[15] Prevention and management of post partum haemorrhage. Royal College of
Obstetricians and Gynaecologists. Greentop Guideline 52. 2016. [Internet –
last accessed 16/12/2016]. Available from https://www.rcog.org.uk/en/guide-
lines-research-services/guidelines/gtg52/.
[16] Lee D, Thornton P, Hirst A, Kutikova L, Deuson R, Brereton N. Cost effectiveness
of romiplostim for the treatment of chronic immune thrombocytopenia in
Ireland. Appl Health Econ Health Policy 2013;11(5):457–69.
[17] Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage
at caesarean section–a survey of practice in the United Kingdom. Eur J Obstet
Gynecol Reprod Biol 2008;137(1):27–30.
[18] Stephens LC, Bruessel T. Systematic review of oxytocin dosing at caesarean
section. Anaesth Intensive Care 2012;40(2):247–52.
[19] Murphy DJ, MacGregor H, Munishankar B, McLeod G. A randomised controlled
trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU
infusion for the control of blood loss at elective caesarean section–pilot study.
ISRCTN 40302163. Eur J Obstet Gynecol Reprod Biol 2009;142(1):30–3.
[20] Mockler JC, Murphy DJ, Wallace EM. An Australian and New Zealand survey of
practice of the use of oxytocin at elective caesarean section. Aust N Z J Obstet
Gynaecol 2010;50(1):30–5.
[21] Dansereau J, Joshi AK, Helewa ME, Doran TA, Lange IR, Luther ER, et al. Double-
blind comparison of carbetocin versus oxytocin in prevention of uterine atony
after cesarean section. Am J Obstet Gynecol 1999;180(3 Pt 1):670–6.
[22] Boucher M, Horbay GL, Grif!n P, Deschamps Y, Desjardins C, Schulz M, et al.
Double-blind, randomized comparison of the effect of carbetocin and oxytocin
on intraoperative blood loss and uterine tone of patients undergoing cesarean
section. J Perinatol 1998;18(3):202–7.
[23] Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al.
Carbetocin versus oxytocin for the prevention of postpartum haemorrhage
following caesarean section: the results of a double-blind randomised trial.
BJOG 2010;117(8):929–36.
[24] Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of
postpartum hemorrhage after cesarean section: a randomized clinical trial.
Arch Gynecol Obstet 2009;280(5):707–12.
[25] Daniel S, Viswanathan M, Simi B, Nazeema A. Study of maternal outcome of
emergency and elective caesarean section in a semi-rural tertiary hospital.
Natl J Med Res 2014;4(1):14–8.
[26] Ghazi A, Karim F, Hussain AM, Ali T, Jabbar S. Maternal morbidity in emergency
versus elective caesarean section at a tertiary care hospital. J Ayub Med Coll
2012;24(1):10–3.
[27] Holm C, Langhoff-Roos J, Petersen KB, Norgaard A, Diness BR. Severe
postpartum haemorrhage and mode of delivery: a retrospective cohort study.
BJOG 2012;119(5):596–604.
H.A. van der Nelson et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 210 (2017) 286–291 291
 
Thesis appendix  
 489 
Associations between birth at, or after, 41 weeks gestation and 




















Associations between birth at, or 
after, 41 weeks gestation and perinatal 
encephalopathy: a cohort study
David E Odd,1,2,3 Christopher Yau,1,3 Cathy Winter,1,3 Timothy Draycott,1,3 
Finn Rasmussen4 
To cite: Odd!DE, Yau!C, 
Winter!C, et!al. Associations 
between birth at, or after, 41 
weeks gestation and perinatal 
encephalopathy: a cohort 
study. BMJ Paediatrics Open 
2018;2:e000010. doi:10.1136/
bmjpo-2017-000010
 Ź Additional material is 
published online only. To view 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjpo- 2017- 000010).
Received 16 March 2017
Revised 16 November 2017
Accepted 12 December 2017
1School of Social and 
Community Medicine, University 
of Bristol, Bristol, UK
2NIHR Bristol Biomedical 
Research Centre, University of 
Bristol, Bristol, UK
3Women and Children's Health, 
North Bristol NHS Trust, Bristol, 
UK
4Department of Public Health 
Sciences, Karolinska Institutet, 
Stockholm, Sweden
Correspondence to




Background Preterm birth causes long-term problems, 
even for infants born 1 or 2 weeks early. However, less is 
known about infants born after their due date and over a 
quarter of infants are born over 1 week late, and many still 
remain undelivered after 2 weeks. The aim of this work is 
to quantify the risks of infants developing encephalopathy 
when birth occurs after the due date, and if other proposed 
risk factors modify this relationship.
Methods The dataset contain information on 4 036 346 
infants born in Sweden between 1973 and 2012. Exposure 
was de"ned as birth 7, or more, days after the infants’ 
due date. The primary outcome was the development 
of neonatal encephalopathy (de"ned as seizures, 
encephalopathy or brain injury caused by asphyxia or with 
unspeci"ed cause). Covariates were selected as presumed 
confounders a priori.
Results 28.4% infants were born 1 or more weeks 
after their due date. An infant’s risk of being born with 
encephalopathy was higher in the post 41 weeks group in 
the unadjusted (OR 1.40 (95% CI 1.32 to 1.49)) and "nal 
model (OR 1.38 (95% CI 1.29 to 1.47)), with the relative 
odds of encephalopathy increasing by an estimated 20% 
per week after the due date, and modi"ed by maternal age 
(P=0.022).
Conclusions Singleton infants born at, or after, 41 
weeks gestation have lower Apgar scores and higher risk 
of developing encephalopathy in the newborn period, and 
the association appeared more marked in older mothers. 
These data could be useful if provided to women as part of 
their decision-making.
INTRODUCTION
Preterm birth causes long-term problems, even 
for infants born 1 or 2 weeks early. However, 
less is known about infants born after their 
due date and over a quarter of infants are 
born over 1 week late, and many still remain 
undelivered after 2 weeks. While there is a 
plethora of work investigating the long-term 
cognitive, educational and social functioning 
of babies born prematurely,1 2 little data exist 
for the outcomes of those infants born after 
their due date or the mechanisms of any 
possible adverse outcomes.3 
Perinatal asphyxia (deprivation of oxygen 
during birth) is a relatively common event 
with around 7% of infants needing support 
after birth.4 While most infants tolerate it well, 
a small proportion, around 0.2%4 of these 
develop immediate signs of brain damage 
(hypoxic–ischaemic encephalopathy).5 The 
clinical impacts can be lifelong and devas-
tating for them and their family; the litigation 
and societal costs notwithstanding.6 The risks 
of perinatal asphyxia may increase in infants 
born after their due date,3 but estimates are 
conflicting.7 However, in contrast to preterm 
birth, interventions can be used to deliver 
the infant if the risks of continuing the preg-
nancy are higher than delivery for either the 
mother or the infant. Indeed, induction of 
labour (IOL) has been shown to be benefi-
cial in high-risk groups,8–11 but its place in the 
management of infants past their due date is 
unclear.11 12
What is already known on this topic?
 Ź Preterm birth causes long-term problems, but less 
is known about infants born after their due date.
 Ź Perinatal asphyxia may increase as infants pass 
their due date, but estimates are con#icting and 
imprecise.
 Ź A current research priority is to try to identify babies 
at particularly high risk of morbidity and mortality 
who will bene"t from induction.
What this study hopes to add?
 Ź The risks of developing perinatal encephalopathy 
increase among infants that remain in utero after 
their due date.
 Ź The association was observed in the most recent 
data, in younger and older mothers and in well-
grown infants.
 Ź However, this increase in risk is higher in women 
over 35 years old.
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This dearth of data makes counselling for women 
difficult and consequently the management of pregnan-
cies beyond term varies hugely between units and coun-
tries (eg, 0.4% in Austria vs 7% in Denmark).13 Current 
National Institute for Health and Clinical Excellence 
guidelines suggest that a research priority is to ‘identify 
babies at particularly high risk of morbidity and mortality 
who will benefit from induction and therefore avoid 
induction for babies who do not need it’14—the primary 
aim of this work. However, even small improvements in 
outcomes would yield substantial health benefits for indi-
viduals and economic benefits for health services and 
society.
The aim of this work is to quantify the risks of devel-
oping perinatal encephalopathy or being born with low 
Apgar score (less than 7 at 5 min), when born 7 or more 




The dataset reviewed contains information on 
4 036 346 infants born in Sweden between 1973 and 
2012 and registered on the nationwide birth registry of 
Sweden. The birth registry provides data on 98%–99% of 
births and includes Apgar scores, as well as both neonatal 
and maternal diagnoses (coded using the International 
Classification of Diseases (ICD), 8th, 9th and 10th revi-
sions). Details of the clinical signs that led to the diag-
noses are not recorded.
Infants born before 37 weeks gestation (n=234 924), 
from multiple births (n=56 493) or with cardiovascular, 
respiratory, neurological or multiple system congen-
ital abnormalities (n=29 535) were removed, leaving 
3 715 394 infants for the study. Infants with missing data 
on Apgar score or gestational age (n=7715) and those 
with missing data on at least one covariate (n=280 229) 
were also removed, leaving 3 427 450 subjects available 
for the analyses (92% of eligible subjects) (online supple-
mentary appendix 1).
Information on birth condition and perinatal well-
being was retrieved from the birth registry. The exposure 
was defined as birth 7, or more, days after the infants’ due 
date (!41 weeks gestation). A primary outcome was the 
development of likely perinatal encephalopathy (defined 
as an ICD coding for either ‘seizures’, ‘encephalopathy’ 
or brain injury caused by ‘asphyxia’ or with ‘unspecified 
cause’ immediately after birth).15 Secondary outcomes 
were Apgar scores at 1, 5 and 10 min, or a low Apgar score 
at 5 min (less than 7).16
Potential confounders and covariates
Covariates were selected as presumed confounders a 
priori,17 and categorised into three groups: (1) social 
(maternal age, maternal occupation, maternal educa-
tion), (2) antenatal (infant gender and primiparity) and 
(3) intrapartum and potential causal factors (maternal or 
infant infection, birth weight (gram), birth by caesarean 
section).
Statistical analysis
Initially, subjects with and without missing data were 
compared. The distribution of risk factors and potential 
confounders was investigated between the infants split 
by their gestation at birth. In univariable analysis the 
mean Apgar score at 1, 5 and 10 min, and the risk of 
developing encephalopathy was derived, split by each 
completed week of gestation. Due to the non-normal 
distribution of the Apgar score, geometric means (with 
95% CIs) were derived. Birth weight and maternal age 
were treated as continuous variable and not grouped 
further beyond their initial units (grams and years, 
respectively).
In the multivariable analyses, linear (for Apgar scores) 
and logistic regression (for encephalopathy and a low 
Apgar score at 5 min) models were used to assess any 
association with gestational age at birth. To account for 
changes in coding over time, models were multilevel 
to account for year of birth. Adjustment for social and 
antenatal confounders was performed by adding the 
variables described above to the models in blocks of 
common variables (defined above). Variables with poten-
tial confounding influence, but with possible causal 
inference, were introduced in a final model. The impact 
of birth at !41 weeks gestation on encephalopathy was 
calculated using the population attributable risk from 
this model.
Five sensitivity analyses were performed:
1. The model was repeated using the number of weeks 
of birth after the due date as an ordinal variable.
2. The model was repeated limiting the analysis to well 
grown (over 2500 g at birth) infants.
3. The model was repeated, testing if maternal age 
(greater than 35 years of age), interacted with the as-
sociation between birth !41 weeks gestation and risk 
of encephalopathy.
4. The model was repeated, restricting the analysis to the 
most recent 10 years of data (2003–2012).
5. The model was repeated using an imputation 
technique (multiple imputation using chained 
equations) to impute missing covariate values. 
Exposure and outcome data (eg, encephalopathy 
or gestational age data) was not imputed. Because 
of computation limitations, only a random 10% of 
infants without encephalopathy were included in this 
analysis to maintain a practical sized dataset, and the 
model weighted to represent the initial population 
(20 datasets with 42 102 infants in each).
All analyses were conducted with Stata V.10.0 soft-
ware (StataCorp), and results are presented as number 
(per cent), mean (SD), OR (95% CI) or median (IQR) 
as appropriate. Due to using registry data, informed 
consent was not obtained, and all data were provided and 
analysed anonymously.
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RESULTS
Infants with missing data weighed less and had older 
mothers (online supplementary appendix 2). Infants 
excluded with missing data were likely to have missing 
data for multiple variables. They were less likely to be 
exposed to pre-eclampsia, but more likely to have been 
exposed to maternal or neonatal infection. Mothers were 
more likely to have been nulliparous, and had a different 
profile of occupations and educational achievements 
(all comparisons P<0.001). There was no difference in 
gender (P=0.726) or risk of encephalopathy (P=0.136) 
between those with or without complete data.
In total, 973 430 (28.4%) infants were born 1 or more 
weeks after their due date. Over the 40-year period, 
there was a slight reduction in the (geometric) mean 
in the population from 40.1 (40.0–40.1) in 1973 to 39.6 
(39.6–39.6) (P<0.001) in 2012. Populations were similar, 
although infants born !41 weeks gestation were more 
likely to be male, had greater birth weight and were less 
likely to be exposed to maternal pre-eclampsia, or be 
born by caesarean section (table 1). They were also more 
likely to develop maternal or neonatal infection. Mothers 
were younger, more likely to be nulliparous, and had a 
different profile of occupations and educational qual-
ifications (all comparisons P<0.001). Due to the large 
numbers in the dataset differences were often small and 
of questionable clinical relevance.
There was strong evidence that the mean Apgar score 
at 1, 5 and 10 min reduced as the infants gestational 
age continued beyond 39 weeks (figure 1 and table 2, 
all P<0.001), although the magnitude of the difference 
in mean values was small. In addition, the risk of being 
born with a low Apgar score and the risk of developing 
encephalopathy became greater as the infants gestational 
age increased (both P<0.001). Interestingly, infants born 
at 37 weeks also appeared to have lower Apgar scores 
and higher rates of encephalopathy than infants born 
at 39 or 40 weeks gestation (post hoc analysis; P<0.001). 
Infants born at 45 weeks gestation appeared to have the 
lowest rate of encephalopathy, however, this is based on 
only one infant developing encephalopathy and hence 
the CIs are wide around the point estimate (0.07% (95% 
CI !0.07% to 0.20%)) and this observation needs to be 
interpreted with caution.
Overall, infants born !41 weeks gestation were more 
likely to develop encephalopathy than those born before 
41 weeks gestation (3040 (0.12%) vs 1640 (0.17%), 
P<0.001). In the unadjusted results, the mean Apgar 
scores at 1, 5 and 10 min were lower in infants born !41 
weeks gestation and this persisted after adjustment for a 
priori defined confounders, and remained after adjusting 
for both confounders and other causal factors (table 3). 
The risk of encephalopathy showed a similar association, 
with an infant’s risk of being born with encephalopathy 
Table 1 Characteristics of the study population according to gestational age at birth (n=3 427 450)
Measure 37+0 to 40+6 weeks 41+0 and above Difference (95% CI)
Antenatal factors
  Male 1 244 878 (50.7%) 511 567 (52.6%) 1.82% (1.71% to 1.94%)
  Birth weight (g) 3511 (473) 3798 (474) 288 (287 to 289)
  Maternal pre-eclampsia 115 578 (4.7%) 38 693 (4.0%) !0.07% (!0.08% to 0.07%)
Intrapartum factors
  Maternal infection 16 092 (0.66%) 7240 (0.74%) 0.09% (0.07% to 0.11%)
  Neonatal infection 10 334 (0.4%) 6125 (0.6%) 0.21% (0.19% to 0.22%)
  Caesarean section 294 707 (12.1%) 85 400 (8.8%) !3.24% (!3.31% to !3.16%)
Demographic factors
  Maternal age 28.1 (5.2) 27.8 (5.1) !0.30 (!0.31 to !0.29)
  Primiparae 995 171 (40.6%) 450 385 (46.3%) 5.72% (5.60% to 5.83%)
  Maternal occupation
   Manual 793 546 (32.3%) 314 211 (32.3%) !0.06% (!0.17% to 0.05%)
   Non-manual 868 071 (35.4%) 371 740 (38.2%) 2.82% (2.70% to 2.93%)
   Other 792 403 (32.3%) 287 479 (29.5%) !2.86% (!2.87% to !2.65%)
  Maternal education status
   <9 years 71 148 (2.9%) 28 652 (2.9%) 0.04% (0.04% to 0.08%)
   9–10 years 919 214 (37.5%) 364 418 (37.4%) !0.02% (!0.01% to 0.09%)
   Full secondary 465 920 (19.0%) 177 561 (18.2%) !0.75% (!0.84% to !0.65%)
   Higher education 997 738 (40.7%) 402 799 (41.4%) 0.72% (0.61% to 0.84%)
Values are number (per cent), mean (±SD) or difference (95% CI) as appropriate.
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higher if they were born 1 or more weeks after their due 
date, in the unadjusted (OR 1.40 (95% CI 1.32 to 1.49)) 
and adjusted analysis (OR 1.34 (95% CI 1.26 to 1.42)), 
and also persisted in the model controlling for potential 
causal factors (OR 1.38 (95% CI 1.29 to 1.47)). The risk 
of a low (<7) 5 min Apgar score showed similar results (all 
comparisons; P<0.001). The population attributable risk 
fraction of infants who developed encephalopathy at, or 
after, 41 weeks gestation was 4.6%.
Using birth after the due date as an ordinal variable 
(eg, 1 week over at 41 weeks, 2 weeks at 42 weeks, etc) 
demonstrated similar results to the main analysis: for 
each week after the due date that the infant stayed in 
utero, there was an associated increase in the risk of 
developing neonatal encephalopathy (OR 1.22 (95% CI 
1.18 to 1.27)).
Repeating the model after restricting to well-grown 
infants (OR 1.36 (95% CI 1.28 to 1.46)) or to the most 
recent 10 years of data (OR 1.35 (95% CI 1.20 to 1.52)) 
provided very similar results.
There was evidence that maternal age modified 
the association between later birth and encephalop-
athy (P=0.022). Mothers aged 35 years and older had 
a higher risk that birth !41 weeks would result in an 
infant with encephalopathy (OR 1.67 (95% CI 1.40 to 
1.98)) compared with those who were younger than 
35 (OR 1.34 (95% CI 1.25 to 1.43)). A multiple impu-
tation model including all infants with exposure and 
outcome date (n=7 17 801, adjusted OR 1.41 (95% CI 
1.31 to 1.51)) also produced similar results to the main 
analysis. A final, post hoc analysis was performed due 
to the possible non-linear association of gestational age 
and encephalopathy. Infants were split by gestation age 
into three exposure groups; early (37/38 weeks), within 
7 days of the due date (39/40 weeks) and late (!41 
weeks). Infants born at 37/38 weeks (OR 1.30 (95% CI 
1.20 to 1.40) and !41 weeks (OR 1.50 (95% CI 1.40 to 
1.60)) both demonstrated higher risks of encephalop-
athy than those born within 7 days of their due date in 
the unadjusted analysis, but the effect was only seen in 
those !41 weeks after correction for potential confounders 
(OR 1.01 (95% CI 0.93 to 1.10) and OR 1.38 (95% CI 
1.29 to 1.48), respectively).
DISCUSSION
We have demonstrated, in a large population-based 
dataset, that the risks of developing perinatal encepha-
lopathy increases significantly for each week that preg-
nancies continue after their due date. Assuming that 
gestational age is accurately assessed and intrapartum 
care of pregnancies is similar for the gestational age at 
birth, then this effect may be readily preventable if this 
association is causal. Indeed, sensitivity analysis suggests 
that the relative risk of encephalopathy increases by an 
estimated 20% per week among infants that remain in 
utero after their due date (compared with infants born 
at, or before it). The association appeared robust, as it 
was observed in the most recent data, in younger and 
older mothers and in well-grown infants.
Limitations of this work include the use of routine 
data, and the number of infants excluded from the 
analysis due to missing data points. Likely perinatal 
encephalopathy was defined using available neonatal 
ICD codes consistent with our previous work,6 but may 
also include infants with other neurological disease, 
Figure 1 Mean Apgar scores, split by gestational age at birth.
group.bmj.com on February 2, 2018 - Published by http://bmjpaedsopen.bmj.com/Downloaded from 
 


































5Odd!DE, et!al. BMJ Paediatrics Open 2018;2:e000010. doi:10.1136/bmjpo-2017-000010
Open Access
and does not identify if the infants were admitted to 
a neonatal intensive care unit (NICU) or not. As a 
routine data source, it is difficult to use the ICD codes 
to further interrogate the individual reasons for the 
neurological signs and some uncertainty about the 
underlying biological causes, and the assumption that 
it can be reversed by earlier delivery must remain. 
Equally, we did not have information on the indication 
for operative deliveries or IOL; although this is likely to 
cause us to underestimate any impact of postdue date 
delivery and this use of routine data is likely to weaken 
any association seen due to misclassification. However, 
the birth registry is considered a robust source of infor-
mation, thus minimising any effect seen rather than 
introducing false positive findings. In particular, the 
measurement of gestational age in this cohort may 
be less accurate than modern measures available to 
clinicians and the methods used to derive it (initially 
clinical measure of last menstrual period, followed by 
ultrasound dating) have changed over the study period. 
However, while diagnostic criteria may have changed 
over the study period, the models used random effects 
to account in part for this, and results from the most 
recent years showed similar results to those from the 
whole cohort.
The groups of infants did appear to vary on a number 
of clinical factors (eg, infection risk), however, the 
cohort was large, and able to show differences in clin-
ical characteristics (eg, a 2–3 months difference in 
maternal age) of minor magnitude and of question-
able clinical significance. Overall, we saw little evidence 
for confounding in this work, but it should be noted 
that residual and uncontrolled confounding remain a 
limitation of any non-randomised study. With respect 
to missing data, we have attempted to investigate the 
impact using a multiple imputation technique, which 
produced almost identical results to the main analysis, 
although again, any interpretation of the results should 
consider this limitation.
This work suggests an increase in significant morbidity 
in infants born after more than 41 weeks gestation, and 
it seems plausible that the presumed deterioration in the 
in utero environment for the foetuses also contributes to 
the known risk of late stillbirth; possibly placental insuffi-
ciency. Alternatively we identified an increase in the risk 
of infection in the later-born infants (0.6% vs 0.4%) which 
may have contributed to seizures or low Apgar scores, 
although this association persisted after adjustment for 
it in the final model. It should be noted that infants over 
43 weeks gestation appeared to have slightly higher 1 min 
Apgar scores (but not 5 or 10 min) than other post-term 
infants. Whether this was a statistical imprecision due to 
the low numbers in these groups or evidence that the 
score may be a less reliable measure of birth condition 
than the later measures is unclear.
It seems possible that IOL or caesarean section at 
40 weeks gestation may improve morbidity and mortality, 
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this work. However, early birth particularly by caesarean 
section is not without risk; in addition to respiratory 
morbidity, recent work suggests poorer long-term cogni-
tive outcomes may occur for infants born just 2 weeks 
early,8 although we were unable to demonstrate a higher 
risk of encephalopathy in infants born before 38 weeks 
(after adjustment for confounders).
There is particular concern with regard to the risks asso-
ciated with pregnancies continuing in older women,18 
and this work demonstrates a higher risk in women over 
35 years old. Furthermore, a recent interventional study 
for women aged over 35 years concluded that IOL at 
39 weeks of gestation, as compared with expectant 
management, had no significant effect on the rate of 
caesarean section and no adverse short-term effects on 
maternal outcomes. However, that study was underpow-
ered for neonatal outcomes.19 A recent systematic review 
demonstrating reductions in caesarean rates for women 
induced at term also showed that there was a reduced risk 
of fetal death and admission to NICUs with IOL.10
Despite these findings, there is no general consensus 
on whether IOL should be offered to all women at 
40 weeks gestation.11 12 Factors that should be considered 
before advocating such a recommendation would include 
the accuracy of the gestational age measurements, and 
impact of the induction process on a woman’s birth 
experience.14 Indeed, midwives or obstetricians may be 
reticent to recommend an earlier intervention for risk of 
over medicalising normal pregnancies. There may also 
be implications on workload and capacity if women were 
to accept earlier IOL.
The results from this study provide further evidence 
to support elective IOL during the 39th or 40th week 
of gestation. However, more randomised trials of IOL at 
40 weeks gestation versus expectant management need 
to be conducted to obtain prospective data on long-
term neonatal and maternal outcomes. More research 
is required in this area, including work looking at the 
role of membrane sweeping or more formal induction 
processes, as well as quantifying any long-term conse-
quences to the infant.
CONCLUSION
Singleton infants born at, or after, 41 weeks gestation 
have a higher risk of developing encephalopathy in the 
newborn period. Expediting birth at 40 weeks gestation, 
including IOL, could prevent a substantial proportion 
(up to 5% (based on the estimated population attribut-
able risk)) of all neonatal encephalopathy. These poor 
outcomes are more common the longer the pregnancy 
continues after the infants’ due date and they do not 
appear to be restricted to older mothers or low birthweight 
infants. While these results should not be viewed in isola-
tion, these data could usefully be provided to women as 
part of their decision-making with regard to IOL. Finally, 
further research is therefore needed to identify the path-
ways through which this effect is mediated, to ascertain 
appropriate intervention points and also establish the 
impact and risk/benefit ratio of pre-emptive birth.
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Table 3 Regression models for the association between birth after 40+6 weeks gestation with measures of birth condition
Measure 
Unadjusted Adjusted* Fully adjusted†
Mean difference (95% CI) Mean difference (95% CI) Mean difference (95% CI)
Apgar score
  1 min !0.13 (!0.13 to !0.13) !0.12 (!0.12 to !0.11) !0.12 (!0.12 to !0.11)
  5 min !0.05 (!0.06 to !0.05) !0.05 (!0.05 to !0.05) !0.05 (!0.05 to !0.05)
  10 min !0.03 (!0.03 to !0.02) !0.02 (!0.02 to !0.02) !0.03 (!0.03 to !0.02)
OR (95% CI) OR (95% CI) OR (95% CI)
Low (<7) Apgar score at 5 min 1.36 (1.33 to 1.40) 1.31 (1.28 to 1.34) 1.45 (1.41 to 1.48)
Encephalopathy 1.40 (1.32 to 1.49) 1.34 (1.26 to 1.42) 1.38 (1.29 to 1.47)
Data are mean difference (95% CI) or OR (95% CI) for each increasing week of gestational age at birth.
All P values are <0.001.
*Adjusted for sex, parity, maternal age, maternal education and maternal occupation.
†Adjusted for maternal pre-eclampsia, multiple birth, caesarean section, birth weight, maternal infection and infant infection.
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Thesis appendix  
 496 
Question to Secretary of State for Health 
A question I asked our local Member of Parliament was submitted for the Secretary of 
State for Health to answer.  
 
